data_2fnb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fnb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.58 134.77 33.96 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.724 1.616 . . . . 0.0 109.803 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -112.64 160.96 17.36 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.031 2.132 . . . . 0.0 108.577 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.7 mt -70.05 87.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.133 0.973 . . . . 0.0 108.686 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.54 -3.9 30.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.468 1.107 . . . . 0.0 111.249 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.57 6.79 15.91 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.62 1.968 . . . . 0.0 112.937 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -52.23 110.99 0.55 Allowed 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.243 1.417 . . . . 0.0 109.172 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.9 m -155.15 165.14 37.61 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.984 0.914 . . . . 0.0 111.964 170.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.1 m-30 -110.95 149.97 29.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.198 1.399 . . . . 0.0 109.626 -162.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.93 175.76 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 128.248 2.619 . . . . 0.0 108.207 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 t70 46.1 52.91 9.78 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.827 2.051 . . . . 0.0 110.618 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.2 52.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 127.361 2.265 . . . . 0.0 108.468 -166.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -77.31 175.2 9.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 110.125 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.61 -5.53 53.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.316 1.046 . . . . 0.0 111.455 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.6 p -122.72 -8.33 8.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.63 1.972 . . . . 0.0 114.732 -162.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -175.11 175.01 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.04 2.536 . . . . 0.0 108.014 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.9 123.13 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 134.94 11.88 Favored Glycine 0 N--CA 1.467 0.75 0 O-C-N 120.415 -1.428 . . . . 0.0 110.043 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.81 155.43 20.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.845 1.322 . . . . 0.0 108.248 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.01 145.27 50.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 162.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 17.0 p90 -157.79 173.64 16.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.526 1.131 . . . . 0.0 109.472 166.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.0 m -90.99 142.6 27.56 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.642 1.11 . . . . 0.0 108.561 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -81.45 125.26 5.0 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.004 1.037 . . . . 0.0 111.997 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.22 88.65 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.209 1.804 . . . . 0.0 110.431 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -79.73 40.49 0.45 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.755 -0.591 . . . . 0.0 111.077 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -35.03 -64.26 0.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.1 p 159.31 -22.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 128.745 2.818 . . . . 0.0 112.761 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.06 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.592 -1.317 . . . . 0.0 111.273 -153.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 tt -43.27 144.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 109.479 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -83.88 -49.47 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.38 -158.2 28.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.51 140.38 52.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 166.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.8 112.46 20.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.56 144.34 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.6 m -131.51 152.59 50.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 145.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 123.8 0.84 . . . . 0.0 111.674 165.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.44 164.47 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.57 99.84 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.425 0 C-N-CA 124.43 1.092 . . . . 0.0 109.475 -177.19 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 118.78 -0.629 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.77 165.24 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.96 2.44 . . . . 0.0 109.718 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -122.81 -82.79 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -148.44 163.55 36.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.579 1.081 . . . . 0.0 109.774 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.77 123.82 48.1 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 164.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -106.61 156.62 18.4 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.13 1.772 . . . . 0.0 108.126 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.86 153.73 45.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.817 0.847 . . . . 0.0 109.212 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.32 -176.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.81 -61.5 1.76 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.618 -157.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p 154.19 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 131.14 3.776 . . . . 0.0 109.902 -172.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -123.62 7.55 8.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.904 2.082 . . . . 0.0 111.926 -163.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -74.48 139.31 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 109.638 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.59 -5.65 18.33 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 123.996 0.807 . . . . 0.0 114.638 158.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -139.68 121.12 15.06 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.848 -1.383 . . . . 0.0 110.108 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -134.15 167.41 20.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.5 m -142.24 118.54 10.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.626 -1.296 . . . . 0.0 108.256 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -84.48 143.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 -171.83 2.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.15 69.29 Favored Glycine 0 CA--C 1.522 0.476 0 O-C-N 120.772 -1.205 . . . . 0.0 112.166 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.67 165.34 18.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.809 0.804 . . . . 0.0 110.589 165.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -134.3 135.09 23.38 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 126.731 2.012 . . . . 0.0 107.879 159.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.84 165.44 25.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.376 2.05 . . . . 0.0 112.451 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.22 -28.6 8.58 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 126.906 2.193 . . . . 0.0 111.746 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.2 mm -115.67 165.19 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -96.09 143.0 27.61 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -123.74 128.05 49.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.36 95.2 9.92 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -84.95 104.5 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m -88.09 147.87 24.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.26 1.024 . . . . 0.0 110.313 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.9 t -145.46 77.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.33 133.92 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.6 m -94.47 136.96 34.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.48 113.53 12.59 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.609 1.164 . . . . 0.0 107.95 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -109.3 -175.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.117 1.767 . . . . 0.0 108.696 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -34.58 104.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.092 1.357 . . . . 0.0 110.848 163.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.69 29.25 5.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.61 1.576 . . . . 0.0 115.005 170.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.37 144.48 9.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.342 1.571 . . . . 0.0 110.925 -173.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -110.78 142.12 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.763 2.025 . . . . 0.0 106.534 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.79 174.41 10.46 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.84 0.746 . . . . 0.0 109.362 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.59 135.86 92.82 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.2 128.98 22.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 N-CA-C 107.805 -1.652 . . . . 0.0 107.805 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 m -122.6 99.4 6.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.9 m -94.23 163.41 13.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.4 mt -132.87 136.16 46.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 164.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 m -84.74 127.87 34.32 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.641 1.976 . . . . 0.0 106.23 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -154.86 147.4 24.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.766 1.166 . . . . 0.0 109.301 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.62 168.01 11.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.293 1.044 . . . . 0.0 110.638 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.251 1.133 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.903 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.99 143.93 20.94 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.174 2.582 . . . . 0.0 111.705 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 174.68 7.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.432 1.893 . . . . 0.0 111.795 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.6 mt -77.64 85.39 3.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 166.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m -56.28 -35.29 67.31 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.582 -0.698 . . . . 0.0 110.201 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -74.21 5.99 3.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.484 2.314 . . . . 0.0 113.006 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.07 110.71 0.87 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.178 0.991 . . . . 0.0 111.075 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -125.89 164.45 20.74 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.86 0.864 . . . . 0.0 110.28 162.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 10.5 m-85 -90.73 166.16 13.28 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 155.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 177.21 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 127.287 2.235 . . . . 0.0 105.48 168.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.25 56.98 5.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.172 1.389 . . . . 0.0 110.355 161.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mm -78.77 59.82 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -69.07 173.63 5.33 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.408 -1.432 . . . . 0.0 109.945 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -98.88 22.11 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.649 1.179 . . . . 0.0 111.675 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -121.47 -13.73 8.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.263 1.425 . . . . 0.0 114.491 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p 170.48 171.96 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.032 2.133 . . . . 0.0 107.928 -154.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -137.44 147.63 26.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 166.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.53 163.74 23.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.12 159.25 36.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.399 1.48 . . . . 0.0 108.515 168.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -143.66 136.04 26.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -154.66 -177.5 6.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.267 1.027 . . . . 0.0 109.667 172.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -107.11 106.13 57.48 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.41 130.99 28.36 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.0 1.8 . . . . 0.0 110.029 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 31' ' ' SER . 2.2 mt -94.18 89.26 5.91 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.845 2.458 . . . . 0.0 105.018 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.55 50.38 0.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 29' ' ' LEU . 4.2 m -81.85 124.16 29.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.082 1.753 . . . . 0.0 109.847 168.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -63.39 38.52 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 130.159 3.384 . . . . 0.0 114.786 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -169.27 -12.42 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.823 2.049 . . . . 0.0 110.371 -171.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.62 161.06 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.091 1.356 . . . . 0.0 108.809 162.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.91 -59.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.71 -164.73 33.39 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -131.21 145.39 51.91 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.83 130.16 56.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.924 1.69 . . . . 0.0 106.975 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.63 133.15 61.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.7 m -128.67 138.56 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.82 123.23 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.487 1.515 . . . . 0.0 108.335 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.19 163.44 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 124.025 0.828 . . . . 0.0 109.304 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 106.24 17.52 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.313 0 C-N-CA 125.499 1.52 . . . . 0.0 109.089 -175.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.57 126.85 13.93 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 122.175 1.917 . . . . 0.0 107.494 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 mm -84.06 -82.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -148.21 175.68 10.86 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.023 -1.048 . . . . 0.0 109.763 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.11 159.83 31.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -148.96 164.86 33.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.622 1.969 . . . . 0.0 107.465 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 153.82 43.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.341 0.656 . . . . 0.0 109.602 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -177.38 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.916 0.78 . . . . 0.0 110.752 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.0 -60.45 2.29 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p 153.64 -41.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 1 C-N-CA 132.504 4.322 . . . . 0.0 107.878 -171.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.6 p -102.48 -1.13 31.2 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.965 1.706 . . . . 0.0 112.902 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.36 129.81 36.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.759 1.223 . . . . 0.0 108.24 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.78 -5.92 21.66 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 125.268 1.413 . . . . 0.0 113.315 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -140.25 116.15 10.33 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.301 1.44 . . . . 0.0 108.321 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.4 136.59 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.3 m -112.19 124.79 53.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.13 165.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.98 1.712 . . . . 0.0 107.629 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.15 -174.29 3.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.45 36.46 30.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.089 0.859 . . . . 0.0 112.536 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.03 162.84 13.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.934 1.293 . . . . 0.0 110.449 171.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.93 135.19 10.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.95 2.5 . . . . 0.0 104.916 162.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.91 170.29 18.3 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.754 2.303 . . . . 0.0 113.099 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.49 -4.83 70.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.772 0.701 . . . . 0.0 113.848 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.9 mm -129.44 147.79 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.944 1.698 . . . . 0.0 106.885 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -84.01 142.85 30.18 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.78 113.69 11.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.301 1.84 . . . . 0.0 106.432 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.402 ' CG ' ' HG1' ' A' ' 92' ' ' THR . 1.6 m-20 -84.21 103.17 13.19 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.921 1.688 . . . . 0.0 107.086 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.401 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 1.5 mp -92.23 107.7 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 80.7 p -92.78 143.56 26.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.289 1.036 . . . . 0.0 110.957 172.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.46 119.19 16.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mt -117.83 129.67 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.0 m -89.77 132.43 35.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.72 126.74 48.14 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.19 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.69 108.72 0.07 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.476 1.91 . . . . 0.0 110.339 169.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.75 26.13 1.05 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.741 1.638 . . . . 0.0 115.543 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.03 159.44 28.04 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.69 1.745 . . . . 0.0 111.688 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.61 141.6 49.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.137 1.775 . . . . 0.0 108.645 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -85.32 -172.62 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.741 0.816 . . . . 0.0 110.252 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.91 136.03 93.23 Favored Pre-proline 0 C--O 1.24 0.578 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.427 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.2 87.45 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.031 3.154 . . . . 0.0 108.482 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.2 m -84.72 92.13 8.12 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -164.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 1.4 m -94.56 150.4 20.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 69.8 mt -134.88 144.47 47.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 160.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.402 ' HG1' ' CG ' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -125.23 129.2 49.59 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -153.57 130.41 10.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 107.573 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.07 137.5 38.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.593 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.38 141.69 39.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.683 1.588 . . . . 0.0 109.429 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.08 161.53 15.81 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.127 2.171 . . . . 0.0 110.404 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.3 mt -66.93 83.89 0.11 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.132 0.973 . . . . 0.0 109.375 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 m -71.91 1.0 7.82 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.884 1.674 . . . . 0.0 111.175 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -111.74 4.34 18.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.317 2.647 . . . . 0.0 111.693 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.67 114.81 4.21 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.563 1.945 . . . . 0.0 110.195 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -151.11 164.84 35.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.617 0.767 . . . . 0.0 111.19 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.434 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 10.3 m-30 -97.29 160.12 14.52 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.511 -0.743 . . . . 0.0 109.212 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.4 170.6 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.841 1.656 . . . . 0.0 107.526 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.7 47.83 17.69 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.836 1.654 . . . . 0.0 109.706 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -80.45 63.01 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -72.18 165.05 25.17 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -74.51 -3.05 28.53 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.331 -0.856 . . . . 0.0 111.212 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -105.51 -16.17 14.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.05 153.18 0.22 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 127.212 2.205 . . . . 0.0 107.924 -169.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.7 138.39 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.79 156.6 23.14 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 171.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.415 HD12 ' CD2' ' A' ' 62' ' ' TYR . 2.1 mp -122.59 154.52 37.84 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -137.8 139.93 40.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -152.95 175.0 13.42 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.073 0.949 . . . . 0.0 108.555 167.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -92.36 107.49 24.0 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.019 1.327 . . . . 0.0 108.094 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.3 134.68 49.87 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.991 -1.196 . . . . 0.0 108.991 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -88.88 -30.04 19.18 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.425 -1.274 . . . . 0.0 112.867 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 p30 42.43 37.69 1.02 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.607 1.192 . . . . 0.0 112.298 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -62.43 170.24 2.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 0.0 110.139 -167.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 p -67.66 -2.2 6.47 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.08 -4.16 0.06 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.401 -1.437 . . . . 0.0 112.925 -164.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.77 145.22 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 163.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.61 -65.94 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 160.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.61 -154.15 12.37 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -163.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -136.24 144.01 44.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -118.9 123.13 43.9 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mp -103.83 146.87 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 m -145.77 112.45 5.94 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.338 1.455 . . . . 0.0 108.699 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.14 131.69 43.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.718 0.807 . . . . 0.0 110.703 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.2 164.23 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.75 114.21 20.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 125.285 1.434 . . . . 0.0 113.315 -177.413 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 mt . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.28 124.02 8.14 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.932 2.421 . . . . 0.0 110.111 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.29 -59.63 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.9 169.22 18.45 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.193 0.906 . . . . 0.0 110.787 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -106.83 157.0 18.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.411 1.484 . . . . 0.0 108.4 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -152.42 166.06 33.12 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.314 1.446 . . . . 0.0 107.828 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.76 161.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.854 1.262 . . . . 0.0 109.979 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.91 -176.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.768 1.627 . . . . 0.0 107.744 172.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -83.69 -61.96 1.7 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.971 -162.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.6 t 155.23 -43.07 0.01 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 130.534 3.534 . . . . 0.0 107.868 -166.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -97.86 -5.73 33.99 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.242 1.417 . . . . 0.0 113.816 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.89 126.05 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.33 -5.58 37.08 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 127.591 2.519 . . . . 0.0 111.637 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -137.76 114.22 10.31 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.296 -1.708 . . . . 0.0 110.573 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.415 ' CD2' HD12 ' A' ' 24' ' ' LEU . 7.4 t80 -139.21 159.24 42.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.315 1.846 . . . . 0.0 107.719 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -147.08 151.21 36.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.04 145.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -168.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.36 -176.4 3.5 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.8 68.75 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 113.565 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.02 144.67 56.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -123.45 98.11 41.45 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.37 166.07 29.57 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.188 1.925 . . . . 0.0 112.609 -159.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.21 -4.67 80.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.001 1.286 . . . . 0.0 113.436 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.44 152.21 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -79.0 111.58 15.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.35 124.44 52.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.14 1.376 . . . . 0.0 109.389 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.33 126.58 33.33 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 169.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.434 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 3.0 mp -110.52 96.43 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.76 133.1 34.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.617 1.567 . . . . 0.0 108.617 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.9 130.5 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -134.85 147.75 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.7 m -94.24 137.69 33.12 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.73 128.43 55.27 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.379 . . . . 0.0 107.541 -175.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 pt -134.23 177.27 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.966 0.906 . . . . 0.0 108.588 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.69 110.43 0.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.821 0.848 . . . . 0.0 111.264 169.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.74 21.72 7.53 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.488 1.994 . . . . 0.0 114.708 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 157.33 29.75 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 119.583 1.691 . . . . 0.0 110.992 -161.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.041 0.937 . . . . 0.0 109.9 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 m -84.3 -172.6 4.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.03 0.919 . . . . 0.0 111.015 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.63 96.24 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.19 130.49 16.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.268 1.979 . . . . 0.0 108.783 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.2 m -103.61 107.92 18.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 165.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.9 m -111.93 84.69 2.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 mt -77.64 153.04 33.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.77 139.76 50.26 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -147.88 130.42 15.85 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.939 0.896 . . . . 0.0 109.725 157.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.49 122.47 21.34 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 154.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.017 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.7 t . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.0 133.46 8.97 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.608 2.872 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.46 174.89 6.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.75 1.22 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.5 mt -67.9 75.85 0.21 Allowed 'General case' 0 C--N 1.34 0.152 0 C-N-CA 125.988 1.715 . . . . 0.0 109.523 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.8 m -54.13 -27.24 32.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.748 1.619 . . . . 0.0 110.465 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.51 -0.29 49.63 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 114.759 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.0 115.51 2.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.317 1.047 . . . . 0.0 110.904 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.4 165.19 28.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.338 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -117.57 154.06 32.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 108.341 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.78 171.19 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.061 1.744 . . . . 0.0 107.782 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 51.11 52.15 15.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.24 1.816 . . . . 0.0 110.767 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -78.83 55.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.923 2.489 . . . . 0.0 108.591 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -69.12 167.31 16.35 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.449 -1.407 . . . . 0.0 111.451 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -74.61 6.04 4.23 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.427 1.491 . . . . 0.0 111.846 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -125.7 -12.7 6.57 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 p -174.89 159.73 2.76 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.702 1.201 . . . . 0.0 109.42 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 tt -118.21 141.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.16 153.97 21.66 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.72 151.36 39.64 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 126.309 1.844 . . . . 0.0 107.81 169.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -142.32 138.18 31.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -154.13 -170.87 3.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.547 0.689 . . . . 0.0 109.308 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -106.05 105.53 53.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.773 1.229 . . . . 0.0 107.795 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -66.05 133.96 35.19 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.077 1.851 . . . . 0.0 110.841 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mp -94.93 104.58 16.47 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 125.893 1.677 . . . . 0.0 109.833 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.33 41.44 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.015 1.326 . . . . 0.0 110.532 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.6 m -65.3 155.29 35.69 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 160.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -77.5 -50.25 13.03 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.581 0.705 . . . . 0.0 110.791 166.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.39 -24.5 57.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.091 1.357 . . . . 0.0 113.272 -161.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.31 136.51 6.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 126.573 1.949 . . . . 0.0 108.247 171.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.35 -64.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.18 -161.88 26.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.47 146.42 50.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 127.35 46.13 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.07 145.62 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.8 m -134.89 121.35 20.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.4 125.9 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.64 164.31 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 129.92 38.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.457 0 O-C-N 121.725 -0.61 . . . . 0.0 110.134 166.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 mt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.93 156.4 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.51 1.473 . . . . 0.0 109.308 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 mm -93.64 -80.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 166.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -156.39 175.8 13.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.464 1.506 . . . . 0.0 109.659 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -126.72 161.96 26.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.207 1.003 . . . . 0.0 109.587 168.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.445 ' CG ' ' HH ' ' A' ' 62' ' ' TYR . 2.0 p30 -150.81 167.11 28.47 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.674 1.59 . . . . 0.0 110.458 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.44 160.16 32.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.743 1.217 . . . . 0.0 109.056 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -177.77 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.65 -61.5 1.82 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -157.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.0 p 166.29 -29.42 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 130.546 3.538 . . . . 0.0 111.42 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -136.26 28.37 3.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.408 0.623 . . . . 0.0 111.298 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -73.36 136.51 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.19 -5.15 17.54 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 124.221 0.915 . . . . 0.0 113.822 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -145.5 128.17 16.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 106.612 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.445 ' HH ' ' CG ' ' A' ' 53' ' ' ASP . 17.0 t80 -139.56 159.83 41.26 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.968 -1.082 . . . . 0.0 108.892 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.0 m -131.92 136.68 47.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.634 1.174 . . . . 0.0 108.645 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.13 131.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 126.404 1.882 . . . . 0.0 106.201 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -99.95 -167.76 1.5 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 165.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.7 32.2 61.79 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 121.013 -1.055 . . . . 0.0 110.95 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.25 157.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 107.968 166.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -144.7 119.93 5.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.11 175.54 6.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -167.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.53 61.44 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.154 -0.803 . . . . 0.0 114.217 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mm -118.01 149.95 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.1 141.02 34.71 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.67 120.74 31.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.756 2.022 . . . . 0.0 108.209 -166.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.59 106.17 15.95 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.48 108.21 20.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -93.58 139.28 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 109.178 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.39 109.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -106.64 134.17 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 m -94.66 134.56 37.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.17 129.1 51.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 107.73 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 pt -116.63 179.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -39.64 112.75 0.28 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 118.36 -0.829 . . . . 0.0 109.577 169.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.79 60.7 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 C-N-CA 127.054 2.264 . . . . 0.0 113.381 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -166.91 144.97 9.47 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -122.99 140.58 52.88 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.107 1.363 . . . . 0.0 108.018 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -84.82 -170.5 3.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.707 0.765 . . . . 0.0 110.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.83 134.73 96.13 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 160.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.77 107.56 2.47 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.33 2.686 . . . . 0.0 110.566 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 106.62 16.33 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -175.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.5 m -115.29 132.88 56.47 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 mt -124.83 107.44 10.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.06 144.6 33.03 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.702 1.601 . . . . 0.0 108.955 174.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -165.63 160.63 17.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.971 0.909 . . . . 0.0 110.738 163.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -93.19 112.37 24.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.255 1.344 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -169.816 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.74 121.1 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.52 2.147 . . . . 0.0 109.677 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.65 ' NE2' ' HG1' ' A' ' 89' ' ' THR . 0.0 OUTLIER -76.41 171.05 15.23 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.615 0.766 . . . . 0.0 109.908 163.265 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.0 mt -76.35 86.13 3.12 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -60.61 -20.31 60.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.117 0.567 . . . . 0.0 111.762 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.85 1.85 57.07 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.896 1.226 . . . . 0.0 112.255 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -54.29 116.23 2.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.225 1.41 . . . . 0.0 110.547 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -142.98 159.24 42.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.639 1.576 . . . . 0.0 109.648 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -106.84 155.17 20.02 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.74 173.21 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 129.13 2.972 . . . . 0.0 108.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.9 58.87 3.4 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.434 1.094 . . . . 0.0 111.689 171.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 mm -76.1 48.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 108.269 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -69.76 166.99 18.1 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.745 -1.222 . . . . 0.0 108.898 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.95 -4.76 37.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.353 -1.467 . . . . 0.0 112.211 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 p -119.56 -10.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.233 1.813 . . . . 0.0 114.79 -168.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.81 168.36 2.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.618 1.167 . . . . 0.0 109.916 -167.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.1 tt -135.98 135.05 50.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.6 162.58 26.78 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 HD11 ' CD2' ' A' ' 62' ' ' TYR . 2.7 mp -135.2 148.54 49.69 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.922 1.289 . . . . 0.0 108.42 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.36 145.55 51.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 164.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -153.97 179.94 8.44 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -100.42 141.87 23.54 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -75.95 123.92 7.67 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.525 1.483 . . . . 0.0 109.06 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.06 -41.09 26.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.091 0.957 . . . . 0.0 112.697 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 37.86 48.61 1.03 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.282 1.833 . . . . 0.0 113.175 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 m -54.26 -62.84 1.4 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.501 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 p -178.45 -104.45 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.39 1.076 . . . . 0.0 108.824 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.1 -4.4 44.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.936 2.095 . . . . 0.0 110.268 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.21 128.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 126.797 2.039 . . . . 0.0 112.857 173.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.49 -61.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.7 -160.89 25.53 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.142 -1.027 . . . . 0.0 112.277 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -130.39 139.68 50.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 114.52 20.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -92.69 144.62 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.2 m -138.39 127.85 24.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.3 144.87 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 118.731 0.696 . . . . 0.0 110.081 163.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.51 164.79 30.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 167.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.06 125.1 28.85 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.144 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -89.87 157.51 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.869 2.38 . . . . 0.0 110.757 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mm -133.43 65.76 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.432 1.9 p90 54.59 175.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.909 1.284 . . . . 0.0 114.318 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.14 125.32 36.83 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -105.45 163.63 12.49 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.83 162.41 31.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.015 1.326 . . . . 0.0 107.984 175.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.38 -177.35 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 171.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.42 -66.07 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.297 0.639 . . . . 0.0 110.876 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 157.22 -41.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 128.452 2.701 . . . . 0.0 108.534 -157.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -121.35 15.71 11.33 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.449 -1.407 . . . . 0.0 110.024 -164.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -74.85 141.26 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.746 0.818 . . . . 0.0 110.325 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.48 0.49 14.1 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.431 1.491 . . . . 0.0 114.473 160.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -145.55 128.38 16.34 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.654 1.227 . . . . 0.0 110.077 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 24' ' ' LEU . 13.7 t80 -149.59 169.06 21.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.654 1.182 . . . . 0.0 109.802 -176.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -151.49 140.35 20.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.616 1.567 . . . . 0.0 109.842 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.58 152.62 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 125.941 1.696 . . . . 0.0 108.147 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.446 ' CG2' ' H ' ' A' ' 66' ' ' GLY . 22.1 m -134.45 -170.1 2.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.922 1.689 . . . . 0.0 106.627 172.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.446 ' H ' ' CG2' ' A' ' 65' ' ' THR . . . 67.64 25.75 73.89 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.045 -1.034 . . . . 0.0 111.911 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.75 164.73 21.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.24 1.816 . . . . 0.0 108.744 164.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.03 104.61 10.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.624 2.37 . . . . 0.0 107.523 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.17 140.2 44.28 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.427 2.085 . . . . 0.0 112.41 -163.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.27 -8.26 55.16 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 126.51 2.005 . . . . 0.0 112.711 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.8 158.52 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 162.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -98.74 129.31 45.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.35 1.86 . . . . 0.0 106.901 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -120.24 133.85 55.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.162 0.985 . . . . 0.0 108.745 -170.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.29 116.45 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 160.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.82 104.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -92.81 145.02 24.71 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.338 1.455 . . . . 0.0 111.177 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.2 t -145.18 97.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.2 mt -100.74 129.76 51.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.4 m -92.99 125.98 37.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.44 123.35 39.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.667 1.587 . . . . 0.0 108.478 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.85 -164.85 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.159 1.383 . . . . 0.0 109.463 -170.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -39.56 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.551 0.74 . . . . 0.0 111.964 157.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.1 31.35 4.36 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.437 1.97 . . . . 0.0 114.306 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.66 144.59 11.83 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 119.162 1.481 . . . . 0.0 110.144 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.14 142.49 39.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.338 1.455 . . . . 0.0 108.447 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.18 -176.96 6.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.62 151.33 92.31 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.77 103.96 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.615 2.21 . . . . 0.0 108.471 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.65 ' HG1' ' NE2' ' A' ' 8' ' ' GLN . 1.5 m -84.06 97.92 9.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 171.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -122.87 126.31 47.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.36 143.28 47.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 m -100.82 110.33 22.4 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -108.35 123.45 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.207 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -75.51 134.12 40.86 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 149.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.345 1.458 . . . . 0.0 107.424 -178.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.24 128.51 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.498 2.132 . . . . 0.0 111.591 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -104.77 178.09 4.66 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 127.776 2.431 . . . . 0.0 110.356 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.04 83.32 5.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.326 1.05 . . . . 0.0 110.232 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -65.03 -21.35 66.82 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.76 1.624 . . . . 0.0 113.561 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -97.85 8.38 44.81 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.06 1.744 . . . . 0.0 111.633 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.22 102.25 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 109.299 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -135.74 132.01 36.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.53 1.132 . . . . 0.0 109.194 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.81 157.14 35.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.09 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.422 1.089 . . . . 0.0 108.672 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 49.92 44.58 25.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.921 1.688 . . . . 0.0 109.689 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.74 65.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 129.493 3.117 . . . . 0.0 106.762 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -57.96 166.99 1.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.494 1.517 . . . . 0.0 109.717 162.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.85 3.39 8.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.391 1.476 . . . . 0.0 112.517 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 p -117.51 -13.66 10.31 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -172.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.14 161.96 0.78 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.547 1.539 . . . . 0.0 110.088 -162.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 tt -130.22 125.85 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.81 159.2 34.27 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -136.71 138.96 41.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 126.698 1.999 . . . . 0.0 107.422 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.3 mtp-105 -112.12 157.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 160.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -162.02 -173.75 3.81 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.982 2.513 . . . . 0.0 106.98 160.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.78 142.15 24.19 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 120.682 1.583 . . . . 0.0 107.885 171.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -75.13 124.41 8.52 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.673 1.582 . . . . 0.0 108.631 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 31' ' ' SER . 14.2 mt -89.68 83.18 6.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -75.76 43.55 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.629 0.649 . . . . 0.0 111.344 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 29' ' ' LEU . 10.4 p -47.86 -60.73 2.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.404 1.082 . . . . 0.0 113.393 -165.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 p 165.99 -61.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.109 0.964 . . . . 0.0 110.141 -152.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.48 -3.46 0.72 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.541 1.936 . . . . 0.0 109.52 -156.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.12 121.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.86 1.664 . . . . 0.0 110.71 164.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 -56.22 5.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.32 -160.55 21.1 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.88 151.31 49.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 164.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 114.85 20.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.905 1.682 . . . . 0.0 107.501 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.49 142.57 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -145.4 113.18 6.38 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.43 130.57 56.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.175 1.39 . . . . 0.0 109.982 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 164.01 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.28 109.17 20.27 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 126.428 1.891 . . . . 0.0 111.425 -170.186 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.2 mt . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 119.438 -0.315 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.65 156.3 35.72 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.077 2.518 . . . . 0.0 108.927 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.52 -61.86 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 166.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -160.49 158.67 29.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.447 0.699 . . . . 0.0 109.681 -163.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.61 141.75 30.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -143.84 166.59 24.49 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.85 1.26 . . . . 0.0 110.652 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.53 154.65 47.59 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.417 -1.72 . . . . 0.0 106.868 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -176.91 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.451 1.101 . . . . 0.0 108.286 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.51 -63.11 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -165.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p 152.42 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.684 4.393 . . . . 0.0 107.736 -173.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.1 p -88.57 1.41 55.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.672 1.189 . . . . 0.0 112.625 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.12 134.56 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 125.366 1.466 . . . . 0.0 108.026 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.91 1.6 9.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 0.0 112.963 162.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -143.19 125.82 15.91 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.183 1.393 . . . . 0.0 107.782 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.49 165.1 28.42 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.5 m -141.72 125.8 17.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.99 152.96 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.862 1.665 . . . . 0.0 107.263 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -157.92 0.75 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 173.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.51 38.39 90.97 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 120.214 1.37 . . . . 0.0 112.353 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.21 154.92 30.3 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.18 1.792 . . . . 0.0 107.482 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.87 107.08 4.59 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 125.629 1.572 . . . . 0.0 107.285 -173.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.58 176.18 9.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.651 2.9 . . . . 0.0 113.454 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.53 4.38 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 124.705 1.145 . . . . 0.0 112.099 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.85 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -74.51 136.11 42.2 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.245 1.818 . . . . 0.0 108.894 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -122.39 141.58 51.43 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.86 111.05 22.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.42 101.49 12.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.1 m -94.91 144.53 25.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 110.504 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.9 t -139.55 98.3 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.29 139.83 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.8 m -105.37 133.83 49.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.51 127.73 41.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 pt -134.7 -167.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 110.319 -172.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -34.72 110.92 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.813 2.045 . . . . 0.0 110.531 166.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 27.26 51.8 0.08 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 127.547 2.498 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 160.59 31.06 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.22 1.01 . . . . 0.0 111.25 -163.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -144.88 145.19 31.48 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 127.057 2.143 . . . . 0.0 105.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.86 -176.21 4.37 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.06 147.21 80.9 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.95 99.09 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.308 2.005 . . . . 0.0 108.082 171.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -83.78 119.26 24.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -131.68 137.79 48.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.92 136.2 55.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -135.66 179.33 6.4 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -167.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 76.68 144.43 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.669 2.388 . . . . 0.0 107.591 -168.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -63.1 -84.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 108.832 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 C--O 1.242 0.673 0 C-N-CA 128.526 2.73 . . . . 0.0 112.573 -160.6 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.24 0.602 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.76 109.31 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.362 2.708 . . . . 0.0 109.533 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.84 157.62 17.8 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.246 1.818 . . . . 0.0 107.912 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.3 76.65 0.54 Allowed 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 m -57.86 -30.54 65.89 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.655 -0.653 . . . . 0.0 110.637 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.96 -0.44 31.03 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.156 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -53.85 125.67 19.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.993 0.917 . . . . 0.0 109.778 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -148.03 149.53 32.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.494 1.118 . . . . 0.0 109.802 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.447 ' CE2' ' HB ' ' A' ' 75' ' ' ILE . 16.1 m-30 -112.78 145.53 40.41 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.848 1.204 . . . . 0.0 107.876 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.71 170.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 125.877 1.671 . . . . 0.0 108.305 -170.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 53.06 44.64 30.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.852 1.661 . . . . 0.0 109.569 171.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.83 64.79 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.779 2.432 . . . . 0.0 107.731 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -77.02 164.54 25.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.897 0.879 . . . . 0.0 109.406 168.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.48 7.44 3.63 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.633 -1.292 . . . . 0.0 112.342 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -123.91 -13.82 7.28 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.033 -1.042 . . . . 0.0 113.74 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -175.33 160.59 2.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.829 2.452 . . . . 0.0 108.096 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.25 133.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.63 152.71 20.67 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mp -129.25 155.17 46.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.91 1.284 . . . . 0.0 109.286 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -139.69 151.72 46.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.477 1.111 . . . . 0.0 108.194 169.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -159.06 -165.41 1.6 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.059 1.344 . . . . 0.0 107.928 165.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -112.75 106.89 55.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.07 1.748 . . . . 0.0 107.491 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.14 124.31 10.39 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.518 2.145 . . . . 0.0 111.856 -174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mt -95.96 100.99 12.61 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.048 1.739 . . . . 0.0 107.481 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -80.47 40.98 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.22 0.608 . . . . 0.0 110.384 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -59.24 -35.53 73.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.009 -1.472 . . . . 0.0 114.704 -159.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 p 154.34 -98.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 128.901 2.881 . . . . 0.0 108.791 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.68 -4.02 47.03 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.058 2.543 . . . . 0.0 108.975 -172.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.49 125.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 128.043 2.537 . . . . 0.0 110.171 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.02 -57.98 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -168.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.93 -158.29 23.19 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -130.59 137.02 49.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 171.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.19 110.87 23.04 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 107.554 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -86.75 153.86 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m -144.29 147.88 34.09 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.65 2.38 . . . . 0.0 105.775 173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.53 130.27 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 123.581 0.752 . . . . 0.0 109.975 170.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.75 164.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.006 171.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.36 111.5 20.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.386 0 C-N-CA 125.298 1.439 . . . . 0.0 108.738 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mt . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 118.316 -0.849 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.73 137.65 30.34 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.54 1.493 . . . . 0.0 110.201 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -89.13 -73.52 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.3 175.42 13.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.661 0.743 . . . . 0.0 110.196 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.63 156.9 47.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 165.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -155.67 166.06 34.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.968 1.307 . . . . 0.0 107.505 -167.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.44 175.15 5.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.642 0.734 . . . . 0.0 109.932 -173.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.75 -177.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 156.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.25 -67.56 0.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.743 1.617 . . . . 0.0 112.941 -166.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.4 p 154.71 -20.41 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.568 3.147 . . . . 0.0 114.137 -165.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.3 p -142.34 26.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.449 1.477 . . . . 0.0 112.137 168.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.54 133.35 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.53 -3.27 27.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.779 1.657 . . . . 0.0 113.593 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.78 123.15 8.4 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.632 1.573 . . . . 0.0 107.248 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.84 164.62 27.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.489 1.116 . . . . 0.0 108.351 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -141.89 134.97 29.01 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.58 152.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.114 1.766 . . . . 0.0 107.059 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.43 171.43 11.56 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.33 24.71 33.15 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.516 1.055 . . . . 0.0 112.031 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.72 156.03 19.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.502 1.521 . . . . 0.0 108.547 163.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.15 134.55 16.79 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.611 1.964 . . . . 0.0 107.506 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.72 161.35 27.62 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.764 1.643 . . . . 0.0 114.33 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.09 64.49 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.271 1.415 . . . . 0.0 113.519 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.52 145.45 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.973 1.309 . . . . 0.0 108.201 -170.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -81.47 129.42 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.318 1.847 . . . . 0.0 106.031 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -117.34 128.18 54.79 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.26 88.44 7.49 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.447 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 2.7 mp -84.43 116.9 28.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.41 139.91 49.6 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.467 1.907 . . . . 0.0 107.916 -165.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.0 t -145.6 111.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -170.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.8 mt -105.43 144.71 14.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 m -105.14 142.79 34.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 166.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.65 118.4 19.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.175 1.79 . . . . 0.0 107.851 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 pt -117.17 -168.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.546 0.739 . . . . 0.0 110.184 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -48.98 105.35 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.531 165.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.53 35.25 15.59 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 124.653 1.121 . . . . 0.0 113.48 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.67 144.92 10.41 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -167.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.93 144.94 48.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 m -84.14 -165.36 1.13 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.47 163.0 18.73 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.077 -1.639 . . . . 0.0 108.627 168.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.75 108.79 2.34 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.835 1.69 . . . . 0.0 109.435 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.49 86.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.5 m -94.56 146.28 24.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 121.2 23.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 140.51 29.65 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -154.03 161.94 41.57 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.555 0.742 . . . . 0.0 109.219 161.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -97.66 173.12 7.29 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.462 1.105 . . . . 0.0 109.587 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 C--O 1.256 1.404 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 159.509 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.6 t . . . . . 0 C--O 1.239 0.549 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.01 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.669 2.246 . . . . 0.0 109.62 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -83.14 178.5 8.08 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.4 mt -77.72 91.56 4.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 161.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.7 p -61.09 -57.47 12.4 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.149 1.379 . . . . 0.0 108.687 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.9 18.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.045 2.538 . . . . 0.0 113.064 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.56 121.41 8.35 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.736 1.215 . . . . 0.0 108.994 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -154.49 164.89 37.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.056 1.742 . . . . 0.0 109.667 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -122.86 152.23 40.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.74 168.85 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.824 1.65 . . . . 0.0 108.501 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 46.72 63.49 1.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.938 2.095 . . . . 0.0 109.494 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.88 65.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -81.23 171.97 14.21 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.896 1.278 . . . . 0.0 109.762 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.09 -0.73 20.06 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p -125.47 -6.01 7.04 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.38 170.85 2.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.631 1.972 . . . . 0.0 108.711 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -132.8 131.78 59.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 162.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.15 149.85 28.3 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -123.33 151.3 42.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 106.362 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -136.18 145.03 45.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -156.91 -173.98 4.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.759 1.224 . . . . 0.0 108.9 168.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 m -109.09 106.19 58.39 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.7 123.6 9.94 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 121.543 1.495 . . . . 0.0 110.481 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -76.14 94.72 3.54 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.554 2.342 . . . . 0.0 105.186 166.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -77.66 38.87 0.26 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.991 0.916 . . . . 0.0 109.225 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 29' ' ' LEU . 29.2 m -74.34 -2.82 26.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -159.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p 70.53 -57.91 0.57 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.156 2.582 . . . . 0.0 113.629 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.39 -28.99 69.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 111.525 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.91 134.59 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.395 1.878 . . . . 0.0 109.825 170.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 mp -84.4 -65.05 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.82 -160.11 19.63 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -127.89 133.22 49.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.63 127.6 54.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 107.271 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.75 152.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 m -138.26 153.69 49.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.267 2.227 . . . . 0.0 106.417 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.36 126.82 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 125.378 1.471 . . . . 0.0 107.55 171.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.18 164.65 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.93 101.94 13.75 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 126.605 1.962 . . . . 0.0 112.389 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.6 mt . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.29 168.2 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.224 1.949 . . . . 0.0 109.015 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.2 mm -111.0 -73.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.502 -2.406 . . . . 0.0 104.502 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -160.14 175.52 12.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.711 1.605 . . . . 0.0 107.916 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.0 159.37 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -152.61 166.03 33.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.053 0.941 . . . . 0.0 110.437 -166.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.15 160.02 33.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.879 0.872 . . . . 0.0 110.302 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.89 -178.32 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 161.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -68.57 -71.3 0.22 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.929 0.871 . . . . 0.0 112.01 -156.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 p 177.07 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.917 3.287 . . . . 0.0 111.183 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -127.32 16.11 7.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.13 130.21 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.03 -6.13 32.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.226 0.917 . . . . 0.0 114.557 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -143.44 125.62 15.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.723 1.209 . . . . 0.0 108.957 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -139.45 160.6 39.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.235 1.414 . . . . 0.0 109.285 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.2 m -134.1 121.46 21.52 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.49 -1.381 . . . . 0.0 107.698 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.3 155.24 3.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 -168.62 1.92 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.866 1.267 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.37 9.96 84.44 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.798 -1.189 . . . . 0.0 113.327 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.5 157.6 30.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.73 133.24 9.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.3 -177.61 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.004 2.469 . . . . 0.0 112.762 -172.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.81 56.82 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.804 2.145 . . . . 0.0 112.199 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mm -131.5 152.14 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 126.416 1.886 . . . . 0.0 107.111 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -94.71 109.84 21.75 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -94.71 124.17 38.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.7 91.66 8.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.51 101.7 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.49 141.93 30.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.652 1.181 . . . . 0.0 109.609 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -140.79 116.19 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.347 0.0 OUTLIER -121.75 145.92 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.9 m -106.04 128.05 53.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.791 2.036 . . . . 0.0 108.179 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.2 123.71 38.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 0.0 108.925 -173.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 pt -116.61 -173.93 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.065 1.346 . . . . 0.0 109.653 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -34.74 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.394 1.878 . . . . 0.0 111.105 166.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.07 61.5 0.06 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.713 2.102 . . . . 0.0 111.707 -171.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.45 144.79 10.76 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -126.38 124.22 39.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.617 1.567 . . . . 0.0 107.108 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 169.94 13.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.97 134.86 95.91 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.259 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.1 136.2 55.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.535 2.157 . . . . 0.0 109.247 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.2 m -131.5 97.99 4.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.3 m -106.09 146.87 29.62 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.65 1.18 . . . . 0.0 107.916 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 104.79 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -75.01 115.55 14.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -109.03 137.5 46.84 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.396 1.478 . . . . 0.0 113.491 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.22 163.18 15.11 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.229 . . . . 0.0 111.379 173.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.25 1.12 0 C-N-CA 129.176 2.991 . . . . 0.0 106.231 161.365 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.65 136.44 33.3 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.156 1.904 . . . . 0.0 110.116 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -95.48 168.21 10.84 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.206 0.602 . . . . 0.0 110.186 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.89 80.22 2.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 m -66.3 -20.98 66.25 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.855 0.462 . . . . 0.0 110.239 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.15 7.31 22.25 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.56 -1.337 . . . . 0.0 113.061 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.46 120.73 12.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 110.438 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -136.55 164.98 26.92 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.817 1.247 . . . . 0.0 111.186 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -109.11 151.99 25.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 168.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.0 168.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.73 1.612 . . . . 0.0 107.393 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 42.07 61.54 1.92 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.425 1.89 . . . . 0.0 110.904 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.74 57.15 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.148 1.779 . . . . 0.0 108.441 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -84.83 170.87 12.74 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.891 1.276 . . . . 0.0 110.682 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.19 2.31 9.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.635 1.574 . . . . 0.0 112.079 -174.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 p -125.53 -16.04 5.93 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.831 1.652 . . . . 0.0 114.786 -163.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -178.17 153.69 0.8 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.449 1.9 . . . . 0.0 108.096 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tt -108.55 132.3 56.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.55 158.35 28.53 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 171.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.471 HD11 ' CD2' ' A' ' 62' ' ' TYR . 2.8 mp -132.75 152.1 51.84 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 126.129 1.772 . . . . 0.0 108.41 174.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -138.52 143.91 39.72 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.37 -173.85 4.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.592 0.757 . . . . 0.0 109.185 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -108.81 106.67 59.18 Favored Pre-proline 0 C--N 1.334 -0.107 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.55 131.42 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.493 1.462 . . . . 0.0 109.773 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.0 OUTLIER -81.55 107.35 14.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -72.78 42.93 0.11 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 29' ' ' LEU . 27.2 m -79.03 6.56 9.1 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.397 3.079 . . . . 0.0 114.766 -168.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.6 p 61.31 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 128.057 2.543 . . . . 0.0 114.607 163.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -7.27 17.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.195 1.798 . . . . 0.0 112.448 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 tt -44.26 146.64 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 121.034 -1.041 . . . . 0.0 110.015 159.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.51 -61.95 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 171.03 -156.96 27.52 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -170.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.8 143.72 50.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 135.83 53.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.745 2.018 . . . . 0.0 106.248 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.69 125.74 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.1 m -119.25 126.01 50.48 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.31 123.65 61.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.98 163.42 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.335 1.454 . . . . 0.0 108.266 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.56 110.96 16.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 127.764 2.426 . . . . 0.0 112.725 174.43 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt . . . . . 0 N--CA 1.448 -0.575 0 CA-C-O 117.906 -1.045 . . . . 0.0 108.913 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.04 167.18 25.55 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.36 2.04 . . . . 0.0 110.673 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.25 -76.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.81 175.48 13.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 175.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.97 154.25 51.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.006 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.6 166.46 30.22 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.48 1.512 . . . . 0.0 109.265 -163.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.67 171.62 10.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.363 1.065 . . . . 0.0 110.378 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.27 -176.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.011 163.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -64.1 -68.93 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.297 1.839 . . . . 0.0 112.362 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 88.3 p 165.14 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.972 3.309 . . . . 0.0 111.227 -175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . 0.264 97.4 p -131.52 23.94 4.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.534 0.607 . . . . 0.0 111.979 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -73.46 131.55 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.35 -0.13 35.1 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.929 1.252 . . . . 0.0 113.303 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -150.68 114.75 5.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.471 ' CD2' HD11 ' A' ' 24' ' ' LEU . 3.8 t80 -140.85 158.97 43.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -173.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -141.51 132.22 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.66 148.29 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 126.364 1.866 . . . . 0.0 106.778 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.67 -173.76 2.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.525 1.53 . . . . 0.0 108.295 -174.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.06 16.79 80.41 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 120.662 -1.274 . . . . 0.0 113.557 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 151.7 45.42 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.16 100.26 7.13 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.5 162.9 40.11 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.395 3.397 . . . . 0.0 113.769 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.57 5.85 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.727 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.59 138.39 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 159.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 39.4 t0 -83.0 158.74 22.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.578 0.751 . . . . 0.0 110.463 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -135.44 123.01 22.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.346 1.458 . . . . 0.0 108.648 -167.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.86 109.3 22.03 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.86 90.91 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.3 p -84.83 104.4 14.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.871 0.868 . . . . 0.0 111.071 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.82 119.42 45.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -116.74 139.56 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.958 1.303 . . . . 0.0 108.264 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.2 m -105.55 134.17 49.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.7 115.43 17.32 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.3 pt -104.29 -164.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 125.362 1.465 . . . . 0.0 108.316 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -34.66 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.07 0.948 . . . . 0.0 111.056 167.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.25 60.65 0.05 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 128.933 3.158 . . . . 0.0 113.261 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.25 166.15 38.89 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.78 146.94 51.52 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.875 1.27 . . . . 0.0 108.253 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 m -84.04 -172.24 4.05 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.139 0.971 . . . . 0.0 110.032 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.69 135.77 71.26 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 162.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.27 155.34 67.86 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.758 2.306 . . . . 0.0 110.892 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -127.3 98.18 5.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 166.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.5 m -94.15 109.01 20.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.8 mt -88.76 155.12 19.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 157.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.5 m -127.74 147.94 50.41 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -155.78 124.52 6.01 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.19 0.905 . . . . 0.0 110.648 -173.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -67.45 -27.08 66.74 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -169.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.25 1.13 0 C-N-CA 128.771 2.828 . . . . 0.0 114.813 166.738 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -69.05 133.48 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.99 1.793 . . . . 0.0 109.74 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.1 166.86 11.05 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.677 1.591 . . . . 0.0 108.952 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.39 88.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.896 0.855 . . . . 0.0 109.201 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m -73.4 -11.52 60.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.812 0.845 . . . . 0.0 112.006 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.39 14.28 30.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.644 1.111 . . . . 0.0 112.082 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.99 109.14 0.59 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.18 -0.95 . . . . 0.0 110.893 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 m -136.57 146.19 45.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.176 1.79 . . . . 0.0 110.128 -170.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -111.3 144.68 40.1 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 177.99 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 128.691 2.796 . . . . 0.0 108.06 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.14 51.14 13.45 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.143 1.777 . . . . 0.0 109.408 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.7 mt -84.01 65.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -87.63 162.54 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.652 1.181 . . . . 0.0 109.056 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.68 -2.38 22.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.218 1.407 . . . . 0.0 111.311 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -107.22 -15.73 14.58 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.383 1.873 . . . . 0.0 114.079 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p 176.25 154.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.053 1.741 . . . . 0.0 109.911 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 128.96 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.58 133.39 11.61 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -174.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mp -110.03 143.05 40.61 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -124.65 146.48 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -149.97 -171.43 3.9 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 165.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -103.31 107.26 55.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -57.08 139.5 90.13 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.49 1.46 . . . . 0.0 110.749 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -88.88 108.97 19.83 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.969 1.708 . . . . 0.0 108.852 164.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.66 28.33 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.321 1.448 . . . . 0.0 112.063 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.0 m -79.38 150.49 31.36 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.494 -1.379 . . . . 0.0 110.455 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 p -83.0 -34.71 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.516 0.598 . . . . 0.0 111.409 167.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.13 -12.0 59.89 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.458 1.103 . . . . 0.0 112.207 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.7 152.25 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 161.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mp -90.62 -67.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 160.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.86 -160.93 22.39 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -130.47 142.15 50.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 118.14 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 mp -93.2 143.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.7 m -141.26 133.56 28.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.56 138.07 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 125.128 1.371 . . . . 0.0 111.899 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.41 164.7 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.68 117.65 20.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 127.357 2.263 . . . . 0.0 113.084 173.23 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.44 159.82 25.75 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.647 2.898 . . . . 0.0 110.239 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.04 -69.4 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.69 164.29 23.95 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.943 1.297 . . . . 0.0 109.511 -172.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.23 144.85 40.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.94 1.696 . . . . 0.0 110.34 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -134.76 164.62 27.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.854 1.662 . . . . 0.0 108.026 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.62 152.46 51.25 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.807 0.843 . . . . 0.0 109.842 177.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.22 -177.71 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.86 -0.525 . . . . 0.0 109.81 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -80.49 -54.86 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.234 0.54 . . . . 0.0 112.169 -150.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p 153.93 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 130.865 3.666 . . . . 0.0 109.916 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.8 p -123.64 10.31 9.04 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.752 1.621 . . . . 0.0 111.22 -164.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.93 137.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.05 1.0 9.84 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.378 1.466 . . . . 0.0 112.714 166.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.94 123.83 12.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.819 1.248 . . . . 0.0 110.008 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -140.14 151.28 45.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.401 1.88 . . . . 0.0 107.542 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.6 m -130.95 126.64 36.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.796 1.18 . . . . 0.0 109.244 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.48 153.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.89 177.11 8.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 166.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.09 7.01 88.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.706 1.146 . . . . 0.0 112.86 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 159.75 19.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 164.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -137.04 127.54 16.07 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.65 171.58 14.09 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.27 1.314 . . . . 0.0 110.575 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.11 -12.23 40.69 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.147 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.52 162.1 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -92.26 125.84 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -107.25 142.44 37.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.8 1.182 . . . . 0.0 108.886 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.37 110.87 23.38 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 168.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.89 103.1 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.3 p -92.86 145.91 24.03 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.959 -1.088 . . . . 0.0 109.774 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 t -146.35 72.08 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-O 122.501 1.143 . . . . 0.0 108.96 -168.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mt -84.8 134.65 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.7 m -89.52 142.45 27.66 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.88 138.01 51.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.883 1.273 . . . . 0.0 109.114 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 pt -133.87 -169.06 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.049 1.339 . . . . 0.0 109.068 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -34.06 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.089 1.756 . . . . 0.0 110.84 162.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 36.74 42.95 0.75 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.985 2.707 . . . . 0.0 114.603 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.46 166.04 38.19 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 120.402 2.101 . . . . 0.0 113.839 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.76 156.03 31.36 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.499 1.919 . . . . 0.0 107.057 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 m -84.1 -170.2 2.97 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 155.53 87.55 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.712 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.74 105.53 1.97 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.903 3.069 . . . . 0.0 110.434 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 m -89.84 74.71 7.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 171.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.3 m -94.58 115.33 27.45 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.9 mt -95.64 145.02 25.58 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 m -104.87 135.43 46.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -155.18 169.0 25.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 166.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -95.38 137.54 34.3 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.25 1.1 0 O-C-N 125.383 1.677 . . . . 0.0 110.551 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 136.55 42.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.448 2.098 . . . . 0.0 110.723 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -75.69 163.18 27.57 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.583 165.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.11 80.3 0.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.44 1.096 . . . . 0.0 109.105 163.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 m -58.15 -27.78 64.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.68 0.792 . . . . 0.0 110.859 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 5.18 49.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.761 0.825 . . . . 0.0 111.918 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.7 129.3 22.55 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.315 1.046 . . . . 0.0 109.653 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 p -149.58 164.21 35.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.482 1.113 . . . . 0.0 110.39 165.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -116.65 146.43 42.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 172.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.52 164.21 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.915 1.286 . . . . 0.0 109.261 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 45.71 59.63 3.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.268 1.827 . . . . 0.0 109.949 -173.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.15 66.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 128.667 2.787 . . . . 0.0 105.804 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 t -94.64 165.35 12.55 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.686 1.594 . . . . 0.0 109.679 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.6 5.29 4.96 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.279 -1.513 . . . . 0.0 113.375 -168.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.1 p -126.5 -12.74 6.11 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -174.0 152.33 1.9 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.949 1.3 . . . . 0.0 108.949 -167.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.49 122.07 61.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.14 151.82 23.97 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.74 153.4 42.47 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.438 1.495 . . . . 0.0 109.71 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -140.05 145.04 37.21 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.66 1.584 . . . . 0.0 106.733 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -160.25 168.71 24.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 164.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.0 m -90.05 140.71 27.54 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 116.883 -1.927 . . . . 0.0 106.888 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.36 141.6 4.93 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.125 1.216 . . . . 0.0 109.023 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mp -83.51 -35.26 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.961 -170.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 49.84 34.86 8.26 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.301 2.24 . . . . 0.0 111.776 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 p -50.34 -46.97 56.03 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.302 1.041 . . . . 0.0 112.824 -162.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 p 153.91 -86.32 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 131.371 3.868 . . . . 0.0 104.973 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -5.43 58.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.51 1.124 . . . . 0.0 111.045 -170.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -34.86 129.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.937 1.295 . . . . 0.0 111.162 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.21 -49.47 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.21 -164.86 36.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -127.02 150.88 49.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 162.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.85 122.96 42.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 mp -104.67 144.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.8 m -145.45 111.26 5.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 143.09 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.829 0.823 . . . . 0.0 110.773 160.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.17 164.33 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 166.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.38 126.89 31.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 163.129 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.9 mt . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 117.301 -1.333 . . . . 0.0 107.901 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 137.81 28.65 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.304 2.003 . . . . 0.0 110.0 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.0 93.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.323 1.0 OUTLIER 54.45 176.95 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.323 2.249 . . . . 0.0 113.28 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.07 159.32 42.47 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.725 -1.235 . . . . 0.0 110.205 165.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -149.33 165.93 30.52 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.252 1.821 . . . . 0.0 111.221 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.07 165.52 18.7 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.629 1.571 . . . . 0.0 109.482 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -178.11 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.168 0.987 . . . . 0.0 109.119 164.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.25 -50.74 8.64 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.028 -1.045 . . . . 0.0 112.528 -157.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 p 157.18 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 1 C-N-CA 132.217 4.207 . . . . 0.0 112.141 174.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -124.9 10.4 8.26 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.9 t -73.61 132.44 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.59 6.37 18.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.075 1.322 . . . . 0.0 112.312 170.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -150.08 120.4 7.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.79 -1.418 . . . . 0.0 107.38 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -143.99 166.27 25.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -132.37 129.0 38.81 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.038 0.935 . . . . 0.0 108.763 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -95.78 154.88 3.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.04 178.45 6.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.388 1.475 . . . . 0.0 107.142 169.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 5.0 73.88 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 119.036 0.834 . . . . 0.0 112.956 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.72 158.8 26.55 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.626 0.727 . . . . 0.0 109.555 167.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.19 103.78 5.61 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.0 169.64 14.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.091 2.527 . . . . 0.0 111.032 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.22 -18.75 50.86 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.595 -0.691 . . . . 0.0 112.176 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mm -124.56 153.38 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.669 1.988 . . . . 0.0 108.155 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -86.25 145.84 26.78 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.658 1.583 . . . . 0.0 108.365 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.56 134.85 51.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.257 1.023 . . . . 0.0 111.87 -175.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.28 104.18 14.1 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.506 1.923 . . . . 0.0 107.098 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -90.52 105.66 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -101.5 136.29 41.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 118.412 0.551 . . . . 0.0 111.873 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.8 t -135.36 108.42 9.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.07 137.42 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -98.78 129.97 45.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.39 112.43 18.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pt -104.45 -164.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -48.62 111.13 0.42 Allowed 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.531 -0.731 . . . . 0.0 110.61 161.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.49 24.76 59.83 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.068 -0.851 . . . . 0.0 114.802 156.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.33 156.39 21.04 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -132.78 153.22 51.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 108.531 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.58 178.41 7.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.78 154.23 94.41 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 121.496 -0.753 . . . . 0.0 110.197 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.87 110.53 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.964 3.109 . . . . 0.0 110.839 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.8 m -85.44 97.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 169.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 m -96.5 153.42 17.85 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.55 135.19 44.19 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 159.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.67 143.29 38.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.37 2.268 . . . . 0.0 108.537 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -164.69 148.61 9.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.559 1.527 . . . . 0.0 110.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -110.94 143.53 41.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.84 1.256 . . . . 0.0 109.626 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.257 1.456 0 C-N-CA 127.572 2.349 . . . . 0.0 111.635 -171.71 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.31 105.61 1.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.316 2.01 . . . . 0.0 109.209 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.29 169.98 1.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 114.248 165.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.24 71.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.449 2.3 . . . . 0.0 110.088 164.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m -50.68 -27.01 6.16 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 111.846 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -87.37 4.59 42.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.772 1.169 . . . . 0.0 112.566 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -55.17 118.42 4.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 109.276 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.0 m -153.33 134.1 13.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.454 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -91.39 146.25 23.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.45 174.23 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 128.845 2.858 . . . . 0.0 109.24 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.374 2.6 p30 43.07 45.62 4.64 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.113 1.765 . . . . 0.0 112.3 -178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.44 62.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 128.117 2.567 . . . . 0.0 107.473 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -73.78 174.55 8.28 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.781 1.232 . . . . 0.0 108.972 168.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.73 -4.7 39.06 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.187 -0.946 . . . . 0.0 111.674 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.7 p -125.58 -9.2 6.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 -158.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 p -176.81 171.91 2.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.188 2.595 . . . . 0.0 108.134 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.65 147.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 142.75 15.64 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 171.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mp -108.82 144.14 37.07 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 124.529 1.132 . . . . 0.0 108.119 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -118.21 150.38 39.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -151.87 -166.12 2.41 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 161.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.92 143.19 39.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.53 129.32 19.83 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.055 1.17 . . . . 0.0 109.39 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 31' ' ' SER . 7.2 mt -85.64 96.98 9.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 172.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -74.52 45.87 0.25 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.38 0.672 . . . . 0.0 109.327 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 29' ' ' LEU . 32.8 m -69.48 2.46 3.08 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.079 -1.638 . . . . 0.0 112.269 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 p 48.13 25.66 0.87 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.787 2.835 . . . . 0.0 114.859 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -165.27 -16.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.881 1.272 . . . . 0.0 111.044 -171.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 tt -39.01 140.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 110.141 156.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -84.79 -63.39 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 165.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.33 -156.9 13.75 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -168.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.7 147.42 48.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 133.97 55.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.0 mp -108.81 143.0 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -133.87 128.13 33.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 161.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.27 137.52 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.36 164.69 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.14 1.376 . . . . 0.0 109.429 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.07 125.94 30.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 C-N-CA 123.591 0.756 . . . . 0.0 110.312 173.441 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.6 mt . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.94 147.16 43.22 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.83 2.354 . . . . 0.0 110.945 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.0 mm -84.85 -74.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.01 175.64 7.46 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.683 1.993 . . . . 0.0 108.66 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.84 156.83 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.727 1.211 . . . . 0.0 110.255 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.417 ' CG ' ' HH ' ' A' ' 62' ' ' TYR . 1.4 p30 -148.2 166.43 27.93 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.737 1.215 . . . . 0.0 110.503 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.77 155.72 49.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.673 1.989 . . . . 0.0 109.935 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.75 -177.21 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.883 1.273 . . . . 0.0 109.864 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.66 -57.71 3.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.527 0.731 . . . . 0.0 112.087 -160.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p 154.7 -29.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 131.089 3.756 . . . . 0.0 111.42 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -123.26 -0.66 8.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.256 1.023 . . . . 0.0 109.506 -167.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.1 t -74.43 124.75 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.0 1.11 33.55 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.46 1.1 . . . . 0.0 112.901 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -142.18 114.21 8.14 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.456 1.102 . . . . 0.0 108.259 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.417 ' HH ' ' CG ' ' A' ' 53' ' ' ASP . 32.6 t80 -145.98 137.82 25.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -172.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -113.42 146.99 38.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.947 1.299 . . . . 0.0 108.836 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.51 148.54 24.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 125.631 1.572 . . . . 0.0 107.181 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.88 -168.78 1.87 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.28 4.34 90.23 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.692 -1.255 . . . . 0.0 113.973 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 149.56 49.65 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.933 1.293 . . . . 0.0 109.965 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -146.9 93.81 4.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.454 1.902 . . . . 0.0 108.643 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.62 167.59 23.81 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.997 3.131 . . . . 0.0 114.982 -152.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.85 -15.85 61.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.128 1.347 . . . . 0.0 112.735 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.15 151.52 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 167.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -89.48 134.41 34.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.309 1.444 . . . . 0.0 108.039 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -118.51 117.33 28.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -167.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.42 113.63 21.32 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 170.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -102.66 105.1 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -91.03 138.24 31.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.097 0.559 . . . . 0.0 109.508 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -134.52 129.54 52.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -131.8 131.42 62.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 m -83.09 144.23 30.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.68 129.88 50.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.6 pt -116.1 175.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -35.37 105.0 0.03 OUTLIER 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.023 1.729 . . . . 0.0 110.119 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.1 26.37 0.87 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.812 1.672 . . . . 0.0 114.823 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.42 144.71 15.93 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.55 1.675 . . . . 0.0 109.663 -160.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.01 117.64 22.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.2 1.0 . . . . 0.0 108.499 -162.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.11 -179.0 6.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 148.8 86.06 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.7 137.7 70.23 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 162.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -129.13 95.99 4.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 168.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.7 m -94.84 149.21 21.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.32 135.0 45.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 166.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t -120.91 140.79 51.33 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -165.24 139.89 5.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -96.81 165.06 12.29 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 161.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.246 0.87 0 C-N-CA 126.865 2.066 . . . . 0.0 111.315 169.748 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.37 117.21 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.746 2.297 . . . . 0.0 109.511 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.27 169.46 11.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.2 mt -78.51 86.73 4.51 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.5 m -76.04 -29.37 58.04 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.53 1.132 . . . . 0.0 111.35 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.61 4.77 20.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.823 1.249 . . . . 0.0 112.611 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.57 129.78 37.56 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.8 1.64 . . . . 0.0 109.853 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.3 m -150.72 165.23 34.1 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -99.72 155.83 17.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 108.724 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.12 167.96 9.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.689 1.996 . . . . 0.0 106.983 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.83 56.21 2.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 128.278 2.631 . . . . 0.0 110.232 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -78.25 65.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.197 2.199 . . . . 0.0 106.232 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -88.18 168.16 12.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.465 1.106 . . . . 0.0 111.3 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.37 12.79 0.69 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.171 2.188 . . . . 0.0 112.465 -174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.4 p -125.68 -15.9 5.89 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p -178.53 147.14 0.39 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -161.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -115.45 140.33 37.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.74 162.29 18.59 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mp -139.15 153.39 47.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.586 1.554 . . . . 0.0 108.988 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -134.71 155.32 50.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.5 p90 -165.35 -170.83 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.415 1.486 . . . . 0.0 108.858 166.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -105.42 106.44 56.06 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.726 1.21 . . . . 0.0 108.521 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -62.24 124.87 15.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.373 2.049 . . . . 0.0 110.632 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.1 mt -93.52 96.67 10.03 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 128.643 2.777 . . . . 0.0 108.042 175.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -74.67 34.12 0.1 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.446 1.098 . . . . 0.0 111.931 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 29' ' ' LEU . 30.4 m -56.2 119.63 6.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.821 2.448 . . . . 0.0 109.216 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 p -67.63 41.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.734 2.414 . . . . 0.0 113.443 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -167.18 -19.7 0.02 OUTLIER 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.741 1.616 . . . . 0.0 111.904 -167.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -55.15 144.44 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.23 -52.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 166.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.66 -152.73 14.56 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.04 136.14 45.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.03 125.82 44.61 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.81 155.05 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 m -142.69 153.52 43.46 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.899 1.68 . . . . 0.0 107.169 167.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.28 135.28 61.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 125.819 1.647 . . . . 0.0 108.999 167.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.55 164.08 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.43 110.24 20.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 128.625 2.77 . . . . 0.0 115.686 176.698 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.26 171.44 18.03 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.358 2.039 . . . . 0.0 109.633 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.72 -95.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 162.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -146.96 166.02 28.04 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.475 0.71 . . . . 0.0 110.371 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -134.23 103.89 5.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.553 1.541 . . . . 0.0 106.988 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.51 159.11 16.19 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.75 176.02 5.3 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.527 1.131 . . . . 0.0 108.039 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -175.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 161.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -79.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.468 1.907 . . . . 0.0 112.041 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p 172.2 -18.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 1 C-N-CA 132.651 4.38 . . . . 0.0 110.883 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -134.27 27.15 3.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.4 t -73.99 138.62 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.92 -1.95 19.02 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.977 0.798 . . . . 0.0 112.265 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.58 114.33 5.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -138.04 141.36 40.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 m -127.21 152.06 47.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.9 0.88 . . . . 0.0 109.358 -171.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.53 156.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.505 1.922 . . . . 0.0 106.944 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.434 HG21 ' H ' ' A' ' 66' ' ' GLY . 3.1 m -130.67 -163.14 1.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.163 1.785 . . . . 0.0 106.374 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.434 ' H ' HG21 ' A' ' 65' ' ' THR . . . 72.51 7.9 69.97 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 120.093 -1.629 . . . . 0.0 114.105 166.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.4 149.67 31.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.186 1.394 . . . . 0.0 108.226 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -126.19 102.07 27.76 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 107.893 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 157.84 57.82 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.622 2.215 . . . . 0.0 112.383 -165.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.55 -30.06 11.19 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.681 1.134 . . . . 0.0 110.543 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.79 158.82 3.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -100.96 145.19 28.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.022 1.329 . . . . 0.0 108.347 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -131.26 134.8 46.77 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.32 116.35 22.96 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 121.22 51.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 p -116.18 142.67 46.52 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.822 0.849 . . . . 0.0 110.687 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.92 128.77 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.09 153.4 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.43 1.014 . . . . 0.0 111.894 175.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -105.84 122.89 47.03 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 126.467 1.907 . . . . 0.0 107.739 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.68 132.91 56.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.7 pt -126.3 178.13 4.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.476 1.111 . . . . 0.0 108.837 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -34.53 103.53 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.281 1.832 . . . . 0.0 110.823 163.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.51 11.47 2.67 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.868 2.175 . . . . 0.0 115.055 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.36 145.85 17.89 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.203 1.501 . . . . 0.0 110.153 -156.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -126.85 155.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.316 1.447 . . . . 0.0 109.494 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -107.54 -166.86 1.19 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.85 2.06 . . . . 0.0 108.604 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.62 134.6 39.57 Favored Pre-proline 0 C--O 1.239 0.543 0 O-C-N 121.016 -1.052 . . . . 0.0 108.678 163.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 127.72 19.5 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.93 2.42 . . . . 0.0 107.214 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.2 m -86.41 103.7 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.2 m -101.4 121.53 42.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.95 150.43 44.78 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.1 m -132.62 136.9 46.81 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -161.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -157.33 142.63 17.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -159.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.08 159.64 15.21 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.867 -0.52 . . . . 0.0 109.878 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.767 1.627 . . . . 0.0 110.063 -170.245 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.7 t . . . . . 0 C--O 1.239 0.52 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.36 143.49 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.04 1.826 . . . . 0.0 109.442 174.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -102.59 169.29 8.74 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 166.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -74.5 80.34 1.94 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 m -61.37 -25.75 67.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.798 0.839 . . . . 0.0 110.544 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.0 -2.47 34.1 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.662 1.585 . . . . 0.0 113.696 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.37 115.14 3.04 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.773 1.229 . . . . 0.0 110.55 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p -134.54 160.97 36.4 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.864 1.266 . . . . 0.0 110.345 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 8.7 m-30 -105.28 143.78 32.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.04 164.96 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.881 1.672 . . . . 0.0 108.348 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 t0 51.7 45.06 28.74 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.96 1.304 . . . . 0.0 110.554 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mt -75.91 63.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 128.811 2.845 . . . . 0.0 106.94 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -87.45 173.77 8.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 111.137 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.36 0.43 16.86 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.637 1.975 . . . . 0.0 112.861 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.7 p -113.39 -15.7 12.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p 176.29 161.7 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.674 1.99 . . . . 0.0 107.536 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.15 127.67 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.85 157.39 29.66 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.633 -1.292 . . . . 0.0 110.143 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.79 150.33 52.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.774 -1.427 . . . . 0.0 108.483 172.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -137.29 133.85 35.46 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -157.54 173.38 16.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.6 m -86.58 106.3 10.09 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.726 1.211 . . . . 0.0 110.093 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.62 124.26 13.4 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.345 1.363 . . . . 0.0 109.29 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.15 101.44 13.0 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -79.34 49.95 1.04 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.536 0.734 . . . . 0.0 109.097 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -61.91 -55.55 28.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.582 1.553 . . . . 0.0 110.164 -168.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p 154.72 -88.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 130.389 3.476 . . . . 0.0 108.891 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.08 -3.64 52.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.978 2.511 . . . . 0.0 110.026 -170.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -35.98 133.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.039 1.336 . . . . 0.0 111.255 166.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -84.32 -48.24 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.87 -158.29 31.03 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -132.15 145.2 51.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -119.89 113.1 20.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.43 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.9 m -145.08 117.58 8.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.425 1.89 . . . . 0.0 107.382 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.09 131.44 40.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.289 0.636 . . . . 0.0 111.064 162.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.48 164.52 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 161.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.56 110.9 11.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.348 0 C-N-CA 124.371 1.068 . . . . 0.0 113.652 -171.422 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.9 mt . . . . . 0 CA--C 1.546 0.792 0 CA-C-O 119.02 -0.515 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.68 131.04 12.06 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.725 2.283 . . . . 0.0 109.008 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.5 mm -84.64 -73.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -157.51 170.46 22.38 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.848 0.859 . . . . 0.0 109.925 173.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.3 150.59 39.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 163.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -152.71 165.91 33.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.48 1.112 . . . . 0.0 108.565 -166.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.12 168.15 15.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.377 0.671 . . . . 0.0 110.53 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.01 -177.01 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.12 . . . . 0.0 108.66 167.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -71.02 -66.42 0.61 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.756 -0.59 . . . . 0.0 111.219 -167.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 p 163.78 -23.02 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 130.787 3.635 . . . . 0.0 112.016 -176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.9 p -132.9 22.93 4.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.988 0.813 . . . . 0.0 112.764 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.54 131.93 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.95 3.26 19.3 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.388 2.423 . . . . 0.0 113.357 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -153.93 119.64 5.26 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.654 1.582 . . . . 0.0 108.225 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -134.94 164.37 27.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.326 1.45 . . . . 0.0 108.081 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.5 m -131.96 147.98 52.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.88 145.04 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.85 -170.76 1.85 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 171.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.25 17.97 77.11 Favored Glycine 0 CA--C 1.522 0.473 0 O-C-N 120.873 -1.142 . . . . 0.0 111.666 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 157.44 20.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.617 1.208 . . . . 0.0 108.691 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 136.41 15.98 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.96 156.12 60.33 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.906 1.737 . . . . 0.0 110.964 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.53 -27.58 8.33 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.527 1.061 . . . . 0.0 113.109 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.17 156.14 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 126.038 1.735 . . . . 0.0 107.818 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.97 135.33 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 107.445 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.26 127.17 51.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.4 106.74 16.23 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.3 mp -98.94 103.12 14.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 174.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 142.16 27.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.939 2.096 . . . . 0.0 108.315 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -146.7 92.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mm -84.34 138.86 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.739 1.216 . . . . 0.0 108.274 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 100.0 m -105.81 131.71 52.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.0 113.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . 0.3 2.6 pt -109.37 -164.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.672 1.189 . . . . 0.0 109.991 -166.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -50.83 108.78 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.315 -1.491 . . . . 0.0 110.52 160.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.18 50.46 2.2 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.583 2.04 . . . . 0.0 113.097 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 144.17 7.58 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -120.26 153.45 36.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 107.931 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -84.42 -165.85 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.579 0.704 . . . . 0.0 112.31 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.64 144.67 73.83 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 151.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.43 137.28 50.29 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.774 1.649 . . . . 0.0 108.879 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.6 m -105.21 104.86 14.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -124.26 137.17 54.54 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.1 126.38 39.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -93.52 145.43 24.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -154.73 138.85 16.49 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -94.97 136.02 35.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.738 1.215 . . . . 0.0 108.279 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.257 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -175.129 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.05 129.92 27.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.261 1.974 . . . . 0.0 110.558 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.22 178.42 4.78 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.139 1.376 . . . . 0.0 110.881 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.1 mt -71.76 86.85 0.95 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -58.57 -20.12 43.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.272 1.429 . . . . 0.0 111.217 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -93.46 6.27 48.74 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.708 1.603 . . . . 0.0 113.585 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.99 106.81 0.54 Allowed 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.723 -1.236 . . . . 0.0 109.905 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -143.36 163.91 31.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.547 1.139 . . . . 0.0 110.046 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 13.4 m-30 -109.02 159.7 16.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.08 168.17 7.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.616 1.966 . . . . 0.0 107.068 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 42.34 59.81 2.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 126.201 1.801 . . . . 0.0 109.653 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mm -79.89 60.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -73.63 175.54 7.03 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.595 1.958 . . . . 0.0 109.966 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -4.97 53.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.997 1.319 . . . . 0.0 112.636 172.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 p -110.78 -12.42 14.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.561 1.544 . . . . 0.0 114.459 -166.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 p 173.84 171.13 0.19 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.034 1.734 . . . . 0.0 108.233 -163.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.79 150.12 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 161.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.26 159.3 14.65 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 171.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.01 146.31 49.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 125.508 1.523 . . . . 0.0 108.184 176.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -124.25 156.83 36.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 158.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -161.38 -173.87 4.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.086 1.755 . . . . 0.0 106.973 163.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -104.04 107.55 57.36 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -59.37 124.07 14.74 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.715 1.61 . . . . 0.0 109.125 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.2 mt -93.4 -19.23 21.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.641 0.776 . . . . 0.0 112.878 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 43.45 29.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.193 2.597 . . . . 0.0 113.577 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 m -87.83 104.95 17.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -167.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -41.88 -1.85 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 131.518 3.927 . . . . 0.0 119.509 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.52 -14.45 8.22 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 130.167 3.387 . . . . 0.0 112.137 -171.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 12.6 tt -60.43 161.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.105 2.162 . . . . 0.0 111.061 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -98.77 -47.99 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 166.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.94 40.99 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -126.91 107.24 9.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 171.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.5 121.95 28.93 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.64 147.4 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -145.49 99.51 3.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.814 1.245 . . . . 0.0 107.672 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.56 134.16 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 120.665 -1.272 . . . . 0.0 109.064 163.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.25 165.13 24.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 136.42 42.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.539 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.925 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -60.97 160.87 24.07 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.716 1.61 . . . . 0.0 111.196 162.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.79 -86.95 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 121.367 1.894 . . . . 0.0 110.555 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.54 146.67 40.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.457 1.503 . . . . 0.0 107.439 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -147.51 162.55 38.84 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.852 1.261 . . . . 0.0 109.437 -168.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.34 153.36 43.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.359 1.463 . . . . 0.0 108.219 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.63 -176.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 108.866 165.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.15 -58.45 5.98 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -161.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 p 153.83 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 130.789 3.636 . . . . 0.0 110.747 -167.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -105.47 3.41 29.49 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 113.233 -166.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.9 150.67 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.98 -2.83 6.49 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 127.016 2.246 . . . . 0.0 113.201 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -160.73 128.7 4.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.727 -1.455 . . . . 0.0 107.883 -171.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -150.08 167.03 27.98 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.961 0.8 . . . . 0.0 109.049 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.4 m -132.9 136.66 46.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.413 1.485 . . . . 0.0 109.999 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.29 165.2 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.93 1.692 . . . . 0.0 107.469 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.513 HG21 ' H ' ' A' ' 66' ' ' GLY . 2.9 m -143.53 -170.69 3.35 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.359 -1.463 . . . . 0.0 107.06 164.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.513 ' H ' HG21 ' A' ' 65' ' ' THR . . . 72.09 15.51 76.55 Favored Glycine 0 N--CA 1.463 0.471 0 C-N-CA 124.713 1.149 . . . . 0.0 112.642 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.64 158.97 35.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.344 1.058 . . . . 0.0 108.826 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.51 107.25 23.57 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 170.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.9 168.05 19.8 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.065 2.51 . . . . 0.0 110.756 -173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.4 -31.18 4.57 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.505 1.05 . . . . 0.0 110.692 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.07 155.24 3.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -101.28 142.7 32.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.103 1.761 . . . . 0.0 108.242 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -134.59 120.48 19.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.043 1.337 . . . . 0.0 109.913 -162.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.15 95.75 9.24 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -84.58 105.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p -88.56 147.5 24.57 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 167.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.85 112.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 mt -112.32 129.31 68.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -82.59 134.86 35.18 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 113.71 18.79 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 18.3 pt -107.58 -167.83 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.961 1.704 . . . . 0.0 110.029 -173.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -44.1 110.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.317 0.508 . . . . 0.0 109.902 167.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.6 63.44 0.06 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.563 2.506 . . . . 0.0 114.121 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.71 158.32 19.17 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.36 150.18 45.03 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.74 -178.28 6.82 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.726 0.774 . . . . 0.0 109.992 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 149.01 98.52 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.184 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.31 102.5 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.325 2.017 . . . . 0.0 108.186 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 m -91.86 93.55 8.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 m -113.2 149.52 33.59 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.409 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -146.67 68.52 1.17 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.667 0.746 . . . . 0.0 110.131 -171.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.4 t -72.28 133.23 44.91 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -157.88 141.7 15.7 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.051 2.141 . . . . 0.0 108.753 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -91.11 157.9 16.96 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.76 0.824 . . . . 0.0 110.682 -175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.25 1.125 0 CA-C-O 115.51 -2.186 . . . . 0.0 108.225 178.779 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.34 120.48 5.31 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.584 2.189 . . . . 0.0 110.769 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -80.89 169.89 16.97 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.298 1.039 . . . . 0.0 110.634 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.13 79.65 0.51 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.2 m -65.79 -14.14 60.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.752 2.021 . . . . 0.0 111.627 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -113.38 24.16 12.51 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.32 1.448 . . . . 0.0 111.458 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.55 127.03 29.25 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.435 0.694 . . . . 0.0 110.847 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.15 165.13 31.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.005 0.922 . . . . 0.0 111.309 172.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.425 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 9.9 m-85 -112.06 154.81 24.83 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.838 1.255 . . . . 0.0 108.348 169.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.0 174.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.961 2.104 . . . . 0.0 106.624 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 56.34 47.13 19.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 0.0 108.791 161.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 mt -79.92 66.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.203 2.201 . . . . 0.0 106.937 -174.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -66.73 176.96 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.974 1.31 . . . . 0.0 109.447 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.02 -3.98 32.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.05 0.94 . . . . 0.0 113.369 162.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -125.44 -15.25 6.2 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 -162.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.18 168.02 4.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 108.525 -170.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 tt -134.56 124.09 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.132 -0.98 . . . . 0.0 108.445 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.46 161.3 46.51 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mp -133.44 161.0 35.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.936 1.294 . . . . 0.0 108.856 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -138.61 147.82 43.39 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 160.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -157.09 172.45 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 158.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 m -79.13 107.09 5.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 124.452 1.101 . . . . 0.0 109.266 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -60.66 133.88 50.98 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.544 1.23 . . . . 0.0 109.033 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.98 133.55 38.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.744 2.018 . . . . 0.0 107.367 166.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -121.31 36.77 4.51 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 m -79.62 101.69 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.437 2.295 . . . . 0.0 108.298 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -59.16 84.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.778 1.631 . . . . 0.0 113.146 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 165.8 -25.38 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 131.438 3.895 . . . . 0.0 109.415 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.24 160.32 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.135 1.774 . . . . 0.0 109.908 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.68 -47.19 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.33 -155.35 24.17 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.293 0.497 . . . . 0.0 111.983 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -137.08 129.63 30.09 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 116.78 33.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.23 150.56 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 123.427 1.584 . . . . 0.0 107.554 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 m -146.21 148.41 32.48 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 171.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.8 133.81 48.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.47 164.65 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 107.618 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.27 119.82 23.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 130.15 3.38 . . . . 0.0 118.826 160.892 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.75 147.63 17.32 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.912 3.075 . . . . 0.0 109.7 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -101.92 -76.4 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.23 171.68 18.14 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 120.849 1.658 . . . . 0.0 110.808 176.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.25 152.97 33.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.878 1.271 . . . . 0.0 109.39 171.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -145.84 165.7 28.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.26 160.61 39.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -177.4 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -59.82 -68.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.09 1.356 . . . . 0.0 110.561 -165.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t 178.81 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 129.206 3.003 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.8 p -136.33 48.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.37 124.78 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.457 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.19 -1.12 44.64 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.366 1.46 . . . . 0.0 114.213 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -158.94 132.94 7.63 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 127.108 2.163 . . . . 0.0 106.929 169.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -135.51 164.6 27.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -142.65 145.79 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -110.88 144.63 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.447 HG21 ' H ' ' A' ' 66' ' ' GLY . 2.6 m -128.29 -178.19 4.45 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.447 ' H ' HG21 ' A' ' 65' ' ' THR . . . 73.91 13.07 81.02 Favored Glycine 0 N--CA 1.463 0.439 0 C-N-CA 123.979 0.799 . . . . 0.0 113.35 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -69.99 165.58 21.48 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.125 0.97 . . . . 0.0 108.847 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.96 105.56 13.87 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.953 1.701 . . . . 0.0 108.56 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.93 152.94 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.007 2.471 . . . . 0.0 110.192 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 -43.89 1.32 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 125.991 1.758 . . . . 0.0 109.188 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -84.09 165.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 122.747 1.261 . . . . 0.0 108.804 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -101.34 138.14 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 128.407 2.683 . . . . 0.0 106.57 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -133.96 142.43 47.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.05 0.841 . . . . 0.0 110.681 -158.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.31 89.74 3.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.277 1.431 . . . . 0.0 109.988 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.425 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 5.1 mp -83.99 111.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -170.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -111.36 125.79 54.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.211 1.804 . . . . 0.0 108.718 -164.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.41 103.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 mt -84.55 144.38 9.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -105.58 131.16 53.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.7 150.22 51.99 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.338 1.426 . . . . 0.0 109.19 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.0 pt -135.72 -179.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.85 1.26 . . . . 0.0 108.954 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -35.2 116.78 0.37 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.61 1.564 . . . . 0.0 110.301 168.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 47.03 2.19 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 124.786 1.304 . . . . 0.0 112.186 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.11 155.45 26.59 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.247 1.023 . . . . 0.0 111.226 -165.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -151.49 127.96 10.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -178.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.82 141.79 84.99 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.374 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.2 100.36 0.87 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.857 2.372 . . . . 0.0 108.568 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 m -83.59 125.89 32.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.7 m -125.32 155.35 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 mt -140.29 141.6 35.76 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.9 m -77.57 146.83 36.04 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -138.72 157.93 45.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.436 1.095 . . . . 0.0 108.662 153.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -125.59 144.16 50.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.644 1.578 . . . . 0.0 109.025 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.248 1.024 0 C-N-CA 125.143 1.377 . . . . 0.0 112.591 166.063 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.59 122.09 4.39 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.177 2.585 . . . . 0.0 111.606 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 163.29 27.54 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.235 1.014 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.26 80.84 1.83 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.665 0.745 . . . . 0.0 110.68 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 m -56.15 -10.79 0.92 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.861 2.065 . . . . 0.0 112.346 168.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -111.0 5.84 20.57 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.631 -1.293 . . . . 0.0 113.825 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.31 118.49 4.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.505 0.593 . . . . 0.0 109.807 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -140.98 165.32 27.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.789 1.636 . . . . 0.0 109.957 166.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' A' ' 91' ' ' LEU . 12.4 m-30 -108.58 155.26 20.86 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 165.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.04 174.68 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 128.406 2.682 . . . . 0.0 107.997 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 48.64 44.8 21.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.397 1.079 . . . . 0.0 110.18 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.76 61.35 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 t -64.38 166.01 8.86 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.925 1.345 . . . . 0.0 109.424 168.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.81 4.63 6.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.209 1.404 . . . . 0.0 111.381 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -126.15 -0.92 7.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.437 2.295 . . . . 0.0 116.908 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.91 166.74 0.53 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.81 2.844 . . . . 0.0 109.125 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 tt -123.65 140.44 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.95 157.33 21.1 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.76 154.53 44.1 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.473 1.509 . . . . 0.0 108.076 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -139.42 141.01 37.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -158.18 -174.35 4.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.504 0.722 . . . . 0.0 110.311 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 m -97.73 107.14 38.16 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.013 1.725 . . . . 0.0 107.141 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -58.79 128.81 29.44 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 121.233 1.476 . . . . 0.0 109.013 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.9 mt -95.35 98.26 10.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 126.694 1.997 . . . . 0.0 105.845 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -75.04 28.58 0.09 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.519 0.728 . . . . 0.0 111.787 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -66.69 131.19 45.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -76.59 52.55 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.113 -0.992 . . . . 0.0 111.213 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.47 -14.43 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.093 1.357 . . . . 0.0 111.0 -164.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.05 141.89 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.44 -65.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.42 -168.08 31.74 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -124.05 138.69 54.41 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.65 118.9 29.21 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.51 149.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -145.13 102.88 3.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.75 127.76 39.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -123.69 164.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.01 110.66 21.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.387 0 C-N-CA 128.11 2.564 . . . . 0.0 113.596 -178.632 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.67 128.38 11.71 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.123 2.549 . . . . 0.0 110.188 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mm -84.89 -62.36 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.95 155.37 34.11 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 107.676 -164.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.13 151.65 40.93 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 174.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.69 158.37 15.3 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.046 0.841 . . . . 0.0 110.792 -156.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.87 154.21 49.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.693 1.197 . . . . 0.0 108.272 -167.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.16 -177.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.5 -57.44 5.8 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -163.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t 157.53 -43.36 0.0 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 128.073 2.549 . . . . 0.0 111.936 -163.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -129.47 37.16 4.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.093 1.315 . . . . 0.0 110.377 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.4 134.77 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.11 -5.71 13.03 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.274 1.416 . . . . 0.0 113.57 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -142.18 130.79 22.63 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.475 1.91 . . . . 0.0 107.336 174.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.22 166.61 24.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -151.74 147.03 26.2 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.664 -1.272 . . . . 0.0 109.328 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.84 158.28 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.754 1.621 . . . . 0.0 108.641 -166.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.09 178.01 7.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.529 1.132 . . . . 0.0 108.889 -174.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 23.65 77.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 165.01 25.92 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 161.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -143.65 135.88 13.27 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.629 1.172 . . . . 0.0 107.975 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 161.67 42.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.191 1.927 . . . . 0.0 111.914 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.27 -14.63 63.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.657 1.599 . . . . 0.0 113.338 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.81 152.01 13.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 118.779 1.289 . . . . 0.0 108.234 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.49 127.73 32.76 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.309 1.844 . . . . 0.0 108.012 174.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -116.47 120.29 38.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.89 102.51 13.17 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 168.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 mt -94.48 89.65 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.2 p -94.58 150.31 20.37 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.707 -0.621 . . . . 0.0 110.293 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.0 t -147.12 123.69 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -172.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.3 mt -118.61 139.65 45.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.5 m -106.06 115.97 31.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.114 1.766 . . . . 0.0 107.532 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.38 137.57 51.91 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.452 1.501 . . . . 0.0 109.779 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.06 -176.66 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.524 1.929 . . . . 0.0 109.154 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -35.2 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.154 1.382 . . . . 0.0 111.793 161.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.98 29.74 35.82 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.728 167.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.08 158.06 30.4 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 119.155 1.478 . . . . 0.0 111.113 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.8 151.43 51.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.674 1.99 . . . . 0.0 105.736 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.08 -171.04 3.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 144.71 88.99 Favored Pre-proline 0 C--O 1.242 0.676 0 O-C-N 120.877 -1.139 . . . . 0.0 108.631 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -63.7 136.6 54.56 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 107.979 -1.585 . . . . 0.0 107.979 171.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.96 96.59 6.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.8 m -114.2 143.54 44.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.487 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 95.0 mt -134.17 111.29 10.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 t -84.52 155.26 22.22 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -163.29 131.9 3.88 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 108.973 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -95.99 78.74 3.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.07 0.948 . . . . 0.0 110.578 169.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.256 1.398 0 C-N-CA 123.807 0.843 . . . . 0.0 110.236 167.067 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.28 116.72 4.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 N-CA-C 105.986 -2.352 . . . . 0.0 105.986 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -73.67 177.5 5.38 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.109 0.964 . . . . 0.0 111.64 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.39 76.92 0.39 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.851 0.834 . . . . 0.0 108.929 161.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m -60.48 -27.88 67.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.202 1.001 . . . . 0.0 109.043 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . . . -83.89 3.89 31.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.53 1.532 . . . . 0.0 114.338 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.34 117.76 7.1 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.124 -0.985 . . . . 0.0 110.409 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -153.02 165.66 34.87 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 168.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 7.5 m-30 -97.54 160.28 14.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.41 172.63 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.278 1.831 . . . . 0.0 106.555 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.71 44.87 19.85 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.246 1.018 . . . . 0.0 110.707 164.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -80.1 52.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.319 1.848 . . . . 0.0 109.695 -169.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.9 t -80.75 174.68 11.37 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.625 1.57 . . . . 0.0 109.684 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -80.33 -1.35 40.7 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.322 -0.861 . . . . 0.0 112.325 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.3 p -125.29 0.92 7.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 126.435 1.894 . . . . 0.0 115.839 -167.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.25 173.28 2.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.564 2.345 . . . . 0.0 106.591 160.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tt -121.98 143.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 160.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.07 163.24 18.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.52 157.68 42.0 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.224 1.41 . . . . 0.0 108.852 170.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -138.43 147.91 43.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 163.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -153.58 -179.73 8.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 163.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -94.19 106.95 25.56 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.55 138.96 73.37 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.923 1.749 . . . . 0.0 110.059 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 132.23 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.347 1.859 . . . . 0.0 106.537 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.95 18.67 21.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -64.44 158.28 24.26 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -165.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -82.65 43.77 0.85 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.791 -1.193 . . . . 0.0 111.656 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -171.05 -21.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.544 -0.723 . . . . 0.0 112.786 -174.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.29 121.23 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.914 0.886 . . . . 0.0 109.213 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.71 -46.41 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.08 -153.61 23.62 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.38 -1.39 . . . . 0.0 114.259 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -138.27 145.81 41.74 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.52 118.73 27.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.77 1.628 . . . . 0.0 107.658 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -114.01 115.25 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -168.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.3 m -126.72 103.78 7.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.72 138.45 19.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.98 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.37 163.23 38.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.5 118.64 22.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 128.121 2.569 . . . . 0.0 115.33 165.593 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.1 mt . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 118.387 -0.815 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.4 152.54 34.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.483 2.122 . . . . 0.0 110.02 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.9 mp -106.49 -92.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 161.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.05 170.55 16.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.981 1.264 . . . . 0.0 110.289 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.98 124.1 48.54 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.613 1.965 . . . . 0.0 107.062 173.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 159.3 15.79 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.068 2.547 . . . . 0.0 109.294 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.22 153.73 46.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 162.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -171.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.086 1.312 . . . . 0.0 111.098 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 p 168.2 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.614 1.965 . . . . 0.0 110.932 -162.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -124.66 20.23 8.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.513 1.525 . . . . 0.0 110.405 -171.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.82 124.34 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.11 3.28 51.53 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.531 1.539 . . . . 0.0 112.809 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -163.28 127.79 2.95 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 110.981 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -139.1 162.54 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.254 1.388 . . . . 0.0 109.133 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -138.19 148.26 44.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.736 1.214 . . . . 0.0 108.121 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.17 143.82 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 107.862 -174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 66' ' ' GLY . 1.9 m -141.79 -175.45 4.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -169.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.444 ' H ' HG23 ' A' ' 65' ' ' THR . . . 61.45 25.96 65.76 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 124.166 0.889 . . . . 0.0 111.855 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -79.51 165.87 22.55 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 170.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -130.19 133.02 24.46 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 165.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -79.19 169.57 18.85 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.233 2.622 . . . . 0.0 110.374 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.83 -4.17 49.57 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.769 -1.017 . . . . 0.0 114.209 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 mm -126.34 165.07 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.469 1.635 . . . . 0.0 107.412 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -86.44 149.42 25.0 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.068 -1.02 . . . . 0.0 109.274 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -138.26 130.65 29.01 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.885 0.874 . . . . 0.0 109.363 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.14 108.34 19.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 165.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.462 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.9 mp -98.5 94.67 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.5 p -95.91 153.26 17.85 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 110.672 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.09 98.05 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -172.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -92.14 129.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.2 m -106.43 125.08 50.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.194 1.397 . . . . 0.0 107.754 -174.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.56 148.77 46.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 111.448 -170.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.5 -176.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.051 2.14 . . . . 0.0 107.49 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -34.46 108.42 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 111.1 165.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.78 43.13 1.62 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.681 2.086 . . . . 0.0 112.923 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.39 158.99 30.09 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -167.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -146.47 161.9 39.44 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.87 1.668 . . . . 0.0 108.452 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.5 m -89.0 -169.94 2.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.158 0.583 . . . . 0.0 109.683 172.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.39 152.46 94.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.49 103.66 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.475 2.116 . . . . 0.0 108.574 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 p -87.03 139.55 30.46 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -145.16 172.78 12.62 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.2 134.3 20.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 156.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -79.64 104.02 9.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.551 1.94 . . . . 0.0 107.043 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.58 108.84 20.3 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.052 -1.655 . . . . 0.0 112.84 171.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 148.4 31.16 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 157.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 C--O 1.243 0.731 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.527 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.17 132.83 30.96 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.829 2.353 . . . . 0.0 112.199 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.05 156.73 17.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.651 1.98 . . . . 0.0 109.554 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.39 87.45 1.54 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.161 0.984 . . . . 0.0 109.95 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 m -66.55 -10.04 41.1 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.393 0.677 . . . . 0.0 112.252 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.46 0.11 55.13 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.411 -1.43 . . . . 0.0 112.487 171.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.31 106.65 0.21 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.981 1.264 . . . . 0.0 111.475 -172.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -140.54 138.48 34.55 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.775 1.23 . . . . 0.0 109.644 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.58 156.47 16.71 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.49 167.6 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.182 1.793 . . . . 0.0 109.05 169.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 50.52 61.03 3.43 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 108.673 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.0 mm -81.02 64.23 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.385 1.874 . . . . 0.0 107.833 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.3 t -95.08 171.84 8.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.242 1.02 . . . . 0.0 111.561 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.57 -4.33 36.33 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.832 1.253 . . . . 0.0 112.351 -165.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.9 p -124.99 -14.53 6.61 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.947 1.299 . . . . 0.0 114.052 -171.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -174.46 148.43 1.21 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.859 1.264 . . . . 0.0 111.517 -166.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.25 132.17 70.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.78 156.39 25.5 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.42 128.24 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.023 1.329 . . . . 0.0 109.071 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -98.51 151.21 20.86 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -151.32 174.99 12.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 150.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -87.9 141.87 31.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 171.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.14 123.41 5.61 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 N-CA-C 105.877 -2.393 . . . . 0.0 105.877 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.16 -19.55 56.69 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 50.39 31.21 5.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.602 2.361 . . . . 0.0 111.681 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -69.49 5.6 1.32 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.47 2.308 . . . . 0.0 113.842 -158.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 64.73 -63.67 0.17 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 112.753 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.325 3.05 . . . . 0.0 113.214 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -53.62 151.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.871 1.269 . . . . 0.0 110.85 167.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.53 -57.17 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.01 -156.2 15.98 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -127.77 144.86 51.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.81 124.03 51.26 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 175.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.75 156.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 168.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -145.14 142.94 30.07 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.84 138.04 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.98 163.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.22 114.12 21.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 166.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.762 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 mt . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 117.6 -1.19 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.68 127.24 3.65 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.073 2.515 . . . . 0.0 109.355 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.57 -70.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.89 164.59 31.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.856 0.753 . . . . 0.0 110.251 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.22 126.39 55.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 167.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -104.44 162.81 12.92 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.862 1.665 . . . . 0.0 107.897 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.09 161.33 27.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.748 0.819 . . . . 0.0 109.568 174.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.72 -176.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.34 -71.41 0.23 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.6 t 155.04 -21.94 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 131.657 3.983 . . . . 0.0 109.841 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.9 p -135.03 20.15 3.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.358 1.435 . . . . 0.0 112.641 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.69 128.91 36.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 169.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.89 2.72 11.83 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.273 2.368 . . . . 0.0 112.651 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -138.84 127.68 23.6 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.264 -1.139 . . . . 0.0 109.222 166.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -142.06 164.34 30.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.885 1.674 . . . . 0.0 109.417 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.2 m -133.77 135.82 44.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.54 1.536 . . . . 0.0 107.547 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.88 155.62 4.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 164.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.31 170.05 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.075 0.95 . . . . 0.0 109.59 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.07 51.21 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.588 -0.695 . . . . 0.0 111.89 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.52 158.02 15.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 128.68 2.792 . . . . 0.0 106.782 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 80.84 39.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.036 1.734 . . . . 0.0 109.344 -170.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.56 124.67 11.4 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.947 1.765 . . . . 0.0 108.682 -169.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.47 -26.5 4.61 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 124.436 1.017 . . . . 0.0 113.488 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.21 166.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.827 1.651 . . . . 0.0 107.219 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.16 126.03 41.1 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.065 1.746 . . . . 0.0 107.244 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.4 126.8 54.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.633 0.773 . . . . 0.0 109.262 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.07 103.36 15.3 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 173.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.33 101.07 11.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.1 p -88.8 143.33 26.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.374 1.083 . . . . 0.0 109.678 173.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.2 t -139.09 119.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 mt -124.69 141.18 45.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -98.59 136.42 38.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.77 132.96 55.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.362 1.065 . . . . 0.0 108.51 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 pt -130.09 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.155 1.782 . . . . 0.0 109.675 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -34.11 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.37 2.268 . . . . 0.0 110.021 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.85 53.7 0.05 OUTLIER Glycine 0 CA--C 1.526 0.772 0 C-N-CA 128.284 2.849 . . . . 0.0 113.604 -172.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.87 160.88 34.44 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 118.065 0.932 . . . . 0.0 111.459 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -139.2 146.11 40.12 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 126.326 1.85 . . . . 0.0 108.414 -168.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -84.51 -174.49 5.3 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.409 0.683 . . . . 0.0 110.472 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.65 134.58 93.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 166.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.83 132.57 32.98 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -118.69 111.15 18.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -124.7 152.16 44.07 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.421 HD22 ' H ' ' A' ' 92' ' ' THR . 1.4 tt -132.97 153.61 51.28 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 152.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.421 ' H ' HD22 ' A' ' 91' ' ' LEU . 4.3 t -112.8 135.1 53.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.53 114.5 12.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -85.78 111.85 20.54 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.251 1.148 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 C--O 1.238 0.466 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 125.61 12.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.466 2.111 . . . . 0.0 109.056 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.96 166.38 23.15 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 163.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.435 HD11 ' CG ' ' A' ' 26' ' ' TRP . 48.7 mt -66.57 88.68 0.14 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -66.86 -13.65 61.86 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.154 0.982 . . . . 0.0 109.19 171.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.14 4.49 50.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.07 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.94 121.08 11.5 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.073 -1.017 . . . . 0.0 110.027 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -146.83 165.57 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.218 1.007 . . . . 0.0 110.543 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -119.64 150.44 40.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.91 0.884 . . . . 0.0 108.895 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.94 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.961 2.104 . . . . 0.0 107.712 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 55.5 45.23 25.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.821 0.848 . . . . 0.0 110.182 161.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.29 56.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.791 2.036 . . . . 0.0 107.035 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.28 166.64 19.71 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -75.11 7.03 3.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.2 p -125.32 -10.13 6.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 115.18 -167.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.88 166.31 0.9 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 127.324 2.25 . . . . 0.0 109.162 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.89 128.41 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.23 150.28 23.6 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.2 141.73 51.38 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.415 1.486 . . . . 0.0 107.994 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -124.88 142.23 51.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.435 ' CG ' HD11 ' A' ' 9' ' ' LEU . 44.2 p90 -156.78 -173.07 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 164.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -108.74 105.46 57.04 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.927 1.291 . . . . 0.0 108.719 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.43 124.67 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.957 2.438 . . . . 0.0 112.076 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.55 103.55 15.16 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.237 1.015 . . . . 0.0 108.797 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -80.61 49.12 1.13 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.564 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 m -61.93 -64.46 0.93 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.985 -166.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 p 156.69 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.828 2.451 . . . . 0.0 112.305 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.85 -4.38 1.77 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.655 1.982 . . . . 0.0 110.157 -163.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -43.19 134.88 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.184 -1.572 . . . . 0.0 109.724 146.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.56 -43.36 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 124.748 1.219 . . . . 0.0 110.26 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.89 -158.24 31.1 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -129.67 125.09 35.22 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 133.22 35.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 174.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 mp -110.3 149.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.8 m -140.82 158.83 43.39 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.54 125.59 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 103.908 -2.626 . . . . 0.0 103.908 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.31 162.81 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.601 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.68 108.02 19.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 123.222 0.609 . . . . 0.0 112.012 -175.542 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.1 mt . . . . . 0 CA--C 1.539 0.528 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.56 132.42 12.17 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.507 2.138 . . . . 0.0 110.324 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -83.75 -67.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -160.0 175.27 13.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.045 0.938 . . . . 0.0 109.567 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -122.02 123.41 41.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.436 1.494 . . . . 0.0 107.921 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -105.93 165.81 10.94 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.004 1.722 . . . . 0.0 109.968 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.48 163.17 28.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.202 1.001 . . . . 0.0 108.634 169.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 -176.63 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.67 -64.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -164.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 m 153.55 -13.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.735 4.014 . . . . 0.0 111.344 -169.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -135.97 13.49 3.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.985 0.811 . . . . 0.0 112.535 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.41 138.98 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.54 5.5 5.21 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.075 1.798 . . . . 0.0 112.93 173.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -146.04 124.81 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -145.95 162.93 36.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.656 1.583 . . . . 0.0 108.231 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -144.83 131.96 20.48 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.258 -0.901 . . . . 0.0 108.983 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.94 149.18 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 -170.67 2.13 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.902 1.681 . . . . 0.0 107.004 170.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.5 14.56 75.84 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 120.12 1.327 . . . . 0.0 112.758 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.99 153.74 38.39 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.741 0.816 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -122.16 115.77 30.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.938 1.695 . . . . 0.0 106.834 163.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.54 144.73 85.79 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.292 1.995 . . . . 0.0 110.833 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.0 -10.49 58.55 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.469 1.509 . . . . 0.0 113.729 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.87 151.02 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 119.706 1.753 . . . . 0.0 107.041 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -80.61 120.06 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.465 1.506 . . . . 0.0 108.488 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.45 120.29 37.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.158 1.383 . . . . 0.0 108.387 -168.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.78 90.66 7.37 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.034 1.734 . . . . 0.0 107.375 174.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.01 109.52 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -114.43 122.04 45.4 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.133 1.773 . . . . 0.0 111.341 -167.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -134.19 132.32 55.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -164.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 tt -143.41 152.79 16.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.419 1.087 . . . . 0.0 111.216 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.3 m -105.29 134.04 49.07 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 106.894 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.78 134.06 55.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.637 1.575 . . . . 0.0 109.034 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -129.67 175.69 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.91 1.284 . . . . 0.0 107.585 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -46.33 110.02 0.24 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.522 0.601 . . . . 0.0 110.106 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.05 42.69 1.21 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 126.516 2.008 . . . . 0.0 113.392 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.72 144.62 12.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -133.45 118.53 18.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -161.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.22 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.92 133.44 41.31 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.896 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.66 109.76 1.72 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.038 2.492 . . . . 0.0 106.524 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -107.28 102.66 11.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.0 m -94.16 158.75 15.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 tt -132.22 101.92 5.57 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 153.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -84.92 119.19 25.08 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -136.72 153.15 50.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.419 1.487 . . . . 0.0 108.74 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.28 157.92 27.65 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 157.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.25 1.092 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.717 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -133.67 112.77 11.69 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 121.365 1.893 . . . . 0.0 108.363 170.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 51.92 -110.18 1.05 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.5 p -134.4 162.88 30.99 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.968 1.707 . . . . 0.0 107.12 161.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -135.16 -77.75 0.44 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.554 1.07 . . . . 0.0 108.432 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t -70.48 133.89 86.86 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.58 134.77 33.96 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.724 1.616 . . . . 0.0 109.803 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -112.64 160.96 17.36 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.031 2.132 . . . . 0.0 108.577 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.7 mt -70.05 87.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.133 0.973 . . . . 0.0 108.686 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.54 -3.9 30.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.468 1.107 . . . . 0.0 111.249 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.57 6.79 15.91 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.62 1.968 . . . . 0.0 112.937 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -52.23 110.99 0.55 Allowed 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.243 1.417 . . . . 0.0 109.172 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.9 m -155.15 165.14 37.61 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.984 0.914 . . . . 0.0 111.964 170.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.1 m-30 -110.95 149.97 29.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.198 1.399 . . . . 0.0 109.626 -162.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.93 175.76 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 128.248 2.619 . . . . 0.0 108.207 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 t70 46.1 52.91 9.78 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.827 2.051 . . . . 0.0 110.618 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.2 52.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 127.361 2.265 . . . . 0.0 108.468 -166.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -77.31 175.2 9.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 110.125 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.61 -5.53 53.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.316 1.046 . . . . 0.0 111.455 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.6 p -122.72 -8.33 8.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.63 1.972 . . . . 0.0 114.732 -162.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -175.11 175.01 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.04 2.536 . . . . 0.0 108.014 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.9 123.13 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 134.94 11.88 Favored Glycine 0 N--CA 1.467 0.75 0 O-C-N 120.415 -1.428 . . . . 0.0 110.043 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.81 155.43 20.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.845 1.322 . . . . 0.0 108.248 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.01 145.27 50.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 162.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 17.0 p90 -157.79 173.64 16.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.526 1.131 . . . . 0.0 109.472 166.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.0 m -90.99 142.6 27.56 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.642 1.11 . . . . 0.0 108.561 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -81.45 125.26 5.0 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.004 1.037 . . . . 0.0 111.997 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.22 88.65 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.209 1.804 . . . . 0.0 110.431 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -79.73 40.49 0.45 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.755 -0.591 . . . . 0.0 111.077 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -35.03 -64.26 0.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.1 p 159.31 -22.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 128.745 2.818 . . . . 0.0 112.761 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.06 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.592 -1.317 . . . . 0.0 111.273 -153.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 tt -43.27 144.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 109.479 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -83.88 -49.47 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.38 -158.2 28.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.51 140.38 52.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 166.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.8 112.46 20.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.56 144.34 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.6 m -131.51 152.59 50.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 145.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 123.8 0.84 . . . . 0.0 111.674 165.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.44 164.47 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.57 99.84 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.4 121.58 11.21 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.43 1.092 . . . . 0.0 109.475 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.37 -33.18 2.61 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -168.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -138.81 175.96 9.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.022 1.329 . . . . 0.0 108.31 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.04 9.06 78.59 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-O 117.935 -1.48 . . . . 0.0 113.142 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.3 mt -45.69 105.53 0.47 Allowed Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 119.191 1.496 . . . . 0.0 110.257 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.77 165.24 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.96 2.44 . . . . 0.0 109.718 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -122.81 -82.79 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -148.44 163.55 36.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.579 1.081 . . . . 0.0 109.774 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.77 123.82 48.1 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 164.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -106.61 156.62 18.4 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.13 1.772 . . . . 0.0 108.126 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.86 153.73 45.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.817 0.847 . . . . 0.0 109.212 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.32 -176.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.81 -61.5 1.76 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.618 -157.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p 154.19 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 131.14 3.776 . . . . 0.0 109.902 -172.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -123.62 7.55 8.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.904 2.082 . . . . 0.0 111.926 -163.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -74.48 139.31 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 109.638 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.59 -5.65 18.33 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 123.996 0.807 . . . . 0.0 114.638 158.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -139.68 121.12 15.06 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.848 -1.383 . . . . 0.0 110.108 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -134.15 167.41 20.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.5 m -142.24 118.54 10.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.626 -1.296 . . . . 0.0 108.256 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -84.48 143.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 -171.83 2.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.15 69.29 Favored Glycine 0 CA--C 1.522 0.476 0 O-C-N 120.772 -1.205 . . . . 0.0 112.166 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.67 165.34 18.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.809 0.804 . . . . 0.0 110.589 165.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -134.3 135.09 23.38 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 126.731 2.012 . . . . 0.0 107.879 159.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.84 165.44 25.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.376 2.05 . . . . 0.0 112.451 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.22 -28.6 8.58 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 126.906 2.193 . . . . 0.0 111.746 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.2 mm -115.67 165.19 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -96.09 143.0 27.61 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -123.74 128.05 49.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.36 95.2 9.92 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -84.95 104.5 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m -88.09 147.87 24.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.26 1.024 . . . . 0.0 110.313 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.9 t -145.46 77.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.33 133.92 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.6 m -94.47 136.96 34.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.48 113.53 12.59 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.609 1.164 . . . . 0.0 107.95 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -109.3 -175.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.117 1.767 . . . . 0.0 108.696 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -34.58 104.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.092 1.357 . . . . 0.0 110.848 163.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.69 29.25 5.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.61 1.576 . . . . 0.0 115.005 170.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.37 144.48 9.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.342 1.571 . . . . 0.0 110.925 -173.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -110.78 142.12 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.763 2.025 . . . . 0.0 106.534 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.79 174.41 10.46 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.84 0.746 . . . . 0.0 109.362 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.59 135.86 92.82 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.2 128.98 22.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 N-CA-C 107.805 -1.652 . . . . 0.0 107.805 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 m -122.6 99.4 6.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.9 m -94.23 163.41 13.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.4 mt -132.87 136.16 46.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 164.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 m -84.74 127.87 34.32 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.641 1.976 . . . . 0.0 106.23 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -154.86 147.4 24.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.766 1.166 . . . . 0.0 109.301 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.62 168.01 11.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.293 1.044 . . . . 0.0 110.638 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.251 1.133 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.903 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptt? . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -144.19 162.71 35.64 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.868 1.667 . . . . 0.0 110.858 -169.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.87 141.44 47.51 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.1 68.98 0.55 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.373 1.869 . . . . 0.0 110.76 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.35 -60.04 2.78 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.068 1.347 . . . . 0.0 110.326 -170.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -139.72 134.09 15.92 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 164.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.99 143.93 20.94 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.174 2.582 . . . . 0.0 111.705 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 174.68 7.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.432 1.893 . . . . 0.0 111.795 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.6 mt -77.64 85.39 3.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 166.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m -56.28 -35.29 67.31 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.582 -0.698 . . . . 0.0 110.201 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -74.21 5.99 3.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.484 2.314 . . . . 0.0 113.006 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.07 110.71 0.87 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.178 0.991 . . . . 0.0 111.075 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -125.89 164.45 20.74 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.86 0.864 . . . . 0.0 110.28 162.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 10.5 m-85 -90.73 166.16 13.28 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 155.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 177.21 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 127.287 2.235 . . . . 0.0 105.48 168.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.25 56.98 5.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.172 1.389 . . . . 0.0 110.355 161.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mm -78.77 59.82 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -69.07 173.63 5.33 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.408 -1.432 . . . . 0.0 109.945 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -98.88 22.11 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.649 1.179 . . . . 0.0 111.675 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -121.47 -13.73 8.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.263 1.425 . . . . 0.0 114.491 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p 170.48 171.96 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.032 2.133 . . . . 0.0 107.928 -154.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -137.44 147.63 26.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 166.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.53 163.74 23.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.12 159.25 36.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.399 1.48 . . . . 0.0 108.515 168.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -143.66 136.04 26.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -154.66 -177.5 6.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.267 1.027 . . . . 0.0 109.667 172.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -107.11 106.13 57.48 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.41 130.99 28.36 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.0 1.8 . . . . 0.0 110.029 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 31' ' ' SER . 2.2 mt -94.18 89.26 5.91 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.845 2.458 . . . . 0.0 105.018 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.55 50.38 0.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 29' ' ' LEU . 4.2 m -81.85 124.16 29.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.082 1.753 . . . . 0.0 109.847 168.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -63.39 38.52 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 130.159 3.384 . . . . 0.0 114.786 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -169.27 -12.42 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.823 2.049 . . . . 0.0 110.371 -171.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.62 161.06 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.091 1.356 . . . . 0.0 108.809 162.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.91 -59.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.71 -164.73 33.39 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -131.21 145.39 51.91 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.83 130.16 56.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.924 1.69 . . . . 0.0 106.975 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.63 133.15 61.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.7 m -128.67 138.56 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.82 123.23 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.487 1.515 . . . . 0.0 108.335 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.19 163.44 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 124.025 0.828 . . . . 0.0 109.304 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 106.24 17.52 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.09 99.29 0.35 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.499 1.52 . . . . 0.0 109.089 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.06 -18.82 2.91 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.075 -1.403 . . . . 0.0 113.305 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -131.88 -5.42 3.57 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.876 1.338 . . . . 0.0 111.159 168.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.25 -1.24 43.12 Favored Glycine 0 C--N 1.34 0.803 0 O-C-N 121.192 -0.943 . . . . 0.0 113.346 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mt -43.09 106.13 0.46 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 128.261 2.624 . . . . 0.0 109.998 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.57 126.85 13.93 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 122.175 1.917 . . . . 0.0 107.494 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 mm -84.06 -82.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -148.21 175.68 10.86 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.023 -1.048 . . . . 0.0 109.763 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.11 159.83 31.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -148.96 164.86 33.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.622 1.969 . . . . 0.0 107.465 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 153.82 43.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.341 0.656 . . . . 0.0 109.602 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -177.38 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.916 0.78 . . . . 0.0 110.752 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.0 -60.45 2.29 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p 153.64 -41.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 1 C-N-CA 132.504 4.322 . . . . 0.0 107.878 -171.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.6 p -102.48 -1.13 31.2 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.965 1.706 . . . . 0.0 112.902 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.36 129.81 36.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.759 1.223 . . . . 0.0 108.24 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.78 -5.92 21.66 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 125.268 1.413 . . . . 0.0 113.315 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -140.25 116.15 10.33 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.301 1.44 . . . . 0.0 108.321 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.4 136.59 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.3 m -112.19 124.79 53.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.13 165.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.98 1.712 . . . . 0.0 107.629 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.15 -174.29 3.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.45 36.46 30.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.089 0.859 . . . . 0.0 112.536 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.03 162.84 13.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.934 1.293 . . . . 0.0 110.449 171.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.93 135.19 10.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.95 2.5 . . . . 0.0 104.916 162.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.91 170.29 18.3 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.754 2.303 . . . . 0.0 113.099 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.49 -4.83 70.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.772 0.701 . . . . 0.0 113.848 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.9 mm -129.44 147.79 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.944 1.698 . . . . 0.0 106.885 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -84.01 142.85 30.18 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.78 113.69 11.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.301 1.84 . . . . 0.0 106.432 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.402 ' CG ' ' HG1' ' A' ' 92' ' ' THR . 1.6 m-20 -84.21 103.17 13.19 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.921 1.688 . . . . 0.0 107.086 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.401 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 1.5 mp -92.23 107.7 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 80.7 p -92.78 143.56 26.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.289 1.036 . . . . 0.0 110.957 172.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.46 119.19 16.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mt -117.83 129.67 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.0 m -89.77 132.43 35.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.72 126.74 48.14 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.19 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.69 108.72 0.07 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.476 1.91 . . . . 0.0 110.339 169.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.75 26.13 1.05 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.741 1.638 . . . . 0.0 115.543 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.03 159.44 28.04 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.69 1.745 . . . . 0.0 111.688 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.61 141.6 49.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.137 1.775 . . . . 0.0 108.645 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -85.32 -172.62 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.741 0.816 . . . . 0.0 110.252 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.91 136.03 93.23 Favored Pre-proline 0 C--O 1.24 0.578 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.427 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.2 87.45 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.031 3.154 . . . . 0.0 108.482 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.2 m -84.72 92.13 8.12 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -164.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 1.4 m -94.56 150.4 20.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 69.8 mt -134.88 144.47 47.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 160.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.402 ' HG1' ' CG ' ' A' ' 74' ' ' ASP . 0.5 OUTLIER -125.23 129.2 49.59 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -153.57 130.41 10.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 107.573 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.07 137.5 38.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.593 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -68.16 22.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 117.109 2.263 . . . . 0.0 117.109 -164.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 67.88 61.72 4.75 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -170.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -171.26 75.05 0.06 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -171.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.78 -106.06 0.21 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.441 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.19 133.87 29.43 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.38 141.69 39.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.683 1.588 . . . . 0.0 109.429 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.08 161.53 15.81 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.127 2.171 . . . . 0.0 110.404 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.3 mt -66.93 83.89 0.11 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.132 0.973 . . . . 0.0 109.375 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 m -71.91 1.0 7.82 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.884 1.674 . . . . 0.0 111.175 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -111.74 4.34 18.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.317 2.647 . . . . 0.0 111.693 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.67 114.81 4.21 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.563 1.945 . . . . 0.0 110.195 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -151.11 164.84 35.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.617 0.767 . . . . 0.0 111.19 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.434 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 10.3 m-30 -97.29 160.12 14.52 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.511 -0.743 . . . . 0.0 109.212 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.4 170.6 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.841 1.656 . . . . 0.0 107.526 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.7 47.83 17.69 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.836 1.654 . . . . 0.0 109.706 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -80.45 63.01 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -72.18 165.05 25.17 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -74.51 -3.05 28.53 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.331 -0.856 . . . . 0.0 111.212 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -105.51 -16.17 14.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.05 153.18 0.22 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 127.212 2.205 . . . . 0.0 107.924 -169.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.7 138.39 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.79 156.6 23.14 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 171.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.415 HD12 ' CD2' ' A' ' 62' ' ' TYR . 2.1 mp -122.59 154.52 37.84 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -137.8 139.93 40.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -152.95 175.0 13.42 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.073 0.949 . . . . 0.0 108.555 167.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -92.36 107.49 24.0 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.019 1.327 . . . . 0.0 108.094 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.3 134.68 49.87 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.991 -1.196 . . . . 0.0 108.991 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -88.88 -30.04 19.18 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.425 -1.274 . . . . 0.0 112.867 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 p30 42.43 37.69 1.02 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.607 1.192 . . . . 0.0 112.298 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -62.43 170.24 2.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 0.0 110.139 -167.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 p -67.66 -2.2 6.47 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.08 -4.16 0.06 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.401 -1.437 . . . . 0.0 112.925 -164.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.77 145.22 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 163.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.61 -65.94 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 160.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.61 -154.15 12.37 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -163.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -136.24 144.01 44.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -118.9 123.13 43.9 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mp -103.83 146.87 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 m -145.77 112.45 5.94 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.338 1.455 . . . . 0.0 108.699 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.14 131.69 43.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.718 0.807 . . . . 0.0 110.703 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.2 164.23 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.75 114.21 20.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.75 -6.04 3.29 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.285 1.434 . . . . 0.0 113.315 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.43 -17.08 47.31 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.583 -1.121 . . . . 0.0 114.726 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -150.83 17.04 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.691 1.745 . . . . 0.0 111.742 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.62 1.52 8.71 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.836 -1.165 . . . . 0.0 114.407 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 mt -45.55 106.24 0.53 Allowed Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 127.778 2.431 . . . . 0.0 109.743 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.28 124.02 8.14 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.932 2.421 . . . . 0.0 110.111 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.29 -59.63 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.9 169.22 18.45 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.193 0.906 . . . . 0.0 110.787 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -106.83 157.0 18.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.411 1.484 . . . . 0.0 108.4 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -152.42 166.06 33.12 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.314 1.446 . . . . 0.0 107.828 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.76 161.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.854 1.262 . . . . 0.0 109.979 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.91 -176.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.768 1.627 . . . . 0.0 107.744 172.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -83.69 -61.96 1.7 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.971 -162.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.6 t 155.23 -43.07 0.01 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 130.534 3.534 . . . . 0.0 107.868 -166.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -97.86 -5.73 33.99 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.242 1.417 . . . . 0.0 113.816 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.89 126.05 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.33 -5.58 37.08 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 127.591 2.519 . . . . 0.0 111.637 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -137.76 114.22 10.31 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.296 -1.708 . . . . 0.0 110.573 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.415 ' CD2' HD12 ' A' ' 24' ' ' LEU . 7.4 t80 -139.21 159.24 42.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.315 1.846 . . . . 0.0 107.719 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -147.08 151.21 36.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.04 145.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -168.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.36 -176.4 3.5 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.8 68.75 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 113.565 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.02 144.67 56.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -123.45 98.11 41.45 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.37 166.07 29.57 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.188 1.925 . . . . 0.0 112.609 -159.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.21 -4.67 80.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.001 1.286 . . . . 0.0 113.436 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.44 152.21 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -79.0 111.58 15.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.35 124.44 52.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.14 1.376 . . . . 0.0 109.389 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.33 126.58 33.33 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 169.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.434 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 3.0 mp -110.52 96.43 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.76 133.1 34.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.617 1.567 . . . . 0.0 108.617 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.9 130.5 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -134.85 147.75 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.7 m -94.24 137.69 33.12 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.73 128.43 55.27 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.379 . . . . 0.0 107.541 -175.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 pt -134.23 177.27 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.966 0.906 . . . . 0.0 108.588 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.69 110.43 0.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.821 0.848 . . . . 0.0 111.264 169.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.74 21.72 7.53 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.488 1.994 . . . . 0.0 114.708 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 157.33 29.75 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 119.583 1.691 . . . . 0.0 110.992 -161.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.041 0.937 . . . . 0.0 109.9 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 m -84.3 -172.6 4.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.03 0.919 . . . . 0.0 111.015 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.63 96.24 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.19 130.49 16.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.268 1.979 . . . . 0.0 108.783 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.2 m -103.61 107.92 18.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 165.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.9 m -111.93 84.69 2.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 mt -77.64 153.04 33.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.77 139.76 50.26 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -147.88 130.42 15.85 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.939 0.896 . . . . 0.0 109.725 157.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.49 122.47 21.34 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 154.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.017 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -164.4 -28.64 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.018 -1.051 . . . . 0.0 110.754 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.71 -124.62 1.11 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 174.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -78.18 -165.24 0.64 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.37 1.068 . . . . 0.0 109.516 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -99.14 -80.27 0.47 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.019 163.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.7 t -119.18 132.93 23.77 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 168.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.0 133.46 8.97 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.608 2.872 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.46 174.89 6.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.75 1.22 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.5 mt -67.9 75.85 0.21 Allowed 'General case' 0 C--N 1.34 0.152 0 C-N-CA 125.988 1.715 . . . . 0.0 109.523 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.8 m -54.13 -27.24 32.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.748 1.619 . . . . 0.0 110.465 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.51 -0.29 49.63 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 114.759 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.0 115.51 2.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.317 1.047 . . . . 0.0 110.904 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.4 165.19 28.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.338 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -117.57 154.06 32.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 108.341 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.78 171.19 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.061 1.744 . . . . 0.0 107.782 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 51.11 52.15 15.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.24 1.816 . . . . 0.0 110.767 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -78.83 55.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.923 2.489 . . . . 0.0 108.591 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -69.12 167.31 16.35 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.449 -1.407 . . . . 0.0 111.451 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -74.61 6.04 4.23 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.427 1.491 . . . . 0.0 111.846 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -125.7 -12.7 6.57 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 p -174.89 159.73 2.76 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.702 1.201 . . . . 0.0 109.42 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 tt -118.21 141.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.16 153.97 21.66 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.72 151.36 39.64 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 126.309 1.844 . . . . 0.0 107.81 169.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -142.32 138.18 31.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -154.13 -170.87 3.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.547 0.689 . . . . 0.0 109.308 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -106.05 105.53 53.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.773 1.229 . . . . 0.0 107.795 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -66.05 133.96 35.19 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.077 1.851 . . . . 0.0 110.841 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mp -94.93 104.58 16.47 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 125.893 1.677 . . . . 0.0 109.833 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.33 41.44 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.015 1.326 . . . . 0.0 110.532 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.6 m -65.3 155.29 35.69 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 160.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -77.5 -50.25 13.03 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.581 0.705 . . . . 0.0 110.791 166.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.39 -24.5 57.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.091 1.357 . . . . 0.0 113.272 -161.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.31 136.51 6.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 126.573 1.949 . . . . 0.0 108.247 171.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.35 -64.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.18 -161.88 26.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.47 146.42 50.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 127.35 46.13 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.07 145.62 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.8 m -134.89 121.35 20.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.4 125.9 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.64 164.31 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 129.92 38.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.79 -23.26 62.35 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.725 -0.61 . . . . 0.0 110.134 166.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.89 -45.24 96.59 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 123.444 0.545 . . . . 0.0 112.246 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 48' ' ' ILE . 57.0 tt0 -155.3 141.65 18.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.53 19.12 0.4 Allowed Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.732 2.11 . . . . 0.0 115.343 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.403 ' H ' ' C ' ' A' ' 46' ' ' GLU . 30.5 mt -46.13 106.68 0.59 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.484 1.914 . . . . 0.0 109.569 151.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.93 156.4 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.51 1.473 . . . . 0.0 109.308 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 mm -93.64 -80.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 166.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -156.39 175.8 13.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.464 1.506 . . . . 0.0 109.659 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -126.72 161.96 26.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.207 1.003 . . . . 0.0 109.587 168.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.445 ' CG ' ' HH ' ' A' ' 62' ' ' TYR . 2.0 p30 -150.81 167.11 28.47 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.674 1.59 . . . . 0.0 110.458 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.44 160.16 32.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.743 1.217 . . . . 0.0 109.056 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -177.77 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.65 -61.5 1.82 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -157.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.0 p 166.29 -29.42 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 130.546 3.538 . . . . 0.0 111.42 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -136.26 28.37 3.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.408 0.623 . . . . 0.0 111.298 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -73.36 136.51 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.19 -5.15 17.54 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 124.221 0.915 . . . . 0.0 113.822 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -145.5 128.17 16.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 106.612 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.445 ' HH ' ' CG ' ' A' ' 53' ' ' ASP . 17.0 t80 -139.56 159.83 41.26 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.968 -1.082 . . . . 0.0 108.892 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.0 m -131.92 136.68 47.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.634 1.174 . . . . 0.0 108.645 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.13 131.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 126.404 1.882 . . . . 0.0 106.201 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -99.95 -167.76 1.5 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 165.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.7 32.2 61.79 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 121.013 -1.055 . . . . 0.0 110.95 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.25 157.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 107.968 166.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -144.7 119.93 5.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.11 175.54 6.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -167.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.53 61.44 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.154 -0.803 . . . . 0.0 114.217 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mm -118.01 149.95 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.1 141.02 34.71 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.67 120.74 31.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.756 2.022 . . . . 0.0 108.209 -166.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.59 106.17 15.95 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.48 108.21 20.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -93.58 139.28 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 109.178 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.39 109.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -106.64 134.17 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 m -94.66 134.56 37.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.17 129.1 51.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 107.73 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 pt -116.63 179.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -39.64 112.75 0.28 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 118.36 -0.829 . . . . 0.0 109.577 169.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.79 60.7 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 C-N-CA 127.054 2.264 . . . . 0.0 113.381 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -166.91 144.97 9.47 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -122.99 140.58 52.88 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.107 1.363 . . . . 0.0 108.018 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -84.82 -170.5 3.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.707 0.765 . . . . 0.0 110.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.83 134.73 96.13 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 160.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.77 107.56 2.47 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.33 2.686 . . . . 0.0 110.566 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 106.62 16.33 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -175.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.5 m -115.29 132.88 56.47 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 mt -124.83 107.44 10.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.06 144.6 33.03 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.702 1.601 . . . . 0.0 108.955 174.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -165.63 160.63 17.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.971 0.909 . . . . 0.0 110.738 163.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -93.19 112.37 24.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.255 1.344 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -169.816 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.5 mtt . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.59 145.16 40.24 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 120.296 1.407 . . . . 0.0 110.008 169.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.26 77.47 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.5 p -137.26 141.65 41.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.363 0.582 . . . . 0.0 110.483 165.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.18 -100.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t -133.21 135.02 24.83 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 127.431 2.293 . . . . 0.0 104.838 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.74 121.1 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.52 2.147 . . . . 0.0 109.677 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.65 ' NE2' ' HG1' ' A' ' 89' ' ' THR . 0.0 OUTLIER -76.41 171.05 15.23 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.615 0.766 . . . . 0.0 109.908 163.265 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.0 mt -76.35 86.13 3.12 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -60.61 -20.31 60.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.117 0.567 . . . . 0.0 111.762 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.85 1.85 57.07 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.896 1.226 . . . . 0.0 112.255 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -54.29 116.23 2.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.225 1.41 . . . . 0.0 110.547 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -142.98 159.24 42.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.639 1.576 . . . . 0.0 109.648 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -106.84 155.17 20.02 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.74 173.21 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 129.13 2.972 . . . . 0.0 108.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.9 58.87 3.4 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.434 1.094 . . . . 0.0 111.689 171.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 mm -76.1 48.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 108.269 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -69.76 166.99 18.1 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.745 -1.222 . . . . 0.0 108.898 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.95 -4.76 37.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.353 -1.467 . . . . 0.0 112.211 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 p -119.56 -10.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.233 1.813 . . . . 0.0 114.79 -168.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.81 168.36 2.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.618 1.167 . . . . 0.0 109.916 -167.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.1 tt -135.98 135.05 50.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.6 162.58 26.78 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD11 ' CD2' ' A' ' 62' ' ' TYR . 2.7 mp -135.2 148.54 49.69 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.922 1.289 . . . . 0.0 108.42 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.36 145.55 51.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 164.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -153.97 179.94 8.44 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -100.42 141.87 23.54 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -75.95 123.92 7.67 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.525 1.483 . . . . 0.0 109.06 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.06 -41.09 26.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.091 0.957 . . . . 0.0 112.697 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 37.86 48.61 1.03 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.282 1.833 . . . . 0.0 113.175 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 m -54.26 -62.84 1.4 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.501 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 p -178.45 -104.45 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.39 1.076 . . . . 0.0 108.824 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.1 -4.4 44.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.936 2.095 . . . . 0.0 110.268 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.21 128.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 126.797 2.039 . . . . 0.0 112.857 173.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.49 -61.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.7 -160.89 25.53 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.142 -1.027 . . . . 0.0 112.277 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -130.39 139.68 50.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 114.52 20.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -92.69 144.62 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.2 m -138.39 127.85 24.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.3 144.87 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 118.731 0.696 . . . . 0.0 110.081 163.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.51 164.79 30.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 167.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.06 125.1 28.85 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.31 95.37 0.43 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.46 -17.48 3.31 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.1 -0.833 . . . . 0.0 114.562 172.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 48' ' ' ILE . 9.3 tt0 -145.34 154.54 42.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.544 1.672 . . . . 0.0 108.436 162.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.54 12.49 1.92 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.218 0.913 . . . . 0.0 113.837 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 46' ' ' GLU . 85.9 mt -45.53 105.13 0.44 Allowed Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 129.333 3.053 . . . . 0.0 109.176 166.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -89.87 157.51 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.869 2.38 . . . . 0.0 110.757 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mm -133.43 65.76 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.432 1.9 p90 54.59 175.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.909 1.284 . . . . 0.0 114.318 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.14 125.32 36.83 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -105.45 163.63 12.49 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.83 162.41 31.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.015 1.326 . . . . 0.0 107.984 175.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.38 -177.35 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 171.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.42 -66.07 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.297 0.639 . . . . 0.0 110.876 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 157.22 -41.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 128.452 2.701 . . . . 0.0 108.534 -157.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -121.35 15.71 11.33 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.449 -1.407 . . . . 0.0 110.024 -164.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -74.85 141.26 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.746 0.818 . . . . 0.0 110.325 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.48 0.49 14.1 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.431 1.491 . . . . 0.0 114.473 160.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -145.55 128.38 16.34 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.654 1.227 . . . . 0.0 110.077 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 24' ' ' LEU . 13.7 t80 -149.59 169.06 21.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.654 1.182 . . . . 0.0 109.802 -176.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -151.49 140.35 20.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.616 1.567 . . . . 0.0 109.842 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.58 152.62 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 125.941 1.696 . . . . 0.0 108.147 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.446 ' CG2' ' H ' ' A' ' 66' ' ' GLY . 22.1 m -134.45 -170.1 2.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.922 1.689 . . . . 0.0 106.627 172.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.446 ' H ' ' CG2' ' A' ' 65' ' ' THR . . . 67.64 25.75 73.89 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.045 -1.034 . . . . 0.0 111.911 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.75 164.73 21.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.24 1.816 . . . . 0.0 108.744 164.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.03 104.61 10.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.624 2.37 . . . . 0.0 107.523 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.17 140.2 44.28 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.427 2.085 . . . . 0.0 112.41 -163.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.27 -8.26 55.16 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 126.51 2.005 . . . . 0.0 112.711 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.8 158.52 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 162.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -98.74 129.31 45.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.35 1.86 . . . . 0.0 106.901 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -120.24 133.85 55.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.162 0.985 . . . . 0.0 108.745 -170.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.29 116.45 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 160.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.82 104.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -92.81 145.02 24.71 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.338 1.455 . . . . 0.0 111.177 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.2 t -145.18 97.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.2 mt -100.74 129.76 51.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.4 m -92.99 125.98 37.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.44 123.35 39.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.667 1.587 . . . . 0.0 108.478 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.85 -164.85 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.159 1.383 . . . . 0.0 109.463 -170.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -39.56 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.551 0.74 . . . . 0.0 111.964 157.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.1 31.35 4.36 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.437 1.97 . . . . 0.0 114.306 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.66 144.59 11.83 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 119.162 1.481 . . . . 0.0 110.144 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.14 142.49 39.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.338 1.455 . . . . 0.0 108.447 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.18 -176.96 6.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.62 151.33 92.31 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.77 103.96 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.615 2.21 . . . . 0.0 108.471 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.65 ' HG1' ' NE2' ' A' ' 8' ' ' GLN . 1.5 m -84.06 97.92 9.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 171.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -122.87 126.31 47.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.36 143.28 47.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 m -100.82 110.33 22.4 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -108.35 123.45 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.207 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -75.51 134.12 40.86 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 149.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.345 1.458 . . . . 0.0 107.424 -178.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.05 178.22 9.67 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 165.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 114.85 -149.44 18.85 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.0 p -69.16 93.66 0.62 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.32 -64.93 0.77 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.043 1.337 . . . . 0.0 109.642 -169.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.2 133.96 20.6 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.24 128.51 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.498 2.132 . . . . 0.0 111.591 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -104.77 178.09 4.66 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 127.776 2.431 . . . . 0.0 110.356 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.04 83.32 5.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.326 1.05 . . . . 0.0 110.232 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -65.03 -21.35 66.82 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.76 1.624 . . . . 0.0 113.561 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -97.85 8.38 44.81 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.06 1.744 . . . . 0.0 111.633 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.22 102.25 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 109.299 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -135.74 132.01 36.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.53 1.132 . . . . 0.0 109.194 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.81 157.14 35.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.09 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.422 1.089 . . . . 0.0 108.672 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 49.92 44.58 25.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.921 1.688 . . . . 0.0 109.689 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.74 65.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 129.493 3.117 . . . . 0.0 106.762 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -57.96 166.99 1.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.494 1.517 . . . . 0.0 109.717 162.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.85 3.39 8.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.391 1.476 . . . . 0.0 112.517 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 p -117.51 -13.66 10.31 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -172.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.14 161.96 0.78 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.547 1.539 . . . . 0.0 110.088 -162.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 tt -130.22 125.85 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.81 159.2 34.27 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -136.71 138.96 41.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 126.698 1.999 . . . . 0.0 107.422 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.3 mtp-105 -112.12 157.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 160.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -162.02 -173.75 3.81 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.982 2.513 . . . . 0.0 106.98 160.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.78 142.15 24.19 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 120.682 1.583 . . . . 0.0 107.885 171.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -75.13 124.41 8.52 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.673 1.582 . . . . 0.0 108.631 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 31' ' ' SER . 14.2 mt -89.68 83.18 6.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -75.76 43.55 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.629 0.649 . . . . 0.0 111.344 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 29' ' ' LEU . 10.4 p -47.86 -60.73 2.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.404 1.082 . . . . 0.0 113.393 -165.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 p 165.99 -61.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.109 0.964 . . . . 0.0 110.141 -152.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.48 -3.46 0.72 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.541 1.936 . . . . 0.0 109.52 -156.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.12 121.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.86 1.664 . . . . 0.0 110.71 164.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 -56.22 5.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.32 -160.55 21.1 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.88 151.31 49.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 164.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 114.85 20.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.905 1.682 . . . . 0.0 107.501 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.49 142.57 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -145.4 113.18 6.38 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.43 130.57 56.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.175 1.39 . . . . 0.0 109.982 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 164.01 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.28 109.17 20.27 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 41.71 -151.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.428 1.891 . . . . 0.0 111.425 -170.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.26 8.88 15.29 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.654 1.121 . . . . 0.0 113.914 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.14 173.49 9.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.388 1.594 . . . . 0.0 109.503 -166.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.35 -34.77 75.91 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.771 169.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.2 mt -45.0 101.21 0.25 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 127.815 2.446 . . . . 0.0 111.383 -172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.65 156.3 35.72 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.077 2.518 . . . . 0.0 108.927 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.52 -61.86 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 166.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -160.49 158.67 29.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.447 0.699 . . . . 0.0 109.681 -163.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.61 141.75 30.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -143.84 166.59 24.49 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.85 1.26 . . . . 0.0 110.652 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.53 154.65 47.59 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.417 -1.72 . . . . 0.0 106.868 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -176.91 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.451 1.101 . . . . 0.0 108.286 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.51 -63.11 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -165.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p 152.42 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.684 4.393 . . . . 0.0 107.736 -173.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.1 p -88.57 1.41 55.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.672 1.189 . . . . 0.0 112.625 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.12 134.56 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 125.366 1.466 . . . . 0.0 108.026 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.91 1.6 9.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 0.0 112.963 162.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -143.19 125.82 15.91 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.183 1.393 . . . . 0.0 107.782 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.49 165.1 28.42 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.5 m -141.72 125.8 17.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.99 152.96 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.862 1.665 . . . . 0.0 107.263 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -157.92 0.75 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 173.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.51 38.39 90.97 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 120.214 1.37 . . . . 0.0 112.353 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.21 154.92 30.3 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.18 1.792 . . . . 0.0 107.482 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.87 107.08 4.59 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 125.629 1.572 . . . . 0.0 107.285 -173.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.58 176.18 9.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.651 2.9 . . . . 0.0 113.454 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.53 4.38 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 124.705 1.145 . . . . 0.0 112.099 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.85 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -74.51 136.11 42.2 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.245 1.818 . . . . 0.0 108.894 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -122.39 141.58 51.43 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.86 111.05 22.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.42 101.49 12.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.1 m -94.91 144.53 25.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 110.504 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.9 t -139.55 98.3 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.29 139.83 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.8 m -105.37 133.83 49.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.51 127.73 41.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 pt -134.7 -167.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 110.319 -172.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -34.72 110.92 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.813 2.045 . . . . 0.0 110.531 166.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 27.26 51.8 0.08 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 127.547 2.498 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 160.59 31.06 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.22 1.01 . . . . 0.0 111.25 -163.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -144.88 145.19 31.48 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 127.057 2.143 . . . . 0.0 105.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.86 -176.21 4.37 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.06 147.21 80.9 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.95 99.09 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.308 2.005 . . . . 0.0 108.082 171.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -83.78 119.26 24.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -131.68 137.79 48.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.92 136.2 55.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -135.66 179.33 6.4 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -167.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 76.68 144.43 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.669 2.388 . . . . 0.0 107.591 -168.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -63.1 -84.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 108.832 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 C--O 1.242 0.673 0 C-N-CA 128.526 2.73 . . . . 0.0 112.573 -160.6 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.95 34.98 1.01 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.795 1.638 . . . . 0.0 111.607 -172.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.31 -162.17 19.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 125.832 1.682 . . . . 0.0 109.712 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.2 p -147.8 69.5 1.13 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.266 2.226 . . . . 0.0 105.485 -169.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.09 -35.01 74.26 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.314 0.645 . . . . 0.0 112.175 -157.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.0 t -116.78 134.37 22.95 Favored Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.76 109.31 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.362 2.708 . . . . 0.0 109.533 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.84 157.62 17.8 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.246 1.818 . . . . 0.0 107.912 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.3 76.65 0.54 Allowed 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 m -57.86 -30.54 65.89 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.655 -0.653 . . . . 0.0 110.637 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.96 -0.44 31.03 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.156 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -53.85 125.67 19.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.993 0.917 . . . . 0.0 109.778 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -148.03 149.53 32.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.494 1.118 . . . . 0.0 109.802 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.447 ' CE2' ' HB ' ' A' ' 75' ' ' ILE . 16.1 m-30 -112.78 145.53 40.41 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.848 1.204 . . . . 0.0 107.876 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.71 170.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 125.877 1.671 . . . . 0.0 108.305 -170.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 53.06 44.64 30.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.852 1.661 . . . . 0.0 109.569 171.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.83 64.79 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.779 2.432 . . . . 0.0 107.731 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -77.02 164.54 25.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.897 0.879 . . . . 0.0 109.406 168.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.48 7.44 3.63 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.633 -1.292 . . . . 0.0 112.342 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -123.91 -13.82 7.28 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.033 -1.042 . . . . 0.0 113.74 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -175.33 160.59 2.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.829 2.452 . . . . 0.0 108.096 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.25 133.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.63 152.71 20.67 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mp -129.25 155.17 46.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.91 1.284 . . . . 0.0 109.286 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -139.69 151.72 46.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.477 1.111 . . . . 0.0 108.194 169.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -159.06 -165.41 1.6 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.059 1.344 . . . . 0.0 107.928 165.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -112.75 106.89 55.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.07 1.748 . . . . 0.0 107.491 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.14 124.31 10.39 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.518 2.145 . . . . 0.0 111.856 -174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mt -95.96 100.99 12.61 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.048 1.739 . . . . 0.0 107.481 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -80.47 40.98 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.22 0.608 . . . . 0.0 110.384 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -59.24 -35.53 73.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.009 -1.472 . . . . 0.0 114.704 -159.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 p 154.34 -98.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 128.901 2.881 . . . . 0.0 108.791 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.68 -4.02 47.03 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.058 2.543 . . . . 0.0 108.975 -172.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.49 125.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 128.043 2.537 . . . . 0.0 110.171 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.02 -57.98 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -168.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.93 -158.29 23.19 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -130.59 137.02 49.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 171.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.19 110.87 23.04 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 107.554 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -86.75 153.86 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m -144.29 147.88 34.09 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.65 2.38 . . . . 0.0 105.775 173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.53 130.27 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 123.581 0.752 . . . . 0.0 109.975 170.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.75 164.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.006 171.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.36 111.5 20.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.75 105.56 1.6 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.298 1.439 . . . . 0.0 108.738 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.07 -26.34 1.43 Allowed Glycine 0 CA--C 1.519 0.339 0 O-C-N 121.223 -0.923 . . . . 0.0 111.002 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.9 -4.03 2.49 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.57 0.685 . . . . 0.0 110.575 161.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.97 13.85 35.7 Favored Glycine 0 CA--C 1.527 0.795 0 O-C-N 120.392 -1.442 . . . . 0.0 111.996 -171.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mt -46.48 106.21 0.55 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 127.584 2.353 . . . . 0.0 108.883 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.73 137.65 30.34 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.54 1.493 . . . . 0.0 110.201 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -89.13 -73.52 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.3 175.42 13.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.661 0.743 . . . . 0.0 110.196 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.63 156.9 47.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 165.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -155.67 166.06 34.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.968 1.307 . . . . 0.0 107.505 -167.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.44 175.15 5.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.642 0.734 . . . . 0.0 109.932 -173.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.75 -177.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 156.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.25 -67.56 0.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.743 1.617 . . . . 0.0 112.941 -166.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.4 p 154.71 -20.41 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.568 3.147 . . . . 0.0 114.137 -165.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.3 p -142.34 26.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.449 1.477 . . . . 0.0 112.137 168.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.54 133.35 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.53 -3.27 27.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.779 1.657 . . . . 0.0 113.593 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.78 123.15 8.4 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.632 1.573 . . . . 0.0 107.248 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.84 164.62 27.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.489 1.116 . . . . 0.0 108.351 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -141.89 134.97 29.01 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.58 152.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.114 1.766 . . . . 0.0 107.059 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.43 171.43 11.56 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.33 24.71 33.15 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.516 1.055 . . . . 0.0 112.031 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.72 156.03 19.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.502 1.521 . . . . 0.0 108.547 163.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.15 134.55 16.79 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.611 1.964 . . . . 0.0 107.506 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.72 161.35 27.62 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.764 1.643 . . . . 0.0 114.33 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.09 64.49 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.271 1.415 . . . . 0.0 113.519 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.52 145.45 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.973 1.309 . . . . 0.0 108.201 -170.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -81.47 129.42 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.318 1.847 . . . . 0.0 106.031 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -117.34 128.18 54.79 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.26 88.44 7.49 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.447 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 2.7 mp -84.43 116.9 28.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.41 139.91 49.6 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.467 1.907 . . . . 0.0 107.916 -165.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.0 t -145.6 111.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -170.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.8 mt -105.43 144.71 14.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 m -105.14 142.79 34.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 166.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.65 118.4 19.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.175 1.79 . . . . 0.0 107.851 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 pt -117.17 -168.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.546 0.739 . . . . 0.0 110.184 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -48.98 105.35 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.531 165.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.53 35.25 15.59 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 124.653 1.121 . . . . 0.0 113.48 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.67 144.92 10.41 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -167.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.93 144.94 48.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 m -84.14 -165.36 1.13 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.47 163.0 18.73 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.077 -1.639 . . . . 0.0 108.627 168.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.75 108.79 2.34 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.835 1.69 . . . . 0.0 109.435 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.49 86.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.5 m -94.56 146.28 24.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 121.2 23.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 140.51 29.65 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -154.03 161.94 41.57 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.555 0.742 . . . . 0.0 109.219 161.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -97.66 173.12 7.29 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.462 1.105 . . . . 0.0 109.587 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 C--O 1.256 1.404 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 159.509 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 117.922 -1.037 . . . . 0.0 108.878 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -133.58 174.9 9.93 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.207 1.403 . . . . 0.0 108.576 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.02 151.94 0.91 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.184 0.897 . . . . 0.0 111.394 -175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p 95.79 148.0 0.02 OUTLIER 'General case' 0 C--O 1.238 0.46 1 C-N-CA 132.619 4.368 . . . . 0.0 108.78 -168.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -130.41 -63.83 0.87 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.08 0.952 . . . . 0.0 110.199 -171.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.6 t -126.79 134.06 25.68 Favored Pre-proline 0 C--O 1.239 0.549 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.01 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.669 2.246 . . . . 0.0 109.62 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -83.14 178.5 8.08 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.4 mt -77.72 91.56 4.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 161.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.7 p -61.09 -57.47 12.4 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.149 1.379 . . . . 0.0 108.687 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.9 18.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.045 2.538 . . . . 0.0 113.064 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.56 121.41 8.35 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.736 1.215 . . . . 0.0 108.994 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -154.49 164.89 37.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.056 1.742 . . . . 0.0 109.667 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -122.86 152.23 40.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.74 168.85 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.824 1.65 . . . . 0.0 108.501 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 46.72 63.49 1.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.938 2.095 . . . . 0.0 109.494 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.88 65.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -81.23 171.97 14.21 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.896 1.278 . . . . 0.0 109.762 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.09 -0.73 20.06 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p -125.47 -6.01 7.04 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.38 170.85 2.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.631 1.972 . . . . 0.0 108.711 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -132.8 131.78 59.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 162.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.15 149.85 28.3 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -123.33 151.3 42.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 106.362 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -136.18 145.03 45.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -156.91 -173.98 4.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.759 1.224 . . . . 0.0 108.9 168.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 m -109.09 106.19 58.39 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.7 123.6 9.94 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 121.543 1.495 . . . . 0.0 110.481 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -76.14 94.72 3.54 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.554 2.342 . . . . 0.0 105.186 166.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -77.66 38.87 0.26 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.991 0.916 . . . . 0.0 109.225 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 29' ' ' LEU . 29.2 m -74.34 -2.82 26.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -159.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p 70.53 -57.91 0.57 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.156 2.582 . . . . 0.0 113.629 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.39 -28.99 69.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 111.525 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.91 134.59 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.395 1.878 . . . . 0.0 109.825 170.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 mp -84.4 -65.05 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.82 -160.11 19.63 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -127.89 133.22 49.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.63 127.6 54.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 107.271 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.75 152.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 m -138.26 153.69 49.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.267 2.227 . . . . 0.0 106.417 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.36 126.82 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 125.378 1.471 . . . . 0.0 107.55 171.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.18 164.65 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.93 101.94 13.75 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 47.65 -150.99 0.11 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.605 1.962 . . . . 0.0 112.389 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.37 8.62 31.99 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 120.44 -1.412 . . . . 0.0 113.036 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -80.32 -6.23 57.63 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.885 2.342 . . . . 0.0 112.155 -167.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.93 -20.88 6.08 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 126.585 2.04 . . . . 0.0 113.007 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.6 mt -44.04 105.19 0.42 Allowed Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 129.354 3.062 . . . . 0.0 108.486 163.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.29 168.2 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.224 1.949 . . . . 0.0 109.015 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.2 mm -111.0 -73.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.502 -2.406 . . . . 0.0 104.502 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -160.14 175.52 12.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.711 1.605 . . . . 0.0 107.916 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.0 159.37 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -152.61 166.03 33.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.053 0.941 . . . . 0.0 110.437 -166.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.15 160.02 33.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.879 0.872 . . . . 0.0 110.302 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.89 -178.32 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 161.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -68.57 -71.3 0.22 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.929 0.871 . . . . 0.0 112.01 -156.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 p 177.07 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.917 3.287 . . . . 0.0 111.183 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -127.32 16.11 7.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.13 130.21 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.03 -6.13 32.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.226 0.917 . . . . 0.0 114.557 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -143.44 125.62 15.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.723 1.209 . . . . 0.0 108.957 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -139.45 160.6 39.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.235 1.414 . . . . 0.0 109.285 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.2 m -134.1 121.46 21.52 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.49 -1.381 . . . . 0.0 107.698 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.3 155.24 3.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 -168.62 1.92 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.866 1.267 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.37 9.96 84.44 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.798 -1.189 . . . . 0.0 113.327 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.5 157.6 30.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.73 133.24 9.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.3 -177.61 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.004 2.469 . . . . 0.0 112.762 -172.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.81 56.82 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.804 2.145 . . . . 0.0 112.199 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mm -131.5 152.14 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 126.416 1.886 . . . . 0.0 107.111 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -94.71 109.84 21.75 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -94.71 124.17 38.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.7 91.66 8.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.51 101.7 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.49 141.93 30.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.652 1.181 . . . . 0.0 109.609 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -140.79 116.19 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . 0.347 0.0 OUTLIER -121.75 145.92 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.9 m -106.04 128.05 53.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.791 2.036 . . . . 0.0 108.179 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.2 123.71 38.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 0.0 108.925 -173.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 pt -116.61 -173.93 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.065 1.346 . . . . 0.0 109.653 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -34.74 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.394 1.878 . . . . 0.0 111.105 166.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.07 61.5 0.06 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.713 2.102 . . . . 0.0 111.707 -171.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.45 144.79 10.76 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -126.38 124.22 39.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.617 1.567 . . . . 0.0 107.108 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 169.94 13.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.97 134.86 95.91 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.259 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.1 136.2 55.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.535 2.157 . . . . 0.0 109.247 174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.2 m -131.5 97.99 4.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.3 m -106.09 146.87 29.62 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.65 1.18 . . . . 0.0 107.916 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 104.79 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -75.01 115.55 14.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -109.03 137.5 46.84 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.396 1.478 . . . . 0.0 113.491 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.22 163.18 15.11 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.229 . . . . 0.0 111.379 173.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.25 1.12 0 C-N-CA 129.176 2.991 . . . . 0.0 106.231 161.365 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ttt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -160.92 134.38 6.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.09 143.34 0.97 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.693 1.616 . . . . 0.0 111.028 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.34 129.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.989 1.716 . . . . 0.0 107.686 -153.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -109.0 -68.83 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t -133.05 136.57 27.78 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.65 136.44 33.3 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.156 1.904 . . . . 0.0 110.116 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -95.48 168.21 10.84 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.206 0.602 . . . . 0.0 110.186 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.89 80.22 2.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 m -66.3 -20.98 66.25 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.855 0.462 . . . . 0.0 110.239 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.15 7.31 22.25 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.56 -1.337 . . . . 0.0 113.061 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.46 120.73 12.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 110.438 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -136.55 164.98 26.92 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.817 1.247 . . . . 0.0 111.186 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -109.11 151.99 25.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 168.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.0 168.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.73 1.612 . . . . 0.0 107.393 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 42.07 61.54 1.92 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.425 1.89 . . . . 0.0 110.904 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.74 57.15 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.148 1.779 . . . . 0.0 108.441 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -84.83 170.87 12.74 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.891 1.276 . . . . 0.0 110.682 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.19 2.31 9.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.635 1.574 . . . . 0.0 112.079 -174.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 p -125.53 -16.04 5.93 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.831 1.652 . . . . 0.0 114.786 -163.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -178.17 153.69 0.8 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.449 1.9 . . . . 0.0 108.096 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tt -108.55 132.3 56.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.55 158.35 28.53 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 171.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.471 HD11 ' CD2' ' A' ' 62' ' ' TYR . 2.8 mp -132.75 152.1 51.84 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 126.129 1.772 . . . . 0.0 108.41 174.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -138.52 143.91 39.72 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.37 -173.85 4.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.592 0.757 . . . . 0.0 109.185 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -108.81 106.67 59.18 Favored Pre-proline 0 C--N 1.334 -0.107 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.55 131.42 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.493 1.462 . . . . 0.0 109.773 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.0 OUTLIER -81.55 107.35 14.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -72.78 42.93 0.11 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 29' ' ' LEU . 27.2 m -79.03 6.56 9.1 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.397 3.079 . . . . 0.0 114.766 -168.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.6 p 61.31 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 128.057 2.543 . . . . 0.0 114.607 163.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -7.27 17.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.195 1.798 . . . . 0.0 112.448 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 tt -44.26 146.64 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 121.034 -1.041 . . . . 0.0 110.015 159.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.51 -61.95 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 171.03 -156.96 27.52 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -170.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.8 143.72 50.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 135.83 53.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.745 2.018 . . . . 0.0 106.248 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.69 125.74 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.1 m -119.25 126.01 50.48 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.31 123.65 61.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.98 163.42 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.335 1.454 . . . . 0.0 108.266 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.56 110.96 16.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 45.87 -155.39 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.764 2.426 . . . . 0.0 112.725 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.48 18.9 6.35 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 118.838 -0.979 . . . . 0.0 112.761 168.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -86.08 -6.47 59.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.123 1.461 . . . . 0.0 110.303 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.41 -16.01 3.21 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 127.283 2.373 . . . . 0.0 113.98 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt -45.66 106.14 0.53 Allowed Pre-proline 0 N--CA 1.448 -0.575 0 C-N-CA 129.816 3.246 . . . . 0.0 108.913 168.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.04 167.18 25.55 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.36 2.04 . . . . 0.0 110.673 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.25 -76.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.81 175.48 13.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 175.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.97 154.25 51.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.006 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.6 166.46 30.22 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.48 1.512 . . . . 0.0 109.265 -163.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.67 171.62 10.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.363 1.065 . . . . 0.0 110.378 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.27 -176.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.011 163.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -64.1 -68.93 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.297 1.839 . . . . 0.0 112.362 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 88.3 p 165.14 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.972 3.309 . . . . 0.0 111.227 -175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . 0.264 97.4 p -131.52 23.94 4.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.534 0.607 . . . . 0.0 111.979 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -73.46 131.55 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.35 -0.13 35.1 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.929 1.252 . . . . 0.0 113.303 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -150.68 114.75 5.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.471 ' CD2' HD11 ' A' ' 24' ' ' LEU . 3.8 t80 -140.85 158.97 43.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -173.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -141.51 132.22 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.66 148.29 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 126.364 1.866 . . . . 0.0 106.778 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.67 -173.76 2.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.525 1.53 . . . . 0.0 108.295 -174.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.06 16.79 80.41 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 120.662 -1.274 . . . . 0.0 113.557 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 151.7 45.42 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.16 100.26 7.13 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.5 162.9 40.11 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.395 3.397 . . . . 0.0 113.769 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.57 5.85 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.727 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.59 138.39 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 159.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 39.4 t0 -83.0 158.74 22.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.578 0.751 . . . . 0.0 110.463 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -135.44 123.01 22.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.346 1.458 . . . . 0.0 108.648 -167.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.86 109.3 22.03 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.86 90.91 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.3 p -84.83 104.4 14.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.871 0.868 . . . . 0.0 111.071 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.82 119.42 45.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -116.74 139.56 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.958 1.303 . . . . 0.0 108.264 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.2 m -105.55 134.17 49.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.7 115.43 17.32 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.3 pt -104.29 -164.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 125.362 1.465 . . . . 0.0 108.316 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -34.66 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.07 0.948 . . . . 0.0 111.056 167.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.25 60.65 0.05 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 128.933 3.158 . . . . 0.0 113.261 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.25 166.15 38.89 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.78 146.94 51.52 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.875 1.27 . . . . 0.0 108.253 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 m -84.04 -172.24 4.05 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.139 0.971 . . . . 0.0 110.032 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.69 135.77 71.26 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 162.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.27 155.34 67.86 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.758 2.306 . . . . 0.0 110.892 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -127.3 98.18 5.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 166.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.5 m -94.15 109.01 20.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.8 mt -88.76 155.12 19.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 157.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.5 m -127.74 147.94 50.41 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -155.78 124.52 6.01 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.19 0.905 . . . . 0.0 110.648 -173.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -67.45 -27.08 66.74 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -169.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.25 1.13 0 C-N-CA 128.771 2.828 . . . . 0.0 114.813 166.738 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtp . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.8 ptt85 -56.6 167.55 0.71 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.342 0.657 . . . . 0.0 111.876 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 148.81 6.62 0.22 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.539 1.066 . . . . 0.0 114.42 171.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 p -76.71 71.09 3.27 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.623 1.569 . . . . 0.0 110.468 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -66.75 0.55 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.763 0.825 . . . . 0.0 109.515 173.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t -72.0 133.96 83.59 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -69.05 133.48 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.99 1.793 . . . . 0.0 109.74 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.1 166.86 11.05 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.677 1.591 . . . . 0.0 108.952 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.39 88.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.896 0.855 . . . . 0.0 109.201 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m -73.4 -11.52 60.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.812 0.845 . . . . 0.0 112.006 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.39 14.28 30.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.644 1.111 . . . . 0.0 112.082 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.99 109.14 0.59 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.18 -0.95 . . . . 0.0 110.893 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 m -136.57 146.19 45.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.176 1.79 . . . . 0.0 110.128 -170.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -111.3 144.68 40.1 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 177.99 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 128.691 2.796 . . . . 0.0 108.06 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.14 51.14 13.45 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.143 1.777 . . . . 0.0 109.408 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.7 mt -84.01 65.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -87.63 162.54 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.652 1.181 . . . . 0.0 109.056 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.68 -2.38 22.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.218 1.407 . . . . 0.0 111.311 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -107.22 -15.73 14.58 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.383 1.873 . . . . 0.0 114.079 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p 176.25 154.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.053 1.741 . . . . 0.0 109.911 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 128.96 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.58 133.39 11.61 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -174.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mp -110.03 143.05 40.61 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -124.65 146.48 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -149.97 -171.43 3.9 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 165.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -103.31 107.26 55.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -57.08 139.5 90.13 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.49 1.46 . . . . 0.0 110.749 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -88.88 108.97 19.83 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.969 1.708 . . . . 0.0 108.852 164.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.66 28.33 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.321 1.448 . . . . 0.0 112.063 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.0 m -79.38 150.49 31.36 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.494 -1.379 . . . . 0.0 110.455 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 p -83.0 -34.71 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.516 0.598 . . . . 0.0 111.409 167.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.13 -12.0 59.89 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.458 1.103 . . . . 0.0 112.207 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.7 152.25 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 161.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mp -90.62 -67.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 160.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.86 -160.93 22.39 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -130.47 142.15 50.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 118.14 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 mp -93.2 143.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.7 m -141.26 133.56 28.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.56 138.07 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 125.128 1.371 . . . . 0.0 111.899 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.41 164.7 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.68 117.65 20.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 37.55 -138.79 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.357 2.263 . . . . 0.0 113.084 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.91 4.29 86.06 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 117.707 -1.607 . . . . 0.0 112.539 170.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.2 -0.2 53.86 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 121.085 2.442 . . . . 0.0 110.738 -166.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.98 -15.21 5.34 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.179 1.371 . . . . 0.0 114.324 168.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 mt -45.9 105.37 0.46 Allowed Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 127.33 2.252 . . . . 0.0 110.33 161.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.44 159.82 25.75 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.647 2.898 . . . . 0.0 110.239 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.04 -69.4 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.69 164.29 23.95 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.943 1.297 . . . . 0.0 109.511 -172.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.23 144.85 40.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.94 1.696 . . . . 0.0 110.34 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -134.76 164.62 27.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.854 1.662 . . . . 0.0 108.026 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.62 152.46 51.25 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.807 0.843 . . . . 0.0 109.842 177.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.22 -177.71 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.86 -0.525 . . . . 0.0 109.81 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -80.49 -54.86 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.234 0.54 . . . . 0.0 112.169 -150.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p 153.93 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 130.865 3.666 . . . . 0.0 109.916 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.8 p -123.64 10.31 9.04 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.752 1.621 . . . . 0.0 111.22 -164.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.93 137.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.05 1.0 9.84 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.378 1.466 . . . . 0.0 112.714 166.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.94 123.83 12.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.819 1.248 . . . . 0.0 110.008 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -140.14 151.28 45.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.401 1.88 . . . . 0.0 107.542 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.6 m -130.95 126.64 36.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.796 1.18 . . . . 0.0 109.244 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.48 153.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.89 177.11 8.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 166.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.09 7.01 88.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.706 1.146 . . . . 0.0 112.86 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 159.75 19.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 164.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -137.04 127.54 16.07 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.65 171.58 14.09 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.27 1.314 . . . . 0.0 110.575 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.11 -12.23 40.69 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.147 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.52 162.1 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -92.26 125.84 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -107.25 142.44 37.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.8 1.182 . . . . 0.0 108.886 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.37 110.87 23.38 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 168.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.89 103.1 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.3 p -92.86 145.91 24.03 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.959 -1.088 . . . . 0.0 109.774 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 t -146.35 72.08 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-O 122.501 1.143 . . . . 0.0 108.96 -168.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mt -84.8 134.65 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.7 m -89.52 142.45 27.66 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.88 138.01 51.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.883 1.273 . . . . 0.0 109.114 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 pt -133.87 -169.06 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.049 1.339 . . . . 0.0 109.068 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -34.06 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.089 1.756 . . . . 0.0 110.84 162.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 36.74 42.95 0.75 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.985 2.707 . . . . 0.0 114.603 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.46 166.04 38.19 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 120.402 2.101 . . . . 0.0 113.839 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.76 156.03 31.36 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.499 1.919 . . . . 0.0 107.057 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 m -84.1 -170.2 2.97 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 155.53 87.55 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.712 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.74 105.53 1.97 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.903 3.069 . . . . 0.0 110.434 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 m -89.84 74.71 7.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 171.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.3 m -94.58 115.33 27.45 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.9 mt -95.64 145.02 25.58 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 m -104.87 135.43 46.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -155.18 169.0 25.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 166.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -95.38 137.54 34.3 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.25 1.1 0 O-C-N 125.383 1.677 . . . . 0.0 110.551 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 117.133 -1.413 . . . . 0.0 108.195 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 163.39 -39.93 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.741 2.416 . . . . 0.0 112.301 175.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.28 106.42 3.12 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 -173.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.7 p 45.6 -147.0 0.13 Allowed 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.992 1.717 . . . . 0.0 111.201 -167.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -132.94 -56.89 0.93 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.158 1.783 . . . . 0.0 110.185 170.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.4 t -147.29 139.57 14.11 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 172.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 136.55 42.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.448 2.098 . . . . 0.0 110.723 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -75.69 163.18 27.57 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.583 165.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.11 80.3 0.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.44 1.096 . . . . 0.0 109.105 163.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 m -58.15 -27.78 64.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.68 0.792 . . . . 0.0 110.859 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 5.18 49.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.761 0.825 . . . . 0.0 111.918 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.7 129.3 22.55 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.315 1.046 . . . . 0.0 109.653 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 p -149.58 164.21 35.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.482 1.113 . . . . 0.0 110.39 165.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -116.65 146.43 42.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 172.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.52 164.21 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.915 1.286 . . . . 0.0 109.261 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 45.71 59.63 3.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.268 1.827 . . . . 0.0 109.949 -173.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.15 66.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 128.667 2.787 . . . . 0.0 105.804 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 t -94.64 165.35 12.55 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.686 1.594 . . . . 0.0 109.679 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.6 5.29 4.96 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.279 -1.513 . . . . 0.0 113.375 -168.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.1 p -126.5 -12.74 6.11 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -174.0 152.33 1.9 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.949 1.3 . . . . 0.0 108.949 -167.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.49 122.07 61.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.14 151.82 23.97 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.74 153.4 42.47 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.438 1.495 . . . . 0.0 109.71 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -140.05 145.04 37.21 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.66 1.584 . . . . 0.0 106.733 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -160.25 168.71 24.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 164.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.0 m -90.05 140.71 27.54 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 116.883 -1.927 . . . . 0.0 106.888 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.36 141.6 4.93 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.125 1.216 . . . . 0.0 109.023 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mp -83.51 -35.26 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.961 -170.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 49.84 34.86 8.26 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.301 2.24 . . . . 0.0 111.776 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 p -50.34 -46.97 56.03 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.302 1.041 . . . . 0.0 112.824 -162.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 p 153.91 -86.32 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 131.371 3.868 . . . . 0.0 104.973 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -5.43 58.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.51 1.124 . . . . 0.0 111.045 -170.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -34.86 129.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.937 1.295 . . . . 0.0 111.162 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.21 -49.47 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.21 -164.86 36.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -127.02 150.88 49.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 162.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.85 122.96 42.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 mp -104.67 144.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.8 m -145.45 111.26 5.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 143.09 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.829 0.823 . . . . 0.0 110.773 160.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.17 164.33 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 166.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.38 126.89 31.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.67 84.2 0.29 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 163.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.34 -45.08 0.06 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.897 1.236 . . . . 0.0 110.659 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -141.16 -2.92 1.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.515 0.726 . . . . 0.0 111.432 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.39 12.71 61.56 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 120.25 -1.531 . . . . 0.0 112.395 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.9 mt -46.17 106.61 0.58 Allowed Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 127.293 2.237 . . . . 0.0 107.901 162.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 137.81 28.65 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.304 2.003 . . . . 0.0 110.0 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.0 93.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.323 1.0 OUTLIER 54.45 176.95 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.323 2.249 . . . . 0.0 113.28 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.07 159.32 42.47 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.725 -1.235 . . . . 0.0 110.205 165.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -149.33 165.93 30.52 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.252 1.821 . . . . 0.0 111.221 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.07 165.52 18.7 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.629 1.571 . . . . 0.0 109.482 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -178.11 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.168 0.987 . . . . 0.0 109.119 164.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.25 -50.74 8.64 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.028 -1.045 . . . . 0.0 112.528 -157.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 p 157.18 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 1 C-N-CA 132.217 4.207 . . . . 0.0 112.141 174.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -124.9 10.4 8.26 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.9 t -73.61 132.44 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.59 6.37 18.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.075 1.322 . . . . 0.0 112.312 170.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -150.08 120.4 7.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.79 -1.418 . . . . 0.0 107.38 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -143.99 166.27 25.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -132.37 129.0 38.81 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.038 0.935 . . . . 0.0 108.763 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -95.78 154.88 3.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.04 178.45 6.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.388 1.475 . . . . 0.0 107.142 169.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 5.0 73.88 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 119.036 0.834 . . . . 0.0 112.956 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.72 158.8 26.55 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.626 0.727 . . . . 0.0 109.555 167.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.19 103.78 5.61 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.0 169.64 14.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.091 2.527 . . . . 0.0 111.032 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.22 -18.75 50.86 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.595 -0.691 . . . . 0.0 112.176 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mm -124.56 153.38 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.669 1.988 . . . . 0.0 108.155 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -86.25 145.84 26.78 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.658 1.583 . . . . 0.0 108.365 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.56 134.85 51.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.257 1.023 . . . . 0.0 111.87 -175.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.28 104.18 14.1 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.506 1.923 . . . . 0.0 107.098 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -90.52 105.66 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -101.5 136.29 41.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 118.412 0.551 . . . . 0.0 111.873 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.8 t -135.36 108.42 9.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.07 137.42 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -98.78 129.97 45.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.39 112.43 18.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pt -104.45 -164.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -48.62 111.13 0.42 Allowed 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.531 -0.731 . . . . 0.0 110.61 161.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.49 24.76 59.83 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.068 -0.851 . . . . 0.0 114.802 156.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.33 156.39 21.04 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -132.78 153.22 51.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 108.531 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.58 178.41 7.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.78 154.23 94.41 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 121.496 -0.753 . . . . 0.0 110.197 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.87 110.53 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.964 3.109 . . . . 0.0 110.839 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.8 m -85.44 97.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 169.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 m -96.5 153.42 17.85 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.55 135.19 44.19 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 159.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.67 143.29 38.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.37 2.268 . . . . 0.0 108.537 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -164.69 148.61 9.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.559 1.527 . . . . 0.0 110.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -110.94 143.53 41.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.84 1.256 . . . . 0.0 109.626 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.257 1.456 0 C-N-CA 127.572 2.349 . . . . 0.0 111.635 -171.71 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.7 mtt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.84 152.79 51.98 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.267 1.394 . . . . 0.0 108.334 161.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.77 -165.4 17.48 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -164.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.01 165.47 13.28 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -64.67 -48.9 73.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.392 0.277 . . . . 0.0 111.12 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t -143.05 141.43 19.55 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.31 105.61 1.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.316 2.01 . . . . 0.0 109.209 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.29 169.98 1.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 114.248 165.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.24 71.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.449 2.3 . . . . 0.0 110.088 164.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m -50.68 -27.01 6.16 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 111.846 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -87.37 4.59 42.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.772 1.169 . . . . 0.0 112.566 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -55.17 118.42 4.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 109.276 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.0 m -153.33 134.1 13.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.454 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -91.39 146.25 23.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.45 174.23 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 128.845 2.858 . . . . 0.0 109.24 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.374 2.6 p30 43.07 45.62 4.64 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.113 1.765 . . . . 0.0 112.3 -178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.44 62.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 128.117 2.567 . . . . 0.0 107.473 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -73.78 174.55 8.28 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.781 1.232 . . . . 0.0 108.972 168.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.73 -4.7 39.06 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.187 -0.946 . . . . 0.0 111.674 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.7 p -125.58 -9.2 6.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 -158.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 p -176.81 171.91 2.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.188 2.595 . . . . 0.0 108.134 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.65 147.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 142.75 15.64 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 171.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mp -108.82 144.14 37.07 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 124.529 1.132 . . . . 0.0 108.119 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -118.21 150.38 39.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -151.87 -166.12 2.41 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 161.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.92 143.19 39.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.53 129.32 19.83 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.055 1.17 . . . . 0.0 109.39 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 31' ' ' SER . 7.2 mt -85.64 96.98 9.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 172.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -74.52 45.87 0.25 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.38 0.672 . . . . 0.0 109.327 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 29' ' ' LEU . 32.8 m -69.48 2.46 3.08 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.079 -1.638 . . . . 0.0 112.269 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 p 48.13 25.66 0.87 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.787 2.835 . . . . 0.0 114.859 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -165.27 -16.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.881 1.272 . . . . 0.0 111.044 -171.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 tt -39.01 140.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 110.141 156.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -84.79 -63.39 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 165.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.33 -156.9 13.75 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -168.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.7 147.42 48.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 133.97 55.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.0 mp -108.81 143.0 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -133.87 128.13 33.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 161.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.27 137.52 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.36 164.69 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.14 1.376 . . . . 0.0 109.429 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.07 125.94 30.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.71 77.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.591 0.756 . . . . 0.0 110.312 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.35 -18.11 71.11 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 117.353 -1.804 . . . . 0.0 116.341 -165.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -142.66 2.73 1.42 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.583 2.191 . . . . 0.0 112.369 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.38 -13.58 15.55 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.617 -1.302 . . . . 0.0 114.144 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.6 mt -45.48 106.25 0.53 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 128.324 2.649 . . . . 0.0 110.72 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.94 147.16 43.22 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.83 2.354 . . . . 0.0 110.945 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.0 mm -84.85 -74.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.01 175.64 7.46 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.683 1.993 . . . . 0.0 108.66 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.84 156.83 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.727 1.211 . . . . 0.0 110.255 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.417 ' CG ' ' HH ' ' A' ' 62' ' ' TYR . 1.4 p30 -148.2 166.43 27.93 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.737 1.215 . . . . 0.0 110.503 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.77 155.72 49.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.673 1.989 . . . . 0.0 109.935 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.75 -177.21 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.883 1.273 . . . . 0.0 109.864 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.66 -57.71 3.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.527 0.731 . . . . 0.0 112.087 -160.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p 154.7 -29.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 131.089 3.756 . . . . 0.0 111.42 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -123.26 -0.66 8.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.256 1.023 . . . . 0.0 109.506 -167.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.1 t -74.43 124.75 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.0 1.11 33.55 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.46 1.1 . . . . 0.0 112.901 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -142.18 114.21 8.14 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.456 1.102 . . . . 0.0 108.259 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.417 ' HH ' ' CG ' ' A' ' 53' ' ' ASP . 32.6 t80 -145.98 137.82 25.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -172.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -113.42 146.99 38.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.947 1.299 . . . . 0.0 108.836 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.51 148.54 24.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 125.631 1.572 . . . . 0.0 107.181 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.88 -168.78 1.87 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.28 4.34 90.23 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.692 -1.255 . . . . 0.0 113.973 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 149.56 49.65 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.933 1.293 . . . . 0.0 109.965 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -146.9 93.81 4.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.454 1.902 . . . . 0.0 108.643 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.62 167.59 23.81 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.997 3.131 . . . . 0.0 114.982 -152.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.85 -15.85 61.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.128 1.347 . . . . 0.0 112.735 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.15 151.52 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 167.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -89.48 134.41 34.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.309 1.444 . . . . 0.0 108.039 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -118.51 117.33 28.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -167.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.42 113.63 21.32 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 170.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -102.66 105.1 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -91.03 138.24 31.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.097 0.559 . . . . 0.0 109.508 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -134.52 129.54 52.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -131.8 131.42 62.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 m -83.09 144.23 30.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.68 129.88 50.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.6 pt -116.1 175.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -35.37 105.0 0.03 OUTLIER 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.023 1.729 . . . . 0.0 110.119 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.1 26.37 0.87 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.812 1.672 . . . . 0.0 114.823 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.42 144.71 15.93 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.55 1.675 . . . . 0.0 109.663 -160.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.01 117.64 22.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.2 1.0 . . . . 0.0 108.499 -162.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.11 -179.0 6.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 148.8 86.06 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.7 137.7 70.23 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 162.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -129.13 95.99 4.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 168.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.7 m -94.84 149.21 21.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.32 135.0 45.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 166.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t -120.91 140.79 51.33 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -165.24 139.89 5.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -96.81 165.06 12.29 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 161.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.246 0.87 0 C-N-CA 126.865 2.066 . . . . 0.0 111.315 169.748 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 154.52 158.55 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 130.406 3.482 . . . . 0.0 111.378 168.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.02 165.42 30.25 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 158.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.02 177.76 4.77 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 109.538 164.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.52 -72.54 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.685 1.594 . . . . 0.0 110.675 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t -143.97 146.98 36.32 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.233 1.813 . . . . 0.0 106.197 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.37 117.21 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.746 2.297 . . . . 0.0 109.511 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.27 169.46 11.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.2 mt -78.51 86.73 4.51 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.5 m -76.04 -29.37 58.04 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.53 1.132 . . . . 0.0 111.35 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.61 4.77 20.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.823 1.249 . . . . 0.0 112.611 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.57 129.78 37.56 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.8 1.64 . . . . 0.0 109.853 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.3 m -150.72 165.23 34.1 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -99.72 155.83 17.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 108.724 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.12 167.96 9.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.689 1.996 . . . . 0.0 106.983 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.83 56.21 2.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 128.278 2.631 . . . . 0.0 110.232 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -78.25 65.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.197 2.199 . . . . 0.0 106.232 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -88.18 168.16 12.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.465 1.106 . . . . 0.0 111.3 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.37 12.79 0.69 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.171 2.188 . . . . 0.0 112.465 -174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.4 p -125.68 -15.9 5.89 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p -178.53 147.14 0.39 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -161.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -115.45 140.33 37.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.74 162.29 18.59 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mp -139.15 153.39 47.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.586 1.554 . . . . 0.0 108.988 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -134.71 155.32 50.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.5 p90 -165.35 -170.83 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.415 1.486 . . . . 0.0 108.858 166.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -105.42 106.44 56.06 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.726 1.21 . . . . 0.0 108.521 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -62.24 124.87 15.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.373 2.049 . . . . 0.0 110.632 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.1 mt -93.52 96.67 10.03 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 128.643 2.777 . . . . 0.0 108.042 175.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -74.67 34.12 0.1 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.446 1.098 . . . . 0.0 111.931 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 29' ' ' LEU . 30.4 m -56.2 119.63 6.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.821 2.448 . . . . 0.0 109.216 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 p -67.63 41.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.734 2.414 . . . . 0.0 113.443 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -167.18 -19.7 0.02 OUTLIER 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.741 1.616 . . . . 0.0 111.904 -167.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -55.15 144.44 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.23 -52.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 166.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.66 -152.73 14.56 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.04 136.14 45.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.03 125.82 44.61 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.81 155.05 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 m -142.69 153.52 43.46 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.899 1.68 . . . . 0.0 107.169 167.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.28 135.28 61.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 125.819 1.647 . . . . 0.0 108.999 167.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.55 164.08 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.43 110.24 20.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.7 9.43 0.08 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.625 2.77 . . . . 0.0 115.686 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.11 12.06 68.05 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.96 -1.087 . . . . 0.0 112.732 -166.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -78.72 42.27 0.44 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.341 1.856 . . . . 0.0 110.076 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.57 -55.49 3.34 Favored Glycine 0 CA--C 1.524 0.653 0 O-C-N 120.522 -1.361 . . . . 0.0 112.933 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.7 mt -45.74 105.19 0.44 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 129.548 3.139 . . . . 0.0 110.272 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.26 171.44 18.03 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.358 2.039 . . . . 0.0 109.633 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.72 -95.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 162.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -146.96 166.02 28.04 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.475 0.71 . . . . 0.0 110.371 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -134.23 103.89 5.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.553 1.541 . . . . 0.0 106.988 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.51 159.11 16.19 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.75 176.02 5.3 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.527 1.131 . . . . 0.0 108.039 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -175.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 161.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -79.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.468 1.907 . . . . 0.0 112.041 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p 172.2 -18.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 1 C-N-CA 132.651 4.38 . . . . 0.0 110.883 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -134.27 27.15 3.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.4 t -73.99 138.62 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.92 -1.95 19.02 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.977 0.798 . . . . 0.0 112.265 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.58 114.33 5.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -138.04 141.36 40.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 m -127.21 152.06 47.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.9 0.88 . . . . 0.0 109.358 -171.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.53 156.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.505 1.922 . . . . 0.0 106.944 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.434 HG21 ' H ' ' A' ' 66' ' ' GLY . 3.1 m -130.67 -163.14 1.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.163 1.785 . . . . 0.0 106.374 174.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' H ' HG21 ' A' ' 65' ' ' THR . . . 72.51 7.9 69.97 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 120.093 -1.629 . . . . 0.0 114.105 166.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.4 149.67 31.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.186 1.394 . . . . 0.0 108.226 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -126.19 102.07 27.76 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 107.893 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 157.84 57.82 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.622 2.215 . . . . 0.0 112.383 -165.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.55 -30.06 11.19 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.681 1.134 . . . . 0.0 110.543 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.79 158.82 3.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -100.96 145.19 28.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.022 1.329 . . . . 0.0 108.347 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -131.26 134.8 46.77 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.32 116.35 22.96 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 121.22 51.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 p -116.18 142.67 46.52 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.822 0.849 . . . . 0.0 110.687 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.92 128.77 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.09 153.4 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.43 1.014 . . . . 0.0 111.894 175.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -105.84 122.89 47.03 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 126.467 1.907 . . . . 0.0 107.739 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.68 132.91 56.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.7 pt -126.3 178.13 4.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.476 1.111 . . . . 0.0 108.837 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -34.53 103.53 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.281 1.832 . . . . 0.0 110.823 163.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.51 11.47 2.67 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.868 2.175 . . . . 0.0 115.055 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.36 145.85 17.89 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.203 1.501 . . . . 0.0 110.153 -156.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -126.85 155.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.316 1.447 . . . . 0.0 109.494 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -107.54 -166.86 1.19 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.85 2.06 . . . . 0.0 108.604 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.62 134.6 39.57 Favored Pre-proline 0 C--O 1.239 0.543 0 O-C-N 121.016 -1.052 . . . . 0.0 108.678 163.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 127.72 19.5 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.93 2.42 . . . . 0.0 107.214 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.2 m -86.41 103.7 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.2 m -101.4 121.53 42.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.95 150.43 44.78 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.1 m -132.62 136.9 46.81 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -161.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -157.33 142.63 17.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -159.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.08 159.64 15.21 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.867 -0.52 . . . . 0.0 109.878 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.767 1.627 . . . . 0.0 110.063 -170.245 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptm . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? 153.79 147.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.003 2.921 . . . . 0.0 109.131 163.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 109.97 51.36 0.64 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 123.559 0.599 . . . . 0.0 111.778 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.41 40.84 1.9 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 160.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -112.37 -67.17 1.02 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.378 0.671 . . . . 0.0 109.978 -155.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.24 135.75 31.0 Favored Pre-proline 0 C--O 1.239 0.52 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.36 143.49 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.04 1.826 . . . . 0.0 109.442 174.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -102.59 169.29 8.74 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 166.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -74.5 80.34 1.94 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 m -61.37 -25.75 67.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.798 0.839 . . . . 0.0 110.544 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.0 -2.47 34.1 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.662 1.585 . . . . 0.0 113.696 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.37 115.14 3.04 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.773 1.229 . . . . 0.0 110.55 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p -134.54 160.97 36.4 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.864 1.266 . . . . 0.0 110.345 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 8.7 m-30 -105.28 143.78 32.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.04 164.96 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.881 1.672 . . . . 0.0 108.348 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 t0 51.7 45.06 28.74 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.96 1.304 . . . . 0.0 110.554 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mt -75.91 63.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 128.811 2.845 . . . . 0.0 106.94 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -87.45 173.77 8.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 111.137 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.36 0.43 16.86 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.637 1.975 . . . . 0.0 112.861 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.7 p -113.39 -15.7 12.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p 176.29 161.7 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.674 1.99 . . . . 0.0 107.536 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.15 127.67 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.85 157.39 29.66 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.633 -1.292 . . . . 0.0 110.143 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.79 150.33 52.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.774 -1.427 . . . . 0.0 108.483 172.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -137.29 133.85 35.46 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -157.54 173.38 16.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.6 m -86.58 106.3 10.09 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.726 1.211 . . . . 0.0 110.093 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.62 124.26 13.4 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.345 1.363 . . . . 0.0 109.29 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.15 101.44 13.0 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -79.34 49.95 1.04 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.536 0.734 . . . . 0.0 109.097 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -61.91 -55.55 28.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.582 1.553 . . . . 0.0 110.164 -168.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p 154.72 -88.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 130.389 3.476 . . . . 0.0 108.891 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.08 -3.64 52.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.978 2.511 . . . . 0.0 110.026 -170.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -35.98 133.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.039 1.336 . . . . 0.0 111.255 166.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -84.32 -48.24 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.87 -158.29 31.03 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -132.15 145.2 51.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -119.89 113.1 20.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.43 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.9 m -145.08 117.58 8.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.425 1.89 . . . . 0.0 107.382 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.09 131.44 40.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.289 0.636 . . . . 0.0 111.064 162.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.48 164.52 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 161.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.56 110.9 11.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.09 -17.36 64.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.371 1.068 . . . . 0.0 113.652 -171.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.53 -25.72 56.03 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 119.728 1.149 . . . . 0.0 112.663 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -136.65 -13.54 1.71 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.378 1.089 . . . . 0.0 113.549 -171.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.71 6.72 88.84 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.758 1.647 . . . . 0.0 114.306 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.9 mt -45.67 105.93 0.51 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.985 1.714 . . . . 0.0 111.091 167.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.68 131.04 12.06 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.725 2.283 . . . . 0.0 109.008 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.5 mm -84.64 -73.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -157.51 170.46 22.38 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.848 0.859 . . . . 0.0 109.925 173.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.3 150.59 39.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 163.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -152.71 165.91 33.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.48 1.112 . . . . 0.0 108.565 -166.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.12 168.15 15.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.377 0.671 . . . . 0.0 110.53 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.01 -177.01 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.12 . . . . 0.0 108.66 167.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -71.02 -66.42 0.61 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.756 -0.59 . . . . 0.0 111.219 -167.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 p 163.78 -23.02 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 130.787 3.635 . . . . 0.0 112.016 -176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.9 p -132.9 22.93 4.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.988 0.813 . . . . 0.0 112.764 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.54 131.93 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.95 3.26 19.3 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.388 2.423 . . . . 0.0 113.357 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -153.93 119.64 5.26 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.654 1.582 . . . . 0.0 108.225 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -134.94 164.37 27.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.326 1.45 . . . . 0.0 108.081 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.5 m -131.96 147.98 52.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.88 145.04 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.85 -170.76 1.85 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 171.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.25 17.97 77.11 Favored Glycine 0 CA--C 1.522 0.473 0 O-C-N 120.873 -1.142 . . . . 0.0 111.666 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 157.44 20.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.617 1.208 . . . . 0.0 108.691 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 136.41 15.98 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.96 156.12 60.33 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.906 1.737 . . . . 0.0 110.964 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.53 -27.58 8.33 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.527 1.061 . . . . 0.0 113.109 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.17 156.14 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 126.038 1.735 . . . . 0.0 107.818 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.97 135.33 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 107.445 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.26 127.17 51.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.4 106.74 16.23 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.3 mp -98.94 103.12 14.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 174.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 142.16 27.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.939 2.096 . . . . 0.0 108.315 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -146.7 92.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mm -84.34 138.86 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.739 1.216 . . . . 0.0 108.274 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 100.0 m -105.81 131.71 52.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.0 113.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . 0.3 2.6 pt -109.37 -164.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.672 1.189 . . . . 0.0 109.991 -166.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -50.83 108.78 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.315 -1.491 . . . . 0.0 110.52 160.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.18 50.46 2.2 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.583 2.04 . . . . 0.0 113.097 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 144.17 7.58 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -120.26 153.45 36.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 107.931 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -84.42 -165.85 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.579 0.704 . . . . 0.0 112.31 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.64 144.67 73.83 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 151.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.43 137.28 50.29 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.774 1.649 . . . . 0.0 108.879 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.6 m -105.21 104.86 14.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -124.26 137.17 54.54 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.1 126.38 39.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -93.52 145.43 24.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -154.73 138.85 16.49 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -94.97 136.02 35.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.738 1.215 . . . . 0.0 108.279 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.257 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -175.129 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.25 62.83 1.63 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.67 171.03 13.54 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -149.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.28 150.6 12.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.483 1.513 . . . . 0.0 107.839 171.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.08 -63.74 1.05 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.002 0.921 . . . . 0.0 110.905 -174.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t -43.01 134.6 3.01 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 127.739 2.415 . . . . 0.0 111.957 -152.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.05 129.92 27.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.261 1.974 . . . . 0.0 110.558 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.22 178.42 4.78 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.139 1.376 . . . . 0.0 110.881 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.1 mt -71.76 86.85 0.95 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -58.57 -20.12 43.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.272 1.429 . . . . 0.0 111.217 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -93.46 6.27 48.74 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.708 1.603 . . . . 0.0 113.585 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.99 106.81 0.54 Allowed 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.723 -1.236 . . . . 0.0 109.905 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -143.36 163.91 31.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.547 1.139 . . . . 0.0 110.046 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 13.4 m-30 -109.02 159.7 16.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.08 168.17 7.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.616 1.966 . . . . 0.0 107.068 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 42.34 59.81 2.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 126.201 1.801 . . . . 0.0 109.653 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mm -79.89 60.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -73.63 175.54 7.03 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.595 1.958 . . . . 0.0 109.966 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -4.97 53.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.997 1.319 . . . . 0.0 112.636 172.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 p -110.78 -12.42 14.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.561 1.544 . . . . 0.0 114.459 -166.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 p 173.84 171.13 0.19 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.034 1.734 . . . . 0.0 108.233 -163.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.79 150.12 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 161.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.26 159.3 14.65 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 171.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.01 146.31 49.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 125.508 1.523 . . . . 0.0 108.184 176.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -124.25 156.83 36.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 158.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -161.38 -173.87 4.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.086 1.755 . . . . 0.0 106.973 163.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -104.04 107.55 57.36 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -59.37 124.07 14.74 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.715 1.61 . . . . 0.0 109.125 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.2 mt -93.4 -19.23 21.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.641 0.776 . . . . 0.0 112.878 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 43.45 29.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.193 2.597 . . . . 0.0 113.577 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 m -87.83 104.95 17.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -167.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -41.88 -1.85 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 131.518 3.927 . . . . 0.0 119.509 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.52 -14.45 8.22 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 130.167 3.387 . . . . 0.0 112.137 -171.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 12.6 tt -60.43 161.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.105 2.162 . . . . 0.0 111.061 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -98.77 -47.99 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 166.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.94 40.99 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -126.91 107.24 9.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 171.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.5 121.95 28.93 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.64 147.4 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -145.49 99.51 3.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.814 1.245 . . . . 0.0 107.672 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.56 134.16 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 120.665 -1.272 . . . . 0.0 109.064 163.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.25 165.13 24.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 136.42 42.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.5 162.26 10.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.63 -11.48 7.1 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 117.933 -1.481 . . . . 0.0 115.431 164.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -146.46 165.12 30.34 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 121.891 2.845 . . . . 0.0 107.988 162.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.8 -0.3 18.22 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.036 -1.424 . . . . 0.0 115.298 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.6 mt -46.05 105.98 0.52 Allowed Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 128.3 2.64 . . . . 0.0 111.399 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -60.97 160.87 24.07 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.716 1.61 . . . . 0.0 111.196 162.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.79 -86.95 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 121.367 1.894 . . . . 0.0 110.555 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.54 146.67 40.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.457 1.503 . . . . 0.0 107.439 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -147.51 162.55 38.84 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.852 1.261 . . . . 0.0 109.437 -168.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.34 153.36 43.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.359 1.463 . . . . 0.0 108.219 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.63 -176.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 108.866 165.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.15 -58.45 5.98 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -161.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 p 153.83 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 130.789 3.636 . . . . 0.0 110.747 -167.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -105.47 3.41 29.49 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 113.233 -166.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.9 150.67 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.98 -2.83 6.49 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 127.016 2.246 . . . . 0.0 113.201 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -160.73 128.7 4.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.727 -1.455 . . . . 0.0 107.883 -171.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -150.08 167.03 27.98 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.961 0.8 . . . . 0.0 109.049 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.4 m -132.9 136.66 46.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.413 1.485 . . . . 0.0 109.999 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.29 165.2 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.93 1.692 . . . . 0.0 107.469 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.513 HG21 ' H ' ' A' ' 66' ' ' GLY . 2.9 m -143.53 -170.69 3.35 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.359 -1.463 . . . . 0.0 107.06 164.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' H ' HG21 ' A' ' 65' ' ' THR . . . 72.09 15.51 76.55 Favored Glycine 0 N--CA 1.463 0.471 0 C-N-CA 124.713 1.149 . . . . 0.0 112.642 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.64 158.97 35.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.344 1.058 . . . . 0.0 108.826 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.51 107.25 23.57 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 170.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.9 168.05 19.8 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.065 2.51 . . . . 0.0 110.756 -173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.4 -31.18 4.57 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.505 1.05 . . . . 0.0 110.692 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.07 155.24 3.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -101.28 142.7 32.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.103 1.761 . . . . 0.0 108.242 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -134.59 120.48 19.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.043 1.337 . . . . 0.0 109.913 -162.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.15 95.75 9.24 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -84.58 105.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p -88.56 147.5 24.57 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 167.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.85 112.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 mt -112.32 129.31 68.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -82.59 134.86 35.18 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 113.71 18.79 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 18.3 pt -107.58 -167.83 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.961 1.704 . . . . 0.0 110.029 -173.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -44.1 110.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.317 0.508 . . . . 0.0 109.902 167.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.6 63.44 0.06 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.563 2.506 . . . . 0.0 114.121 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.71 158.32 19.17 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.36 150.18 45.03 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.74 -178.28 6.82 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.726 0.774 . . . . 0.0 109.992 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 149.01 98.52 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.184 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.31 102.5 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.325 2.017 . . . . 0.0 108.186 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 m -91.86 93.55 8.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 m -113.2 149.52 33.59 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.409 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -146.67 68.52 1.17 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.667 0.746 . . . . 0.0 110.131 -171.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.4 t -72.28 133.23 44.91 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -157.88 141.7 15.7 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.051 2.141 . . . . 0.0 108.753 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -91.11 157.9 16.96 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.76 0.824 . . . . 0.0 110.682 -175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.25 1.125 0 CA-C-O 115.51 -2.186 . . . . 0.0 108.225 178.779 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.27 -169.28 2.82 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.566 1.146 . . . . 0.0 108.332 168.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.85 35.04 23.0 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-O 119.214 -0.77 . . . . 0.0 111.92 167.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.5 m -151.15 144.72 24.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.447 1.499 . . . . 0.0 107.2 167.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -97.89 -106.01 0.19 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 158.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t -97.7 144.72 28.48 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.875 1.27 . . . . 0.0 108.457 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.34 120.48 5.31 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.584 2.189 . . . . 0.0 110.769 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -80.89 169.89 16.97 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.298 1.039 . . . . 0.0 110.634 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.13 79.65 0.51 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.2 m -65.79 -14.14 60.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.752 2.021 . . . . 0.0 111.627 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -113.38 24.16 12.51 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.32 1.448 . . . . 0.0 111.458 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.55 127.03 29.25 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.435 0.694 . . . . 0.0 110.847 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.15 165.13 31.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.005 0.922 . . . . 0.0 111.309 172.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.425 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 9.9 m-85 -112.06 154.81 24.83 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.838 1.255 . . . . 0.0 108.348 169.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.0 174.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.961 2.104 . . . . 0.0 106.624 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 56.34 47.13 19.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 0.0 108.791 161.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 mt -79.92 66.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.203 2.201 . . . . 0.0 106.937 -174.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -66.73 176.96 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.974 1.31 . . . . 0.0 109.447 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.02 -3.98 32.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.05 0.94 . . . . 0.0 113.369 162.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -125.44 -15.25 6.2 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 -162.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.18 168.02 4.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 108.525 -170.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 tt -134.56 124.09 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.132 -0.98 . . . . 0.0 108.445 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.46 161.3 46.51 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mp -133.44 161.0 35.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.936 1.294 . . . . 0.0 108.856 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -138.61 147.82 43.39 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 160.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -157.09 172.45 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 158.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 m -79.13 107.09 5.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 124.452 1.101 . . . . 0.0 109.266 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -60.66 133.88 50.98 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.544 1.23 . . . . 0.0 109.033 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.98 133.55 38.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.744 2.018 . . . . 0.0 107.367 166.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -121.31 36.77 4.51 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 m -79.62 101.69 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.437 2.295 . . . . 0.0 108.298 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -59.16 84.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.778 1.631 . . . . 0.0 113.146 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 165.8 -25.38 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 131.438 3.895 . . . . 0.0 109.415 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.24 160.32 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.135 1.774 . . . . 0.0 109.908 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.68 -47.19 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.33 -155.35 24.17 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.293 0.497 . . . . 0.0 111.983 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -137.08 129.63 30.09 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 116.78 33.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.23 150.56 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 123.427 1.584 . . . . 0.0 107.554 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 m -146.21 148.41 32.48 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 171.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.8 133.81 48.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.47 164.65 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 107.618 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.27 119.82 23.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 44.9 15.5 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 130.15 3.38 . . . . 0.0 118.826 160.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.9 23.43 65.65 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 120.447 -1.408 . . . . 0.0 111.745 -164.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -70.73 4.54 2.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.833 2.853 . . . . 0.0 111.838 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.55 -53.88 3.79 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 126.67 2.081 . . . . 0.0 108.686 -167.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt -44.56 104.94 0.41 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 128.937 2.895 . . . . 0.0 111.042 -177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.75 147.63 17.32 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.912 3.075 . . . . 0.0 109.7 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -101.92 -76.4 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.23 171.68 18.14 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 120.849 1.658 . . . . 0.0 110.808 176.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.25 152.97 33.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.878 1.271 . . . . 0.0 109.39 171.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -145.84 165.7 28.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.26 160.61 39.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -177.4 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -59.82 -68.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.09 1.356 . . . . 0.0 110.561 -165.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t 178.81 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 129.206 3.003 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.8 p -136.33 48.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.37 124.78 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.457 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.19 -1.12 44.64 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.366 1.46 . . . . 0.0 114.213 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -158.94 132.94 7.63 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 127.108 2.163 . . . . 0.0 106.929 169.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -135.51 164.6 27.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -142.65 145.79 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -110.88 144.63 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.447 HG21 ' H ' ' A' ' 66' ' ' GLY . 2.6 m -128.29 -178.19 4.45 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.447 ' H ' HG21 ' A' ' 65' ' ' THR . . . 73.91 13.07 81.02 Favored Glycine 0 N--CA 1.463 0.439 0 C-N-CA 123.979 0.799 . . . . 0.0 113.35 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -69.99 165.58 21.48 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.125 0.97 . . . . 0.0 108.847 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.96 105.56 13.87 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.953 1.701 . . . . 0.0 108.56 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.93 152.94 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.007 2.471 . . . . 0.0 110.192 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 -43.89 1.32 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 125.991 1.758 . . . . 0.0 109.188 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -84.09 165.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 122.747 1.261 . . . . 0.0 108.804 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -101.34 138.14 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 128.407 2.683 . . . . 0.0 106.57 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -133.96 142.43 47.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.05 0.841 . . . . 0.0 110.681 -158.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.31 89.74 3.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.277 1.431 . . . . 0.0 109.988 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.425 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 5.1 mp -83.99 111.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -170.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -111.36 125.79 54.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.211 1.804 . . . . 0.0 108.718 -164.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.41 103.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 mt -84.55 144.38 9.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -105.58 131.16 53.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.7 150.22 51.99 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.338 1.426 . . . . 0.0 109.19 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.0 pt -135.72 -179.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.85 1.26 . . . . 0.0 108.954 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -35.2 116.78 0.37 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.61 1.564 . . . . 0.0 110.301 168.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 47.03 2.19 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 124.786 1.304 . . . . 0.0 112.186 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.11 155.45 26.59 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.247 1.023 . . . . 0.0 111.226 -165.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -151.49 127.96 10.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -178.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.82 141.79 84.99 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.374 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.2 100.36 0.87 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.857 2.372 . . . . 0.0 108.568 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 m -83.59 125.89 32.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.7 m -125.32 155.35 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 mt -140.29 141.6 35.76 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.9 m -77.57 146.83 36.04 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -138.72 157.93 45.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.436 1.095 . . . . 0.0 108.662 153.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -125.59 144.16 50.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.644 1.578 . . . . 0.0 109.025 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.248 1.024 0 C-N-CA 125.143 1.377 . . . . 0.0 112.591 166.063 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 34.75 72.62 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.142 2.577 . . . . 0.0 114.61 157.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.77 128.55 9.51 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . 0.319 2.7 p 46.55 -161.92 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.827 2.451 . . . . 0.0 113.059 -174.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -118.89 -73.58 0.64 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.878 0.871 . . . . 0.0 109.826 -171.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.1 t -135.11 133.68 20.99 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 119.736 1.153 . . . . 0.0 108.059 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.59 122.09 4.39 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.177 2.585 . . . . 0.0 111.606 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 163.29 27.54 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.235 1.014 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.26 80.84 1.83 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.665 0.745 . . . . 0.0 110.68 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 m -56.15 -10.79 0.92 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.861 2.065 . . . . 0.0 112.346 168.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -111.0 5.84 20.57 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.631 -1.293 . . . . 0.0 113.825 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.31 118.49 4.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.505 0.593 . . . . 0.0 109.807 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -140.98 165.32 27.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.789 1.636 . . . . 0.0 109.957 166.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' A' ' 91' ' ' LEU . 12.4 m-30 -108.58 155.26 20.86 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 165.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.04 174.68 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 128.406 2.682 . . . . 0.0 107.997 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 48.64 44.8 21.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.397 1.079 . . . . 0.0 110.18 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.76 61.35 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 t -64.38 166.01 8.86 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.925 1.345 . . . . 0.0 109.424 168.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.81 4.63 6.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.209 1.404 . . . . 0.0 111.381 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -126.15 -0.92 7.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.437 2.295 . . . . 0.0 116.908 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.91 166.74 0.53 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.81 2.844 . . . . 0.0 109.125 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 tt -123.65 140.44 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.95 157.33 21.1 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.76 154.53 44.1 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.473 1.509 . . . . 0.0 108.076 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -139.42 141.01 37.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -158.18 -174.35 4.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.504 0.722 . . . . 0.0 110.311 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 m -97.73 107.14 38.16 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.013 1.725 . . . . 0.0 107.141 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -58.79 128.81 29.44 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 121.233 1.476 . . . . 0.0 109.013 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.9 mt -95.35 98.26 10.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 126.694 1.997 . . . . 0.0 105.845 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -75.04 28.58 0.09 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.519 0.728 . . . . 0.0 111.787 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -66.69 131.19 45.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -76.59 52.55 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.113 -0.992 . . . . 0.0 111.213 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.47 -14.43 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.093 1.357 . . . . 0.0 111.0 -164.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.05 141.89 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.44 -65.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.42 -168.08 31.74 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -124.05 138.69 54.41 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.65 118.9 29.21 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.51 149.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -145.13 102.88 3.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.75 127.76 39.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -123.69 164.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.01 110.66 21.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 48.39 -165.73 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 128.11 2.564 . . . . 0.0 113.596 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.21 7.33 0.07 OUTLIER Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.789 -1.562 . . . . 0.0 114.44 161.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -79.98 -12.19 59.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 121.734 2.767 . . . . 0.0 110.037 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.91 -11.37 6.11 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.863 1.697 . . . . 0.0 113.206 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mt -45.06 105.82 0.49 Allowed Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 128.26 2.624 . . . . 0.0 110.969 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.67 128.38 11.71 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.123 2.549 . . . . 0.0 110.188 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mm -84.89 -62.36 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.95 155.37 34.11 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 107.676 -164.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.13 151.65 40.93 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 174.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.69 158.37 15.3 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.046 0.841 . . . . 0.0 110.792 -156.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.87 154.21 49.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.693 1.197 . . . . 0.0 108.272 -167.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.16 -177.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.5 -57.44 5.8 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -163.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t 157.53 -43.36 0.0 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 128.073 2.549 . . . . 0.0 111.936 -163.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -129.47 37.16 4.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.093 1.315 . . . . 0.0 110.377 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.4 134.77 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.11 -5.71 13.03 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.274 1.416 . . . . 0.0 113.57 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -142.18 130.79 22.63 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.475 1.91 . . . . 0.0 107.336 174.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.22 166.61 24.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -151.74 147.03 26.2 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.664 -1.272 . . . . 0.0 109.328 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.84 158.28 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.754 1.621 . . . . 0.0 108.641 -166.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.09 178.01 7.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.529 1.132 . . . . 0.0 108.889 -174.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 23.65 77.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 165.01 25.92 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 161.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -143.65 135.88 13.27 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.629 1.172 . . . . 0.0 107.975 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 161.67 42.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.191 1.927 . . . . 0.0 111.914 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.27 -14.63 63.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.657 1.599 . . . . 0.0 113.338 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.81 152.01 13.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 118.779 1.289 . . . . 0.0 108.234 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.49 127.73 32.76 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.309 1.844 . . . . 0.0 108.012 174.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -116.47 120.29 38.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.89 102.51 13.17 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 168.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 mt -94.48 89.65 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.2 p -94.58 150.31 20.37 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.707 -0.621 . . . . 0.0 110.293 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.0 t -147.12 123.69 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -172.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.3 mt -118.61 139.65 45.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.5 m -106.06 115.97 31.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.114 1.766 . . . . 0.0 107.532 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.38 137.57 51.91 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.452 1.501 . . . . 0.0 109.779 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.06 -176.66 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.524 1.929 . . . . 0.0 109.154 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -35.2 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.154 1.382 . . . . 0.0 111.793 161.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.98 29.74 35.82 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.728 167.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.08 158.06 30.4 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 119.155 1.478 . . . . 0.0 111.113 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.8 151.43 51.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.674 1.99 . . . . 0.0 105.736 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.08 -171.04 3.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 144.71 88.99 Favored Pre-proline 0 C--O 1.242 0.676 0 O-C-N 120.877 -1.139 . . . . 0.0 108.631 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -63.7 136.6 54.56 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 107.979 -1.585 . . . . 0.0 107.979 171.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.96 96.59 6.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.8 m -114.2 143.54 44.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.487 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 95.0 mt -134.17 111.29 10.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 t -84.52 155.26 22.22 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -163.29 131.9 3.88 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 108.973 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -95.99 78.74 3.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.07 0.948 . . . . 0.0 110.578 169.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.256 1.398 0 C-N-CA 123.807 0.843 . . . . 0.0 110.236 167.067 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mtt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.05 -17.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.648 2.379 . . . . 0.0 113.28 170.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.97 -152.71 24.71 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -160.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.2 p 60.18 47.02 9.78 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.666 1.986 . . . . 0.0 113.724 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.43 -79.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.591 1.156 . . . . 0.0 109.389 170.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.24 133.51 71.67 Favored Pre-proline 0 N--CA 1.448 -0.571 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -173.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.28 116.72 4.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 N-CA-C 105.986 -2.352 . . . . 0.0 105.986 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -73.67 177.5 5.38 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.109 0.964 . . . . 0.0 111.64 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.39 76.92 0.39 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.851 0.834 . . . . 0.0 108.929 161.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m -60.48 -27.88 67.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.202 1.001 . . . . 0.0 109.043 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . . . -83.89 3.89 31.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.53 1.532 . . . . 0.0 114.338 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.34 117.76 7.1 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.124 -0.985 . . . . 0.0 110.409 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -153.02 165.66 34.87 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 168.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 7.5 m-30 -97.54 160.28 14.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.41 172.63 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.278 1.831 . . . . 0.0 106.555 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.71 44.87 19.85 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.246 1.018 . . . . 0.0 110.707 164.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -80.1 52.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.319 1.848 . . . . 0.0 109.695 -169.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.9 t -80.75 174.68 11.37 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.625 1.57 . . . . 0.0 109.684 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -80.33 -1.35 40.7 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.322 -0.861 . . . . 0.0 112.325 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.3 p -125.29 0.92 7.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 126.435 1.894 . . . . 0.0 115.839 -167.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.25 173.28 2.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.564 2.345 . . . . 0.0 106.591 160.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tt -121.98 143.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 160.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.07 163.24 18.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.52 157.68 42.0 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.224 1.41 . . . . 0.0 108.852 170.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -138.43 147.91 43.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 163.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -153.58 -179.73 8.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 163.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -94.19 106.95 25.56 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.55 138.96 73.37 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.923 1.749 . . . . 0.0 110.059 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 132.23 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.347 1.859 . . . . 0.0 106.537 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.95 18.67 21.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -64.44 158.28 24.26 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -165.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -82.65 43.77 0.85 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.791 -1.193 . . . . 0.0 111.656 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -171.05 -21.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.544 -0.723 . . . . 0.0 112.786 -174.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.29 121.23 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.914 0.886 . . . . 0.0 109.213 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.71 -46.41 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.08 -153.61 23.62 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.38 -1.39 . . . . 0.0 114.259 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -138.27 145.81 41.74 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.52 118.73 27.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.77 1.628 . . . . 0.0 107.658 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -114.01 115.25 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -168.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.3 m -126.72 103.78 7.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.72 138.45 19.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.98 174.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.37 163.23 38.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.5 118.64 22.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.01 13.63 3.84 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.121 2.569 . . . . 0.0 115.33 165.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.76 17.54 60.61 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.057 -1.027 . . . . 0.0 111.875 -166.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -76.34 -6.34 51.13 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.762 1.781 . . . . 0.0 111.405 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.13 -37.98 3.52 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.634 2.064 . . . . 0.0 110.753 -174.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.1 mt -45.2 101.67 0.27 Allowed Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 128.6 2.76 . . . . 0.0 110.145 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.4 152.54 34.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.483 2.122 . . . . 0.0 110.02 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.9 mp -106.49 -92.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 161.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.05 170.55 16.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.981 1.264 . . . . 0.0 110.289 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.98 124.1 48.54 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.613 1.965 . . . . 0.0 107.062 173.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 159.3 15.79 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.068 2.547 . . . . 0.0 109.294 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.22 153.73 46.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 162.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -171.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.086 1.312 . . . . 0.0 111.098 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 p 168.2 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.614 1.965 . . . . 0.0 110.932 -162.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -124.66 20.23 8.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.513 1.525 . . . . 0.0 110.405 -171.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.82 124.34 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.11 3.28 51.53 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.531 1.539 . . . . 0.0 112.809 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -163.28 127.79 2.95 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 110.981 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -139.1 162.54 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.254 1.388 . . . . 0.0 109.133 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -138.19 148.26 44.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.736 1.214 . . . . 0.0 108.121 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.17 143.82 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 107.862 -174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 66' ' ' GLY . 1.9 m -141.79 -175.45 4.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -169.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.444 ' H ' HG23 ' A' ' 65' ' ' THR . . . 61.45 25.96 65.76 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 124.166 0.889 . . . . 0.0 111.855 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -79.51 165.87 22.55 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 170.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -130.19 133.02 24.46 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 165.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -79.19 169.57 18.85 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.233 2.622 . . . . 0.0 110.374 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.83 -4.17 49.57 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.769 -1.017 . . . . 0.0 114.209 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 mm -126.34 165.07 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.469 1.635 . . . . 0.0 107.412 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -86.44 149.42 25.0 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.068 -1.02 . . . . 0.0 109.274 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -138.26 130.65 29.01 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.885 0.874 . . . . 0.0 109.363 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.14 108.34 19.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 165.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.462 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.9 mp -98.5 94.67 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.5 p -95.91 153.26 17.85 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 110.672 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.09 98.05 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -172.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -92.14 129.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.2 m -106.43 125.08 50.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.194 1.397 . . . . 0.0 107.754 -174.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.56 148.77 46.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 111.448 -170.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.5 -176.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.051 2.14 . . . . 0.0 107.49 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -34.46 108.42 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 111.1 165.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.78 43.13 1.62 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.681 2.086 . . . . 0.0 112.923 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.39 158.99 30.09 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -167.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -146.47 161.9 39.44 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.87 1.668 . . . . 0.0 108.452 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.5 m -89.0 -169.94 2.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.158 0.583 . . . . 0.0 109.683 172.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.39 152.46 94.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.49 103.66 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.475 2.116 . . . . 0.0 108.574 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 p -87.03 139.55 30.46 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -145.16 172.78 12.62 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.2 134.3 20.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 156.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -79.64 104.02 9.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.551 1.94 . . . . 0.0 107.043 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.58 108.84 20.3 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.052 -1.655 . . . . 0.0 112.84 171.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 148.4 31.16 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 157.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 C--O 1.243 0.731 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.527 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -151.79 173.02 15.26 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.35 1.86 . . . . 0.0 108.367 174.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.59 134.78 2.66 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 118.475 0.58 . . . . 0.0 111.787 173.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 p 57.6 9.85 0.9 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.833 2.453 . . . . 0.0 116.158 165.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -61.41 -79.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.198 1.399 . . . . 0.0 112.813 -148.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.8 t -77.42 134.22 66.67 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.17 132.83 30.96 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.829 2.353 . . . . 0.0 112.199 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.05 156.73 17.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.651 1.98 . . . . 0.0 109.554 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.39 87.45 1.54 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.161 0.984 . . . . 0.0 109.95 -173.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 m -66.55 -10.04 41.1 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.393 0.677 . . . . 0.0 112.252 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.46 0.11 55.13 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.411 -1.43 . . . . 0.0 112.487 171.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.31 106.65 0.21 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.981 1.264 . . . . 0.0 111.475 -172.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -140.54 138.48 34.55 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.775 1.23 . . . . 0.0 109.644 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.58 156.47 16.71 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.49 167.6 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.182 1.793 . . . . 0.0 109.05 169.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 50.52 61.03 3.43 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 108.673 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.0 mm -81.02 64.23 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.385 1.874 . . . . 0.0 107.833 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.3 t -95.08 171.84 8.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.242 1.02 . . . . 0.0 111.561 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.57 -4.33 36.33 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.832 1.253 . . . . 0.0 112.351 -165.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.9 p -124.99 -14.53 6.61 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.947 1.299 . . . . 0.0 114.052 -171.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -174.46 148.43 1.21 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.859 1.264 . . . . 0.0 111.517 -166.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.25 132.17 70.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.78 156.39 25.5 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.42 128.24 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.023 1.329 . . . . 0.0 109.071 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -98.51 151.21 20.86 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -151.32 174.99 12.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 150.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -87.9 141.87 31.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 171.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.14 123.41 5.61 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 N-CA-C 105.877 -2.393 . . . . 0.0 105.877 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.16 -19.55 56.69 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 50.39 31.21 5.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.602 2.361 . . . . 0.0 111.681 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -69.49 5.6 1.32 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.47 2.308 . . . . 0.0 113.842 -158.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 64.73 -63.67 0.17 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 112.753 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.325 3.05 . . . . 0.0 113.214 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -53.62 151.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.871 1.269 . . . . 0.0 110.85 167.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.53 -57.17 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.01 -156.2 15.98 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -127.77 144.86 51.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.81 124.03 51.26 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 175.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.75 156.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 168.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -145.14 142.94 30.07 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.84 138.04 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.98 163.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.22 114.12 21.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 166.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.68 138.51 47.22 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.37 -45.96 1.18 Allowed Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 124.194 0.902 . . . . 0.0 111.499 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -110.65 -26.53 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.907 -0.761 . . . . 0.0 109.651 168.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.57 13.54 81.85 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 120.946 -1.096 . . . . 0.0 111.296 -170.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 mt -41.84 105.55 0.4 Allowed Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 128.157 2.583 . . . . 0.0 108.587 165.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.68 127.24 3.65 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.073 2.515 . . . . 0.0 109.355 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.57 -70.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.89 164.59 31.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.856 0.753 . . . . 0.0 110.251 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.22 126.39 55.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 167.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -104.44 162.81 12.92 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.862 1.665 . . . . 0.0 107.897 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.09 161.33 27.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.748 0.819 . . . . 0.0 109.568 174.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.72 -176.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.34 -71.41 0.23 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.6 t 155.04 -21.94 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 131.657 3.983 . . . . 0.0 109.841 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.9 p -135.03 20.15 3.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.358 1.435 . . . . 0.0 112.641 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.69 128.91 36.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 169.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.89 2.72 11.83 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.273 2.368 . . . . 0.0 112.651 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -138.84 127.68 23.6 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.264 -1.139 . . . . 0.0 109.222 166.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -142.06 164.34 30.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.885 1.674 . . . . 0.0 109.417 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.2 m -133.77 135.82 44.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.54 1.536 . . . . 0.0 107.547 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.88 155.62 4.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 164.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.31 170.05 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.075 0.95 . . . . 0.0 109.59 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.07 51.21 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.588 -0.695 . . . . 0.0 111.89 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.52 158.02 15.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 128.68 2.792 . . . . 0.0 106.782 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 80.84 39.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.036 1.734 . . . . 0.0 109.344 -170.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.56 124.67 11.4 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.947 1.765 . . . . 0.0 108.682 -169.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.47 -26.5 4.61 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 124.436 1.017 . . . . 0.0 113.488 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.21 166.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.827 1.651 . . . . 0.0 107.219 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.16 126.03 41.1 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.065 1.746 . . . . 0.0 107.244 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.4 126.8 54.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.633 0.773 . . . . 0.0 109.262 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.07 103.36 15.3 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 173.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.33 101.07 11.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.1 p -88.8 143.33 26.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.374 1.083 . . . . 0.0 109.678 173.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.2 t -139.09 119.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 mt -124.69 141.18 45.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -98.59 136.42 38.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.77 132.96 55.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.362 1.065 . . . . 0.0 108.51 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 pt -130.09 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.155 1.782 . . . . 0.0 109.675 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -34.11 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.37 2.268 . . . . 0.0 110.021 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.85 53.7 0.05 OUTLIER Glycine 0 CA--C 1.526 0.772 0 C-N-CA 128.284 2.849 . . . . 0.0 113.604 -172.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.87 160.88 34.44 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 118.065 0.932 . . . . 0.0 111.459 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -139.2 146.11 40.12 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 126.326 1.85 . . . . 0.0 108.414 -168.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -84.51 -174.49 5.3 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.409 0.683 . . . . 0.0 110.472 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.65 134.58 93.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 166.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.83 132.57 32.98 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -118.69 111.15 18.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -124.7 152.16 44.07 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.421 HD22 ' H ' ' A' ' 92' ' ' THR . 1.4 tt -132.97 153.61 51.28 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 152.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.421 ' H ' HD22 ' A' ' 91' ' ' LEU . 4.3 t -112.8 135.1 53.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.53 114.5 12.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -85.78 111.85 20.54 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.251 1.148 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.9 mtp . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 154.72 154.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 131.578 3.951 . . . . 0.0 106.203 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.74 151.1 15.23 Favored Glycine 0 C--O 1.235 0.181 0 CA-C-N 119.426 1.012 . . . . 0.0 111.906 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 m -62.45 153.89 30.1 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.149 0.979 . . . . 0.0 109.426 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -85.23 -59.28 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.996 0.518 . . . . 0.0 111.729 -160.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -134.72 138.9 30.88 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 171.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 125.61 12.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.466 2.111 . . . . 0.0 109.056 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.96 166.38 23.15 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 163.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.435 HD11 ' CG ' ' A' ' 26' ' ' TRP . 48.7 mt -66.57 88.68 0.14 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -66.86 -13.65 61.86 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.154 0.982 . . . . 0.0 109.19 171.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.14 4.49 50.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.07 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.94 121.08 11.5 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.073 -1.017 . . . . 0.0 110.027 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -146.83 165.57 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.218 1.007 . . . . 0.0 110.543 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -119.64 150.44 40.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.91 0.884 . . . . 0.0 108.895 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.94 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.961 2.104 . . . . 0.0 107.712 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 55.5 45.23 25.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.821 0.848 . . . . 0.0 110.182 161.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.29 56.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.791 2.036 . . . . 0.0 107.035 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.28 166.64 19.71 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -75.11 7.03 3.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.2 p -125.32 -10.13 6.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 115.18 -167.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.88 166.31 0.9 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 127.324 2.25 . . . . 0.0 109.162 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.89 128.41 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.23 150.28 23.6 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.2 141.73 51.38 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.415 1.486 . . . . 0.0 107.994 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -124.88 142.23 51.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.435 ' CG ' HD11 ' A' ' 9' ' ' LEU . 44.2 p90 -156.78 -173.07 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 164.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -108.74 105.46 57.04 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.927 1.291 . . . . 0.0 108.719 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.43 124.67 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.957 2.438 . . . . 0.0 112.076 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.55 103.55 15.16 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.237 1.015 . . . . 0.0 108.797 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -80.61 49.12 1.13 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.564 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 m -61.93 -64.46 0.93 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.985 -166.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 p 156.69 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.828 2.451 . . . . 0.0 112.305 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.85 -4.38 1.77 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.655 1.982 . . . . 0.0 110.157 -163.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -43.19 134.88 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.184 -1.572 . . . . 0.0 109.724 146.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.56 -43.36 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 124.748 1.219 . . . . 0.0 110.26 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.89 -158.24 31.1 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -129.67 125.09 35.22 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 133.22 35.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 174.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 mp -110.3 149.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.8 m -140.82 158.83 43.39 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.54 125.59 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 103.908 -2.626 . . . . 0.0 103.908 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.31 162.81 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.601 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.68 108.02 19.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.96 -30.34 58.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.222 0.609 . . . . 0.0 112.012 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.9 -18.32 59.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.604 -1.109 . . . . 0.0 115.607 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -148.0 5.77 0.77 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.643 1.721 . . . . 0.0 112.651 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.86 -5.83 5.72 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.76 -1.212 . . . . 0.0 113.34 -173.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.1 mt -45.56 105.54 0.47 Allowed Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 128.742 2.817 . . . . 0.0 110.15 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.56 132.42 12.17 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.507 2.138 . . . . 0.0 110.324 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -83.75 -67.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -160.0 175.27 13.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.045 0.938 . . . . 0.0 109.567 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -122.02 123.41 41.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.436 1.494 . . . . 0.0 107.921 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -105.93 165.81 10.94 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.004 1.722 . . . . 0.0 109.968 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.48 163.17 28.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.202 1.001 . . . . 0.0 108.634 169.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 -176.63 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.67 -64.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -164.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 m 153.55 -13.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.735 4.014 . . . . 0.0 111.344 -169.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -135.97 13.49 3.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.985 0.811 . . . . 0.0 112.535 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.41 138.98 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.54 5.5 5.21 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.075 1.798 . . . . 0.0 112.93 173.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -146.04 124.81 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -145.95 162.93 36.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.656 1.583 . . . . 0.0 108.231 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -144.83 131.96 20.48 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.258 -0.901 . . . . 0.0 108.983 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.94 149.18 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 -170.67 2.13 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.902 1.681 . . . . 0.0 107.004 170.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.5 14.56 75.84 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 120.12 1.327 . . . . 0.0 112.758 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.99 153.74 38.39 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.741 0.816 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -122.16 115.77 30.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.938 1.695 . . . . 0.0 106.834 163.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.54 144.73 85.79 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.292 1.995 . . . . 0.0 110.833 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.0 -10.49 58.55 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.469 1.509 . . . . 0.0 113.729 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.87 151.02 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 119.706 1.753 . . . . 0.0 107.041 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -80.61 120.06 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.465 1.506 . . . . 0.0 108.488 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.45 120.29 37.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.158 1.383 . . . . 0.0 108.387 -168.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.78 90.66 7.37 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.034 1.734 . . . . 0.0 107.375 174.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.01 109.52 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -114.43 122.04 45.4 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.133 1.773 . . . . 0.0 111.341 -167.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -134.19 132.32 55.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -164.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 tt -143.41 152.79 16.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.419 1.087 . . . . 0.0 111.216 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.3 m -105.29 134.04 49.07 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 106.894 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.78 134.06 55.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.637 1.575 . . . . 0.0 109.034 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -129.67 175.69 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.91 1.284 . . . . 0.0 107.585 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -46.33 110.02 0.24 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.522 0.601 . . . . 0.0 110.106 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.05 42.69 1.21 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 126.516 2.008 . . . . 0.0 113.392 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.72 144.62 12.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -133.45 118.53 18.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -161.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.22 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.92 133.44 41.31 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.896 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.66 109.76 1.72 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.038 2.492 . . . . 0.0 106.524 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -107.28 102.66 11.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.0 m -94.16 158.75 15.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 tt -132.22 101.92 5.57 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 153.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -84.92 119.19 25.08 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -136.72 153.15 50.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.419 1.487 . . . . 0.0 108.74 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.28 157.92 27.65 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 157.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.25 1.092 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.717 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.58 134.77 33.96 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.724 1.616 . . . . 0.0 109.803 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -112.64 160.96 17.36 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.031 2.132 . . . . 0.0 108.577 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.548 HD13 ' CG ' ' A' ' 26' ' ' TRP . 72.7 mt -70.05 87.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.133 0.973 . . . . 0.0 108.686 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.54 -3.9 30.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.468 1.107 . . . . 0.0 111.249 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.57 6.79 15.91 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.62 1.968 . . . . 0.0 112.937 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -52.23 110.99 0.55 Allowed 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.243 1.417 . . . . 0.0 109.172 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.9 m -155.15 165.14 37.61 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.984 0.914 . . . . 0.0 111.964 170.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 12.1 m-30 -110.95 149.97 29.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.198 1.399 . . . . 0.0 109.626 -162.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.93 175.76 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 128.248 2.619 . . . . 0.0 108.207 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 t70 46.1 52.91 9.78 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.827 2.051 . . . . 0.0 110.618 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.2 52.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 127.361 2.265 . . . . 0.0 108.468 -166.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 20' ' ' SER . 14.6 t -77.31 175.2 9.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 110.125 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.61 -5.53 53.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.316 1.046 . . . . 0.0 111.455 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.45 ' H ' HG23 ' A' ' 18' ' ' THR . 58.6 p -122.72 -8.33 8.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.63 1.972 . . . . 0.0 114.732 -162.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -175.11 175.01 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.04 2.536 . . . . 0.0 108.014 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.9 123.13 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 134.94 11.88 Favored Glycine 0 N--CA 1.467 0.75 0 O-C-N 120.415 -1.428 . . . . 0.0 110.043 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.81 155.43 20.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.845 1.322 . . . . 0.0 108.248 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.01 145.27 50.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 162.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.548 ' CG ' HD13 ' A' ' 9' ' ' LEU . 17.0 p90 -157.79 173.64 16.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.526 1.131 . . . . 0.0 109.472 166.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.0 m -90.99 142.6 27.56 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.642 1.11 . . . . 0.0 108.561 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -81.45 125.26 5.0 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.004 1.037 . . . . 0.0 111.997 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.22 88.65 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.209 1.804 . . . . 0.0 110.431 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -79.73 40.49 0.45 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.755 -0.591 . . . . 0.0 111.077 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -35.03 -64.26 0.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.1 p 159.31 -22.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 128.745 2.818 . . . . 0.0 112.761 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 34' ' ' ILE . 0.8 OUTLIER -165.06 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.592 -1.317 . . . . 0.0 111.273 -153.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.401 ' H ' ' H ' ' A' ' 33' ' ' THR . 5.1 tt -43.27 144.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 109.479 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.467 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.2 mp -83.88 -49.47 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.38 -158.2 28.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.51 140.38 52.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 166.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.8 112.46 20.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.56 144.34 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.6 m -131.51 152.59 50.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 145.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 123.8 0.84 . . . . 0.0 111.674 165.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.44 164.47 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.57 99.84 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.425 0 C-N-CA 124.43 1.092 . . . . 0.0 109.475 -177.19 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 118.78 -0.629 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.77 165.24 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.96 2.44 . . . . 0.0 109.718 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -122.81 -82.79 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -148.44 163.55 36.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.579 1.081 . . . . 0.0 109.774 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.77 123.82 48.1 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 164.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -106.61 156.62 18.4 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.13 1.772 . . . . 0.0 108.126 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.445 ' CZ ' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -126.86 153.73 45.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.817 0.847 . . . . 0.0 109.212 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.32 -176.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.81 -61.5 1.76 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.618 -157.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p 154.19 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 131.14 3.776 . . . . 0.0 109.902 -172.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -123.62 7.55 8.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.904 2.082 . . . . 0.0 111.926 -163.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -74.48 139.31 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 109.638 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.59 -5.65 18.33 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 123.996 0.807 . . . . 0.0 114.638 158.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -139.68 121.12 15.06 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.848 -1.383 . . . . 0.0 110.108 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -134.15 167.41 20.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.5 m -142.24 118.54 10.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.626 -1.296 . . . . 0.0 108.256 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -84.48 143.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 -171.83 2.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.15 69.29 Favored Glycine 0 CA--C 1.522 0.476 0 O-C-N 120.772 -1.205 . . . . 0.0 112.166 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.67 165.34 18.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.809 0.804 . . . . 0.0 110.589 165.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -134.3 135.09 23.38 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 126.731 2.012 . . . . 0.0 107.879 159.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.84 165.44 25.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.376 2.05 . . . . 0.0 112.451 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.22 -28.6 8.58 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 126.906 2.193 . . . . 0.0 111.746 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.2 mm -115.67 165.19 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -96.09 143.0 27.61 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -123.74 128.05 49.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.36 95.2 9.92 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -84.95 104.5 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m -88.09 147.87 24.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.26 1.024 . . . . 0.0 110.313 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.9 t -145.46 77.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.33 133.92 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.6 m -94.47 136.96 34.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.467 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -133.48 113.53 12.59 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.609 1.164 . . . . 0.0 107.95 -178.365 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -109.3 -175.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.117 1.767 . . . . 0.0 108.696 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -34.58 104.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.092 1.357 . . . . 0.0 110.848 163.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.69 29.25 5.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.61 1.576 . . . . 0.0 115.005 170.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.37 144.48 9.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.342 1.571 . . . . 0.0 110.925 -173.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -110.78 142.12 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.763 2.025 . . . . 0.0 106.534 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.79 174.41 10.46 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.84 0.746 . . . . 0.0 109.362 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.59 135.86 92.82 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.2 128.98 22.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 N-CA-C 107.805 -1.652 . . . . 0.0 107.805 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 m -122.6 99.4 6.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.9 m -94.23 163.41 13.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 5.4 mt -132.87 136.16 46.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 164.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 m -84.74 127.87 34.32 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.641 1.976 . . . . 0.0 106.23 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -154.86 147.4 24.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.766 1.166 . . . . 0.0 109.301 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.62 168.01 11.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.293 1.044 . . . . 0.0 110.638 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.251 1.133 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.903 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.99 143.93 20.94 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.174 2.582 . . . . 0.0 111.705 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 174.68 7.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.432 1.893 . . . . 0.0 111.795 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.46 HD13 ' CG ' ' A' ' 26' ' ' TRP . 61.6 mt -77.64 85.39 3.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 166.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m -56.28 -35.29 67.31 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.582 -0.698 . . . . 0.0 110.201 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -74.21 5.99 3.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.484 2.314 . . . . 0.0 113.006 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.07 110.71 0.87 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.178 0.991 . . . . 0.0 111.075 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -125.89 164.45 20.74 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.86 0.864 . . . . 0.0 110.28 162.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 10.5 m-85 -90.73 166.16 13.28 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 155.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 177.21 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 127.287 2.235 . . . . 0.0 105.48 168.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.25 56.98 5.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.172 1.389 . . . . 0.0 110.355 161.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mm -78.77 59.82 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -69.07 173.63 5.33 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.408 -1.432 . . . . 0.0 109.945 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -98.88 22.11 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.649 1.179 . . . . 0.0 111.675 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -121.47 -13.73 8.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.263 1.425 . . . . 0.0 114.491 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p 170.48 171.96 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.032 2.133 . . . . 0.0 107.928 -154.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -137.44 147.63 26.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 166.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.53 163.74 23.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.12 159.25 36.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.399 1.48 . . . . 0.0 108.515 168.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -143.66 136.04 26.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.46 ' CG ' HD13 ' A' ' 9' ' ' LEU . 9.8 p90 -154.66 -177.5 6.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.267 1.027 . . . . 0.0 109.667 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -107.11 106.13 57.48 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.41 130.99 28.36 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.0 1.8 . . . . 0.0 110.029 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 31' ' ' SER . 2.2 mt -94.18 89.26 5.91 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.845 2.458 . . . . 0.0 105.018 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.55 50.38 0.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' LEU . 4.2 m -81.85 124.16 29.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.082 1.753 . . . . 0.0 109.847 168.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -63.39 38.52 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 130.159 3.384 . . . . 0.0 114.786 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -169.27 -12.42 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.823 2.049 . . . . 0.0 110.371 -171.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.62 161.06 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.091 1.356 . . . . 0.0 108.809 162.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.91 -59.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.71 -164.73 33.39 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' HD11 ' A' ' 9' ' ' LEU . 5.1 m-85 -131.21 145.39 51.91 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.83 130.16 56.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.924 1.69 . . . . 0.0 106.975 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.63 133.15 61.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.7 m -128.67 138.56 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.82 123.23 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.487 1.515 . . . . 0.0 108.335 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.19 163.44 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 124.025 0.828 . . . . 0.0 109.304 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 106.24 17.52 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.313 0 C-N-CA 125.499 1.52 . . . . 0.0 109.089 -175.936 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.57 126.85 13.93 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 122.175 1.917 . . . . 0.0 107.494 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 mm -84.06 -82.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -148.21 175.68 10.86 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.023 -1.048 . . . . 0.0 109.763 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.11 159.83 31.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -148.96 164.86 33.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.622 1.969 . . . . 0.0 107.465 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 153.82 43.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.341 0.656 . . . . 0.0 109.602 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -177.38 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.916 0.78 . . . . 0.0 110.752 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.0 -60.45 2.29 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p 153.64 -41.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 1 C-N-CA 132.504 4.322 . . . . 0.0 107.878 -171.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.6 p -102.48 -1.13 31.2 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.965 1.706 . . . . 0.0 112.902 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.36 129.81 36.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.759 1.223 . . . . 0.0 108.24 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.78 -5.92 21.66 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 125.268 1.413 . . . . 0.0 113.315 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -140.25 116.15 10.33 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.301 1.44 . . . . 0.0 108.321 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.4 136.59 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.3 m -112.19 124.79 53.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.13 165.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.98 1.712 . . . . 0.0 107.629 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.15 -174.29 3.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.45 36.46 30.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.089 0.859 . . . . 0.0 112.536 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.03 162.84 13.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.934 1.293 . . . . 0.0 110.449 171.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.93 135.19 10.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.95 2.5 . . . . 0.0 104.916 162.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.91 170.29 18.3 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.754 2.303 . . . . 0.0 113.099 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.49 -4.83 70.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.772 0.701 . . . . 0.0 113.848 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.9 mm -129.44 147.79 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.944 1.698 . . . . 0.0 106.885 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -84.01 142.85 30.18 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.78 113.69 11.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.301 1.84 . . . . 0.0 106.432 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.21 103.17 13.19 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.921 1.688 . . . . 0.0 107.086 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.449 HG23 HG13 ' A' ' 41' ' ' VAL . 1.5 mp -92.23 107.7 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 80.7 p -92.78 143.56 26.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.289 1.036 . . . . 0.0 110.957 172.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.46 119.19 16.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mt -117.83 129.67 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.0 m -89.77 132.43 35.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.72 126.74 48.14 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.19 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.69 108.72 0.07 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.476 1.91 . . . . 0.0 110.339 169.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.75 26.13 1.05 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.741 1.638 . . . . 0.0 115.543 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.03 159.44 28.04 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.69 1.745 . . . . 0.0 111.688 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.61 141.6 49.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.137 1.775 . . . . 0.0 108.645 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -85.32 -172.62 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.741 0.816 . . . . 0.0 110.252 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.91 136.03 93.23 Favored Pre-proline 0 C--O 1.24 0.578 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.427 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.2 87.45 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.031 3.154 . . . . 0.0 108.482 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.2 m -84.72 92.13 8.12 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -164.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 1.4 m -94.56 150.4 20.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 69.8 mt -134.88 144.47 47.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 160.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.23 129.2 49.59 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -153.57 130.41 10.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 107.573 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.07 137.5 38.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.593 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.38 141.69 39.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.683 1.588 . . . . 0.0 109.429 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.08 161.53 15.81 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.127 2.171 . . . . 0.0 110.404 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 37' ' ' TYR . 67.3 mt -66.93 83.89 0.11 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.132 0.973 . . . . 0.0 109.375 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 m -71.91 1.0 7.82 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.884 1.674 . . . . 0.0 111.175 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -111.74 4.34 18.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.317 2.647 . . . . 0.0 111.693 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.67 114.81 4.21 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.563 1.945 . . . . 0.0 110.195 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -151.11 164.84 35.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.617 0.767 . . . . 0.0 111.19 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 10.3 m-30 -97.29 160.12 14.52 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.511 -0.743 . . . . 0.0 109.212 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.4 170.6 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.841 1.656 . . . . 0.0 107.526 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.7 47.83 17.69 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.836 1.654 . . . . 0.0 109.706 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -80.45 63.01 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -72.18 165.05 25.17 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -74.51 -3.05 28.53 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.331 -0.856 . . . . 0.0 111.212 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -105.51 -16.17 14.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.05 153.18 0.22 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 127.212 2.205 . . . . 0.0 107.924 -169.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.7 138.39 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.79 156.6 23.14 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 171.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.1 mp -122.59 154.52 37.84 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -137.8 139.93 40.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.418 ' CG ' HD13 ' A' ' 9' ' ' LEU . 36.4 p90 -152.95 175.0 13.42 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.073 0.949 . . . . 0.0 108.555 167.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -92.36 107.49 24.0 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.019 1.327 . . . . 0.0 108.094 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.3 134.68 49.87 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.991 -1.196 . . . . 0.0 108.991 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -88.88 -30.04 19.18 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.425 -1.274 . . . . 0.0 112.867 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 p30 42.43 37.69 1.02 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.607 1.192 . . . . 0.0 112.298 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -62.43 170.24 2.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 0.0 110.139 -167.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 p -67.66 -2.2 6.47 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.08 -4.16 0.06 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.401 -1.437 . . . . 0.0 112.925 -164.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.77 145.22 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 163.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.61 -65.94 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 160.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.61 -154.15 12.37 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -163.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.527 ' CD2' HD11 ' A' ' 9' ' ' LEU . 3.4 m-85 -136.24 144.01 44.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -118.9 123.13 43.9 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.421 HG13 HG13 ' A' ' 77' ' ' VAL . 3.0 mp -103.83 146.87 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 m -145.77 112.45 5.94 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.338 1.455 . . . . 0.0 108.699 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.14 131.69 43.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.718 0.807 . . . . 0.0 110.703 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.2 164.23 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.75 114.21 20.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 125.285 1.434 . . . . 0.0 113.315 -177.413 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 mt . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.28 124.02 8.14 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.932 2.421 . . . . 0.0 110.111 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.29 -59.63 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.9 169.22 18.45 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.193 0.906 . . . . 0.0 110.787 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -106.83 157.0 18.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.411 1.484 . . . . 0.0 108.4 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -152.42 166.06 33.12 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.314 1.446 . . . . 0.0 107.828 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.76 161.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.854 1.262 . . . . 0.0 109.979 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.91 -176.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.768 1.627 . . . . 0.0 107.744 172.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -83.69 -61.96 1.7 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.971 -162.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.6 t 155.23 -43.07 0.01 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 130.534 3.534 . . . . 0.0 107.868 -166.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -97.86 -5.73 33.99 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.242 1.417 . . . . 0.0 113.816 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.89 126.05 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.33 -5.58 37.08 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 127.591 2.519 . . . . 0.0 111.637 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -137.76 114.22 10.31 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.296 -1.708 . . . . 0.0 110.573 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.438 ' CD2' HD13 ' A' ' 24' ' ' LEU . 7.4 t80 -139.21 159.24 42.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.315 1.846 . . . . 0.0 107.719 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -147.08 151.21 36.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.04 145.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -168.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.36 -176.4 3.5 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.8 68.75 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 113.565 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.02 144.67 56.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -123.45 98.11 41.45 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.37 166.07 29.57 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.188 1.925 . . . . 0.0 112.609 -159.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.21 -4.67 80.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.001 1.286 . . . . 0.0 113.436 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.44 152.21 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -79.0 111.58 15.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.35 124.44 52.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.14 1.376 . . . . 0.0 109.389 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.33 126.58 33.33 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 169.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 3.0 mp -110.52 96.43 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.76 133.1 34.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.617 1.567 . . . . 0.0 108.617 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 39' ' ' ILE . 21.5 t -141.9 130.5 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -134.85 147.75 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 37' ' ' TYR . 21.7 m -94.24 137.69 33.12 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.73 128.43 55.27 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.379 . . . . 0.0 107.541 -175.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 pt -134.23 177.27 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.966 0.906 . . . . 0.0 108.588 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.69 110.43 0.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.821 0.848 . . . . 0.0 111.264 169.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.74 21.72 7.53 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.488 1.994 . . . . 0.0 114.708 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 157.33 29.75 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 119.583 1.691 . . . . 0.0 110.992 -161.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.041 0.937 . . . . 0.0 109.9 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 m -84.3 -172.6 4.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.03 0.919 . . . . 0.0 111.015 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.63 96.24 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.19 130.49 16.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.268 1.979 . . . . 0.0 108.783 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.2 m -103.61 107.92 18.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 165.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.9 m -111.93 84.69 2.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 mt -77.64 153.04 33.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.77 139.76 50.26 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -147.88 130.42 15.85 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.939 0.896 . . . . 0.0 109.725 157.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.49 122.47 21.34 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 154.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.017 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.7 t . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.0 133.46 8.97 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.608 2.872 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.46 174.89 6.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.75 1.22 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.5 mt -67.9 75.85 0.21 Allowed 'General case' 0 C--N 1.34 0.152 0 C-N-CA 125.988 1.715 . . . . 0.0 109.523 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.8 m -54.13 -27.24 32.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.748 1.619 . . . . 0.0 110.465 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.51 -0.29 49.63 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 114.759 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.0 115.51 2.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.317 1.047 . . . . 0.0 110.904 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.4 165.19 28.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.338 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -117.57 154.06 32.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 108.341 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.78 171.19 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.061 1.744 . . . . 0.0 107.782 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 51.11 52.15 15.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.24 1.816 . . . . 0.0 110.767 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -78.83 55.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.923 2.489 . . . . 0.0 108.591 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -69.12 167.31 16.35 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.449 -1.407 . . . . 0.0 111.451 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -74.61 6.04 4.23 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.427 1.491 . . . . 0.0 111.846 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -125.7 -12.7 6.57 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 p -174.89 159.73 2.76 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.702 1.201 . . . . 0.0 109.42 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 tt -118.21 141.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.16 153.97 21.66 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.72 151.36 39.64 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 126.309 1.844 . . . . 0.0 107.81 169.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -142.32 138.18 31.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -154.13 -170.87 3.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.547 0.689 . . . . 0.0 109.308 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -106.05 105.53 53.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.773 1.229 . . . . 0.0 107.795 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -66.05 133.96 35.19 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.077 1.851 . . . . 0.0 110.841 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mp -94.93 104.58 16.47 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 125.893 1.677 . . . . 0.0 109.833 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.33 41.44 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.015 1.326 . . . . 0.0 110.532 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.6 m -65.3 155.29 35.69 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 160.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -77.5 -50.25 13.03 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.581 0.705 . . . . 0.0 110.791 166.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.39 -24.5 57.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.091 1.357 . . . . 0.0 113.272 -161.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.31 136.51 6.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 126.573 1.949 . . . . 0.0 108.247 171.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.35 -64.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.18 -161.88 26.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.47 146.42 50.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 127.35 46.13 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.07 145.62 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.8 m -134.89 121.35 20.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.537 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.4 125.9 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.187 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.64 164.31 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 129.92 38.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.457 0 O-C-N 121.725 -0.61 . . . . 0.0 110.134 166.912 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 mt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.93 156.4 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.51 1.473 . . . . 0.0 109.308 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 mm -93.64 -80.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 166.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -156.39 175.8 13.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.464 1.506 . . . . 0.0 109.659 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -126.72 161.96 26.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.207 1.003 . . . . 0.0 109.587 168.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.81 167.11 28.47 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.674 1.59 . . . . 0.0 110.458 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.44 160.16 32.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.743 1.217 . . . . 0.0 109.056 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -177.77 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.65 -61.5 1.82 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -157.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.0 p 166.29 -29.42 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 130.546 3.538 . . . . 0.0 111.42 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -136.26 28.37 3.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.408 0.623 . . . . 0.0 111.298 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -73.36 136.51 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.19 -5.15 17.54 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 124.221 0.915 . . . . 0.0 113.822 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -145.5 128.17 16.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 106.612 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -139.56 159.83 41.26 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.968 -1.082 . . . . 0.0 108.892 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.0 m -131.92 136.68 47.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.634 1.174 . . . . 0.0 108.645 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.13 131.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 126.404 1.882 . . . . 0.0 106.201 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -99.95 -167.76 1.5 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 165.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.7 32.2 61.79 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 121.013 -1.055 . . . . 0.0 110.95 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.25 157.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 107.968 166.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -144.7 119.93 5.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.11 175.54 6.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -167.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.53 61.44 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.154 -0.803 . . . . 0.0 114.217 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mm -118.01 149.95 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.1 141.02 34.71 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.67 120.74 31.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.756 2.022 . . . . 0.0 108.209 -166.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.59 106.17 15.95 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.537 HG23 HG13 ' A' ' 41' ' ' VAL . 1.8 mp -93.48 108.21 20.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -93.58 139.28 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 109.178 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.39 109.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -106.64 134.17 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 m -94.66 134.56 37.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.17 129.1 51.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 107.73 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 pt -116.63 179.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -39.64 112.75 0.28 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 118.36 -0.829 . . . . 0.0 109.577 169.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.79 60.7 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 C-N-CA 127.054 2.264 . . . . 0.0 113.381 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -166.91 144.97 9.47 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -122.99 140.58 52.88 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.107 1.363 . . . . 0.0 108.018 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -84.82 -170.5 3.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.707 0.765 . . . . 0.0 110.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.83 134.73 96.13 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 160.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.77 107.56 2.47 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.33 2.686 . . . . 0.0 110.566 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 106.62 16.33 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -175.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.5 m -115.29 132.88 56.47 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 mt -124.83 107.44 10.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.06 144.6 33.03 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.702 1.601 . . . . 0.0 108.955 174.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -165.63 160.63 17.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.971 0.909 . . . . 0.0 110.738 163.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -93.19 112.37 24.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.255 1.344 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -169.816 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.74 121.1 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.52 2.147 . . . . 0.0 109.677 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.41 171.05 15.23 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.615 0.766 . . . . 0.0 109.908 163.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.0 mt -76.35 86.13 3.12 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -60.61 -20.31 60.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.117 0.567 . . . . 0.0 111.762 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.85 1.85 57.07 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.896 1.226 . . . . 0.0 112.255 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -54.29 116.23 2.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.225 1.41 . . . . 0.0 110.547 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -142.98 159.24 42.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.639 1.576 . . . . 0.0 109.648 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 9.6 m-30 -106.84 155.17 20.02 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.74 173.21 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 129.13 2.972 . . . . 0.0 108.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.9 58.87 3.4 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.434 1.094 . . . . 0.0 111.689 171.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 mm -76.1 48.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 108.269 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -69.76 166.99 18.1 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.745 -1.222 . . . . 0.0 108.898 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.95 -4.76 37.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.353 -1.467 . . . . 0.0 112.211 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 p -119.56 -10.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.233 1.813 . . . . 0.0 114.79 -168.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.81 168.36 2.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.618 1.167 . . . . 0.0 109.916 -167.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.1 tt -135.98 135.05 50.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.6 162.58 26.78 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.7 mp -135.2 148.54 49.69 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.922 1.289 . . . . 0.0 108.42 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.36 145.55 51.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 164.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -153.97 179.94 8.44 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -100.42 141.87 23.54 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -75.95 123.92 7.67 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.525 1.483 . . . . 0.0 109.06 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.06 -41.09 26.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.091 0.957 . . . . 0.0 112.697 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 37.86 48.61 1.03 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.282 1.833 . . . . 0.0 113.175 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 m -54.26 -62.84 1.4 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.501 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 p -178.45 -104.45 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.39 1.076 . . . . 0.0 108.824 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.1 -4.4 44.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.936 2.095 . . . . 0.0 110.268 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.21 128.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 126.797 2.039 . . . . 0.0 112.857 173.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.49 -61.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.7 -160.89 25.53 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.142 -1.027 . . . . 0.0 112.277 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -130.39 139.68 50.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 114.52 20.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.552 HG13 HG13 ' A' ' 77' ' ' VAL . 3.3 mp -92.69 144.62 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.2 m -138.39 127.85 24.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.3 144.87 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 118.731 0.696 . . . . 0.0 110.081 163.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.51 164.79 30.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 167.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.06 125.1 28.85 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.144 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -89.87 157.51 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.869 2.38 . . . . 0.0 110.757 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mm -133.43 65.76 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.432 1.9 p90 54.59 175.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.909 1.284 . . . . 0.0 114.318 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.14 125.32 36.83 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -105.45 163.63 12.49 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.83 162.41 31.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.015 1.326 . . . . 0.0 107.984 175.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.38 -177.35 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 171.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.42 -66.07 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.297 0.639 . . . . 0.0 110.876 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 157.22 -41.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 128.452 2.701 . . . . 0.0 108.534 -157.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -121.35 15.71 11.33 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.449 -1.407 . . . . 0.0 110.024 -164.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -74.85 141.26 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.746 0.818 . . . . 0.0 110.325 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.48 0.49 14.1 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.431 1.491 . . . . 0.0 114.473 160.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -145.55 128.38 16.34 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.654 1.227 . . . . 0.0 110.077 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.442 ' CD2' HD13 ' A' ' 24' ' ' LEU . 13.7 t80 -149.59 169.06 21.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.654 1.182 . . . . 0.0 109.802 -176.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -151.49 140.35 20.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.616 1.567 . . . . 0.0 109.842 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.58 152.62 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 125.941 1.696 . . . . 0.0 108.147 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 66' ' ' GLY . 22.1 m -134.45 -170.1 2.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.922 1.689 . . . . 0.0 106.627 172.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.67 ' H ' HG22 ' A' ' 65' ' ' THR . . . 67.64 25.75 73.89 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.045 -1.034 . . . . 0.0 111.911 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.75 164.73 21.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.24 1.816 . . . . 0.0 108.744 164.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.03 104.61 10.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.624 2.37 . . . . 0.0 107.523 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.17 140.2 44.28 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.427 2.085 . . . . 0.0 112.41 -163.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.27 -8.26 55.16 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 126.51 2.005 . . . . 0.0 112.711 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.8 158.52 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 162.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -98.74 129.31 45.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.35 1.86 . . . . 0.0 106.901 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -120.24 133.85 55.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.162 0.985 . . . . 0.0 108.745 -170.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.29 116.45 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 160.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.82 104.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -92.81 145.02 24.71 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.338 1.455 . . . . 0.0 111.177 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.552 HG13 HG13 ' A' ' 39' ' ' ILE . 23.2 t -145.18 97.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.2 mt -100.74 129.76 51.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.4 m -92.99 125.98 37.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.44 123.35 39.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.667 1.587 . . . . 0.0 108.478 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.85 -164.85 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.159 1.383 . . . . 0.0 109.463 -170.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -39.56 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.551 0.74 . . . . 0.0 111.964 157.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.1 31.35 4.36 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.437 1.97 . . . . 0.0 114.306 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.66 144.59 11.83 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 119.162 1.481 . . . . 0.0 110.144 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.14 142.49 39.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.338 1.455 . . . . 0.0 108.447 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.18 -176.96 6.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.62 151.33 92.31 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.77 103.96 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.615 2.21 . . . . 0.0 108.471 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.5 m -84.06 97.92 9.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 171.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -122.87 126.31 47.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 4.8 mt -119.36 143.28 47.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 m -100.82 110.33 22.4 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -108.35 123.45 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.207 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -75.51 134.12 40.86 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 149.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.345 1.458 . . . . 0.0 107.424 -178.966 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.24 128.51 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.498 2.132 . . . . 0.0 111.591 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -104.77 178.09 4.66 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 127.776 2.431 . . . . 0.0 110.356 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.452 HD13 ' CG ' ' A' ' 26' ' ' TRP . 96.3 mt -80.04 83.32 5.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.326 1.05 . . . . 0.0 110.232 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -65.03 -21.35 66.82 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.76 1.624 . . . . 0.0 113.561 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -97.85 8.38 44.81 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.06 1.744 . . . . 0.0 111.633 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.22 102.25 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 109.299 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -135.74 132.01 36.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.53 1.132 . . . . 0.0 109.194 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.81 157.14 35.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.09 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.422 1.089 . . . . 0.0 108.672 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 49.92 44.58 25.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.921 1.688 . . . . 0.0 109.689 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.74 65.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 129.493 3.117 . . . . 0.0 106.762 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -57.96 166.99 1.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.494 1.517 . . . . 0.0 109.717 162.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.85 3.39 8.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.391 1.476 . . . . 0.0 112.517 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 p -117.51 -13.66 10.31 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -172.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.14 161.96 0.78 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.547 1.539 . . . . 0.0 110.088 -162.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 tt -130.22 125.85 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.81 159.2 34.27 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -136.71 138.96 41.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 126.698 1.999 . . . . 0.0 107.422 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.3 mtp-105 -112.12 157.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 160.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.452 ' CG ' HD13 ' A' ' 9' ' ' LEU . 41.2 p90 -162.02 -173.75 3.81 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.982 2.513 . . . . 0.0 106.98 160.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.78 142.15 24.19 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 120.682 1.583 . . . . 0.0 107.885 171.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -75.13 124.41 8.52 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.673 1.582 . . . . 0.0 108.631 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.68 83.18 6.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -75.76 43.55 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.629 0.649 . . . . 0.0 111.344 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.4 p -47.86 -60.73 2.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.404 1.082 . . . . 0.0 113.393 -165.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 p 165.99 -61.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.109 0.964 . . . . 0.0 110.141 -152.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.48 -3.46 0.72 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.541 1.936 . . . . 0.0 109.52 -156.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.12 121.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.86 1.664 . . . . 0.0 110.71 164.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 -56.22 5.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.32 -160.55 21.1 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.88 151.31 49.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 164.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 114.85 20.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.905 1.682 . . . . 0.0 107.501 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.49 142.57 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -145.4 113.18 6.38 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.43 130.57 56.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.175 1.39 . . . . 0.0 109.982 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 164.01 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.28 109.17 20.27 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 126.428 1.891 . . . . 0.0 111.425 -170.186 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.2 mt . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 119.438 -0.315 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.65 156.3 35.72 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.077 2.518 . . . . 0.0 108.927 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.52 -61.86 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 166.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 53' ' ' ASP . 78.1 t80 -160.49 158.67 29.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.447 0.699 . . . . 0.0 109.681 -163.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.61 141.75 30.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.419 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 1.7 p30 -143.84 166.59 24.49 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.85 1.26 . . . . 0.0 110.652 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.53 154.65 47.59 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.417 -1.72 . . . . 0.0 106.868 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -176.91 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.451 1.101 . . . . 0.0 108.286 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.51 -63.11 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -165.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p 152.42 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.684 4.393 . . . . 0.0 107.736 -173.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.1 p -88.57 1.41 55.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.672 1.189 . . . . 0.0 112.625 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.12 134.56 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 125.366 1.466 . . . . 0.0 108.026 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.91 1.6 9.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 0.0 112.963 162.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -143.19 125.82 15.91 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.183 1.393 . . . . 0.0 107.782 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.49 165.1 28.42 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.5 m -141.72 125.8 17.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.99 152.96 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.862 1.665 . . . . 0.0 107.263 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -157.92 0.75 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 173.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.51 38.39 90.97 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 120.214 1.37 . . . . 0.0 112.353 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.21 154.92 30.3 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.18 1.792 . . . . 0.0 107.482 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.87 107.08 4.59 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 125.629 1.572 . . . . 0.0 107.285 -173.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.58 176.18 9.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.651 2.9 . . . . 0.0 113.454 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.53 4.38 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 124.705 1.145 . . . . 0.0 112.099 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.85 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -74.51 136.11 42.2 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.245 1.818 . . . . 0.0 108.894 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -122.39 141.58 51.43 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.86 111.05 22.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.42 101.49 12.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.1 m -94.91 144.53 25.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 110.504 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.9 t -139.55 98.3 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.29 139.83 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.8 m -105.37 133.83 49.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.51 127.73 41.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 pt -134.7 -167.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 110.319 -172.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -34.72 110.92 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.813 2.045 . . . . 0.0 110.531 166.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 27.26 51.8 0.08 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 127.547 2.498 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 160.59 31.06 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.22 1.01 . . . . 0.0 111.25 -163.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -144.88 145.19 31.48 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 127.057 2.143 . . . . 0.0 105.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.86 -176.21 4.37 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.06 147.21 80.9 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.95 99.09 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.308 2.005 . . . . 0.0 108.082 171.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -83.78 119.26 24.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -131.68 137.79 48.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.92 136.2 55.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 93' ' ' GLN . 2.8 m -135.66 179.33 6.4 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.587 ' H ' HG22 ' A' ' 92' ' ' THR . 0.6 OUTLIER 76.68 144.43 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.669 2.388 . . . . 0.0 107.591 -168.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.1 -84.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 108.832 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 C--O 1.242 0.673 0 C-N-CA 128.526 2.73 . . . . 0.0 112.573 -160.6 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.24 0.602 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.76 109.31 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.362 2.708 . . . . 0.0 109.533 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 87' ' ' ALA . 6.5 mm100 -61.84 157.62 17.8 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.246 1.818 . . . . 0.0 107.912 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.3 76.65 0.54 Allowed 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 m -57.86 -30.54 65.89 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.655 -0.653 . . . . 0.0 110.637 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.96 -0.44 31.03 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.156 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.465 HD11 ' CE1' ' A' ' 14' ' ' PHE . 2.8 tm? -53.85 125.67 19.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.993 0.917 . . . . 0.0 109.778 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -148.03 149.53 32.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.494 1.118 . . . . 0.0 109.802 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CE1' HD11 ' A' ' 12' ' ' LEU . 16.1 m-30 -112.78 145.53 40.41 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.848 1.204 . . . . 0.0 107.876 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.71 170.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 125.877 1.671 . . . . 0.0 108.305 -170.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 53.06 44.64 30.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.852 1.661 . . . . 0.0 109.569 171.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.83 64.79 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.779 2.432 . . . . 0.0 107.731 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -77.02 164.54 25.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.897 0.879 . . . . 0.0 109.406 168.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.48 7.44 3.63 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.633 -1.292 . . . . 0.0 112.342 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -123.91 -13.82 7.28 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.033 -1.042 . . . . 0.0 113.74 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -175.33 160.59 2.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.829 2.452 . . . . 0.0 108.096 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.25 133.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.63 152.71 20.67 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mp -129.25 155.17 46.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.91 1.284 . . . . 0.0 109.286 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -139.69 151.72 46.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.477 1.111 . . . . 0.0 108.194 169.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -159.06 -165.41 1.6 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.059 1.344 . . . . 0.0 107.928 165.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -112.75 106.89 55.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.07 1.748 . . . . 0.0 107.491 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.14 124.31 10.39 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.518 2.145 . . . . 0.0 111.856 -174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mt -95.96 100.99 12.61 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.048 1.739 . . . . 0.0 107.481 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -80.47 40.98 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.22 0.608 . . . . 0.0 110.384 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -59.24 -35.53 73.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.009 -1.472 . . . . 0.0 114.704 -159.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 p 154.34 -98.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 128.901 2.881 . . . . 0.0 108.791 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.68 -4.02 47.03 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.058 2.543 . . . . 0.0 108.975 -172.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.49 125.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 128.043 2.537 . . . . 0.0 110.171 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.02 -57.98 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -168.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.93 -158.29 23.19 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.472 ' CD2' HG23 ' A' ' 79' ' ' THR . 0.9 OUTLIER -130.59 137.02 49.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 171.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.19 110.87 23.04 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 107.554 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.422 HG13 HG22 ' A' ' 77' ' ' VAL . 3.3 mp -86.75 153.86 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m -144.29 147.88 34.09 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.65 2.38 . . . . 0.0 105.775 173.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -133.53 130.27 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 123.581 0.752 . . . . 0.0 109.975 170.46 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.75 164.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.006 171.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.36 111.5 20.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.386 0 C-N-CA 125.298 1.439 . . . . 0.0 108.738 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mt . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 118.316 -0.849 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.73 137.65 30.34 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.54 1.493 . . . . 0.0 110.201 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -89.13 -73.52 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.3 175.42 13.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.661 0.743 . . . . 0.0 110.196 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.63 156.9 47.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 165.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -155.67 166.06 34.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.968 1.307 . . . . 0.0 107.505 -167.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.44 175.15 5.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.642 0.734 . . . . 0.0 109.932 -173.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.75 -177.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 156.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.25 -67.56 0.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.743 1.617 . . . . 0.0 112.941 -166.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.4 p 154.71 -20.41 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.568 3.147 . . . . 0.0 114.137 -165.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.3 p -142.34 26.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.449 1.477 . . . . 0.0 112.137 168.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.54 133.35 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.53 -3.27 27.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.779 1.657 . . . . 0.0 113.593 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.78 123.15 8.4 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.632 1.573 . . . . 0.0 107.248 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.84 164.62 27.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.489 1.116 . . . . 0.0 108.351 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -141.89 134.97 29.01 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.58 152.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.114 1.766 . . . . 0.0 107.059 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.43 171.43 11.56 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.33 24.71 33.15 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.516 1.055 . . . . 0.0 112.031 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.72 156.03 19.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.502 1.521 . . . . 0.0 108.547 163.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.15 134.55 16.79 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.611 1.964 . . . . 0.0 107.506 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.72 161.35 27.62 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.764 1.643 . . . . 0.0 114.33 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.09 64.49 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.271 1.415 . . . . 0.0 113.519 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.52 145.45 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.973 1.309 . . . . 0.0 108.201 -170.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -81.47 129.42 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.318 1.847 . . . . 0.0 106.031 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -117.34 128.18 54.79 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.26 88.44 7.49 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 2.7 mp -84.43 116.9 28.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.41 139.91 49.6 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.467 1.907 . . . . 0.0 107.916 -165.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.422 HG22 HG13 ' A' ' 39' ' ' ILE . 26.0 t -145.6 111.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -170.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.8 mt -105.43 144.71 14.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.472 HG23 ' CD2' ' A' ' 37' ' ' TYR . 7.4 m -105.14 142.79 34.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 166.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.65 118.4 19.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.175 1.79 . . . . 0.0 107.851 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 pt -117.17 -168.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.546 0.739 . . . . 0.0 110.184 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -48.98 105.35 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.531 165.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.53 35.25 15.59 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 124.653 1.121 . . . . 0.0 113.48 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.67 144.92 10.41 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -167.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.93 144.94 48.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 m -84.14 -165.36 1.13 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -101.47 163.0 18.73 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.077 -1.639 . . . . 0.0 108.627 168.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 73.6 Cg_endo -70.75 108.79 2.34 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.835 1.69 . . . . 0.0 109.435 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.49 86.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.5 m -94.56 146.28 24.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 121.2 23.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 140.51 29.65 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -154.03 161.94 41.57 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.555 0.742 . . . . 0.0 109.219 161.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -97.66 173.12 7.29 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.462 1.105 . . . . 0.0 109.587 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 C--O 1.256 1.404 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 159.509 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.6 t . . . . . 0 C--O 1.239 0.549 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.01 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.669 2.246 . . . . 0.0 109.62 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -83.14 178.5 8.08 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.615 HD22 ' CD1' ' A' ' 26' ' ' TRP . 88.4 mt -77.72 91.56 4.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 161.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.7 p -61.09 -57.47 12.4 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.149 1.379 . . . . 0.0 108.687 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.9 18.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.045 2.538 . . . . 0.0 113.064 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.56 121.41 8.35 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.736 1.215 . . . . 0.0 108.994 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -154.49 164.89 37.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.056 1.742 . . . . 0.0 109.667 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CZ ' HD21 ' A' ' 24' ' ' LEU . 45.6 m-85 -122.86 152.23 40.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.74 168.85 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.824 1.65 . . . . 0.0 108.501 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 46.72 63.49 1.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.938 2.095 . . . . 0.0 109.494 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.88 65.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -81.23 171.97 14.21 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.896 1.278 . . . . 0.0 109.762 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.09 -0.73 20.06 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p -125.47 -6.01 7.04 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.38 170.85 2.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.631 1.972 . . . . 0.0 108.711 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -132.8 131.78 59.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 162.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.15 149.85 28.3 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 3.1 mt -123.33 151.3 42.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 106.362 172.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -136.18 145.03 45.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.615 ' CD1' HD22 ' A' ' 9' ' ' LEU . 9.0 p90 -156.91 -173.98 4.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.759 1.224 . . . . 0.0 108.9 168.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 m -109.09 106.19 58.39 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.7 123.6 9.94 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 121.543 1.495 . . . . 0.0 110.481 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.14 94.72 3.54 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.554 2.342 . . . . 0.0 105.186 166.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -77.66 38.87 0.26 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.991 0.916 . . . . 0.0 109.225 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.2 m -74.34 -2.82 26.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -159.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p 70.53 -57.91 0.57 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.156 2.582 . . . . 0.0 113.629 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.39 -28.99 69.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 111.525 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -50.91 134.59 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.395 1.878 . . . . 0.0 109.825 170.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.434 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.0 mp -84.4 -65.05 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.82 -160.11 19.63 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -127.89 133.22 49.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.63 127.6 54.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 107.271 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 77' ' ' VAL . 3.1 mp -101.75 152.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 m -138.26 153.69 49.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.267 2.227 . . . . 0.0 106.417 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.36 126.82 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 125.378 1.471 . . . . 0.0 107.55 171.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.18 164.65 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.93 101.94 13.75 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 126.605 1.962 . . . . 0.0 112.389 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.6 mt . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.29 168.2 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.224 1.949 . . . . 0.0 109.015 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.2 mm -111.0 -73.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.502 -2.406 . . . . 0.0 104.502 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -160.14 175.52 12.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.711 1.605 . . . . 0.0 107.916 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.0 159.37 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -152.61 166.03 33.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.053 0.941 . . . . 0.0 110.437 -166.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.15 160.02 33.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.879 0.872 . . . . 0.0 110.302 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.89 -178.32 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 161.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -68.57 -71.3 0.22 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.929 0.871 . . . . 0.0 112.01 -156.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 p 177.07 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.917 3.287 . . . . 0.0 111.183 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -127.32 16.11 7.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.13 130.21 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.03 -6.13 32.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.226 0.917 . . . . 0.0 114.557 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -143.44 125.62 15.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.723 1.209 . . . . 0.0 108.957 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -139.45 160.6 39.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.235 1.414 . . . . 0.0 109.285 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.2 m -134.1 121.46 21.52 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.49 -1.381 . . . . 0.0 107.698 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.3 155.24 3.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 -168.62 1.92 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.866 1.267 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.37 9.96 84.44 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.798 -1.189 . . . . 0.0 113.327 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.5 157.6 30.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.73 133.24 9.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.3 -177.61 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.004 2.469 . . . . 0.0 112.762 -172.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.81 56.82 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.804 2.145 . . . . 0.0 112.199 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mm -131.5 152.14 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 126.416 1.886 . . . . 0.0 107.111 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -94.71 109.84 21.75 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -94.71 124.17 38.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.7 91.66 8.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.51 101.7 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.49 141.93 30.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.652 1.181 . . . . 0.0 109.609 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.456 HG22 HG13 ' A' ' 39' ' ' ILE . 42.8 t -140.79 116.19 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.594 HG23 ' HA ' ' A' ' 88' ' ' PRO 0.347 0.0 OUTLIER -121.75 145.92 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.467 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.9 m -106.04 128.05 53.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.791 2.036 . . . . 0.0 108.179 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.434 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -126.2 123.71 38.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 0.0 108.925 -173.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 3.6 pt -116.61 -173.93 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.065 1.346 . . . . 0.0 109.653 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -34.74 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.394 1.878 . . . . 0.0 111.105 166.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.07 61.5 0.06 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.713 2.102 . . . . 0.0 111.707 -171.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.45 144.79 10.76 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -126.38 124.22 39.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.617 1.567 . . . . 0.0 107.108 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 169.94 13.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.97 134.86 95.91 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.259 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.594 ' HA ' HG23 ' A' ' 78' ' ' ILE . 59.2 Cg_endo -63.1 136.2 55.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.535 2.157 . . . . 0.0 109.247 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.2 m -131.5 97.99 4.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.3 m -106.09 146.87 29.62 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.65 1.18 . . . . 0.0 107.916 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 104.79 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -75.01 115.55 14.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -109.03 137.5 46.84 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.396 1.478 . . . . 0.0 113.491 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.22 163.18 15.11 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.229 . . . . 0.0 111.379 173.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.25 1.12 0 C-N-CA 129.176 2.991 . . . . 0.0 106.231 161.365 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.65 136.44 33.3 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.156 1.904 . . . . 0.0 110.116 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -95.48 168.21 10.84 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.206 0.602 . . . . 0.0 110.186 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.89 80.22 2.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 m -66.3 -20.98 66.25 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.855 0.462 . . . . 0.0 110.239 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.15 7.31 22.25 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.56 -1.337 . . . . 0.0 113.061 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.46 120.73 12.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 110.438 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -136.55 164.98 26.92 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.817 1.247 . . . . 0.0 111.186 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -109.11 151.99 25.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 168.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.0 168.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.73 1.612 . . . . 0.0 107.393 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 42.07 61.54 1.92 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.425 1.89 . . . . 0.0 110.904 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.74 57.15 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.148 1.779 . . . . 0.0 108.441 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -84.83 170.87 12.74 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.891 1.276 . . . . 0.0 110.682 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.19 2.31 9.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.635 1.574 . . . . 0.0 112.079 -174.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 p -125.53 -16.04 5.93 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.831 1.652 . . . . 0.0 114.786 -163.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -178.17 153.69 0.8 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.449 1.9 . . . . 0.0 108.096 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tt -108.55 132.3 56.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.55 158.35 28.53 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 171.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.505 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.8 mp -132.75 152.1 51.84 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 126.129 1.772 . . . . 0.0 108.41 174.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -138.52 143.91 39.72 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.37 -173.85 4.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.592 0.757 . . . . 0.0 109.185 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -108.81 106.67 59.18 Favored Pre-proline 0 C--N 1.334 -0.107 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.55 131.42 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.493 1.462 . . . . 0.0 109.773 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.55 107.35 14.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -72.78 42.93 0.11 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 m -79.03 6.56 9.1 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.397 3.079 . . . . 0.0 114.766 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.6 p 61.31 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 128.057 2.543 . . . . 0.0 114.607 163.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -7.27 17.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.195 1.798 . . . . 0.0 112.448 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 tt -44.26 146.64 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 121.034 -1.041 . . . . 0.0 110.015 159.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 80' ' ' LEU . 3.3 mt -84.51 -61.95 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 171.03 -156.96 27.52 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -170.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.8 143.72 50.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 135.83 53.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.745 2.018 . . . . 0.0 106.248 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.69 125.74 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.1 m -119.25 126.01 50.48 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.31 123.65 61.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.98 163.42 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.335 1.454 . . . . 0.0 108.266 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.56 110.96 16.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 127.764 2.426 . . . . 0.0 112.725 174.43 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt . . . . . 0 N--CA 1.448 -0.575 0 CA-C-O 117.906 -1.045 . . . . 0.0 108.913 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.04 167.18 25.55 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.36 2.04 . . . . 0.0 110.673 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.25 -76.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.81 175.48 13.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 175.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.97 154.25 51.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.006 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.6 166.46 30.22 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.48 1.512 . . . . 0.0 109.265 -163.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HZ ' HD11 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -125.67 171.62 10.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.363 1.065 . . . . 0.0 110.378 177.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.27 -176.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.011 163.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -64.1 -68.93 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.297 1.839 . . . . 0.0 112.362 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.464 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 88.3 p 165.14 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.972 3.309 . . . . 0.0 111.227 -175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . 0.264 97.4 p -131.52 23.94 4.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.534 0.607 . . . . 0.0 111.979 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -73.46 131.55 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.35 -0.13 35.1 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.929 1.252 . . . . 0.0 113.303 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -150.68 114.75 5.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.505 ' CD2' HD13 ' A' ' 24' ' ' LEU . 3.8 t80 -140.85 158.97 43.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -173.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -141.51 132.22 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.66 148.29 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 126.364 1.866 . . . . 0.0 106.778 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.67 -173.76 2.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.525 1.53 . . . . 0.0 108.295 -174.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.06 16.79 80.41 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 120.662 -1.274 . . . . 0.0 113.557 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 151.7 45.42 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.16 100.26 7.13 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.5 162.9 40.11 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.395 3.397 . . . . 0.0 113.769 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.57 5.85 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.727 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.59 138.39 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 159.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 39.4 t0 -83.0 158.74 22.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.578 0.751 . . . . 0.0 110.463 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -135.44 123.01 22.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.346 1.458 . . . . 0.0 108.648 -167.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.86 109.3 22.03 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.86 90.91 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.3 p -84.83 104.4 14.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.871 0.868 . . . . 0.0 111.071 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.82 119.42 45.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -116.74 139.56 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.958 1.303 . . . . 0.0 108.264 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.2 m -105.55 134.17 49.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.461 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -129.7 115.43 17.32 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.3 pt -104.29 -164.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 125.362 1.465 . . . . 0.0 108.316 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -34.66 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.07 0.948 . . . . 0.0 111.056 167.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.25 60.65 0.05 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 128.933 3.158 . . . . 0.0 113.261 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.25 166.15 38.89 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.78 146.94 51.52 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.875 1.27 . . . . 0.0 108.253 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 m -84.04 -172.24 4.05 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.139 0.971 . . . . 0.0 110.032 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.69 135.77 71.26 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 162.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.27 155.34 67.86 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.758 2.306 . . . . 0.0 110.892 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -127.3 98.18 5.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 166.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.5 m -94.15 109.01 20.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.8 mt -88.76 155.12 19.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 157.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.5 m -127.74 147.94 50.41 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -155.78 124.52 6.01 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.19 0.905 . . . . 0.0 110.648 -173.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -67.45 -27.08 66.74 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -169.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.25 1.13 0 C-N-CA 128.771 2.828 . . . . 0.0 114.813 166.738 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -69.05 133.48 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.99 1.793 . . . . 0.0 109.74 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.1 166.86 11.05 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.677 1.591 . . . . 0.0 108.952 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.444 HD22 ' CD1' ' A' ' 26' ' ' TRP . 80.0 mt -70.39 88.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.896 0.855 . . . . 0.0 109.201 176.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m -73.4 -11.52 60.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.812 0.845 . . . . 0.0 112.006 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.39 14.28 30.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.644 1.111 . . . . 0.0 112.082 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.99 109.14 0.59 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.18 -0.95 . . . . 0.0 110.893 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 m -136.57 146.19 45.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.176 1.79 . . . . 0.0 110.128 -170.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 14.2 m-30 -111.3 144.68 40.1 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 177.99 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 128.691 2.796 . . . . 0.0 108.06 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.14 51.14 13.45 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.143 1.777 . . . . 0.0 109.408 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.7 mt -84.01 65.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -87.63 162.54 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.652 1.181 . . . . 0.0 109.056 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.68 -2.38 22.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.218 1.407 . . . . 0.0 111.311 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -107.22 -15.73 14.58 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.383 1.873 . . . . 0.0 114.079 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p 176.25 154.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.053 1.741 . . . . 0.0 109.911 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 128.96 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.58 133.39 11.61 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -174.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.8 mp -110.03 143.05 40.61 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -124.65 146.48 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.444 ' CD1' HD22 ' A' ' 9' ' ' LEU . 42.0 p90 -149.97 -171.43 3.9 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 165.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -103.31 107.26 55.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -57.08 139.5 90.13 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.49 1.46 . . . . 0.0 110.749 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -88.88 108.97 19.83 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.969 1.708 . . . . 0.0 108.852 164.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.66 28.33 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.321 1.448 . . . . 0.0 112.063 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.0 m -79.38 150.49 31.36 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.494 -1.379 . . . . 0.0 110.455 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 p -83.0 -34.71 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.516 0.598 . . . . 0.0 111.409 167.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.13 -12.0 59.89 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.458 1.103 . . . . 0.0 112.207 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.7 152.25 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 161.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.406 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.6 mp -90.62 -67.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 160.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.86 -160.93 22.39 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -130.47 142.15 50.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 118.14 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 mp -93.2 143.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.7 m -141.26 133.56 28.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.56 138.07 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 125.128 1.371 . . . . 0.0 111.899 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.41 164.7 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.68 117.65 20.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 127.357 2.263 . . . . 0.0 113.084 173.23 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.44 159.82 25.75 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.647 2.898 . . . . 0.0 110.239 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.04 -69.4 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.69 164.29 23.95 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.943 1.297 . . . . 0.0 109.511 -172.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.23 144.85 40.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.94 1.696 . . . . 0.0 110.34 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -134.76 164.62 27.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.854 1.662 . . . . 0.0 108.026 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.62 152.46 51.25 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.807 0.843 . . . . 0.0 109.842 177.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.22 -177.71 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.86 -0.525 . . . . 0.0 109.81 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -80.49 -54.86 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.234 0.54 . . . . 0.0 112.169 -150.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p 153.93 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 130.865 3.666 . . . . 0.0 109.916 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.8 p -123.64 10.31 9.04 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.752 1.621 . . . . 0.0 111.22 -164.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.93 137.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.05 1.0 9.84 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.378 1.466 . . . . 0.0 112.714 166.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.94 123.83 12.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.819 1.248 . . . . 0.0 110.008 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.453 ' CD2' HD13 ' A' ' 24' ' ' LEU . 7.4 t80 -140.14 151.28 45.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.401 1.88 . . . . 0.0 107.542 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.6 m -130.95 126.64 36.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.796 1.18 . . . . 0.0 109.244 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.48 153.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.89 177.11 8.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 166.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.09 7.01 88.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.706 1.146 . . . . 0.0 112.86 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 159.75 19.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 164.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -137.04 127.54 16.07 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.65 171.58 14.09 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.27 1.314 . . . . 0.0 110.575 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.11 -12.23 40.69 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.147 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.52 162.1 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -92.26 125.84 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -107.25 142.44 37.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.8 1.182 . . . . 0.0 108.886 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.37 110.87 23.38 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 168.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.89 103.1 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.3 p -92.86 145.91 24.03 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.959 -1.088 . . . . 0.0 109.774 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 t -146.35 72.08 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-O 122.501 1.143 . . . . 0.0 108.96 -168.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mt -84.8 134.65 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.7 m -89.52 142.45 27.66 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -128.88 138.01 51.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.883 1.273 . . . . 0.0 109.114 177.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 pt -133.87 -169.06 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.049 1.339 . . . . 0.0 109.068 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -34.06 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.089 1.756 . . . . 0.0 110.84 162.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 36.74 42.95 0.75 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.985 2.707 . . . . 0.0 114.603 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.46 166.04 38.19 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 120.402 2.101 . . . . 0.0 113.839 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.76 156.03 31.36 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.499 1.919 . . . . 0.0 107.057 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 m -84.1 -170.2 2.97 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 155.53 87.55 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.712 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.74 105.53 1.97 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.903 3.069 . . . . 0.0 110.434 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 m -89.84 74.71 7.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 171.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.3 m -94.58 115.33 27.45 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 10.9 mt -95.64 145.02 25.58 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 m -104.87 135.43 46.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -155.18 169.0 25.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 166.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -95.38 137.54 34.3 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.25 1.1 0 O-C-N 125.383 1.677 . . . . 0.0 110.551 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 136.55 42.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.448 2.098 . . . . 0.0 110.723 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -75.69 163.18 27.57 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.583 165.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.11 80.3 0.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.44 1.096 . . . . 0.0 109.105 163.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 m -58.15 -27.78 64.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.68 0.792 . . . . 0.0 110.859 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 5.18 49.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.761 0.825 . . . . 0.0 111.918 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.7 129.3 22.55 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.315 1.046 . . . . 0.0 109.653 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 p -149.58 164.21 35.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.482 1.113 . . . . 0.0 110.39 165.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -116.65 146.43 42.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 172.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.52 164.21 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.915 1.286 . . . . 0.0 109.261 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 45.71 59.63 3.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.268 1.827 . . . . 0.0 109.949 -173.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.15 66.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 128.667 2.787 . . . . 0.0 105.804 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 t -94.64 165.35 12.55 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.686 1.594 . . . . 0.0 109.679 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.6 5.29 4.96 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.279 -1.513 . . . . 0.0 113.375 -168.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.1 p -126.5 -12.74 6.11 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -174.0 152.33 1.9 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.949 1.3 . . . . 0.0 108.949 -167.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.49 122.07 61.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.14 151.82 23.97 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.74 153.4 42.47 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.438 1.495 . . . . 0.0 109.71 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -140.05 145.04 37.21 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.66 1.584 . . . . 0.0 106.733 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -160.25 168.71 24.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 164.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.0 m -90.05 140.71 27.54 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 116.883 -1.927 . . . . 0.0 106.888 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.36 141.6 4.93 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.125 1.216 . . . . 0.0 109.023 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mp -83.51 -35.26 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.961 -170.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 49.84 34.86 8.26 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.301 2.24 . . . . 0.0 111.776 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 p -50.34 -46.97 56.03 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.302 1.041 . . . . 0.0 112.824 -162.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 p 153.91 -86.32 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 131.371 3.868 . . . . 0.0 104.973 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -5.43 58.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.51 1.124 . . . . 0.0 111.045 -170.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -34.86 129.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.937 1.295 . . . . 0.0 111.162 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.21 -49.47 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 174.21 -164.86 36.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -127.02 150.88 49.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 162.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.85 122.96 42.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.433 HG13 HG22 ' A' ' 77' ' ' VAL . 2.7 mp -104.67 144.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.8 m -145.45 111.26 5.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 143.09 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.829 0.823 . . . . 0.0 110.773 160.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.17 164.33 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 166.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.38 126.89 31.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 163.129 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.9 mt . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 117.301 -1.333 . . . . 0.0 107.901 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 137.81 28.65 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.304 2.003 . . . . 0.0 110.0 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.0 93.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.323 1.0 OUTLIER 54.45 176.95 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.323 2.249 . . . . 0.0 113.28 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.07 159.32 42.47 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.725 -1.235 . . . . 0.0 110.205 165.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -149.33 165.93 30.52 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.252 1.821 . . . . 0.0 111.221 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.07 165.52 18.7 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.629 1.571 . . . . 0.0 109.482 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -178.11 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.168 0.987 . . . . 0.0 109.119 164.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.25 -50.74 8.64 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.028 -1.045 . . . . 0.0 112.528 -157.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.408 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 32.3 p 157.18 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 1 C-N-CA 132.217 4.207 . . . . 0.0 112.141 174.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -124.9 10.4 8.26 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.9 t -73.61 132.44 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.59 6.37 18.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.075 1.322 . . . . 0.0 112.312 170.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -150.08 120.4 7.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.79 -1.418 . . . . 0.0 107.38 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -143.99 166.27 25.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -132.37 129.0 38.81 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.038 0.935 . . . . 0.0 108.763 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -95.78 154.88 3.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.04 178.45 6.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.388 1.475 . . . . 0.0 107.142 169.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 5.0 73.88 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 119.036 0.834 . . . . 0.0 112.956 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.72 158.8 26.55 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.626 0.727 . . . . 0.0 109.555 167.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.19 103.78 5.61 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.0 169.64 14.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.091 2.527 . . . . 0.0 111.032 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.22 -18.75 50.86 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.595 -0.691 . . . . 0.0 112.176 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mm -124.56 153.38 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.669 1.988 . . . . 0.0 108.155 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -86.25 145.84 26.78 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.658 1.583 . . . . 0.0 108.365 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.56 134.85 51.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.257 1.023 . . . . 0.0 111.87 -175.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.28 104.18 14.1 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.506 1.923 . . . . 0.0 107.098 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -90.52 105.66 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -101.5 136.29 41.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 118.412 0.551 . . . . 0.0 111.873 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 39' ' ' ILE . 38.8 t -135.36 108.42 9.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.07 137.42 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -98.78 129.97 45.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.39 112.43 18.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pt -104.45 -164.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -48.62 111.13 0.42 Allowed 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.531 -0.731 . . . . 0.0 110.61 161.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.49 24.76 59.83 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.068 -0.851 . . . . 0.0 114.802 156.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.33 156.39 21.04 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -132.78 153.22 51.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 108.531 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.58 178.41 7.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.78 154.23 94.41 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 121.496 -0.753 . . . . 0.0 110.197 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.87 110.53 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.964 3.109 . . . . 0.0 110.839 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.8 m -85.44 97.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 169.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 m -96.5 153.42 17.85 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.55 135.19 44.19 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 159.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.67 143.29 38.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.37 2.268 . . . . 0.0 108.537 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -164.69 148.61 9.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.559 1.527 . . . . 0.0 110.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -110.94 143.53 41.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.84 1.256 . . . . 0.0 109.626 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.257 1.456 0 C-N-CA 127.572 2.349 . . . . 0.0 111.635 -171.71 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.31 105.61 1.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.316 2.01 . . . . 0.0 109.209 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.29 169.98 1.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 114.248 165.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.462 HD13 ' CG ' ' A' ' 26' ' ' TRP . 95.0 mt -67.24 71.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.449 2.3 . . . . 0.0 110.088 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m -50.68 -27.01 6.16 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 111.846 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -87.37 4.59 42.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.772 1.169 . . . . 0.0 112.566 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -55.17 118.42 4.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 109.276 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.0 m -153.33 134.1 13.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.454 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -91.39 146.25 23.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.45 174.23 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 128.845 2.858 . . . . 0.0 109.24 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.374 2.6 p30 43.07 45.62 4.64 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.113 1.765 . . . . 0.0 112.3 -178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.44 62.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 128.117 2.567 . . . . 0.0 107.473 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 20' ' ' SER . 7.7 t -73.78 174.55 8.28 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.781 1.232 . . . . 0.0 108.972 168.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.73 -4.7 39.06 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.187 -0.946 . . . . 0.0 111.674 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.471 ' H ' HG23 ' A' ' 18' ' ' THR . 53.7 p -125.58 -9.2 6.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 -158.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 p -176.81 171.91 2.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.188 2.595 . . . . 0.0 108.134 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.65 147.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 142.75 15.64 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 171.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mp -108.82 144.14 37.07 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 124.529 1.132 . . . . 0.0 108.119 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -118.21 150.38 39.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.462 ' CG ' HD13 ' A' ' 9' ' ' LEU . 47.7 p90 -151.87 -166.12 2.41 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 161.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.92 143.19 39.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.53 129.32 19.83 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.055 1.17 . . . . 0.0 109.39 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.64 96.98 9.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -74.52 45.87 0.25 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.38 0.672 . . . . 0.0 109.327 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.8 m -69.48 2.46 3.08 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.079 -1.638 . . . . 0.0 112.269 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 p 48.13 25.66 0.87 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.787 2.835 . . . . 0.0 114.859 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -165.27 -16.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.881 1.272 . . . . 0.0 111.044 -171.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 9.4 tt -39.01 140.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 110.141 156.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.401 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.2 mp -84.79 -63.39 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 165.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.33 -156.9 13.75 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -168.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -135.7 147.42 48.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 133.97 55.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.0 mp -108.81 143.0 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -133.87 128.13 33.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 161.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.651 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.27 137.52 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.173 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.36 164.69 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.14 1.376 . . . . 0.0 109.429 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.07 125.94 30.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 C-N-CA 123.591 0.756 . . . . 0.0 110.312 173.441 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.6 mt . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.94 147.16 43.22 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.83 2.354 . . . . 0.0 110.945 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.0 mm -84.85 -74.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.01 175.64 7.46 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.683 1.993 . . . . 0.0 108.66 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.84 156.83 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.727 1.211 . . . . 0.0 110.255 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -148.2 166.43 27.93 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.737 1.215 . . . . 0.0 110.503 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.77 155.72 49.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.673 1.989 . . . . 0.0 109.935 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.75 -177.21 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.883 1.273 . . . . 0.0 109.864 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.66 -57.71 3.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.527 0.731 . . . . 0.0 112.087 -160.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p 154.7 -29.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 131.089 3.756 . . . . 0.0 111.42 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -123.26 -0.66 8.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.256 1.023 . . . . 0.0 109.506 -167.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.1 t -74.43 124.75 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.0 1.11 33.55 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.46 1.1 . . . . 0.0 112.901 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -142.18 114.21 8.14 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.456 1.102 . . . . 0.0 108.259 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -145.98 137.82 25.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -113.42 146.99 38.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.947 1.299 . . . . 0.0 108.836 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.51 148.54 24.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 125.631 1.572 . . . . 0.0 107.181 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.88 -168.78 1.87 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.28 4.34 90.23 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.692 -1.255 . . . . 0.0 113.973 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 149.56 49.65 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.933 1.293 . . . . 0.0 109.965 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -146.9 93.81 4.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.454 1.902 . . . . 0.0 108.643 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.62 167.59 23.81 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.997 3.131 . . . . 0.0 114.982 -152.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.85 -15.85 61.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.128 1.347 . . . . 0.0 112.735 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.15 151.52 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 167.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -89.48 134.41 34.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.309 1.444 . . . . 0.0 108.039 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -118.51 117.33 28.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -167.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.42 113.63 21.32 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 170.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.651 HG23 HG13 ' A' ' 41' ' ' VAL . 1.9 mp -102.66 105.1 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -91.03 138.24 31.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.097 0.559 . . . . 0.0 109.508 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -134.52 129.54 52.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -131.8 131.42 62.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 m -83.09 144.23 30.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.401 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -125.68 129.88 50.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 15.6 pt -116.1 175.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -35.37 105.0 0.03 OUTLIER 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.023 1.729 . . . . 0.0 110.119 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.1 26.37 0.87 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.812 1.672 . . . . 0.0 114.823 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.42 144.71 15.93 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.55 1.675 . . . . 0.0 109.663 -160.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.01 117.64 22.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.2 1.0 . . . . 0.0 108.499 -162.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.11 -179.0 6.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 148.8 86.06 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.7 137.7 70.23 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 162.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -129.13 95.99 4.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 168.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.7 m -94.84 149.21 21.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.32 135.0 45.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 166.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t -120.91 140.79 51.33 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -165.24 139.89 5.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -96.81 165.06 12.29 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 161.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.246 0.87 0 C-N-CA 126.865 2.066 . . . . 0.0 111.315 169.748 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.37 117.21 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.746 2.297 . . . . 0.0 109.511 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.27 169.46 11.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.524 HD13 ' CG ' ' A' ' 26' ' ' TRP . 55.2 mt -78.51 86.73 4.51 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.5 m -76.04 -29.37 58.04 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.53 1.132 . . . . 0.0 111.35 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.61 4.77 20.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.823 1.249 . . . . 0.0 112.611 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.57 129.78 37.56 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.8 1.64 . . . . 0.0 109.853 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.3 m -150.72 165.23 34.1 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -99.72 155.83 17.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 108.724 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.12 167.96 9.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.689 1.996 . . . . 0.0 106.983 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.83 56.21 2.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 128.278 2.631 . . . . 0.0 110.232 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -78.25 65.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.197 2.199 . . . . 0.0 106.232 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -88.18 168.16 12.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.465 1.106 . . . . 0.0 111.3 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.37 12.79 0.69 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.171 2.188 . . . . 0.0 112.465 -174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.4 p -125.68 -15.9 5.89 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p -178.53 147.14 0.39 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -161.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -115.45 140.33 37.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.74 162.29 18.59 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mp -139.15 153.39 47.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.586 1.554 . . . . 0.0 108.988 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -134.71 155.32 50.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.524 ' CG ' HD13 ' A' ' 9' ' ' LEU . 42.5 p90 -165.35 -170.83 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.415 1.486 . . . . 0.0 108.858 166.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -105.42 106.44 56.06 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.726 1.21 . . . . 0.0 108.521 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -62.24 124.87 15.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.373 2.049 . . . . 0.0 110.632 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.1 mt -93.52 96.67 10.03 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 128.643 2.777 . . . . 0.0 108.042 175.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -74.67 34.12 0.1 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.446 1.098 . . . . 0.0 111.931 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 29' ' ' LEU . 30.4 m -56.2 119.63 6.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.821 2.448 . . . . 0.0 109.216 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 p -67.63 41.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.734 2.414 . . . . 0.0 113.443 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -167.18 -19.7 0.02 OUTLIER 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.741 1.616 . . . . 0.0 111.904 -167.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -55.15 144.44 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.23 -52.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 166.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.66 -152.73 14.56 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.04 136.14 45.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.03 125.82 44.61 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.81 155.05 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 m -142.69 153.52 43.46 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.899 1.68 . . . . 0.0 107.169 167.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.28 135.28 61.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 125.819 1.647 . . . . 0.0 108.999 167.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.55 164.08 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.43 110.24 20.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 128.625 2.77 . . . . 0.0 115.686 176.698 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.26 171.44 18.03 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.358 2.039 . . . . 0.0 109.633 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.72 -95.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 162.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -146.96 166.02 28.04 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.475 0.71 . . . . 0.0 110.371 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -134.23 103.89 5.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.553 1.541 . . . . 0.0 106.988 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.51 159.11 16.19 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HZ ' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -105.75 176.02 5.3 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.527 1.131 . . . . 0.0 108.039 176.231 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -175.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 161.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -79.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.468 1.907 . . . . 0.0 112.041 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p 172.2 -18.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 1 C-N-CA 132.651 4.38 . . . . 0.0 110.883 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -134.27 27.15 3.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.4 t -73.99 138.62 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.92 -1.95 19.02 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.977 0.798 . . . . 0.0 112.265 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.58 114.33 5.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -138.04 141.36 40.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 m -127.21 152.06 47.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.9 0.88 . . . . 0.0 109.358 -171.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.53 156.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.505 1.922 . . . . 0.0 106.944 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -130.67 -163.14 1.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.163 1.785 . . . . 0.0 106.374 174.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.51 7.9 69.97 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 120.093 -1.629 . . . . 0.0 114.105 166.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.4 149.67 31.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.186 1.394 . . . . 0.0 108.226 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -126.19 102.07 27.76 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 107.893 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 157.84 57.82 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.622 2.215 . . . . 0.0 112.383 -165.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.55 -30.06 11.19 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.681 1.134 . . . . 0.0 110.543 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.79 158.82 3.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -100.96 145.19 28.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.022 1.329 . . . . 0.0 108.347 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -131.26 134.8 46.77 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.32 116.35 22.96 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 121.22 51.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 p -116.18 142.67 46.52 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.822 0.849 . . . . 0.0 110.687 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.92 128.77 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.09 153.4 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.43 1.014 . . . . 0.0 111.894 175.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -105.84 122.89 47.03 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 126.467 1.907 . . . . 0.0 107.739 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.408 HD11 ' HZ ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -114.68 132.91 56.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.7 pt -126.3 178.13 4.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.476 1.111 . . . . 0.0 108.837 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -34.53 103.53 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.281 1.832 . . . . 0.0 110.823 163.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.51 11.47 2.67 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.868 2.175 . . . . 0.0 115.055 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.36 145.85 17.89 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.203 1.501 . . . . 0.0 110.153 -156.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -126.85 155.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.316 1.447 . . . . 0.0 109.494 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -107.54 -166.86 1.19 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.85 2.06 . . . . 0.0 108.604 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.62 134.6 39.57 Favored Pre-proline 0 C--O 1.239 0.543 0 O-C-N 121.016 -1.052 . . . . 0.0 108.678 163.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 127.72 19.5 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.93 2.42 . . . . 0.0 107.214 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.2 m -86.41 103.7 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.2 m -101.4 121.53 42.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.95 150.43 44.78 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.1 m -132.62 136.9 46.81 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -161.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -157.33 142.63 17.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -159.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.08 159.64 15.21 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.867 -0.52 . . . . 0.0 109.878 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.767 1.627 . . . . 0.0 110.063 -170.245 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.7 t . . . . . 0 C--O 1.239 0.52 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.36 143.49 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.04 1.826 . . . . 0.0 109.442 174.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -102.59 169.29 8.74 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 166.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -74.5 80.34 1.94 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 m -61.37 -25.75 67.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.798 0.839 . . . . 0.0 110.544 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.0 -2.47 34.1 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.662 1.585 . . . . 0.0 113.696 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.37 115.14 3.04 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.773 1.229 . . . . 0.0 110.55 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p -134.54 160.97 36.4 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.864 1.266 . . . . 0.0 110.345 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 8.7 m-30 -105.28 143.78 32.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.04 164.96 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.881 1.672 . . . . 0.0 108.348 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 t0 51.7 45.06 28.74 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.96 1.304 . . . . 0.0 110.554 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mt -75.91 63.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 128.811 2.845 . . . . 0.0 106.94 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 20' ' ' SER . 14.5 t -87.45 173.77 8.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 111.137 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.36 0.43 16.86 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.637 1.975 . . . . 0.0 112.861 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.479 ' H ' HG23 ' A' ' 18' ' ' THR . 55.7 p -113.39 -15.7 12.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -176.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p 176.29 161.7 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.674 1.99 . . . . 0.0 107.536 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.15 127.67 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.85 157.39 29.66 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.633 -1.292 . . . . 0.0 110.143 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.79 150.33 52.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.774 -1.427 . . . . 0.0 108.483 172.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -137.29 133.85 35.46 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -157.54 173.38 16.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.6 m -86.58 106.3 10.09 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.726 1.211 . . . . 0.0 110.093 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.62 124.26 13.4 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.345 1.363 . . . . 0.0 109.29 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.15 101.44 13.0 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -79.34 49.95 1.04 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.536 0.734 . . . . 0.0 109.097 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -61.91 -55.55 28.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.582 1.553 . . . . 0.0 110.164 -168.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p 154.72 -88.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 130.389 3.476 . . . . 0.0 108.891 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.08 -3.64 52.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.978 2.511 . . . . 0.0 110.026 -170.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -35.98 133.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.039 1.336 . . . . 0.0 111.255 166.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -84.32 -48.24 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 164.87 -158.29 31.03 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -132.15 145.2 51.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -119.89 113.1 20.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.43 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.9 m -145.08 117.58 8.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.425 1.89 . . . . 0.0 107.382 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.09 131.44 40.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.289 0.636 . . . . 0.0 111.064 162.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.48 164.52 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 161.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.56 110.9 11.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.348 0 C-N-CA 124.371 1.068 . . . . 0.0 113.652 -171.422 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.9 mt . . . . . 0 CA--C 1.546 0.792 0 CA-C-O 119.02 -0.515 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.68 131.04 12.06 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.725 2.283 . . . . 0.0 109.008 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.5 mm -84.64 -73.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -157.51 170.46 22.38 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.848 0.859 . . . . 0.0 109.925 173.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.3 150.59 39.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 163.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -152.71 165.91 33.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.48 1.112 . . . . 0.0 108.565 -166.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.12 168.15 15.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.377 0.671 . . . . 0.0 110.53 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.01 -177.01 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.12 . . . . 0.0 108.66 167.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -71.02 -66.42 0.61 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.756 -0.59 . . . . 0.0 111.219 -167.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.445 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 9.5 p 163.78 -23.02 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 130.787 3.635 . . . . 0.0 112.016 -176.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.9 p -132.9 22.93 4.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.988 0.813 . . . . 0.0 112.764 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.54 131.93 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.95 3.26 19.3 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.388 2.423 . . . . 0.0 113.357 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -153.93 119.64 5.26 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.654 1.582 . . . . 0.0 108.225 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -134.94 164.37 27.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.326 1.45 . . . . 0.0 108.081 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.5 m -131.96 147.98 52.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.88 145.04 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' GLY . 0.9 OUTLIER -115.85 -170.76 1.85 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 171.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' H ' HG22 ' A' ' 65' ' ' THR . . . 78.25 17.97 77.11 Favored Glycine 0 CA--C 1.522 0.473 0 O-C-N 120.873 -1.142 . . . . 0.0 111.666 176.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 157.44 20.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.617 1.208 . . . . 0.0 108.691 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 136.41 15.98 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.96 156.12 60.33 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.906 1.737 . . . . 0.0 110.964 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.53 -27.58 8.33 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.527 1.061 . . . . 0.0 113.109 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.17 156.14 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 126.038 1.735 . . . . 0.0 107.818 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.97 135.33 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 107.445 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.26 127.17 51.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.4 106.74 16.23 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.427 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.3 mp -98.94 103.12 14.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 174.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 142.16 27.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.939 2.096 . . . . 0.0 108.315 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -146.7 92.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mm -84.34 138.86 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.739 1.216 . . . . 0.0 108.274 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 100.0 m -105.81 131.71 52.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.0 113.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . 0.3 2.6 pt -109.37 -164.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.672 1.189 . . . . 0.0 109.991 -166.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -50.83 108.78 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.315 -1.491 . . . . 0.0 110.52 160.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.18 50.46 2.2 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.583 2.04 . . . . 0.0 113.097 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 144.17 7.58 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -120.26 153.45 36.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 107.931 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -84.42 -165.85 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.579 0.704 . . . . 0.0 112.31 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.64 144.67 73.83 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 151.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.43 137.28 50.29 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.774 1.649 . . . . 0.0 108.879 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.6 m -105.21 104.86 14.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -124.26 137.17 54.54 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.1 126.38 39.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -93.52 145.43 24.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -154.73 138.85 16.49 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -94.97 136.02 35.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.738 1.215 . . . . 0.0 108.279 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.257 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -175.129 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.05 129.92 27.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.261 1.974 . . . . 0.0 110.558 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.22 178.42 4.78 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.139 1.376 . . . . 0.0 110.881 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.472 HD13 ' CG ' ' A' ' 26' ' ' TRP . 63.1 mt -71.76 86.85 0.95 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -58.57 -20.12 43.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.272 1.429 . . . . 0.0 111.217 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -93.46 6.27 48.74 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.708 1.603 . . . . 0.0 113.585 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.99 106.81 0.54 Allowed 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.723 -1.236 . . . . 0.0 109.905 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -143.36 163.91 31.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.547 1.139 . . . . 0.0 110.046 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 13.4 m-30 -109.02 159.7 16.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.08 168.17 7.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.616 1.966 . . . . 0.0 107.068 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 42.34 59.81 2.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 126.201 1.801 . . . . 0.0 109.653 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mm -79.89 60.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -73.63 175.54 7.03 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.595 1.958 . . . . 0.0 109.966 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -4.97 53.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.997 1.319 . . . . 0.0 112.636 172.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 p -110.78 -12.42 14.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.561 1.544 . . . . 0.0 114.459 -166.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 p 173.84 171.13 0.19 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.034 1.734 . . . . 0.0 108.233 -163.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.79 150.12 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 161.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.26 159.3 14.65 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 171.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.01 146.31 49.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 125.508 1.523 . . . . 0.0 108.184 176.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -124.25 156.83 36.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 158.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.472 ' CG ' HD13 ' A' ' 9' ' ' LEU . 32.6 p90 -161.38 -173.87 4.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.086 1.755 . . . . 0.0 106.973 163.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -104.04 107.55 57.36 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -59.37 124.07 14.74 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.715 1.61 . . . . 0.0 109.125 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.2 mt -93.4 -19.23 21.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.641 0.776 . . . . 0.0 112.878 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 43.45 29.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.193 2.597 . . . . 0.0 113.577 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 m -87.83 104.95 17.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -167.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -41.88 -1.85 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 131.518 3.927 . . . . 0.0 119.509 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.52 -14.45 8.22 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 130.167 3.387 . . . . 0.0 112.137 -171.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 12.6 tt -60.43 161.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.105 2.162 . . . . 0.0 111.061 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -98.77 -47.99 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 166.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.94 40.99 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.442 ' CD1' HD11 ' A' ' 9' ' ' LEU . 11.3 m-85 -126.91 107.24 9.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 171.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.5 121.95 28.93 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.64 147.4 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -145.49 99.51 3.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.814 1.245 . . . . 0.0 107.672 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.56 134.16 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 120.665 -1.272 . . . . 0.0 109.064 163.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.25 165.13 24.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 136.42 42.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.539 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.925 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -60.97 160.87 24.07 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.716 1.61 . . . . 0.0 111.196 162.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.79 -86.95 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 121.367 1.894 . . . . 0.0 110.555 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.54 146.67 40.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.457 1.503 . . . . 0.0 107.439 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -147.51 162.55 38.84 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.852 1.261 . . . . 0.0 109.437 -168.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.34 153.36 43.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.359 1.463 . . . . 0.0 108.219 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.63 -176.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 108.866 165.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.15 -58.45 5.98 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -161.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 p 153.83 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 130.789 3.636 . . . . 0.0 110.747 -167.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -105.47 3.41 29.49 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 113.233 -166.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.9 150.67 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.98 -2.83 6.49 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 127.016 2.246 . . . . 0.0 113.201 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -160.73 128.7 4.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.727 -1.455 . . . . 0.0 107.883 -171.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -150.08 167.03 27.98 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.961 0.8 . . . . 0.0 109.049 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.4 m -132.9 136.66 46.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.413 1.485 . . . . 0.0 109.999 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.29 165.2 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.93 1.692 . . . . 0.0 107.469 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' GLY . 2.9 m -143.53 -170.69 3.35 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.359 -1.463 . . . . 0.0 107.06 164.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.506 ' H ' HG22 ' A' ' 65' ' ' THR . . . 72.09 15.51 76.55 Favored Glycine 0 N--CA 1.463 0.471 0 C-N-CA 124.713 1.149 . . . . 0.0 112.642 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.64 158.97 35.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.344 1.058 . . . . 0.0 108.826 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.51 107.25 23.57 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 170.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.9 168.05 19.8 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.065 2.51 . . . . 0.0 110.756 -173.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.4 -31.18 4.57 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.505 1.05 . . . . 0.0 110.692 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.07 155.24 3.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -101.28 142.7 32.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.103 1.761 . . . . 0.0 108.242 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -134.59 120.48 19.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.043 1.337 . . . . 0.0 109.913 -162.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.15 95.75 9.24 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.406 HD13 ' CE2' ' A' ' 14' ' ' PHE . 2.4 mp -84.58 105.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p -88.56 147.5 24.57 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 167.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.85 112.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 mt -112.32 129.31 68.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -82.59 134.86 35.18 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 113.71 18.79 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 18.3 pt -107.58 -167.83 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.961 1.704 . . . . 0.0 110.029 -173.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -44.1 110.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.317 0.508 . . . . 0.0 109.902 167.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.6 63.44 0.06 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.563 2.506 . . . . 0.0 114.121 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.71 158.32 19.17 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.36 150.18 45.03 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.74 -178.28 6.82 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.726 0.774 . . . . 0.0 109.992 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 149.01 98.52 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.184 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.31 102.5 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.325 2.017 . . . . 0.0 108.186 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 m -91.86 93.55 8.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 m -113.2 149.52 33.59 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -146.67 68.52 1.17 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.667 0.746 . . . . 0.0 110.131 -171.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.4 t -72.28 133.23 44.91 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -157.88 141.7 15.7 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.051 2.141 . . . . 0.0 108.753 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -91.11 157.9 16.96 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.76 0.824 . . . . 0.0 110.682 -175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.25 1.125 0 CA-C-O 115.51 -2.186 . . . . 0.0 108.225 178.779 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.34 120.48 5.31 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.584 2.189 . . . . 0.0 110.769 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -80.89 169.89 16.97 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.298 1.039 . . . . 0.0 110.634 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.401 HD13 ' CG ' ' A' ' 26' ' ' TRP . 81.5 mt -70.13 79.65 0.51 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.2 m -65.79 -14.14 60.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.752 2.021 . . . . 0.0 111.627 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -113.38 24.16 12.51 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.32 1.448 . . . . 0.0 111.458 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.55 127.03 29.25 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.435 0.694 . . . . 0.0 110.847 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.15 165.13 31.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.005 0.922 . . . . 0.0 111.309 172.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 9.9 m-85 -112.06 154.81 24.83 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.838 1.255 . . . . 0.0 108.348 169.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.0 174.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.961 2.104 . . . . 0.0 106.624 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 56.34 47.13 19.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 0.0 108.791 161.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 mt -79.92 66.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.203 2.201 . . . . 0.0 106.937 -174.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -66.73 176.96 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.974 1.31 . . . . 0.0 109.447 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.02 -3.98 32.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.05 0.94 . . . . 0.0 113.369 162.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -125.44 -15.25 6.2 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 -162.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.18 168.02 4.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 108.525 -170.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 tt -134.56 124.09 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.132 -0.98 . . . . 0.0 108.445 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.46 161.3 46.51 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.526 HD13 ' CD2' ' A' ' 62' ' ' TYR . 3.0 mp -133.44 161.0 35.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.936 1.294 . . . . 0.0 108.856 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -138.61 147.82 43.39 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 160.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.401 ' CG ' HD13 ' A' ' 9' ' ' LEU . 12.1 p90 -157.09 172.45 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 158.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 m -79.13 107.09 5.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 124.452 1.101 . . . . 0.0 109.266 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -60.66 133.88 50.98 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.544 1.23 . . . . 0.0 109.033 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.98 133.55 38.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.744 2.018 . . . . 0.0 107.367 166.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -121.31 36.77 4.51 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 m -79.62 101.69 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.437 2.295 . . . . 0.0 108.298 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -59.16 84.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.778 1.631 . . . . 0.0 113.146 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 165.8 -25.38 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 131.438 3.895 . . . . 0.0 109.415 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.24 160.32 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.135 1.774 . . . . 0.0 109.908 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.68 -47.19 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.33 -155.35 24.17 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.293 0.497 . . . . 0.0 111.983 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -137.08 129.63 30.09 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 116.78 33.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.548 HG13 HG22 ' A' ' 77' ' ' VAL . 1.5 mp -89.23 150.56 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 123.427 1.584 . . . . 0.0 107.554 171.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 m -146.21 148.41 32.48 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 171.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.8 133.81 48.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.47 164.65 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 107.618 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.27 119.82 23.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 130.15 3.38 . . . . 0.0 118.826 160.892 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.75 147.63 17.32 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.912 3.075 . . . . 0.0 109.7 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -101.92 -76.4 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.23 171.68 18.14 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 120.849 1.658 . . . . 0.0 110.808 176.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.25 152.97 33.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.878 1.271 . . . . 0.0 109.39 171.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -145.84 165.7 28.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.26 160.61 39.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -177.4 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -59.82 -68.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.09 1.356 . . . . 0.0 110.561 -165.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t 178.81 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 129.206 3.003 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.8 p -136.33 48.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.37 124.78 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.457 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.19 -1.12 44.64 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.366 1.46 . . . . 0.0 114.213 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -158.94 132.94 7.63 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 127.108 2.163 . . . . 0.0 106.929 169.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CD2' HD13 ' A' ' 24' ' ' LEU . 14.0 t80 -135.51 164.6 27.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -142.65 145.79 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -110.88 144.63 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 66' ' ' GLY . 2.6 m -128.29 -178.19 4.45 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 65' ' ' THR . . . 73.91 13.07 81.02 Favored Glycine 0 N--CA 1.463 0.439 0 C-N-CA 123.979 0.799 . . . . 0.0 113.35 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -69.99 165.58 21.48 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.125 0.97 . . . . 0.0 108.847 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.96 105.56 13.87 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.953 1.701 . . . . 0.0 108.56 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.93 152.94 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.007 2.471 . . . . 0.0 110.192 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 -43.89 1.32 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 125.991 1.758 . . . . 0.0 109.188 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -84.09 165.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 122.747 1.261 . . . . 0.0 108.804 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -101.34 138.14 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 128.407 2.683 . . . . 0.0 106.57 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -133.96 142.43 47.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.05 0.841 . . . . 0.0 110.681 -158.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.31 89.74 3.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.277 1.431 . . . . 0.0 109.988 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 5.1 mp -83.99 111.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -170.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -111.36 125.79 54.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.211 1.804 . . . . 0.0 108.718 -164.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 39' ' ' ILE . 22.0 t -134.41 103.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 mt -84.55 144.38 9.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -105.58 131.16 53.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.7 150.22 51.99 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.338 1.426 . . . . 0.0 109.19 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.0 pt -135.72 -179.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.85 1.26 . . . . 0.0 108.954 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -35.2 116.78 0.37 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.61 1.564 . . . . 0.0 110.301 168.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 47.03 2.19 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 124.786 1.304 . . . . 0.0 112.186 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.11 155.45 26.59 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.247 1.023 . . . . 0.0 111.226 -165.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -151.49 127.96 10.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -178.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.82 141.79 84.99 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.374 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.2 100.36 0.87 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.857 2.372 . . . . 0.0 108.568 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 m -83.59 125.89 32.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.7 m -125.32 155.35 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 mt -140.29 141.6 35.76 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.9 m -77.57 146.83 36.04 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -138.72 157.93 45.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.436 1.095 . . . . 0.0 108.662 153.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -125.59 144.16 50.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.644 1.578 . . . . 0.0 109.025 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.248 1.024 0 C-N-CA 125.143 1.377 . . . . 0.0 112.591 166.063 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.59 122.09 4.39 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.177 2.585 . . . . 0.0 111.606 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 163.29 27.54 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.235 1.014 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.26 80.84 1.83 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.665 0.745 . . . . 0.0 110.68 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 m -56.15 -10.79 0.92 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.861 2.065 . . . . 0.0 112.346 168.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -111.0 5.84 20.57 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.631 -1.293 . . . . 0.0 113.825 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.31 118.49 4.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.505 0.593 . . . . 0.0 109.807 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -140.98 165.32 27.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.789 1.636 . . . . 0.0 109.957 166.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.555 ' CE2' ' HB2' ' A' ' 91' ' ' LEU . 12.4 m-30 -108.58 155.26 20.86 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 165.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.04 174.68 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 128.406 2.682 . . . . 0.0 107.997 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 48.64 44.8 21.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.397 1.079 . . . . 0.0 110.18 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.76 61.35 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 t -64.38 166.01 8.86 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.925 1.345 . . . . 0.0 109.424 168.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.81 4.63 6.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.209 1.404 . . . . 0.0 111.381 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -126.15 -0.92 7.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.437 2.295 . . . . 0.0 116.908 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.91 166.74 0.53 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.81 2.844 . . . . 0.0 109.125 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 tt -123.65 140.44 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.95 157.33 21.1 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.76 154.53 44.1 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.473 1.509 . . . . 0.0 108.076 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -139.42 141.01 37.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -158.18 -174.35 4.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.504 0.722 . . . . 0.0 110.311 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 m -97.73 107.14 38.16 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.013 1.725 . . . . 0.0 107.141 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -58.79 128.81 29.44 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 121.233 1.476 . . . . 0.0 109.013 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.9 mt -95.35 98.26 10.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 126.694 1.997 . . . . 0.0 105.845 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -75.04 28.58 0.09 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.519 0.728 . . . . 0.0 111.787 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -66.69 131.19 45.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -76.59 52.55 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.113 -0.992 . . . . 0.0 111.213 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.47 -14.43 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.093 1.357 . . . . 0.0 111.0 -164.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.05 141.89 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.44 -65.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.42 -168.08 31.74 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -124.05 138.69 54.41 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.65 118.9 29.21 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.459 HG13 HG22 ' A' ' 77' ' ' VAL . 3.8 mp -93.51 149.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -145.13 102.88 3.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.75 127.76 39.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -123.69 164.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.01 110.66 21.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.387 0 C-N-CA 128.11 2.564 . . . . 0.0 113.596 -178.632 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.67 128.38 11.71 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.123 2.549 . . . . 0.0 110.188 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mm -84.89 -62.36 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.95 155.37 34.11 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 107.676 -164.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.13 151.65 40.93 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 174.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.69 158.37 15.3 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.046 0.841 . . . . 0.0 110.792 -156.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.87 154.21 49.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.693 1.197 . . . . 0.0 108.272 -167.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.16 -177.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.5 -57.44 5.8 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -163.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t 157.53 -43.36 0.0 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 128.073 2.549 . . . . 0.0 111.936 -163.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -129.47 37.16 4.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.093 1.315 . . . . 0.0 110.377 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.4 134.77 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.11 -5.71 13.03 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.274 1.416 . . . . 0.0 113.57 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -142.18 130.79 22.63 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.475 1.91 . . . . 0.0 107.336 174.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.22 166.61 24.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -151.74 147.03 26.2 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.664 -1.272 . . . . 0.0 109.328 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.84 158.28 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.754 1.621 . . . . 0.0 108.641 -166.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.09 178.01 7.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.529 1.132 . . . . 0.0 108.889 -174.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 23.65 77.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 165.01 25.92 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 161.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -143.65 135.88 13.27 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.629 1.172 . . . . 0.0 107.975 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 161.67 42.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.191 1.927 . . . . 0.0 111.914 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.27 -14.63 63.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.657 1.599 . . . . 0.0 113.338 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.81 152.01 13.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 118.779 1.289 . . . . 0.0 108.234 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.49 127.73 32.76 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.309 1.844 . . . . 0.0 108.012 174.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -116.47 120.29 38.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.89 102.51 13.17 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 168.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 mt -94.48 89.65 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.2 p -94.58 150.31 20.37 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.707 -0.621 . . . . 0.0 110.293 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 39' ' ' ILE . 40.0 t -147.12 123.69 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -172.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.3 mt -118.61 139.65 45.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.5 m -106.06 115.97 31.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.114 1.766 . . . . 0.0 107.532 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.38 137.57 51.91 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.452 1.501 . . . . 0.0 109.779 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.06 -176.66 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.524 1.929 . . . . 0.0 109.154 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -35.2 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.154 1.382 . . . . 0.0 111.793 161.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.98 29.74 35.82 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.728 167.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.08 158.06 30.4 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 119.155 1.478 . . . . 0.0 111.113 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.8 151.43 51.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.674 1.99 . . . . 0.0 105.736 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.08 -171.04 3.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 144.71 88.99 Favored Pre-proline 0 C--O 1.242 0.676 0 O-C-N 120.877 -1.139 . . . . 0.0 108.631 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -63.7 136.6 54.56 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 107.979 -1.585 . . . . 0.0 107.979 171.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.96 96.59 6.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.8 m -114.2 143.54 44.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.555 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 95.0 mt -134.17 111.29 10.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 t -84.52 155.26 22.22 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -163.29 131.9 3.88 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 108.973 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -95.99 78.74 3.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.07 0.948 . . . . 0.0 110.578 169.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.256 1.398 0 C-N-CA 123.807 0.843 . . . . 0.0 110.236 167.067 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.28 116.72 4.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 N-CA-C 105.986 -2.352 . . . . 0.0 105.986 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -73.67 177.5 5.38 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.109 0.964 . . . . 0.0 111.64 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.504 HD13 ' CG ' ' A' ' 26' ' ' TRP . 92.3 mt -69.39 76.92 0.39 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.851 0.834 . . . . 0.0 108.929 161.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m -60.48 -27.88 67.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.202 1.001 . . . . 0.0 109.043 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . . . -83.89 3.89 31.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.53 1.532 . . . . 0.0 114.338 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.34 117.76 7.1 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.124 -0.985 . . . . 0.0 110.409 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -153.02 165.66 34.87 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 168.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 7.5 m-30 -97.54 160.28 14.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.41 172.63 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.278 1.831 . . . . 0.0 106.555 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.71 44.87 19.85 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.246 1.018 . . . . 0.0 110.707 164.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -80.1 52.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.319 1.848 . . . . 0.0 109.695 -169.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 20' ' ' SER . 10.9 t -80.75 174.68 11.37 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.625 1.57 . . . . 0.0 109.684 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -80.33 -1.35 40.7 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.322 -0.861 . . . . 0.0 112.325 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.423 ' H ' HG23 ' A' ' 18' ' ' THR . 58.3 p -125.29 0.92 7.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 126.435 1.894 . . . . 0.0 115.839 -167.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.25 173.28 2.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.564 2.345 . . . . 0.0 106.591 160.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tt -121.98 143.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 160.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.07 163.24 18.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.52 157.68 42.0 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.224 1.41 . . . . 0.0 108.852 170.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -138.43 147.91 43.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 163.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.504 ' CG ' HD13 ' A' ' 9' ' ' LEU . 23.7 p90 -153.58 -179.73 8.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 163.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -94.19 106.95 25.56 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.55 138.96 73.37 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.923 1.749 . . . . 0.0 110.059 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 132.23 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.347 1.859 . . . . 0.0 106.537 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.95 18.67 21.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -64.44 158.28 24.26 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -165.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -82.65 43.77 0.85 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.791 -1.193 . . . . 0.0 111.656 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -171.05 -21.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.544 -0.723 . . . . 0.0 112.786 -174.409 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.29 121.23 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.914 0.886 . . . . 0.0 109.213 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.413 ' HB ' HD12 ' A' ' 80' ' ' LEU . 3.4 mt -83.71 -46.41 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.08 -153.61 23.62 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.38 -1.39 . . . . 0.0 114.259 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.445 ' CD2' HG23 ' A' ' 79' ' ' THR . 1.8 m-85 -138.27 145.81 41.74 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.52 118.73 27.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.77 1.628 . . . . 0.0 107.658 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.535 HG12 HG22 ' A' ' 77' ' ' VAL . 71.8 mt -114.01 115.25 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -168.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.3 m -126.72 103.78 7.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -87.72 138.45 19.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.98 174.052 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.37 163.23 38.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.5 118.64 22.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.419 ' H ' ' HA ' ' A' ' 73' ' ' TYR . . . . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 128.121 2.569 . . . . 0.0 115.33 165.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.1 mt . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 118.387 -0.815 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.4 152.54 34.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.483 2.122 . . . . 0.0 110.02 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.9 mp -106.49 -92.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 161.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.05 170.55 16.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.981 1.264 . . . . 0.0 110.289 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.98 124.1 48.54 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.613 1.965 . . . . 0.0 107.062 173.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 159.3 15.79 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.068 2.547 . . . . 0.0 109.294 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.22 153.73 46.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 162.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -171.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.086 1.312 . . . . 0.0 111.098 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 p 168.2 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.614 1.965 . . . . 0.0 110.932 -162.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -124.66 20.23 8.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.513 1.525 . . . . 0.0 110.405 -171.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.82 124.34 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.11 3.28 51.53 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.531 1.539 . . . . 0.0 112.809 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -163.28 127.79 2.95 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 110.981 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -139.1 162.54 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.254 1.388 . . . . 0.0 109.133 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -138.19 148.26 44.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.736 1.214 . . . . 0.0 108.121 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.17 143.82 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 107.862 -174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 66' ' ' GLY . 1.9 m -141.79 -175.45 4.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -169.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.549 ' H ' HG22 ' A' ' 65' ' ' THR . . . 61.45 25.96 65.76 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 124.166 0.889 . . . . 0.0 111.855 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -79.51 165.87 22.55 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 170.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -130.19 133.02 24.46 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 165.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -79.19 169.57 18.85 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.233 2.622 . . . . 0.0 110.374 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.83 -4.17 49.57 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.769 -1.017 . . . . 0.0 114.209 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 mm -126.34 165.07 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.469 1.635 . . . . 0.0 107.412 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -86.44 149.42 25.0 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.068 -1.02 . . . . 0.0 109.274 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.419 ' HA ' ' H ' ' A' ' 44' ' ' ALA . 3.9 m-85 -138.26 130.65 29.01 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.885 0.874 . . . . 0.0 109.363 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.14 108.34 19.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 165.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.472 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.9 mp -98.5 94.67 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.5 p -95.91 153.26 17.85 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 110.672 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 39' ' ' ILE . 39.7 t -142.09 98.05 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -172.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -92.14 129.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.445 HG23 ' CD2' ' A' ' 37' ' ' TYR . 92.2 m -106.43 125.08 50.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.194 1.397 . . . . 0.0 107.754 -174.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.413 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -123.56 148.77 46.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 111.448 -170.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.5 -176.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.051 2.14 . . . . 0.0 107.49 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.41 ' H ' HG23 ' A' ' 33' ' ' THR . 7.5 t30 -34.46 108.42 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 111.1 165.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.78 43.13 1.62 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.681 2.086 . . . . 0.0 112.923 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.39 158.99 30.09 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -167.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -146.47 161.9 39.44 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.87 1.668 . . . . 0.0 108.452 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.5 m -89.0 -169.94 2.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.158 0.583 . . . . 0.0 109.683 172.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.39 152.46 94.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.49 103.66 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.475 2.116 . . . . 0.0 108.574 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 p -87.03 139.55 30.46 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -145.16 172.78 12.62 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -147.2 134.3 20.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 156.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -79.64 104.02 9.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.551 1.94 . . . . 0.0 107.043 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -107.58 108.84 20.3 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.052 -1.655 . . . . 0.0 112.84 171.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 148.4 31.16 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 157.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 C--O 1.243 0.731 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.527 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.17 132.83 30.96 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.829 2.353 . . . . 0.0 112.199 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.05 156.73 17.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.651 1.98 . . . . 0.0 109.554 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.492 HD13 ' CG ' ' A' ' 26' ' ' TRP . 85.3 mt -73.39 87.45 1.54 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.161 0.984 . . . . 0.0 109.95 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 m -66.55 -10.04 41.1 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.393 0.677 . . . . 0.0 112.252 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.46 0.11 55.13 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.411 -1.43 . . . . 0.0 112.487 171.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.31 106.65 0.21 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.981 1.264 . . . . 0.0 111.475 -172.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -140.54 138.48 34.55 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.775 1.23 . . . . 0.0 109.644 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.58 156.47 16.71 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.49 167.6 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.182 1.793 . . . . 0.0 109.05 169.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 50.52 61.03 3.43 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 108.673 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.0 mm -81.02 64.23 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.385 1.874 . . . . 0.0 107.833 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.3 t -95.08 171.84 8.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.242 1.02 . . . . 0.0 111.561 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.57 -4.33 36.33 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.832 1.253 . . . . 0.0 112.351 -165.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.9 p -124.99 -14.53 6.61 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.947 1.299 . . . . 0.0 114.052 -171.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.535 ' HA ' HD23 ' A' ' 67' ' ' LEU . 2.5 p -174.46 148.43 1.21 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.859 1.264 . . . . 0.0 111.517 -166.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.25 132.17 70.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.78 156.39 25.5 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.42 128.24 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.023 1.329 . . . . 0.0 109.071 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -98.51 151.21 20.86 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CG ' HD13 ' A' ' 9' ' ' LEU . 44.1 p90 -151.32 174.99 12.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 150.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -87.9 141.87 31.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 171.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.14 123.41 5.61 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 N-CA-C 105.877 -2.393 . . . . 0.0 105.877 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.16 -19.55 56.69 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 50.39 31.21 5.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.602 2.361 . . . . 0.0 111.681 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -69.49 5.6 1.32 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.47 2.308 . . . . 0.0 113.842 -158.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 64.73 -63.67 0.17 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 112.753 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.325 3.05 . . . . 0.0 113.214 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -53.62 151.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.871 1.269 . . . . 0.0 110.85 167.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.53 -57.17 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.01 -156.2 15.98 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -127.77 144.86 51.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.81 124.03 51.26 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 175.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.606 HG13 HG13 ' A' ' 77' ' ' VAL . 3.0 mp -93.75 156.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 168.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -145.14 142.94 30.07 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.84 138.04 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.98 163.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.22 114.12 21.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 166.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.762 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 mt . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 117.6 -1.19 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.68 127.24 3.65 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.073 2.515 . . . . 0.0 109.355 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.57 -70.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.89 164.59 31.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.856 0.753 . . . . 0.0 110.251 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.22 126.39 55.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 167.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -104.44 162.81 12.92 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.862 1.665 . . . . 0.0 107.897 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.09 161.33 27.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.748 0.819 . . . . 0.0 109.568 174.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.72 -176.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.34 -71.41 0.23 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.6 t 155.04 -21.94 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 131.657 3.983 . . . . 0.0 109.841 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.9 p -135.03 20.15 3.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.358 1.435 . . . . 0.0 112.641 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.69 128.91 36.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 169.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.89 2.72 11.83 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.273 2.368 . . . . 0.0 112.651 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -138.84 127.68 23.6 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.264 -1.139 . . . . 0.0 109.222 166.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -142.06 164.34 30.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.885 1.674 . . . . 0.0 109.417 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.2 m -133.77 135.82 44.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.54 1.536 . . . . 0.0 107.547 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.88 155.62 4.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 164.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -137.31 170.05 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.075 0.95 . . . . 0.0 109.59 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.07 51.21 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.588 -0.695 . . . . 0.0 111.89 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 21' ' ' SER . 4.1 mm? -61.52 158.02 15.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 128.68 2.792 . . . . 0.0 106.782 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 80.84 39.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.036 1.734 . . . . 0.0 109.344 -170.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.56 124.67 11.4 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.947 1.765 . . . . 0.0 108.682 -169.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.47 -26.5 4.61 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 124.436 1.017 . . . . 0.0 113.488 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.21 166.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.827 1.651 . . . . 0.0 107.219 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.16 126.03 41.1 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.065 1.746 . . . . 0.0 107.244 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.4 126.8 54.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.633 0.773 . . . . 0.0 109.262 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.07 103.36 15.3 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 173.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.33 101.07 11.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.1 p -88.8 143.33 26.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.374 1.083 . . . . 0.0 109.678 173.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.606 HG13 HG13 ' A' ' 39' ' ' ILE . 39.2 t -139.09 119.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 -177.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 mt -124.69 141.18 45.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -98.59 136.42 38.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.77 132.96 55.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.362 1.065 . . . . 0.0 108.51 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 pt -130.09 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.155 1.782 . . . . 0.0 109.675 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -34.11 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.37 2.268 . . . . 0.0 110.021 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.85 53.7 0.05 OUTLIER Glycine 0 CA--C 1.526 0.772 0 C-N-CA 128.284 2.849 . . . . 0.0 113.604 -172.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.87 160.88 34.44 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 118.065 0.932 . . . . 0.0 111.459 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -139.2 146.11 40.12 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 126.326 1.85 . . . . 0.0 108.414 -168.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -84.51 -174.49 5.3 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.409 0.683 . . . . 0.0 110.472 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.65 134.58 93.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 166.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.83 132.57 32.98 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -118.69 111.15 18.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -124.7 152.16 44.07 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 92' ' ' THR . 1.4 tt -132.97 153.61 51.28 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 152.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.511 ' H ' HD23 ' A' ' 91' ' ' LEU . 4.3 t -112.8 135.1 53.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.53 114.5 12.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -85.78 111.85 20.54 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.251 1.148 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 C--O 1.238 0.466 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 125.61 12.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.466 2.111 . . . . 0.0 109.056 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.96 166.38 23.15 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 163.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.566 HD13 ' CG ' ' A' ' 26' ' ' TRP . 48.7 mt -66.57 88.68 0.14 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -66.86 -13.65 61.86 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.154 0.982 . . . . 0.0 109.19 171.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.14 4.49 50.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.07 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.94 121.08 11.5 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.073 -1.017 . . . . 0.0 110.027 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -146.83 165.57 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.218 1.007 . . . . 0.0 110.543 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 24' ' ' LEU . 75.0 m-85 -119.64 150.44 40.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.91 0.884 . . . . 0.0 108.895 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.94 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.961 2.104 . . . . 0.0 107.712 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 55.5 45.23 25.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.821 0.848 . . . . 0.0 110.182 161.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.29 56.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.791 2.036 . . . . 0.0 107.035 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.28 166.64 19.71 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -75.11 7.03 3.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.2 p -125.32 -10.13 6.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 115.18 -167.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.88 166.31 0.9 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 127.324 2.25 . . . . 0.0 109.162 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.89 128.41 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.23 150.28 23.6 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 1.1 mt -128.2 141.73 51.38 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.415 1.486 . . . . 0.0 107.994 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -124.88 142.23 51.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.566 ' CG ' HD13 ' A' ' 9' ' ' LEU . 44.2 p90 -156.78 -173.07 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 164.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -108.74 105.46 57.04 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.927 1.291 . . . . 0.0 108.719 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.43 124.67 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.957 2.438 . . . . 0.0 112.076 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.55 103.55 15.16 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.237 1.015 . . . . 0.0 108.797 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -80.61 49.12 1.13 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.564 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 m -61.93 -64.46 0.93 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.985 -166.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 p 156.69 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.828 2.451 . . . . 0.0 112.305 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.85 -4.38 1.77 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.655 1.982 . . . . 0.0 110.157 -163.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -43.19 134.88 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.184 -1.572 . . . . 0.0 109.724 146.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.56 -43.36 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 124.748 1.219 . . . . 0.0 110.26 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.89 -158.24 31.1 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -129.67 125.09 35.22 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 133.22 35.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 174.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.477 HG13 HG13 ' A' ' 77' ' ' VAL . 2.7 mp -110.3 149.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.8 m -140.82 158.83 43.39 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.425 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -138.54 125.59 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 103.908 -2.626 . . . . 0.0 103.908 178.685 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.31 162.81 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.601 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.68 108.02 19.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 123.222 0.609 . . . . 0.0 112.012 -175.542 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.1 mt . . . . . 0 CA--C 1.539 0.528 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.56 132.42 12.17 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.507 2.138 . . . . 0.0 110.324 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -83.75 -67.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -160.0 175.27 13.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.045 0.938 . . . . 0.0 109.567 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -122.02 123.41 41.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.436 1.494 . . . . 0.0 107.921 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -105.93 165.81 10.94 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.004 1.722 . . . . 0.0 109.968 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.48 163.17 28.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.202 1.001 . . . . 0.0 108.634 169.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 -176.63 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.67 -64.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -164.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 m 153.55 -13.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.735 4.014 . . . . 0.0 111.344 -169.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -135.97 13.49 3.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.985 0.811 . . . . 0.0 112.535 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.41 138.98 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.54 5.5 5.21 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.075 1.798 . . . . 0.0 112.93 173.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -146.04 124.81 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -145.95 162.93 36.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.656 1.583 . . . . 0.0 108.231 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -144.83 131.96 20.48 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.258 -0.901 . . . . 0.0 108.983 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.94 149.18 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 -170.67 2.13 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.902 1.681 . . . . 0.0 107.004 170.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.5 14.56 75.84 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 120.12 1.327 . . . . 0.0 112.758 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.99 153.74 38.39 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.741 0.816 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -122.16 115.77 30.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.938 1.695 . . . . 0.0 106.834 163.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.54 144.73 85.79 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.292 1.995 . . . . 0.0 110.833 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.0 -10.49 58.55 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.469 1.509 . . . . 0.0 113.729 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.87 151.02 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 119.706 1.753 . . . . 0.0 107.041 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -80.61 120.06 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.465 1.506 . . . . 0.0 108.488 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.45 120.29 37.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.158 1.383 . . . . 0.0 108.387 -168.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.78 90.66 7.37 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.034 1.734 . . . . 0.0 107.375 174.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 41' ' ' VAL . 1.8 mp -84.01 109.52 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -114.43 122.04 45.4 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.133 1.773 . . . . 0.0 111.341 -167.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 39' ' ' ILE . 59.7 t -134.19 132.32 55.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -164.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 tt -143.41 152.79 16.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.419 1.087 . . . . 0.0 111.216 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.3 m -105.29 134.04 49.07 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 106.894 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.78 134.06 55.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.637 1.575 . . . . 0.0 109.034 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -129.67 175.69 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.91 1.284 . . . . 0.0 107.585 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -46.33 110.02 0.24 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.522 0.601 . . . . 0.0 110.106 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.05 42.69 1.21 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 126.516 2.008 . . . . 0.0 113.392 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.72 144.62 12.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -133.45 118.53 18.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -161.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.22 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.92 133.44 41.31 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.896 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.66 109.76 1.72 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.038 2.492 . . . . 0.0 106.524 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -107.28 102.66 11.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.0 m -94.16 158.75 15.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 tt -132.22 101.92 5.57 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 153.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -84.92 119.19 25.08 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -136.72 153.15 50.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.419 1.487 . . . . 0.0 108.74 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.28 157.92 27.65 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 157.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.25 1.092 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.717 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -133.67 112.77 11.69 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 121.365 1.893 . . . . 0.0 108.363 170.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 51.92 -110.18 1.05 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.5 p -134.4 162.88 30.99 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.968 1.707 . . . . 0.0 107.12 161.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -135.16 -77.75 0.44 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.554 1.07 . . . . 0.0 108.432 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t -70.48 133.89 86.86 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.58 134.77 33.96 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.724 1.616 . . . . 0.0 109.803 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -112.64 160.96 17.36 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.031 2.132 . . . . 0.0 108.577 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.548 HD13 ' CG ' ' A' ' 26' ' ' TRP . 72.7 mt -70.05 87.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.133 0.973 . . . . 0.0 108.686 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.54 -3.9 30.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.468 1.107 . . . . 0.0 111.249 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.57 6.79 15.91 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.62 1.968 . . . . 0.0 112.937 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -52.23 110.99 0.55 Allowed 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.243 1.417 . . . . 0.0 109.172 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.9 m -155.15 165.14 37.61 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.984 0.914 . . . . 0.0 111.964 170.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 12.1 m-30 -110.95 149.97 29.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.198 1.399 . . . . 0.0 109.626 -162.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.93 175.76 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 128.248 2.619 . . . . 0.0 108.207 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 t70 46.1 52.91 9.78 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.827 2.051 . . . . 0.0 110.618 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.2 52.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 127.361 2.265 . . . . 0.0 108.468 -166.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 20' ' ' SER . 14.6 t -77.31 175.2 9.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 110.125 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.61 -5.53 53.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.316 1.046 . . . . 0.0 111.455 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.45 ' H ' HG23 ' A' ' 18' ' ' THR . 58.6 p -122.72 -8.33 8.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.63 1.972 . . . . 0.0 114.732 -162.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -175.11 175.01 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.04 2.536 . . . . 0.0 108.014 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.9 123.13 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 134.94 11.88 Favored Glycine 0 N--CA 1.467 0.75 0 O-C-N 120.415 -1.428 . . . . 0.0 110.043 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.81 155.43 20.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.845 1.322 . . . . 0.0 108.248 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.01 145.27 50.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 162.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.548 ' CG ' HD13 ' A' ' 9' ' ' LEU . 17.0 p90 -157.79 173.64 16.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.526 1.131 . . . . 0.0 109.472 166.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.0 m -90.99 142.6 27.56 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.642 1.11 . . . . 0.0 108.561 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -81.45 125.26 5.0 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.004 1.037 . . . . 0.0 111.997 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.22 88.65 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.209 1.804 . . . . 0.0 110.431 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -79.73 40.49 0.45 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.755 -0.591 . . . . 0.0 111.077 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -35.03 -64.26 0.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.1 p 159.31 -22.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 128.745 2.818 . . . . 0.0 112.761 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 34' ' ' ILE . 0.8 OUTLIER -165.06 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.592 -1.317 . . . . 0.0 111.273 -153.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.401 ' H ' ' H ' ' A' ' 33' ' ' THR . 5.1 tt -43.27 144.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 109.479 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.467 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.2 mp -83.88 -49.47 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.38 -158.2 28.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.51 140.38 52.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 166.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.8 112.46 20.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.56 144.34 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.6 m -131.51 152.59 50.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 145.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 123.8 0.84 . . . . 0.0 111.674 165.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.44 164.47 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.57 99.84 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.4 121.58 11.21 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.43 1.092 . . . . 0.0 109.475 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.37 -33.18 2.61 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -168.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -138.81 175.96 9.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.022 1.329 . . . . 0.0 108.31 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.04 9.06 78.59 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-O 117.935 -1.48 . . . . 0.0 113.142 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.3 mt -45.69 105.53 0.47 Allowed Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 119.191 1.496 . . . . 0.0 110.257 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.77 165.24 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.96 2.44 . . . . 0.0 109.718 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -122.81 -82.79 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -148.44 163.55 36.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.579 1.081 . . . . 0.0 109.774 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.77 123.82 48.1 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 164.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -106.61 156.62 18.4 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.13 1.772 . . . . 0.0 108.126 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.445 ' CZ ' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -126.86 153.73 45.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.817 0.847 . . . . 0.0 109.212 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.32 -176.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.81 -61.5 1.76 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.618 -157.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p 154.19 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 131.14 3.776 . . . . 0.0 109.902 -172.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -123.62 7.55 8.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.904 2.082 . . . . 0.0 111.926 -163.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -74.48 139.31 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 109.638 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.59 -5.65 18.33 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 123.996 0.807 . . . . 0.0 114.638 158.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -139.68 121.12 15.06 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.848 -1.383 . . . . 0.0 110.108 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -134.15 167.41 20.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.5 m -142.24 118.54 10.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.626 -1.296 . . . . 0.0 108.256 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -84.48 143.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 -171.83 2.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.15 69.29 Favored Glycine 0 CA--C 1.522 0.476 0 O-C-N 120.772 -1.205 . . . . 0.0 112.166 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.67 165.34 18.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.809 0.804 . . . . 0.0 110.589 165.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -134.3 135.09 23.38 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 126.731 2.012 . . . . 0.0 107.879 159.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.84 165.44 25.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.376 2.05 . . . . 0.0 112.451 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.22 -28.6 8.58 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 126.906 2.193 . . . . 0.0 111.746 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.2 mm -115.67 165.19 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -96.09 143.0 27.61 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -123.74 128.05 49.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.36 95.2 9.92 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -84.95 104.5 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m -88.09 147.87 24.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.26 1.024 . . . . 0.0 110.313 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.9 t -145.46 77.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.33 133.92 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.6 m -94.47 136.96 34.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.467 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -133.48 113.53 12.59 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.609 1.164 . . . . 0.0 107.95 -178.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -109.3 -175.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.117 1.767 . . . . 0.0 108.696 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -34.58 104.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.092 1.357 . . . . 0.0 110.848 163.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.69 29.25 5.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.61 1.576 . . . . 0.0 115.005 170.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.37 144.48 9.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.342 1.571 . . . . 0.0 110.925 -173.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -110.78 142.12 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.763 2.025 . . . . 0.0 106.534 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.79 174.41 10.46 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.84 0.746 . . . . 0.0 109.362 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.59 135.86 92.82 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.2 128.98 22.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 N-CA-C 107.805 -1.652 . . . . 0.0 107.805 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 m -122.6 99.4 6.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.9 m -94.23 163.41 13.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 5.4 mt -132.87 136.16 46.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 164.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 m -84.74 127.87 34.32 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.641 1.976 . . . . 0.0 106.23 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -154.86 147.4 24.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.766 1.166 . . . . 0.0 109.301 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.62 168.01 11.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.293 1.044 . . . . 0.0 110.638 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.251 1.133 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.903 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptt? . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -144.19 162.71 35.64 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.868 1.667 . . . . 0.0 110.858 -169.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.87 141.44 47.51 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.1 68.98 0.55 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.373 1.869 . . . . 0.0 110.76 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.35 -60.04 2.78 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.068 1.347 . . . . 0.0 110.326 -170.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -139.72 134.09 15.92 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 164.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.99 143.93 20.94 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.174 2.582 . . . . 0.0 111.705 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 174.68 7.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.432 1.893 . . . . 0.0 111.795 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.46 HD13 ' CG ' ' A' ' 26' ' ' TRP . 61.6 mt -77.64 85.39 3.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 166.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m -56.28 -35.29 67.31 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.582 -0.698 . . . . 0.0 110.201 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -74.21 5.99 3.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.484 2.314 . . . . 0.0 113.006 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.07 110.71 0.87 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.178 0.991 . . . . 0.0 111.075 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -125.89 164.45 20.74 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.86 0.864 . . . . 0.0 110.28 162.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 10.5 m-85 -90.73 166.16 13.28 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 155.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 177.21 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 127.287 2.235 . . . . 0.0 105.48 168.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.25 56.98 5.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.172 1.389 . . . . 0.0 110.355 161.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mm -78.77 59.82 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -69.07 173.63 5.33 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.408 -1.432 . . . . 0.0 109.945 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -98.88 22.11 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.649 1.179 . . . . 0.0 111.675 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -121.47 -13.73 8.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.263 1.425 . . . . 0.0 114.491 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p 170.48 171.96 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.032 2.133 . . . . 0.0 107.928 -154.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -137.44 147.63 26.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 166.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.53 163.74 23.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.12 159.25 36.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.399 1.48 . . . . 0.0 108.515 168.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -143.66 136.04 26.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.46 ' CG ' HD13 ' A' ' 9' ' ' LEU . 9.8 p90 -154.66 -177.5 6.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.267 1.027 . . . . 0.0 109.667 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -107.11 106.13 57.48 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.41 130.99 28.36 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.0 1.8 . . . . 0.0 110.029 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 31' ' ' SER . 2.2 mt -94.18 89.26 5.91 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.845 2.458 . . . . 0.0 105.018 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.55 50.38 0.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' LEU . 4.2 m -81.85 124.16 29.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.082 1.753 . . . . 0.0 109.847 168.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -63.39 38.52 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 130.159 3.384 . . . . 0.0 114.786 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -169.27 -12.42 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.823 2.049 . . . . 0.0 110.371 -171.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.62 161.06 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.091 1.356 . . . . 0.0 108.809 162.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.91 -59.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.71 -164.73 33.39 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' HD11 ' A' ' 9' ' ' LEU . 5.1 m-85 -131.21 145.39 51.91 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.83 130.16 56.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.924 1.69 . . . . 0.0 106.975 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.63 133.15 61.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.7 m -128.67 138.56 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.82 123.23 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.487 1.515 . . . . 0.0 108.335 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.19 163.44 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 124.025 0.828 . . . . 0.0 109.304 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 106.24 17.52 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.09 99.29 0.35 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.499 1.52 . . . . 0.0 109.089 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.06 -18.82 2.91 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.075 -1.403 . . . . 0.0 113.305 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -131.88 -5.42 3.57 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.876 1.338 . . . . 0.0 111.159 168.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.25 -1.24 43.12 Favored Glycine 0 C--N 1.34 0.803 0 O-C-N 121.192 -0.943 . . . . 0.0 113.346 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mt -43.09 106.13 0.46 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 128.261 2.624 . . . . 0.0 109.998 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.57 126.85 13.93 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 122.175 1.917 . . . . 0.0 107.494 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 mm -84.06 -82.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -148.21 175.68 10.86 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.023 -1.048 . . . . 0.0 109.763 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.11 159.83 31.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -148.96 164.86 33.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.622 1.969 . . . . 0.0 107.465 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 153.82 43.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.341 0.656 . . . . 0.0 109.602 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -177.38 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.916 0.78 . . . . 0.0 110.752 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.0 -60.45 2.29 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p 153.64 -41.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 1 C-N-CA 132.504 4.322 . . . . 0.0 107.878 -171.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.6 p -102.48 -1.13 31.2 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.965 1.706 . . . . 0.0 112.902 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.36 129.81 36.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.759 1.223 . . . . 0.0 108.24 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.78 -5.92 21.66 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 125.268 1.413 . . . . 0.0 113.315 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -140.25 116.15 10.33 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.301 1.44 . . . . 0.0 108.321 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.4 136.59 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.3 m -112.19 124.79 53.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.13 165.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.98 1.712 . . . . 0.0 107.629 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.15 -174.29 3.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.45 36.46 30.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.089 0.859 . . . . 0.0 112.536 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.03 162.84 13.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.934 1.293 . . . . 0.0 110.449 171.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.93 135.19 10.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.95 2.5 . . . . 0.0 104.916 162.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.91 170.29 18.3 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.754 2.303 . . . . 0.0 113.099 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.49 -4.83 70.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.772 0.701 . . . . 0.0 113.848 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.9 mm -129.44 147.79 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.944 1.698 . . . . 0.0 106.885 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -84.01 142.85 30.18 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.78 113.69 11.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.301 1.84 . . . . 0.0 106.432 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.21 103.17 13.19 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.921 1.688 . . . . 0.0 107.086 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.449 HG23 HG13 ' A' ' 41' ' ' VAL . 1.5 mp -92.23 107.7 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 80.7 p -92.78 143.56 26.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.289 1.036 . . . . 0.0 110.957 172.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.46 119.19 16.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mt -117.83 129.67 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.0 m -89.77 132.43 35.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.72 126.74 48.14 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.19 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.69 108.72 0.07 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.476 1.91 . . . . 0.0 110.339 169.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.75 26.13 1.05 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.741 1.638 . . . . 0.0 115.543 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.03 159.44 28.04 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.69 1.745 . . . . 0.0 111.688 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.61 141.6 49.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.137 1.775 . . . . 0.0 108.645 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -85.32 -172.62 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.741 0.816 . . . . 0.0 110.252 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.91 136.03 93.23 Favored Pre-proline 0 C--O 1.24 0.578 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.427 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.2 87.45 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.031 3.154 . . . . 0.0 108.482 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.2 m -84.72 92.13 8.12 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -164.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 1.4 m -94.56 150.4 20.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 69.8 mt -134.88 144.47 47.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 160.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.23 129.2 49.59 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -153.57 130.41 10.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 107.573 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.07 137.5 38.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.593 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -68.16 22.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 117.109 2.263 . . . . 0.0 117.109 -164.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 67.88 61.72 4.75 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -170.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -171.26 75.05 0.06 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -171.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' H ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -135.78 -106.06 0.21 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.441 177.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.429 ' H ' ' HB3' ' A' ' 5' ' ' GLU . 90.1 t -92.19 133.87 29.43 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.38 141.69 39.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.683 1.588 . . . . 0.0 109.429 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.08 161.53 15.81 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.127 2.171 . . . . 0.0 110.404 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 37' ' ' TYR . 67.3 mt -66.93 83.89 0.11 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.132 0.973 . . . . 0.0 109.375 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 m -71.91 1.0 7.82 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.884 1.674 . . . . 0.0 111.175 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -111.74 4.34 18.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.317 2.647 . . . . 0.0 111.693 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.67 114.81 4.21 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.563 1.945 . . . . 0.0 110.195 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -151.11 164.84 35.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.617 0.767 . . . . 0.0 111.19 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 10.3 m-30 -97.29 160.12 14.52 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.511 -0.743 . . . . 0.0 109.212 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.4 170.6 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.841 1.656 . . . . 0.0 107.526 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.7 47.83 17.69 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.836 1.654 . . . . 0.0 109.706 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -80.45 63.01 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -72.18 165.05 25.17 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -74.51 -3.05 28.53 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.331 -0.856 . . . . 0.0 111.212 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -105.51 -16.17 14.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.05 153.18 0.22 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 127.212 2.205 . . . . 0.0 107.924 -169.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.7 138.39 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.79 156.6 23.14 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 171.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.1 mp -122.59 154.52 37.84 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -137.8 139.93 40.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.418 ' CG ' HD13 ' A' ' 9' ' ' LEU . 36.4 p90 -152.95 175.0 13.42 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.073 0.949 . . . . 0.0 108.555 167.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -92.36 107.49 24.0 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.019 1.327 . . . . 0.0 108.094 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.3 134.68 49.87 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.991 -1.196 . . . . 0.0 108.991 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -88.88 -30.04 19.18 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.425 -1.274 . . . . 0.0 112.867 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 p30 42.43 37.69 1.02 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.607 1.192 . . . . 0.0 112.298 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -62.43 170.24 2.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 0.0 110.139 -167.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 p -67.66 -2.2 6.47 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.08 -4.16 0.06 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.401 -1.437 . . . . 0.0 112.925 -164.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.77 145.22 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 163.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.61 -65.94 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 160.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.61 -154.15 12.37 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -163.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.527 ' CD2' HD11 ' A' ' 9' ' ' LEU . 3.4 m-85 -136.24 144.01 44.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -118.9 123.13 43.9 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.421 HG13 HG13 ' A' ' 77' ' ' VAL . 3.0 mp -103.83 146.87 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 m -145.77 112.45 5.94 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.338 1.455 . . . . 0.0 108.699 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.14 131.69 43.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.718 0.807 . . . . 0.0 110.703 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.2 164.23 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.75 114.21 20.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.75 -6.04 3.29 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.285 1.434 . . . . 0.0 113.315 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.43 -17.08 47.31 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.583 -1.121 . . . . 0.0 114.726 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -150.83 17.04 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.691 1.745 . . . . 0.0 111.742 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.62 1.52 8.71 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.836 -1.165 . . . . 0.0 114.407 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 mt -45.55 106.24 0.53 Allowed Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 127.778 2.431 . . . . 0.0 109.743 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.28 124.02 8.14 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.932 2.421 . . . . 0.0 110.111 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.29 -59.63 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.9 169.22 18.45 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.193 0.906 . . . . 0.0 110.787 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -106.83 157.0 18.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.411 1.484 . . . . 0.0 108.4 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -152.42 166.06 33.12 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.314 1.446 . . . . 0.0 107.828 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.76 161.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.854 1.262 . . . . 0.0 109.979 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.91 -176.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.768 1.627 . . . . 0.0 107.744 172.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -83.69 -61.96 1.7 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.971 -162.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.6 t 155.23 -43.07 0.01 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 130.534 3.534 . . . . 0.0 107.868 -166.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -97.86 -5.73 33.99 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.242 1.417 . . . . 0.0 113.816 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.89 126.05 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.33 -5.58 37.08 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 127.591 2.519 . . . . 0.0 111.637 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -137.76 114.22 10.31 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.296 -1.708 . . . . 0.0 110.573 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.438 ' CD2' HD13 ' A' ' 24' ' ' LEU . 7.4 t80 -139.21 159.24 42.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.315 1.846 . . . . 0.0 107.719 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -147.08 151.21 36.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.04 145.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -168.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.36 -176.4 3.5 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.8 68.75 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 113.565 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.02 144.67 56.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -123.45 98.11 41.45 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.37 166.07 29.57 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.188 1.925 . . . . 0.0 112.609 -159.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.21 -4.67 80.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.001 1.286 . . . . 0.0 113.436 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.44 152.21 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -79.0 111.58 15.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.35 124.44 52.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.14 1.376 . . . . 0.0 109.389 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.33 126.58 33.33 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 169.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 3.0 mp -110.52 96.43 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.76 133.1 34.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.617 1.567 . . . . 0.0 108.617 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 39' ' ' ILE . 21.5 t -141.9 130.5 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -134.85 147.75 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 37' ' ' TYR . 21.7 m -94.24 137.69 33.12 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.73 128.43 55.27 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.379 . . . . 0.0 107.541 -175.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 pt -134.23 177.27 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.966 0.906 . . . . 0.0 108.588 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.69 110.43 0.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.821 0.848 . . . . 0.0 111.264 169.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.74 21.72 7.53 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.488 1.994 . . . . 0.0 114.708 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 157.33 29.75 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 119.583 1.691 . . . . 0.0 110.992 -161.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.041 0.937 . . . . 0.0 109.9 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 m -84.3 -172.6 4.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.03 0.919 . . . . 0.0 111.015 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.63 96.24 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.19 130.49 16.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.268 1.979 . . . . 0.0 108.783 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.2 m -103.61 107.92 18.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 165.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.9 m -111.93 84.69 2.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 mt -77.64 153.04 33.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.77 139.76 50.26 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -147.88 130.42 15.85 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.939 0.896 . . . . 0.0 109.725 157.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.49 122.47 21.34 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 154.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.017 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -164.4 -28.64 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.018 -1.051 . . . . 0.0 110.754 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.71 -124.62 1.11 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 174.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -78.18 -165.24 0.64 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.37 1.068 . . . . 0.0 109.516 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -99.14 -80.27 0.47 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.019 163.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.7 t -119.18 132.93 23.77 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 168.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.0 133.46 8.97 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.608 2.872 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.46 174.89 6.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.75 1.22 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.5 mt -67.9 75.85 0.21 Allowed 'General case' 0 C--N 1.34 0.152 0 C-N-CA 125.988 1.715 . . . . 0.0 109.523 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.8 m -54.13 -27.24 32.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.748 1.619 . . . . 0.0 110.465 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.51 -0.29 49.63 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 114.759 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.0 115.51 2.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.317 1.047 . . . . 0.0 110.904 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.4 165.19 28.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.338 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -117.57 154.06 32.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 108.341 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.78 171.19 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.061 1.744 . . . . 0.0 107.782 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 51.11 52.15 15.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.24 1.816 . . . . 0.0 110.767 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -78.83 55.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.923 2.489 . . . . 0.0 108.591 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -69.12 167.31 16.35 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.449 -1.407 . . . . 0.0 111.451 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -74.61 6.04 4.23 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.427 1.491 . . . . 0.0 111.846 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -125.7 -12.7 6.57 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 p -174.89 159.73 2.76 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.702 1.201 . . . . 0.0 109.42 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 tt -118.21 141.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.16 153.97 21.66 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.72 151.36 39.64 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 126.309 1.844 . . . . 0.0 107.81 169.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -142.32 138.18 31.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -154.13 -170.87 3.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.547 0.689 . . . . 0.0 109.308 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -106.05 105.53 53.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.773 1.229 . . . . 0.0 107.795 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -66.05 133.96 35.19 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.077 1.851 . . . . 0.0 110.841 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mp -94.93 104.58 16.47 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 125.893 1.677 . . . . 0.0 109.833 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.33 41.44 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.015 1.326 . . . . 0.0 110.532 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.6 m -65.3 155.29 35.69 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 160.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -77.5 -50.25 13.03 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.581 0.705 . . . . 0.0 110.791 166.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.39 -24.5 57.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.091 1.357 . . . . 0.0 113.272 -161.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.31 136.51 6.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 126.573 1.949 . . . . 0.0 108.247 171.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.35 -64.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.18 -161.88 26.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.47 146.42 50.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 127.35 46.13 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.07 145.62 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.8 m -134.89 121.35 20.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.537 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.4 125.9 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.64 164.31 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 129.92 38.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.79 -23.26 62.35 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.725 -0.61 . . . . 0.0 110.134 166.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.89 -45.24 96.59 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 123.444 0.545 . . . . 0.0 112.246 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -155.3 141.65 18.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.53 19.12 0.4 Allowed Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.732 2.11 . . . . 0.0 115.343 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 mt -46.13 106.68 0.59 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.484 1.914 . . . . 0.0 109.569 151.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.93 156.4 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.51 1.473 . . . . 0.0 109.308 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 mm -93.64 -80.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 166.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -156.39 175.8 13.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.464 1.506 . . . . 0.0 109.659 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -126.72 161.96 26.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.207 1.003 . . . . 0.0 109.587 168.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.81 167.11 28.47 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.674 1.59 . . . . 0.0 110.458 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.44 160.16 32.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.743 1.217 . . . . 0.0 109.056 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -177.77 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.65 -61.5 1.82 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -157.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.0 p 166.29 -29.42 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 130.546 3.538 . . . . 0.0 111.42 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -136.26 28.37 3.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.408 0.623 . . . . 0.0 111.298 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -73.36 136.51 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.19 -5.15 17.54 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 124.221 0.915 . . . . 0.0 113.822 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -145.5 128.17 16.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 106.612 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -139.56 159.83 41.26 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.968 -1.082 . . . . 0.0 108.892 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.0 m -131.92 136.68 47.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.634 1.174 . . . . 0.0 108.645 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.13 131.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 126.404 1.882 . . . . 0.0 106.201 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -99.95 -167.76 1.5 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 165.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.7 32.2 61.79 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 121.013 -1.055 . . . . 0.0 110.95 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.25 157.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 107.968 166.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -144.7 119.93 5.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.11 175.54 6.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -167.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.53 61.44 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.154 -0.803 . . . . 0.0 114.217 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mm -118.01 149.95 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.1 141.02 34.71 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.67 120.74 31.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.756 2.022 . . . . 0.0 108.209 -166.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.59 106.17 15.95 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.537 HG23 HG13 ' A' ' 41' ' ' VAL . 1.8 mp -93.48 108.21 20.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -93.58 139.28 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 109.178 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.39 109.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -106.64 134.17 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 m -94.66 134.56 37.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.17 129.1 51.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 107.73 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 pt -116.63 179.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -39.64 112.75 0.28 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 118.36 -0.829 . . . . 0.0 109.577 169.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.79 60.7 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 C-N-CA 127.054 2.264 . . . . 0.0 113.381 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -166.91 144.97 9.47 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -122.99 140.58 52.88 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.107 1.363 . . . . 0.0 108.018 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -84.82 -170.5 3.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.707 0.765 . . . . 0.0 110.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.83 134.73 96.13 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 160.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.77 107.56 2.47 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.33 2.686 . . . . 0.0 110.566 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 106.62 16.33 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -175.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.5 m -115.29 132.88 56.47 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 mt -124.83 107.44 10.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.06 144.6 33.03 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.702 1.601 . . . . 0.0 108.955 174.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -165.63 160.63 17.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.971 0.909 . . . . 0.0 110.738 163.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -93.19 112.37 24.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.255 1.344 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -169.816 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.5 mtt . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.59 145.16 40.24 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 120.296 1.407 . . . . 0.0 110.008 169.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.26 77.47 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.5 p -137.26 141.65 41.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.363 0.582 . . . . 0.0 110.483 165.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.18 -100.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t -133.21 135.02 24.83 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 127.431 2.293 . . . . 0.0 104.838 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.74 121.1 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.52 2.147 . . . . 0.0 109.677 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.41 171.05 15.23 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.615 0.766 . . . . 0.0 109.908 163.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.0 mt -76.35 86.13 3.12 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -60.61 -20.31 60.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.117 0.567 . . . . 0.0 111.762 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.85 1.85 57.07 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.896 1.226 . . . . 0.0 112.255 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -54.29 116.23 2.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.225 1.41 . . . . 0.0 110.547 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -142.98 159.24 42.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.639 1.576 . . . . 0.0 109.648 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 9.6 m-30 -106.84 155.17 20.02 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.74 173.21 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 129.13 2.972 . . . . 0.0 108.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.9 58.87 3.4 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.434 1.094 . . . . 0.0 111.689 171.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 mm -76.1 48.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 108.269 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -69.76 166.99 18.1 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.745 -1.222 . . . . 0.0 108.898 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.95 -4.76 37.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.353 -1.467 . . . . 0.0 112.211 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 p -119.56 -10.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.233 1.813 . . . . 0.0 114.79 -168.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.81 168.36 2.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.618 1.167 . . . . 0.0 109.916 -167.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.1 tt -135.98 135.05 50.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.6 162.58 26.78 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.7 mp -135.2 148.54 49.69 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.922 1.289 . . . . 0.0 108.42 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.36 145.55 51.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 164.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -153.97 179.94 8.44 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -100.42 141.87 23.54 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -75.95 123.92 7.67 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.525 1.483 . . . . 0.0 109.06 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.06 -41.09 26.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.091 0.957 . . . . 0.0 112.697 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 37.86 48.61 1.03 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.282 1.833 . . . . 0.0 113.175 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 m -54.26 -62.84 1.4 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.501 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 p -178.45 -104.45 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.39 1.076 . . . . 0.0 108.824 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.1 -4.4 44.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.936 2.095 . . . . 0.0 110.268 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.21 128.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 126.797 2.039 . . . . 0.0 112.857 173.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.49 -61.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.7 -160.89 25.53 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.142 -1.027 . . . . 0.0 112.277 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -130.39 139.68 50.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 114.52 20.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.552 HG13 HG13 ' A' ' 77' ' ' VAL . 3.3 mp -92.69 144.62 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.2 m -138.39 127.85 24.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.3 144.87 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 118.731 0.696 . . . . 0.0 110.081 163.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.51 164.79 30.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 167.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.06 125.1 28.85 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.31 95.37 0.43 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.46 -17.48 3.31 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.1 -0.833 . . . . 0.0 114.562 172.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -145.34 154.54 42.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.544 1.672 . . . . 0.0 108.436 162.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.54 12.49 1.92 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.218 0.913 . . . . 0.0 113.837 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.9 mt -45.53 105.13 0.44 Allowed Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 129.333 3.053 . . . . 0.0 109.176 166.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -89.87 157.51 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.869 2.38 . . . . 0.0 110.757 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mm -133.43 65.76 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.432 1.9 p90 54.59 175.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.909 1.284 . . . . 0.0 114.318 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.14 125.32 36.83 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -105.45 163.63 12.49 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.83 162.41 31.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.015 1.326 . . . . 0.0 107.984 175.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.38 -177.35 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 171.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.42 -66.07 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.297 0.639 . . . . 0.0 110.876 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 157.22 -41.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 128.452 2.701 . . . . 0.0 108.534 -157.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -121.35 15.71 11.33 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.449 -1.407 . . . . 0.0 110.024 -164.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -74.85 141.26 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.746 0.818 . . . . 0.0 110.325 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.48 0.49 14.1 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.431 1.491 . . . . 0.0 114.473 160.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -145.55 128.38 16.34 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.654 1.227 . . . . 0.0 110.077 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.442 ' CD2' HD13 ' A' ' 24' ' ' LEU . 13.7 t80 -149.59 169.06 21.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.654 1.182 . . . . 0.0 109.802 -176.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -151.49 140.35 20.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.616 1.567 . . . . 0.0 109.842 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.58 152.62 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 125.941 1.696 . . . . 0.0 108.147 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 66' ' ' GLY . 22.1 m -134.45 -170.1 2.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.922 1.689 . . . . 0.0 106.627 172.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.67 ' H ' HG22 ' A' ' 65' ' ' THR . . . 67.64 25.75 73.89 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.045 -1.034 . . . . 0.0 111.911 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.75 164.73 21.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.24 1.816 . . . . 0.0 108.744 164.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.03 104.61 10.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.624 2.37 . . . . 0.0 107.523 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.17 140.2 44.28 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.427 2.085 . . . . 0.0 112.41 -163.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.27 -8.26 55.16 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 126.51 2.005 . . . . 0.0 112.711 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.8 158.52 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 162.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -98.74 129.31 45.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.35 1.86 . . . . 0.0 106.901 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -120.24 133.85 55.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.162 0.985 . . . . 0.0 108.745 -170.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.29 116.45 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 160.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.82 104.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -92.81 145.02 24.71 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.338 1.455 . . . . 0.0 111.177 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.552 HG13 HG13 ' A' ' 39' ' ' ILE . 23.2 t -145.18 97.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.2 mt -100.74 129.76 51.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.4 m -92.99 125.98 37.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.44 123.35 39.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.667 1.587 . . . . 0.0 108.478 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.85 -164.85 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.159 1.383 . . . . 0.0 109.463 -170.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -39.56 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.551 0.74 . . . . 0.0 111.964 157.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.1 31.35 4.36 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.437 1.97 . . . . 0.0 114.306 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.66 144.59 11.83 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 119.162 1.481 . . . . 0.0 110.144 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.14 142.49 39.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.338 1.455 . . . . 0.0 108.447 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.18 -176.96 6.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.62 151.33 92.31 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.77 103.96 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.615 2.21 . . . . 0.0 108.471 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.5 m -84.06 97.92 9.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 171.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -122.87 126.31 47.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 4.8 mt -119.36 143.28 47.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 m -100.82 110.33 22.4 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -108.35 123.45 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.207 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -75.51 134.12 40.86 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 149.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.345 1.458 . . . . 0.0 107.424 -178.966 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.05 178.22 9.67 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 165.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 114.85 -149.44 18.85 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.0 p -69.16 93.66 0.62 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.32 -64.93 0.77 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.043 1.337 . . . . 0.0 109.642 -169.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.2 133.96 20.6 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.24 128.51 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.498 2.132 . . . . 0.0 111.591 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -104.77 178.09 4.66 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 127.776 2.431 . . . . 0.0 110.356 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.452 HD13 ' CG ' ' A' ' 26' ' ' TRP . 96.3 mt -80.04 83.32 5.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.326 1.05 . . . . 0.0 110.232 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -65.03 -21.35 66.82 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.76 1.624 . . . . 0.0 113.561 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -97.85 8.38 44.81 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.06 1.744 . . . . 0.0 111.633 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.22 102.25 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 109.299 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -135.74 132.01 36.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.53 1.132 . . . . 0.0 109.194 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.81 157.14 35.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.09 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.422 1.089 . . . . 0.0 108.672 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 49.92 44.58 25.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.921 1.688 . . . . 0.0 109.689 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.74 65.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 129.493 3.117 . . . . 0.0 106.762 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -57.96 166.99 1.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.494 1.517 . . . . 0.0 109.717 162.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.85 3.39 8.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.391 1.476 . . . . 0.0 112.517 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 p -117.51 -13.66 10.31 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -172.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.14 161.96 0.78 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.547 1.539 . . . . 0.0 110.088 -162.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 tt -130.22 125.85 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.81 159.2 34.27 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -136.71 138.96 41.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 126.698 1.999 . . . . 0.0 107.422 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.3 mtp-105 -112.12 157.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 160.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.452 ' CG ' HD13 ' A' ' 9' ' ' LEU . 41.2 p90 -162.02 -173.75 3.81 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.982 2.513 . . . . 0.0 106.98 160.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.78 142.15 24.19 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 120.682 1.583 . . . . 0.0 107.885 171.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -75.13 124.41 8.52 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.673 1.582 . . . . 0.0 108.631 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.68 83.18 6.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -75.76 43.55 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.629 0.649 . . . . 0.0 111.344 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.4 p -47.86 -60.73 2.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.404 1.082 . . . . 0.0 113.393 -165.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 p 165.99 -61.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.109 0.964 . . . . 0.0 110.141 -152.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.48 -3.46 0.72 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.541 1.936 . . . . 0.0 109.52 -156.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.12 121.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.86 1.664 . . . . 0.0 110.71 164.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 -56.22 5.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.32 -160.55 21.1 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.88 151.31 49.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 164.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 114.85 20.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.905 1.682 . . . . 0.0 107.501 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.49 142.57 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -145.4 113.18 6.38 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.43 130.57 56.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.175 1.39 . . . . 0.0 109.982 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 164.01 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.28 109.17 20.27 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 41.71 -151.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.428 1.891 . . . . 0.0 111.425 -170.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.26 8.88 15.29 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.654 1.121 . . . . 0.0 113.914 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.14 173.49 9.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.388 1.594 . . . . 0.0 109.503 -166.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.35 -34.77 75.91 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.771 169.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.2 mt -45.0 101.21 0.25 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 127.815 2.446 . . . . 0.0 111.383 -172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.65 156.3 35.72 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.077 2.518 . . . . 0.0 108.927 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.52 -61.86 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 166.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 53' ' ' ASP . 78.1 t80 -160.49 158.67 29.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.447 0.699 . . . . 0.0 109.681 -163.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.61 141.75 30.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.419 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 1.7 p30 -143.84 166.59 24.49 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.85 1.26 . . . . 0.0 110.652 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.53 154.65 47.59 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.417 -1.72 . . . . 0.0 106.868 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -176.91 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.451 1.101 . . . . 0.0 108.286 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.51 -63.11 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -165.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p 152.42 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.684 4.393 . . . . 0.0 107.736 -173.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.1 p -88.57 1.41 55.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.672 1.189 . . . . 0.0 112.625 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.12 134.56 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 125.366 1.466 . . . . 0.0 108.026 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.91 1.6 9.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 0.0 112.963 162.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -143.19 125.82 15.91 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.183 1.393 . . . . 0.0 107.782 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.49 165.1 28.42 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.5 m -141.72 125.8 17.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.99 152.96 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.862 1.665 . . . . 0.0 107.263 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -157.92 0.75 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 173.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.51 38.39 90.97 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 120.214 1.37 . . . . 0.0 112.353 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.21 154.92 30.3 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.18 1.792 . . . . 0.0 107.482 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.87 107.08 4.59 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 125.629 1.572 . . . . 0.0 107.285 -173.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.58 176.18 9.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.651 2.9 . . . . 0.0 113.454 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.53 4.38 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 124.705 1.145 . . . . 0.0 112.099 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.85 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -74.51 136.11 42.2 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.245 1.818 . . . . 0.0 108.894 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -122.39 141.58 51.43 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.86 111.05 22.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.42 101.49 12.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.1 m -94.91 144.53 25.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 110.504 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.9 t -139.55 98.3 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.29 139.83 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.8 m -105.37 133.83 49.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.51 127.73 41.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 pt -134.7 -167.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 110.319 -172.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -34.72 110.92 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.813 2.045 . . . . 0.0 110.531 166.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 27.26 51.8 0.08 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 127.547 2.498 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 160.59 31.06 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.22 1.01 . . . . 0.0 111.25 -163.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -144.88 145.19 31.48 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 127.057 2.143 . . . . 0.0 105.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.86 -176.21 4.37 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.06 147.21 80.9 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.95 99.09 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.308 2.005 . . . . 0.0 108.082 171.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -83.78 119.26 24.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -131.68 137.79 48.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.92 136.2 55.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 93' ' ' GLN . 2.8 m -135.66 179.33 6.4 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.587 ' H ' HG22 ' A' ' 92' ' ' THR . 0.6 OUTLIER 76.68 144.43 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.669 2.388 . . . . 0.0 107.591 -168.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -63.1 -84.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 108.832 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 C--O 1.242 0.673 0 C-N-CA 128.526 2.73 . . . . 0.0 112.573 -160.6 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.95 34.98 1.01 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.795 1.638 . . . . 0.0 111.607 -172.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.31 -162.17 19.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 125.832 1.682 . . . . 0.0 109.712 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.2 p -147.8 69.5 1.13 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.266 2.226 . . . . 0.0 105.485 -169.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.09 -35.01 74.26 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.314 0.645 . . . . 0.0 112.175 -157.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.0 t -116.78 134.37 22.95 Favored Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.76 109.31 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.362 2.708 . . . . 0.0 109.533 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 87' ' ' ALA . 6.5 mm100 -61.84 157.62 17.8 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.246 1.818 . . . . 0.0 107.912 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.3 76.65 0.54 Allowed 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 m -57.86 -30.54 65.89 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.655 -0.653 . . . . 0.0 110.637 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.96 -0.44 31.03 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.156 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.465 HD11 ' CE1' ' A' ' 14' ' ' PHE . 2.8 tm? -53.85 125.67 19.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.993 0.917 . . . . 0.0 109.778 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -148.03 149.53 32.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.494 1.118 . . . . 0.0 109.802 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CE1' HD11 ' A' ' 12' ' ' LEU . 16.1 m-30 -112.78 145.53 40.41 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.848 1.204 . . . . 0.0 107.876 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.71 170.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 125.877 1.671 . . . . 0.0 108.305 -170.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 53.06 44.64 30.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.852 1.661 . . . . 0.0 109.569 171.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.83 64.79 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.779 2.432 . . . . 0.0 107.731 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -77.02 164.54 25.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.897 0.879 . . . . 0.0 109.406 168.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.48 7.44 3.63 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.633 -1.292 . . . . 0.0 112.342 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -123.91 -13.82 7.28 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.033 -1.042 . . . . 0.0 113.74 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -175.33 160.59 2.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.829 2.452 . . . . 0.0 108.096 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.25 133.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.63 152.71 20.67 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mp -129.25 155.17 46.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.91 1.284 . . . . 0.0 109.286 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -139.69 151.72 46.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.477 1.111 . . . . 0.0 108.194 169.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -159.06 -165.41 1.6 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.059 1.344 . . . . 0.0 107.928 165.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -112.75 106.89 55.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.07 1.748 . . . . 0.0 107.491 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.14 124.31 10.39 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.518 2.145 . . . . 0.0 111.856 -174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mt -95.96 100.99 12.61 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.048 1.739 . . . . 0.0 107.481 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -80.47 40.98 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.22 0.608 . . . . 0.0 110.384 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -59.24 -35.53 73.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.009 -1.472 . . . . 0.0 114.704 -159.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 p 154.34 -98.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 128.901 2.881 . . . . 0.0 108.791 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.68 -4.02 47.03 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.058 2.543 . . . . 0.0 108.975 -172.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.49 125.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 128.043 2.537 . . . . 0.0 110.171 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.02 -57.98 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -168.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.93 -158.29 23.19 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.472 ' CD2' HG23 ' A' ' 79' ' ' THR . 0.9 OUTLIER -130.59 137.02 49.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 171.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.19 110.87 23.04 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 107.554 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.422 HG13 HG22 ' A' ' 77' ' ' VAL . 3.3 mp -86.75 153.86 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m -144.29 147.88 34.09 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.65 2.38 . . . . 0.0 105.775 173.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -133.53 130.27 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 123.581 0.752 . . . . 0.0 109.975 170.46 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.75 164.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.006 171.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.36 111.5 20.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.75 105.56 1.6 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.298 1.439 . . . . 0.0 108.738 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.07 -26.34 1.43 Allowed Glycine 0 CA--C 1.519 0.339 0 O-C-N 121.223 -0.923 . . . . 0.0 111.002 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.9 -4.03 2.49 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.57 0.685 . . . . 0.0 110.575 161.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.97 13.85 35.7 Favored Glycine 0 CA--C 1.527 0.795 0 O-C-N 120.392 -1.442 . . . . 0.0 111.996 -171.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mt -46.48 106.21 0.55 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 127.584 2.353 . . . . 0.0 108.883 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.73 137.65 30.34 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.54 1.493 . . . . 0.0 110.201 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -89.13 -73.52 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.3 175.42 13.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.661 0.743 . . . . 0.0 110.196 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.63 156.9 47.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 165.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -155.67 166.06 34.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.968 1.307 . . . . 0.0 107.505 -167.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.44 175.15 5.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.642 0.734 . . . . 0.0 109.932 -173.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.75 -177.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 156.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.25 -67.56 0.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.743 1.617 . . . . 0.0 112.941 -166.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.4 p 154.71 -20.41 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.568 3.147 . . . . 0.0 114.137 -165.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.3 p -142.34 26.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.449 1.477 . . . . 0.0 112.137 168.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.54 133.35 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.53 -3.27 27.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.779 1.657 . . . . 0.0 113.593 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.78 123.15 8.4 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.632 1.573 . . . . 0.0 107.248 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.84 164.62 27.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.489 1.116 . . . . 0.0 108.351 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -141.89 134.97 29.01 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.58 152.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.114 1.766 . . . . 0.0 107.059 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.43 171.43 11.56 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.33 24.71 33.15 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.516 1.055 . . . . 0.0 112.031 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.72 156.03 19.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.502 1.521 . . . . 0.0 108.547 163.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.15 134.55 16.79 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.611 1.964 . . . . 0.0 107.506 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.72 161.35 27.62 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.764 1.643 . . . . 0.0 114.33 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.09 64.49 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.271 1.415 . . . . 0.0 113.519 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.52 145.45 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.973 1.309 . . . . 0.0 108.201 -170.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -81.47 129.42 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.318 1.847 . . . . 0.0 106.031 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -117.34 128.18 54.79 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.26 88.44 7.49 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 2.7 mp -84.43 116.9 28.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.41 139.91 49.6 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.467 1.907 . . . . 0.0 107.916 -165.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.422 HG22 HG13 ' A' ' 39' ' ' ILE . 26.0 t -145.6 111.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -170.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.8 mt -105.43 144.71 14.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.472 HG23 ' CD2' ' A' ' 37' ' ' TYR . 7.4 m -105.14 142.79 34.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 166.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.65 118.4 19.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.175 1.79 . . . . 0.0 107.851 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 pt -117.17 -168.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.546 0.739 . . . . 0.0 110.184 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -48.98 105.35 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.531 165.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.53 35.25 15.59 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 124.653 1.121 . . . . 0.0 113.48 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.67 144.92 10.41 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -167.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.93 144.94 48.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 m -84.14 -165.36 1.13 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -101.47 163.0 18.73 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.077 -1.639 . . . . 0.0 108.627 168.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 73.6 Cg_endo -70.75 108.79 2.34 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.835 1.69 . . . . 0.0 109.435 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.49 86.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.5 m -94.56 146.28 24.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 121.2 23.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 140.51 29.65 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -154.03 161.94 41.57 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.555 0.742 . . . . 0.0 109.219 161.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -97.66 173.12 7.29 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.462 1.105 . . . . 0.0 109.587 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 C--O 1.256 1.404 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 159.509 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 117.922 -1.037 . . . . 0.0 108.878 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -133.58 174.9 9.93 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.207 1.403 . . . . 0.0 108.576 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.02 151.94 0.91 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.184 0.897 . . . . 0.0 111.394 -175.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p 95.79 148.0 0.02 OUTLIER 'General case' 0 C--O 1.238 0.46 1 C-N-CA 132.619 4.368 . . . . 0.0 108.78 -168.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -130.41 -63.83 0.87 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.08 0.952 . . . . 0.0 110.199 -171.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.6 t -126.79 134.06 25.68 Favored Pre-proline 0 C--O 1.239 0.549 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.01 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.669 2.246 . . . . 0.0 109.62 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -83.14 178.5 8.08 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.615 HD22 ' CD1' ' A' ' 26' ' ' TRP . 88.4 mt -77.72 91.56 4.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 161.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.7 p -61.09 -57.47 12.4 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.149 1.379 . . . . 0.0 108.687 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.9 18.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.045 2.538 . . . . 0.0 113.064 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.56 121.41 8.35 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.736 1.215 . . . . 0.0 108.994 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -154.49 164.89 37.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.056 1.742 . . . . 0.0 109.667 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CZ ' HD21 ' A' ' 24' ' ' LEU . 45.6 m-85 -122.86 152.23 40.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.74 168.85 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.824 1.65 . . . . 0.0 108.501 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 46.72 63.49 1.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.938 2.095 . . . . 0.0 109.494 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.88 65.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -81.23 171.97 14.21 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.896 1.278 . . . . 0.0 109.762 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.09 -0.73 20.06 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p -125.47 -6.01 7.04 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.38 170.85 2.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.631 1.972 . . . . 0.0 108.711 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -132.8 131.78 59.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 162.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.15 149.85 28.3 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 3.1 mt -123.33 151.3 42.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 106.362 172.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -136.18 145.03 45.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.615 ' CD1' HD22 ' A' ' 9' ' ' LEU . 9.0 p90 -156.91 -173.98 4.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.759 1.224 . . . . 0.0 108.9 168.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 m -109.09 106.19 58.39 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.7 123.6 9.94 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 121.543 1.495 . . . . 0.0 110.481 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.14 94.72 3.54 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.554 2.342 . . . . 0.0 105.186 166.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -77.66 38.87 0.26 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.991 0.916 . . . . 0.0 109.225 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.2 m -74.34 -2.82 26.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -159.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p 70.53 -57.91 0.57 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.156 2.582 . . . . 0.0 113.629 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.39 -28.99 69.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 111.525 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -50.91 134.59 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.395 1.878 . . . . 0.0 109.825 170.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.0 mp -84.4 -65.05 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.82 -160.11 19.63 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -127.89 133.22 49.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.63 127.6 54.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 107.271 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 77' ' ' VAL . 3.1 mp -101.75 152.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 m -138.26 153.69 49.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.267 2.227 . . . . 0.0 106.417 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.36 126.82 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 125.378 1.471 . . . . 0.0 107.55 171.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.18 164.65 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.93 101.94 13.75 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 47.65 -150.99 0.11 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.605 1.962 . . . . 0.0 112.389 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.37 8.62 31.99 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 120.44 -1.412 . . . . 0.0 113.036 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -80.32 -6.23 57.63 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.885 2.342 . . . . 0.0 112.155 -167.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.93 -20.88 6.08 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 126.585 2.04 . . . . 0.0 113.007 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.6 mt -44.04 105.19 0.42 Allowed Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 129.354 3.062 . . . . 0.0 108.486 163.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.29 168.2 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.224 1.949 . . . . 0.0 109.015 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.2 mm -111.0 -73.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.502 -2.406 . . . . 0.0 104.502 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -160.14 175.52 12.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.711 1.605 . . . . 0.0 107.916 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.0 159.37 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -152.61 166.03 33.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.053 0.941 . . . . 0.0 110.437 -166.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.15 160.02 33.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.879 0.872 . . . . 0.0 110.302 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.89 -178.32 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 161.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -68.57 -71.3 0.22 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.929 0.871 . . . . 0.0 112.01 -156.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 p 177.07 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.917 3.287 . . . . 0.0 111.183 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -127.32 16.11 7.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.13 130.21 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.03 -6.13 32.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.226 0.917 . . . . 0.0 114.557 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -143.44 125.62 15.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.723 1.209 . . . . 0.0 108.957 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -139.45 160.6 39.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.235 1.414 . . . . 0.0 109.285 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.2 m -134.1 121.46 21.52 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.49 -1.381 . . . . 0.0 107.698 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.3 155.24 3.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 -168.62 1.92 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.866 1.267 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.37 9.96 84.44 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.798 -1.189 . . . . 0.0 113.327 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.5 157.6 30.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.73 133.24 9.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.3 -177.61 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.004 2.469 . . . . 0.0 112.762 -172.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.81 56.82 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.804 2.145 . . . . 0.0 112.199 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mm -131.5 152.14 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 126.416 1.886 . . . . 0.0 107.111 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -94.71 109.84 21.75 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -94.71 124.17 38.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.7 91.66 8.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.51 101.7 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.49 141.93 30.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.652 1.181 . . . . 0.0 109.609 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.456 HG22 HG13 ' A' ' 39' ' ' ILE . 42.8 t -140.79 116.19 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.594 HG23 ' HA ' ' A' ' 88' ' ' PRO 0.347 0.0 OUTLIER -121.75 145.92 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.467 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.9 m -106.04 128.05 53.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.791 2.036 . . . . 0.0 108.179 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.434 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -126.2 123.71 38.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 0.0 108.925 -173.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 3.6 pt -116.61 -173.93 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.065 1.346 . . . . 0.0 109.653 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -34.74 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.394 1.878 . . . . 0.0 111.105 166.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.07 61.5 0.06 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.713 2.102 . . . . 0.0 111.707 -171.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.45 144.79 10.76 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -126.38 124.22 39.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.617 1.567 . . . . 0.0 107.108 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 169.94 13.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.97 134.86 95.91 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.259 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.594 ' HA ' HG23 ' A' ' 78' ' ' ILE . 59.2 Cg_endo -63.1 136.2 55.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.535 2.157 . . . . 0.0 109.247 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.2 m -131.5 97.99 4.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.3 m -106.09 146.87 29.62 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.65 1.18 . . . . 0.0 107.916 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 104.79 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -75.01 115.55 14.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -109.03 137.5 46.84 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.396 1.478 . . . . 0.0 113.491 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.22 163.18 15.11 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.229 . . . . 0.0 111.379 173.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.25 1.12 0 C-N-CA 129.176 2.991 . . . . 0.0 106.231 161.365 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ttt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -160.92 134.38 6.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.09 143.34 0.97 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.693 1.616 . . . . 0.0 111.028 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.34 129.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.989 1.716 . . . . 0.0 107.686 -153.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -109.0 -68.83 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t -133.05 136.57 27.78 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.65 136.44 33.3 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.156 1.904 . . . . 0.0 110.116 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -95.48 168.21 10.84 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.206 0.602 . . . . 0.0 110.186 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.89 80.22 2.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 m -66.3 -20.98 66.25 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.855 0.462 . . . . 0.0 110.239 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.15 7.31 22.25 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.56 -1.337 . . . . 0.0 113.061 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.46 120.73 12.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 110.438 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -136.55 164.98 26.92 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.817 1.247 . . . . 0.0 111.186 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -109.11 151.99 25.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 168.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.0 168.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.73 1.612 . . . . 0.0 107.393 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 42.07 61.54 1.92 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.425 1.89 . . . . 0.0 110.904 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.74 57.15 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.148 1.779 . . . . 0.0 108.441 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -84.83 170.87 12.74 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.891 1.276 . . . . 0.0 110.682 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.19 2.31 9.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.635 1.574 . . . . 0.0 112.079 -174.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 p -125.53 -16.04 5.93 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.831 1.652 . . . . 0.0 114.786 -163.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -178.17 153.69 0.8 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.449 1.9 . . . . 0.0 108.096 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tt -108.55 132.3 56.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.55 158.35 28.53 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 171.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.505 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.8 mp -132.75 152.1 51.84 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 126.129 1.772 . . . . 0.0 108.41 174.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -138.52 143.91 39.72 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.37 -173.85 4.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.592 0.757 . . . . 0.0 109.185 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -108.81 106.67 59.18 Favored Pre-proline 0 C--N 1.334 -0.107 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.55 131.42 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.493 1.462 . . . . 0.0 109.773 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.55 107.35 14.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -72.78 42.93 0.11 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 m -79.03 6.56 9.1 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.397 3.079 . . . . 0.0 114.766 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.6 p 61.31 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 128.057 2.543 . . . . 0.0 114.607 163.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -7.27 17.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.195 1.798 . . . . 0.0 112.448 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 tt -44.26 146.64 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 121.034 -1.041 . . . . 0.0 110.015 159.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 80' ' ' LEU . 3.3 mt -84.51 -61.95 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 171.03 -156.96 27.52 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -170.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.8 143.72 50.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 135.83 53.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.745 2.018 . . . . 0.0 106.248 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.69 125.74 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.1 m -119.25 126.01 50.48 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.31 123.65 61.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.98 163.42 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.335 1.454 . . . . 0.0 108.266 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.56 110.96 16.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 45.87 -155.39 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.764 2.426 . . . . 0.0 112.725 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.48 18.9 6.35 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 118.838 -0.979 . . . . 0.0 112.761 168.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -86.08 -6.47 59.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.123 1.461 . . . . 0.0 110.303 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.41 -16.01 3.21 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 127.283 2.373 . . . . 0.0 113.98 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt -45.66 106.14 0.53 Allowed Pre-proline 0 N--CA 1.448 -0.575 0 C-N-CA 129.816 3.246 . . . . 0.0 108.913 168.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.04 167.18 25.55 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.36 2.04 . . . . 0.0 110.673 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.25 -76.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.81 175.48 13.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 175.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.97 154.25 51.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.006 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.6 166.46 30.22 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.48 1.512 . . . . 0.0 109.265 -163.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HZ ' HD11 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -125.67 171.62 10.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.363 1.065 . . . . 0.0 110.378 177.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.27 -176.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.011 163.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -64.1 -68.93 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.297 1.839 . . . . 0.0 112.362 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.464 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 88.3 p 165.14 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.972 3.309 . . . . 0.0 111.227 -175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . 0.264 97.4 p -131.52 23.94 4.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.534 0.607 . . . . 0.0 111.979 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -73.46 131.55 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.35 -0.13 35.1 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.929 1.252 . . . . 0.0 113.303 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -150.68 114.75 5.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.505 ' CD2' HD13 ' A' ' 24' ' ' LEU . 3.8 t80 -140.85 158.97 43.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -173.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -141.51 132.22 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.66 148.29 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 126.364 1.866 . . . . 0.0 106.778 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.67 -173.76 2.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.525 1.53 . . . . 0.0 108.295 -174.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.06 16.79 80.41 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 120.662 -1.274 . . . . 0.0 113.557 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 151.7 45.42 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.16 100.26 7.13 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.5 162.9 40.11 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.395 3.397 . . . . 0.0 113.769 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.57 5.85 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.727 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.59 138.39 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 159.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 39.4 t0 -83.0 158.74 22.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.578 0.751 . . . . 0.0 110.463 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -135.44 123.01 22.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.346 1.458 . . . . 0.0 108.648 -167.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.86 109.3 22.03 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.86 90.91 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.3 p -84.83 104.4 14.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.871 0.868 . . . . 0.0 111.071 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.82 119.42 45.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -116.74 139.56 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.958 1.303 . . . . 0.0 108.264 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.2 m -105.55 134.17 49.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.461 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -129.7 115.43 17.32 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.3 pt -104.29 -164.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 125.362 1.465 . . . . 0.0 108.316 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -34.66 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.07 0.948 . . . . 0.0 111.056 167.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.25 60.65 0.05 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 128.933 3.158 . . . . 0.0 113.261 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.25 166.15 38.89 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.78 146.94 51.52 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.875 1.27 . . . . 0.0 108.253 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 m -84.04 -172.24 4.05 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.139 0.971 . . . . 0.0 110.032 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.69 135.77 71.26 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 162.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.27 155.34 67.86 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.758 2.306 . . . . 0.0 110.892 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -127.3 98.18 5.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 166.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.5 m -94.15 109.01 20.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.8 mt -88.76 155.12 19.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 157.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.5 m -127.74 147.94 50.41 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -155.78 124.52 6.01 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.19 0.905 . . . . 0.0 110.648 -173.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -67.45 -27.08 66.74 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -169.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.25 1.13 0 C-N-CA 128.771 2.828 . . . . 0.0 114.813 166.738 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtp . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.8 ptt85 -56.6 167.55 0.71 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.342 0.657 . . . . 0.0 111.876 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 148.81 6.62 0.22 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.539 1.066 . . . . 0.0 114.42 171.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 p -76.71 71.09 3.27 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.623 1.569 . . . . 0.0 110.468 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -66.75 0.55 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.763 0.825 . . . . 0.0 109.515 173.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t -72.0 133.96 83.59 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -69.05 133.48 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.99 1.793 . . . . 0.0 109.74 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.1 166.86 11.05 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.677 1.591 . . . . 0.0 108.952 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.444 HD22 ' CD1' ' A' ' 26' ' ' TRP . 80.0 mt -70.39 88.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.896 0.855 . . . . 0.0 109.201 176.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m -73.4 -11.52 60.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.812 0.845 . . . . 0.0 112.006 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.39 14.28 30.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.644 1.111 . . . . 0.0 112.082 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.99 109.14 0.59 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.18 -0.95 . . . . 0.0 110.893 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 m -136.57 146.19 45.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.176 1.79 . . . . 0.0 110.128 -170.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 14.2 m-30 -111.3 144.68 40.1 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 177.99 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 128.691 2.796 . . . . 0.0 108.06 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.14 51.14 13.45 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.143 1.777 . . . . 0.0 109.408 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.7 mt -84.01 65.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -87.63 162.54 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.652 1.181 . . . . 0.0 109.056 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.68 -2.38 22.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.218 1.407 . . . . 0.0 111.311 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -107.22 -15.73 14.58 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.383 1.873 . . . . 0.0 114.079 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p 176.25 154.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.053 1.741 . . . . 0.0 109.911 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 128.96 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.58 133.39 11.61 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -174.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.8 mp -110.03 143.05 40.61 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -124.65 146.48 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.444 ' CD1' HD22 ' A' ' 9' ' ' LEU . 42.0 p90 -149.97 -171.43 3.9 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 165.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -103.31 107.26 55.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -57.08 139.5 90.13 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.49 1.46 . . . . 0.0 110.749 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -88.88 108.97 19.83 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.969 1.708 . . . . 0.0 108.852 164.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.66 28.33 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.321 1.448 . . . . 0.0 112.063 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.0 m -79.38 150.49 31.36 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.494 -1.379 . . . . 0.0 110.455 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 p -83.0 -34.71 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.516 0.598 . . . . 0.0 111.409 167.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.13 -12.0 59.89 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.458 1.103 . . . . 0.0 112.207 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.7 152.25 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 161.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.406 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.6 mp -90.62 -67.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 160.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.86 -160.93 22.39 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -130.47 142.15 50.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 118.14 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 mp -93.2 143.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.7 m -141.26 133.56 28.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.56 138.07 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 125.128 1.371 . . . . 0.0 111.899 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.41 164.7 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.68 117.65 20.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 37.55 -138.79 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.357 2.263 . . . . 0.0 113.084 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.91 4.29 86.06 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 117.707 -1.607 . . . . 0.0 112.539 170.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.2 -0.2 53.86 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 121.085 2.442 . . . . 0.0 110.738 -166.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.98 -15.21 5.34 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.179 1.371 . . . . 0.0 114.324 168.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 mt -45.9 105.37 0.46 Allowed Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 127.33 2.252 . . . . 0.0 110.33 161.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.44 159.82 25.75 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.647 2.898 . . . . 0.0 110.239 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.04 -69.4 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.69 164.29 23.95 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.943 1.297 . . . . 0.0 109.511 -172.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.23 144.85 40.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.94 1.696 . . . . 0.0 110.34 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -134.76 164.62 27.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.854 1.662 . . . . 0.0 108.026 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.62 152.46 51.25 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.807 0.843 . . . . 0.0 109.842 177.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.22 -177.71 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.86 -0.525 . . . . 0.0 109.81 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -80.49 -54.86 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.234 0.54 . . . . 0.0 112.169 -150.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p 153.93 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 130.865 3.666 . . . . 0.0 109.916 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.8 p -123.64 10.31 9.04 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.752 1.621 . . . . 0.0 111.22 -164.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.93 137.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.05 1.0 9.84 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.378 1.466 . . . . 0.0 112.714 166.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.94 123.83 12.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.819 1.248 . . . . 0.0 110.008 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.453 ' CD2' HD13 ' A' ' 24' ' ' LEU . 7.4 t80 -140.14 151.28 45.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.401 1.88 . . . . 0.0 107.542 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.6 m -130.95 126.64 36.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.796 1.18 . . . . 0.0 109.244 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.48 153.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.89 177.11 8.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 166.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.09 7.01 88.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.706 1.146 . . . . 0.0 112.86 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 159.75 19.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 164.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -137.04 127.54 16.07 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.65 171.58 14.09 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.27 1.314 . . . . 0.0 110.575 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.11 -12.23 40.69 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.147 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.52 162.1 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -92.26 125.84 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -107.25 142.44 37.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.8 1.182 . . . . 0.0 108.886 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.37 110.87 23.38 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 168.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.89 103.1 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.3 p -92.86 145.91 24.03 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.959 -1.088 . . . . 0.0 109.774 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 t -146.35 72.08 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-O 122.501 1.143 . . . . 0.0 108.96 -168.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mt -84.8 134.65 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.7 m -89.52 142.45 27.66 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -128.88 138.01 51.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.883 1.273 . . . . 0.0 109.114 177.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 pt -133.87 -169.06 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.049 1.339 . . . . 0.0 109.068 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -34.06 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.089 1.756 . . . . 0.0 110.84 162.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 36.74 42.95 0.75 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.985 2.707 . . . . 0.0 114.603 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.46 166.04 38.19 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 120.402 2.101 . . . . 0.0 113.839 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.76 156.03 31.36 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.499 1.919 . . . . 0.0 107.057 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 m -84.1 -170.2 2.97 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 155.53 87.55 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.712 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.74 105.53 1.97 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.903 3.069 . . . . 0.0 110.434 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 m -89.84 74.71 7.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 171.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.3 m -94.58 115.33 27.45 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 10.9 mt -95.64 145.02 25.58 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 m -104.87 135.43 46.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -155.18 169.0 25.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 166.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -95.38 137.54 34.3 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.25 1.1 0 O-C-N 125.383 1.677 . . . . 0.0 110.551 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 117.133 -1.413 . . . . 0.0 108.195 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 163.39 -39.93 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.741 2.416 . . . . 0.0 112.301 175.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.28 106.42 3.12 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 -173.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.7 p 45.6 -147.0 0.13 Allowed 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.992 1.717 . . . . 0.0 111.201 -167.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -132.94 -56.89 0.93 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.158 1.783 . . . . 0.0 110.185 170.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.4 t -147.29 139.57 14.11 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 172.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 136.55 42.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.448 2.098 . . . . 0.0 110.723 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -75.69 163.18 27.57 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.583 165.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.11 80.3 0.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.44 1.096 . . . . 0.0 109.105 163.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 m -58.15 -27.78 64.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.68 0.792 . . . . 0.0 110.859 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 5.18 49.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.761 0.825 . . . . 0.0 111.918 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.7 129.3 22.55 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.315 1.046 . . . . 0.0 109.653 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 p -149.58 164.21 35.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.482 1.113 . . . . 0.0 110.39 165.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -116.65 146.43 42.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 172.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.52 164.21 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.915 1.286 . . . . 0.0 109.261 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 45.71 59.63 3.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.268 1.827 . . . . 0.0 109.949 -173.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.15 66.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 128.667 2.787 . . . . 0.0 105.804 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 t -94.64 165.35 12.55 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.686 1.594 . . . . 0.0 109.679 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.6 5.29 4.96 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.279 -1.513 . . . . 0.0 113.375 -168.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.1 p -126.5 -12.74 6.11 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -174.0 152.33 1.9 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.949 1.3 . . . . 0.0 108.949 -167.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.49 122.07 61.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.14 151.82 23.97 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.74 153.4 42.47 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.438 1.495 . . . . 0.0 109.71 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -140.05 145.04 37.21 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.66 1.584 . . . . 0.0 106.733 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -160.25 168.71 24.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 164.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.0 m -90.05 140.71 27.54 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 116.883 -1.927 . . . . 0.0 106.888 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.36 141.6 4.93 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.125 1.216 . . . . 0.0 109.023 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mp -83.51 -35.26 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.961 -170.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 49.84 34.86 8.26 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.301 2.24 . . . . 0.0 111.776 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 p -50.34 -46.97 56.03 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.302 1.041 . . . . 0.0 112.824 -162.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 p 153.91 -86.32 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 131.371 3.868 . . . . 0.0 104.973 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -5.43 58.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.51 1.124 . . . . 0.0 111.045 -170.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -34.86 129.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.937 1.295 . . . . 0.0 111.162 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.21 -49.47 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 174.21 -164.86 36.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -127.02 150.88 49.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 162.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.85 122.96 42.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.433 HG13 HG22 ' A' ' 77' ' ' VAL . 2.7 mp -104.67 144.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.8 m -145.45 111.26 5.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 143.09 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.829 0.823 . . . . 0.0 110.773 160.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.17 164.33 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 166.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.38 126.89 31.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.67 84.2 0.29 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 163.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.34 -45.08 0.06 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.897 1.236 . . . . 0.0 110.659 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -141.16 -2.92 1.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.515 0.726 . . . . 0.0 111.432 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.39 12.71 61.56 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 120.25 -1.531 . . . . 0.0 112.395 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.9 mt -46.17 106.61 0.58 Allowed Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 127.293 2.237 . . . . 0.0 107.901 162.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 137.81 28.65 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.304 2.003 . . . . 0.0 110.0 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.0 93.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.323 1.0 OUTLIER 54.45 176.95 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.323 2.249 . . . . 0.0 113.28 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.07 159.32 42.47 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.725 -1.235 . . . . 0.0 110.205 165.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -149.33 165.93 30.52 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.252 1.821 . . . . 0.0 111.221 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.07 165.52 18.7 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.629 1.571 . . . . 0.0 109.482 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -178.11 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.168 0.987 . . . . 0.0 109.119 164.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.25 -50.74 8.64 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.028 -1.045 . . . . 0.0 112.528 -157.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.408 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 32.3 p 157.18 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 1 C-N-CA 132.217 4.207 . . . . 0.0 112.141 174.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -124.9 10.4 8.26 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.9 t -73.61 132.44 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.59 6.37 18.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.075 1.322 . . . . 0.0 112.312 170.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -150.08 120.4 7.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.79 -1.418 . . . . 0.0 107.38 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -143.99 166.27 25.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -132.37 129.0 38.81 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.038 0.935 . . . . 0.0 108.763 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -95.78 154.88 3.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.04 178.45 6.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.388 1.475 . . . . 0.0 107.142 169.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 5.0 73.88 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 119.036 0.834 . . . . 0.0 112.956 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.72 158.8 26.55 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.626 0.727 . . . . 0.0 109.555 167.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.19 103.78 5.61 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.0 169.64 14.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.091 2.527 . . . . 0.0 111.032 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.22 -18.75 50.86 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.595 -0.691 . . . . 0.0 112.176 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mm -124.56 153.38 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.669 1.988 . . . . 0.0 108.155 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -86.25 145.84 26.78 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.658 1.583 . . . . 0.0 108.365 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.56 134.85 51.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.257 1.023 . . . . 0.0 111.87 -175.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.28 104.18 14.1 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.506 1.923 . . . . 0.0 107.098 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -90.52 105.66 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -101.5 136.29 41.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 118.412 0.551 . . . . 0.0 111.873 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 39' ' ' ILE . 38.8 t -135.36 108.42 9.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.07 137.42 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -98.78 129.97 45.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.39 112.43 18.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pt -104.45 -164.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -48.62 111.13 0.42 Allowed 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.531 -0.731 . . . . 0.0 110.61 161.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.49 24.76 59.83 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.068 -0.851 . . . . 0.0 114.802 156.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.33 156.39 21.04 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -132.78 153.22 51.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 108.531 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.58 178.41 7.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.78 154.23 94.41 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 121.496 -0.753 . . . . 0.0 110.197 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.87 110.53 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.964 3.109 . . . . 0.0 110.839 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.8 m -85.44 97.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 169.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 m -96.5 153.42 17.85 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.55 135.19 44.19 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 159.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.67 143.29 38.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.37 2.268 . . . . 0.0 108.537 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -164.69 148.61 9.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.559 1.527 . . . . 0.0 110.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -110.94 143.53 41.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.84 1.256 . . . . 0.0 109.626 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.257 1.456 0 C-N-CA 127.572 2.349 . . . . 0.0 111.635 -171.71 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.7 mtt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.84 152.79 51.98 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.267 1.394 . . . . 0.0 108.334 161.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.77 -165.4 17.48 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -164.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.01 165.47 13.28 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -64.67 -48.9 73.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.392 0.277 . . . . 0.0 111.12 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t -143.05 141.43 19.55 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.31 105.61 1.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.316 2.01 . . . . 0.0 109.209 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.29 169.98 1.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 114.248 165.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.462 HD13 ' CG ' ' A' ' 26' ' ' TRP . 95.0 mt -67.24 71.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.449 2.3 . . . . 0.0 110.088 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m -50.68 -27.01 6.16 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 111.846 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -87.37 4.59 42.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.772 1.169 . . . . 0.0 112.566 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -55.17 118.42 4.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 109.276 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.0 m -153.33 134.1 13.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.454 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -91.39 146.25 23.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.45 174.23 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 128.845 2.858 . . . . 0.0 109.24 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.374 2.6 p30 43.07 45.62 4.64 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.113 1.765 . . . . 0.0 112.3 -178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.44 62.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 128.117 2.567 . . . . 0.0 107.473 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 20' ' ' SER . 7.7 t -73.78 174.55 8.28 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.781 1.232 . . . . 0.0 108.972 168.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.73 -4.7 39.06 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.187 -0.946 . . . . 0.0 111.674 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.471 ' H ' HG23 ' A' ' 18' ' ' THR . 53.7 p -125.58 -9.2 6.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 -158.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 p -176.81 171.91 2.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.188 2.595 . . . . 0.0 108.134 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.65 147.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 142.75 15.64 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 171.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mp -108.82 144.14 37.07 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 124.529 1.132 . . . . 0.0 108.119 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -118.21 150.38 39.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.462 ' CG ' HD13 ' A' ' 9' ' ' LEU . 47.7 p90 -151.87 -166.12 2.41 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 161.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.92 143.19 39.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.53 129.32 19.83 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.055 1.17 . . . . 0.0 109.39 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.64 96.98 9.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -74.52 45.87 0.25 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.38 0.672 . . . . 0.0 109.327 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.8 m -69.48 2.46 3.08 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.079 -1.638 . . . . 0.0 112.269 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 p 48.13 25.66 0.87 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.787 2.835 . . . . 0.0 114.859 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -165.27 -16.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.881 1.272 . . . . 0.0 111.044 -171.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 9.4 tt -39.01 140.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 110.141 156.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.401 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.2 mp -84.79 -63.39 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 165.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.33 -156.9 13.75 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -168.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -135.7 147.42 48.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 133.97 55.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.0 mp -108.81 143.0 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -133.87 128.13 33.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 161.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.651 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.27 137.52 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.173 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.36 164.69 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.14 1.376 . . . . 0.0 109.429 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.07 125.94 30.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.71 77.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.591 0.756 . . . . 0.0 110.312 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.35 -18.11 71.11 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 117.353 -1.804 . . . . 0.0 116.341 -165.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -142.66 2.73 1.42 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.583 2.191 . . . . 0.0 112.369 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.38 -13.58 15.55 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.617 -1.302 . . . . 0.0 114.144 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.6 mt -45.48 106.25 0.53 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 128.324 2.649 . . . . 0.0 110.72 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.94 147.16 43.22 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.83 2.354 . . . . 0.0 110.945 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.0 mm -84.85 -74.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.01 175.64 7.46 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.683 1.993 . . . . 0.0 108.66 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.84 156.83 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.727 1.211 . . . . 0.0 110.255 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -148.2 166.43 27.93 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.737 1.215 . . . . 0.0 110.503 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.77 155.72 49.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.673 1.989 . . . . 0.0 109.935 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.75 -177.21 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.883 1.273 . . . . 0.0 109.864 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.66 -57.71 3.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.527 0.731 . . . . 0.0 112.087 -160.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p 154.7 -29.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 131.089 3.756 . . . . 0.0 111.42 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -123.26 -0.66 8.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.256 1.023 . . . . 0.0 109.506 -167.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.1 t -74.43 124.75 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.0 1.11 33.55 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.46 1.1 . . . . 0.0 112.901 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -142.18 114.21 8.14 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.456 1.102 . . . . 0.0 108.259 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -145.98 137.82 25.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -113.42 146.99 38.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.947 1.299 . . . . 0.0 108.836 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.51 148.54 24.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 125.631 1.572 . . . . 0.0 107.181 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.88 -168.78 1.87 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.28 4.34 90.23 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.692 -1.255 . . . . 0.0 113.973 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 149.56 49.65 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.933 1.293 . . . . 0.0 109.965 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -146.9 93.81 4.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.454 1.902 . . . . 0.0 108.643 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.62 167.59 23.81 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.997 3.131 . . . . 0.0 114.982 -152.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.85 -15.85 61.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.128 1.347 . . . . 0.0 112.735 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.15 151.52 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 167.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -89.48 134.41 34.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.309 1.444 . . . . 0.0 108.039 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -118.51 117.33 28.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -167.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.42 113.63 21.32 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 170.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.651 HG23 HG13 ' A' ' 41' ' ' VAL . 1.9 mp -102.66 105.1 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -91.03 138.24 31.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.097 0.559 . . . . 0.0 109.508 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -134.52 129.54 52.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -131.8 131.42 62.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 m -83.09 144.23 30.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.401 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -125.68 129.88 50.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 15.6 pt -116.1 175.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -35.37 105.0 0.03 OUTLIER 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.023 1.729 . . . . 0.0 110.119 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.1 26.37 0.87 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.812 1.672 . . . . 0.0 114.823 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.42 144.71 15.93 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.55 1.675 . . . . 0.0 109.663 -160.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.01 117.64 22.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.2 1.0 . . . . 0.0 108.499 -162.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.11 -179.0 6.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 148.8 86.06 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.7 137.7 70.23 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 162.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -129.13 95.99 4.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 168.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.7 m -94.84 149.21 21.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.32 135.0 45.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 166.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t -120.91 140.79 51.33 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -165.24 139.89 5.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -96.81 165.06 12.29 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 161.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.246 0.87 0 C-N-CA 126.865 2.066 . . . . 0.0 111.315 169.748 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 154.52 158.55 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 130.406 3.482 . . . . 0.0 111.378 168.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.02 165.42 30.25 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 158.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.02 177.76 4.77 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 109.538 164.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.52 -72.54 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.685 1.594 . . . . 0.0 110.675 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t -143.97 146.98 36.32 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.233 1.813 . . . . 0.0 106.197 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.37 117.21 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.746 2.297 . . . . 0.0 109.511 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.27 169.46 11.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.524 HD13 ' CG ' ' A' ' 26' ' ' TRP . 55.2 mt -78.51 86.73 4.51 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.5 m -76.04 -29.37 58.04 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.53 1.132 . . . . 0.0 111.35 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.61 4.77 20.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.823 1.249 . . . . 0.0 112.611 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.57 129.78 37.56 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.8 1.64 . . . . 0.0 109.853 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.3 m -150.72 165.23 34.1 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -99.72 155.83 17.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 108.724 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.12 167.96 9.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.689 1.996 . . . . 0.0 106.983 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.83 56.21 2.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 128.278 2.631 . . . . 0.0 110.232 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -78.25 65.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.197 2.199 . . . . 0.0 106.232 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -88.18 168.16 12.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.465 1.106 . . . . 0.0 111.3 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.37 12.79 0.69 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.171 2.188 . . . . 0.0 112.465 -174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.4 p -125.68 -15.9 5.89 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p -178.53 147.14 0.39 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -161.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -115.45 140.33 37.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.74 162.29 18.59 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mp -139.15 153.39 47.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.586 1.554 . . . . 0.0 108.988 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -134.71 155.32 50.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.524 ' CG ' HD13 ' A' ' 9' ' ' LEU . 42.5 p90 -165.35 -170.83 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.415 1.486 . . . . 0.0 108.858 166.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -105.42 106.44 56.06 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.726 1.21 . . . . 0.0 108.521 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -62.24 124.87 15.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.373 2.049 . . . . 0.0 110.632 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.1 mt -93.52 96.67 10.03 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 128.643 2.777 . . . . 0.0 108.042 175.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -74.67 34.12 0.1 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.446 1.098 . . . . 0.0 111.931 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 29' ' ' LEU . 30.4 m -56.2 119.63 6.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.821 2.448 . . . . 0.0 109.216 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 p -67.63 41.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.734 2.414 . . . . 0.0 113.443 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -167.18 -19.7 0.02 OUTLIER 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.741 1.616 . . . . 0.0 111.904 -167.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -55.15 144.44 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.23 -52.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 166.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.66 -152.73 14.56 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.04 136.14 45.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.03 125.82 44.61 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.81 155.05 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 m -142.69 153.52 43.46 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.899 1.68 . . . . 0.0 107.169 167.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.28 135.28 61.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 125.819 1.647 . . . . 0.0 108.999 167.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.55 164.08 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.43 110.24 20.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.7 9.43 0.08 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.625 2.77 . . . . 0.0 115.686 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.11 12.06 68.05 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.96 -1.087 . . . . 0.0 112.732 -166.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -78.72 42.27 0.44 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.341 1.856 . . . . 0.0 110.076 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.57 -55.49 3.34 Favored Glycine 0 CA--C 1.524 0.653 0 O-C-N 120.522 -1.361 . . . . 0.0 112.933 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.7 mt -45.74 105.19 0.44 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 129.548 3.139 . . . . 0.0 110.272 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.26 171.44 18.03 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.358 2.039 . . . . 0.0 109.633 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.72 -95.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 162.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -146.96 166.02 28.04 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.475 0.71 . . . . 0.0 110.371 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -134.23 103.89 5.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.553 1.541 . . . . 0.0 106.988 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.51 159.11 16.19 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HZ ' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -105.75 176.02 5.3 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.527 1.131 . . . . 0.0 108.039 176.231 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -175.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 161.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -79.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.468 1.907 . . . . 0.0 112.041 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p 172.2 -18.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 1 C-N-CA 132.651 4.38 . . . . 0.0 110.883 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -134.27 27.15 3.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.4 t -73.99 138.62 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.92 -1.95 19.02 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.977 0.798 . . . . 0.0 112.265 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.58 114.33 5.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -138.04 141.36 40.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 m -127.21 152.06 47.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.9 0.88 . . . . 0.0 109.358 -171.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.53 156.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.505 1.922 . . . . 0.0 106.944 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -130.67 -163.14 1.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.163 1.785 . . . . 0.0 106.374 174.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.51 7.9 69.97 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 120.093 -1.629 . . . . 0.0 114.105 166.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.4 149.67 31.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.186 1.394 . . . . 0.0 108.226 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -126.19 102.07 27.76 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 107.893 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 157.84 57.82 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.622 2.215 . . . . 0.0 112.383 -165.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.55 -30.06 11.19 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.681 1.134 . . . . 0.0 110.543 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.79 158.82 3.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -100.96 145.19 28.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.022 1.329 . . . . 0.0 108.347 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -131.26 134.8 46.77 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.32 116.35 22.96 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 121.22 51.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 p -116.18 142.67 46.52 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.822 0.849 . . . . 0.0 110.687 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.92 128.77 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.09 153.4 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.43 1.014 . . . . 0.0 111.894 175.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -105.84 122.89 47.03 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 126.467 1.907 . . . . 0.0 107.739 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.408 HD11 ' HZ ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -114.68 132.91 56.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.7 pt -126.3 178.13 4.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.476 1.111 . . . . 0.0 108.837 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -34.53 103.53 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.281 1.832 . . . . 0.0 110.823 163.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.51 11.47 2.67 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.868 2.175 . . . . 0.0 115.055 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.36 145.85 17.89 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.203 1.501 . . . . 0.0 110.153 -156.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -126.85 155.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.316 1.447 . . . . 0.0 109.494 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -107.54 -166.86 1.19 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.85 2.06 . . . . 0.0 108.604 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.62 134.6 39.57 Favored Pre-proline 0 C--O 1.239 0.543 0 O-C-N 121.016 -1.052 . . . . 0.0 108.678 163.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 127.72 19.5 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.93 2.42 . . . . 0.0 107.214 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.2 m -86.41 103.7 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.2 m -101.4 121.53 42.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.95 150.43 44.78 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.1 m -132.62 136.9 46.81 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -161.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -157.33 142.63 17.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -159.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.08 159.64 15.21 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.867 -0.52 . . . . 0.0 109.878 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.767 1.627 . . . . 0.0 110.063 -170.245 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptm . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? 153.79 147.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.003 2.921 . . . . 0.0 109.131 163.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 109.97 51.36 0.64 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 123.559 0.599 . . . . 0.0 111.778 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.41 40.84 1.9 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 160.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -112.37 -67.17 1.02 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.378 0.671 . . . . 0.0 109.978 -155.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.24 135.75 31.0 Favored Pre-proline 0 C--O 1.239 0.52 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.36 143.49 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.04 1.826 . . . . 0.0 109.442 174.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -102.59 169.29 8.74 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 166.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -74.5 80.34 1.94 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 m -61.37 -25.75 67.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.798 0.839 . . . . 0.0 110.544 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.0 -2.47 34.1 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.662 1.585 . . . . 0.0 113.696 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.37 115.14 3.04 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.773 1.229 . . . . 0.0 110.55 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p -134.54 160.97 36.4 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.864 1.266 . . . . 0.0 110.345 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 8.7 m-30 -105.28 143.78 32.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.04 164.96 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.881 1.672 . . . . 0.0 108.348 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 t0 51.7 45.06 28.74 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.96 1.304 . . . . 0.0 110.554 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mt -75.91 63.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 128.811 2.845 . . . . 0.0 106.94 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 20' ' ' SER . 14.5 t -87.45 173.77 8.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 111.137 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.36 0.43 16.86 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.637 1.975 . . . . 0.0 112.861 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.479 ' H ' HG23 ' A' ' 18' ' ' THR . 55.7 p -113.39 -15.7 12.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -176.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p 176.29 161.7 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.674 1.99 . . . . 0.0 107.536 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.15 127.67 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.85 157.39 29.66 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.633 -1.292 . . . . 0.0 110.143 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.79 150.33 52.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.774 -1.427 . . . . 0.0 108.483 172.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -137.29 133.85 35.46 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -157.54 173.38 16.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.6 m -86.58 106.3 10.09 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.726 1.211 . . . . 0.0 110.093 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.62 124.26 13.4 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.345 1.363 . . . . 0.0 109.29 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.15 101.44 13.0 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -79.34 49.95 1.04 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.536 0.734 . . . . 0.0 109.097 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -61.91 -55.55 28.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.582 1.553 . . . . 0.0 110.164 -168.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p 154.72 -88.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 130.389 3.476 . . . . 0.0 108.891 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.08 -3.64 52.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.978 2.511 . . . . 0.0 110.026 -170.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -35.98 133.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.039 1.336 . . . . 0.0 111.255 166.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -84.32 -48.24 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 164.87 -158.29 31.03 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -132.15 145.2 51.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -119.89 113.1 20.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.43 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.9 m -145.08 117.58 8.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.425 1.89 . . . . 0.0 107.382 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.09 131.44 40.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.289 0.636 . . . . 0.0 111.064 162.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.48 164.52 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 161.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.56 110.9 11.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.09 -17.36 64.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.371 1.068 . . . . 0.0 113.652 -171.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.53 -25.72 56.03 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 119.728 1.149 . . . . 0.0 112.663 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -136.65 -13.54 1.71 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.378 1.089 . . . . 0.0 113.549 -171.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.71 6.72 88.84 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.758 1.647 . . . . 0.0 114.306 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.9 mt -45.67 105.93 0.51 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.985 1.714 . . . . 0.0 111.091 167.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.68 131.04 12.06 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.725 2.283 . . . . 0.0 109.008 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.5 mm -84.64 -73.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -157.51 170.46 22.38 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.848 0.859 . . . . 0.0 109.925 173.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.3 150.59 39.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 163.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -152.71 165.91 33.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.48 1.112 . . . . 0.0 108.565 -166.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.12 168.15 15.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.377 0.671 . . . . 0.0 110.53 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.01 -177.01 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.12 . . . . 0.0 108.66 167.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -71.02 -66.42 0.61 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.756 -0.59 . . . . 0.0 111.219 -167.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.445 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 9.5 p 163.78 -23.02 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 130.787 3.635 . . . . 0.0 112.016 -176.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.9 p -132.9 22.93 4.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.988 0.813 . . . . 0.0 112.764 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.54 131.93 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.95 3.26 19.3 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.388 2.423 . . . . 0.0 113.357 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -153.93 119.64 5.26 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.654 1.582 . . . . 0.0 108.225 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -134.94 164.37 27.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.326 1.45 . . . . 0.0 108.081 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.5 m -131.96 147.98 52.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.88 145.04 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' GLY . 0.9 OUTLIER -115.85 -170.76 1.85 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 171.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' H ' HG22 ' A' ' 65' ' ' THR . . . 78.25 17.97 77.11 Favored Glycine 0 CA--C 1.522 0.473 0 O-C-N 120.873 -1.142 . . . . 0.0 111.666 176.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 157.44 20.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.617 1.208 . . . . 0.0 108.691 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 136.41 15.98 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.96 156.12 60.33 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.906 1.737 . . . . 0.0 110.964 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.53 -27.58 8.33 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.527 1.061 . . . . 0.0 113.109 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.17 156.14 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 126.038 1.735 . . . . 0.0 107.818 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.97 135.33 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 107.445 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.26 127.17 51.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.4 106.74 16.23 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.427 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.3 mp -98.94 103.12 14.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 174.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 142.16 27.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.939 2.096 . . . . 0.0 108.315 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -146.7 92.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mm -84.34 138.86 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.739 1.216 . . . . 0.0 108.274 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 100.0 m -105.81 131.71 52.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.0 113.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . 0.3 2.6 pt -109.37 -164.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.672 1.189 . . . . 0.0 109.991 -166.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -50.83 108.78 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.315 -1.491 . . . . 0.0 110.52 160.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.18 50.46 2.2 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.583 2.04 . . . . 0.0 113.097 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 144.17 7.58 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -120.26 153.45 36.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 107.931 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -84.42 -165.85 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.579 0.704 . . . . 0.0 112.31 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.64 144.67 73.83 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 151.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.43 137.28 50.29 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.774 1.649 . . . . 0.0 108.879 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.6 m -105.21 104.86 14.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -124.26 137.17 54.54 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.1 126.38 39.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -93.52 145.43 24.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -154.73 138.85 16.49 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -94.97 136.02 35.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.738 1.215 . . . . 0.0 108.279 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.257 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -175.129 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.25 62.83 1.63 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.67 171.03 13.54 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -149.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.28 150.6 12.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.483 1.513 . . . . 0.0 107.839 171.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.08 -63.74 1.05 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.002 0.921 . . . . 0.0 110.905 -174.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t -43.01 134.6 3.01 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 127.739 2.415 . . . . 0.0 111.957 -152.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.05 129.92 27.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.261 1.974 . . . . 0.0 110.558 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.22 178.42 4.78 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.139 1.376 . . . . 0.0 110.881 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.472 HD13 ' CG ' ' A' ' 26' ' ' TRP . 63.1 mt -71.76 86.85 0.95 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -58.57 -20.12 43.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.272 1.429 . . . . 0.0 111.217 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -93.46 6.27 48.74 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.708 1.603 . . . . 0.0 113.585 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.99 106.81 0.54 Allowed 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.723 -1.236 . . . . 0.0 109.905 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -143.36 163.91 31.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.547 1.139 . . . . 0.0 110.046 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 13.4 m-30 -109.02 159.7 16.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.08 168.17 7.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.616 1.966 . . . . 0.0 107.068 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 42.34 59.81 2.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 126.201 1.801 . . . . 0.0 109.653 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mm -79.89 60.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -73.63 175.54 7.03 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.595 1.958 . . . . 0.0 109.966 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -4.97 53.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.997 1.319 . . . . 0.0 112.636 172.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 p -110.78 -12.42 14.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.561 1.544 . . . . 0.0 114.459 -166.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 p 173.84 171.13 0.19 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.034 1.734 . . . . 0.0 108.233 -163.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.79 150.12 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 161.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.26 159.3 14.65 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 171.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.01 146.31 49.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 125.508 1.523 . . . . 0.0 108.184 176.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -124.25 156.83 36.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 158.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.472 ' CG ' HD13 ' A' ' 9' ' ' LEU . 32.6 p90 -161.38 -173.87 4.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.086 1.755 . . . . 0.0 106.973 163.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -104.04 107.55 57.36 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -59.37 124.07 14.74 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.715 1.61 . . . . 0.0 109.125 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.2 mt -93.4 -19.23 21.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.641 0.776 . . . . 0.0 112.878 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 43.45 29.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.193 2.597 . . . . 0.0 113.577 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 m -87.83 104.95 17.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -167.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -41.88 -1.85 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 131.518 3.927 . . . . 0.0 119.509 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.52 -14.45 8.22 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 130.167 3.387 . . . . 0.0 112.137 -171.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 12.6 tt -60.43 161.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.105 2.162 . . . . 0.0 111.061 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -98.77 -47.99 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 166.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.94 40.99 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.442 ' CD1' HD11 ' A' ' 9' ' ' LEU . 11.3 m-85 -126.91 107.24 9.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 171.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.5 121.95 28.93 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.64 147.4 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -145.49 99.51 3.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.814 1.245 . . . . 0.0 107.672 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.56 134.16 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 120.665 -1.272 . . . . 0.0 109.064 163.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.25 165.13 24.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 136.42 42.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.5 162.26 10.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.63 -11.48 7.1 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 117.933 -1.481 . . . . 0.0 115.431 164.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -146.46 165.12 30.34 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 121.891 2.845 . . . . 0.0 107.988 162.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.8 -0.3 18.22 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.036 -1.424 . . . . 0.0 115.298 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.6 mt -46.05 105.98 0.52 Allowed Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 128.3 2.64 . . . . 0.0 111.399 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -60.97 160.87 24.07 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.716 1.61 . . . . 0.0 111.196 162.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.79 -86.95 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 121.367 1.894 . . . . 0.0 110.555 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.54 146.67 40.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.457 1.503 . . . . 0.0 107.439 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -147.51 162.55 38.84 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.852 1.261 . . . . 0.0 109.437 -168.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.34 153.36 43.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.359 1.463 . . . . 0.0 108.219 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.63 -176.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 108.866 165.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.15 -58.45 5.98 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -161.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 p 153.83 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 130.789 3.636 . . . . 0.0 110.747 -167.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -105.47 3.41 29.49 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 113.233 -166.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.9 150.67 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.98 -2.83 6.49 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 127.016 2.246 . . . . 0.0 113.201 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -160.73 128.7 4.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.727 -1.455 . . . . 0.0 107.883 -171.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -150.08 167.03 27.98 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.961 0.8 . . . . 0.0 109.049 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.4 m -132.9 136.66 46.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.413 1.485 . . . . 0.0 109.999 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.29 165.2 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.93 1.692 . . . . 0.0 107.469 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' GLY . 2.9 m -143.53 -170.69 3.35 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.359 -1.463 . . . . 0.0 107.06 164.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.506 ' H ' HG22 ' A' ' 65' ' ' THR . . . 72.09 15.51 76.55 Favored Glycine 0 N--CA 1.463 0.471 0 C-N-CA 124.713 1.149 . . . . 0.0 112.642 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.64 158.97 35.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.344 1.058 . . . . 0.0 108.826 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.51 107.25 23.57 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 170.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.9 168.05 19.8 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.065 2.51 . . . . 0.0 110.756 -173.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.4 -31.18 4.57 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.505 1.05 . . . . 0.0 110.692 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.07 155.24 3.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -101.28 142.7 32.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.103 1.761 . . . . 0.0 108.242 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -134.59 120.48 19.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.043 1.337 . . . . 0.0 109.913 -162.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.15 95.75 9.24 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.406 HD13 ' CE2' ' A' ' 14' ' ' PHE . 2.4 mp -84.58 105.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p -88.56 147.5 24.57 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 167.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.85 112.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 mt -112.32 129.31 68.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -82.59 134.86 35.18 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 113.71 18.79 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 18.3 pt -107.58 -167.83 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.961 1.704 . . . . 0.0 110.029 -173.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -44.1 110.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.317 0.508 . . . . 0.0 109.902 167.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.6 63.44 0.06 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.563 2.506 . . . . 0.0 114.121 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.71 158.32 19.17 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.36 150.18 45.03 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.74 -178.28 6.82 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.726 0.774 . . . . 0.0 109.992 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 149.01 98.52 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.184 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.31 102.5 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.325 2.017 . . . . 0.0 108.186 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 m -91.86 93.55 8.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 m -113.2 149.52 33.59 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -146.67 68.52 1.17 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.667 0.746 . . . . 0.0 110.131 -171.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.4 t -72.28 133.23 44.91 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -157.88 141.7 15.7 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.051 2.141 . . . . 0.0 108.753 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -91.11 157.9 16.96 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.76 0.824 . . . . 0.0 110.682 -175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.25 1.125 0 CA-C-O 115.51 -2.186 . . . . 0.0 108.225 178.779 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.27 -169.28 2.82 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.566 1.146 . . . . 0.0 108.332 168.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.85 35.04 23.0 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-O 119.214 -0.77 . . . . 0.0 111.92 167.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.5 m -151.15 144.72 24.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.447 1.499 . . . . 0.0 107.2 167.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -97.89 -106.01 0.19 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 158.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t -97.7 144.72 28.48 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.875 1.27 . . . . 0.0 108.457 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.34 120.48 5.31 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.584 2.189 . . . . 0.0 110.769 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -80.89 169.89 16.97 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.298 1.039 . . . . 0.0 110.634 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.401 HD13 ' CG ' ' A' ' 26' ' ' TRP . 81.5 mt -70.13 79.65 0.51 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.2 m -65.79 -14.14 60.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.752 2.021 . . . . 0.0 111.627 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -113.38 24.16 12.51 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.32 1.448 . . . . 0.0 111.458 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.55 127.03 29.25 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.435 0.694 . . . . 0.0 110.847 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.15 165.13 31.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.005 0.922 . . . . 0.0 111.309 172.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 9.9 m-85 -112.06 154.81 24.83 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.838 1.255 . . . . 0.0 108.348 169.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.0 174.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.961 2.104 . . . . 0.0 106.624 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 56.34 47.13 19.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 0.0 108.791 161.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 mt -79.92 66.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.203 2.201 . . . . 0.0 106.937 -174.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -66.73 176.96 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.974 1.31 . . . . 0.0 109.447 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.02 -3.98 32.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.05 0.94 . . . . 0.0 113.369 162.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -125.44 -15.25 6.2 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 -162.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.18 168.02 4.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 108.525 -170.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 tt -134.56 124.09 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.132 -0.98 . . . . 0.0 108.445 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.46 161.3 46.51 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.526 HD13 ' CD2' ' A' ' 62' ' ' TYR . 3.0 mp -133.44 161.0 35.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.936 1.294 . . . . 0.0 108.856 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -138.61 147.82 43.39 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 160.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.401 ' CG ' HD13 ' A' ' 9' ' ' LEU . 12.1 p90 -157.09 172.45 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 158.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 m -79.13 107.09 5.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 124.452 1.101 . . . . 0.0 109.266 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -60.66 133.88 50.98 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.544 1.23 . . . . 0.0 109.033 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.98 133.55 38.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.744 2.018 . . . . 0.0 107.367 166.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -121.31 36.77 4.51 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 m -79.62 101.69 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.437 2.295 . . . . 0.0 108.298 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -59.16 84.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.778 1.631 . . . . 0.0 113.146 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 165.8 -25.38 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 131.438 3.895 . . . . 0.0 109.415 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.24 160.32 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.135 1.774 . . . . 0.0 109.908 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.68 -47.19 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.33 -155.35 24.17 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.293 0.497 . . . . 0.0 111.983 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -137.08 129.63 30.09 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 116.78 33.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.548 HG13 HG22 ' A' ' 77' ' ' VAL . 1.5 mp -89.23 150.56 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 123.427 1.584 . . . . 0.0 107.554 171.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 m -146.21 148.41 32.48 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 171.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.8 133.81 48.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.47 164.65 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 107.618 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.27 119.82 23.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 44.9 15.5 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 130.15 3.38 . . . . 0.0 118.826 160.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.9 23.43 65.65 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 120.447 -1.408 . . . . 0.0 111.745 -164.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -70.73 4.54 2.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.833 2.853 . . . . 0.0 111.838 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.55 -53.88 3.79 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 126.67 2.081 . . . . 0.0 108.686 -167.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt -44.56 104.94 0.41 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 128.937 2.895 . . . . 0.0 111.042 -177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.75 147.63 17.32 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.912 3.075 . . . . 0.0 109.7 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -101.92 -76.4 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.23 171.68 18.14 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 120.849 1.658 . . . . 0.0 110.808 176.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.25 152.97 33.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.878 1.271 . . . . 0.0 109.39 171.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -145.84 165.7 28.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.26 160.61 39.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -177.4 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -59.82 -68.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.09 1.356 . . . . 0.0 110.561 -165.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t 178.81 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 129.206 3.003 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.8 p -136.33 48.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.37 124.78 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.457 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.19 -1.12 44.64 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.366 1.46 . . . . 0.0 114.213 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -158.94 132.94 7.63 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 127.108 2.163 . . . . 0.0 106.929 169.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CD2' HD13 ' A' ' 24' ' ' LEU . 14.0 t80 -135.51 164.6 27.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -142.65 145.79 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -110.88 144.63 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 66' ' ' GLY . 2.6 m -128.29 -178.19 4.45 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 65' ' ' THR . . . 73.91 13.07 81.02 Favored Glycine 0 N--CA 1.463 0.439 0 C-N-CA 123.979 0.799 . . . . 0.0 113.35 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -69.99 165.58 21.48 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.125 0.97 . . . . 0.0 108.847 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.96 105.56 13.87 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.953 1.701 . . . . 0.0 108.56 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.93 152.94 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.007 2.471 . . . . 0.0 110.192 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 -43.89 1.32 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 125.991 1.758 . . . . 0.0 109.188 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -84.09 165.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 122.747 1.261 . . . . 0.0 108.804 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -101.34 138.14 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 128.407 2.683 . . . . 0.0 106.57 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -133.96 142.43 47.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.05 0.841 . . . . 0.0 110.681 -158.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.31 89.74 3.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.277 1.431 . . . . 0.0 109.988 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 5.1 mp -83.99 111.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -170.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -111.36 125.79 54.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.211 1.804 . . . . 0.0 108.718 -164.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 39' ' ' ILE . 22.0 t -134.41 103.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 mt -84.55 144.38 9.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -105.58 131.16 53.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.7 150.22 51.99 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.338 1.426 . . . . 0.0 109.19 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.0 pt -135.72 -179.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.85 1.26 . . . . 0.0 108.954 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -35.2 116.78 0.37 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.61 1.564 . . . . 0.0 110.301 168.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 47.03 2.19 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 124.786 1.304 . . . . 0.0 112.186 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.11 155.45 26.59 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.247 1.023 . . . . 0.0 111.226 -165.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -151.49 127.96 10.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -178.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.82 141.79 84.99 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.374 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.2 100.36 0.87 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.857 2.372 . . . . 0.0 108.568 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 m -83.59 125.89 32.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.7 m -125.32 155.35 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 mt -140.29 141.6 35.76 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.9 m -77.57 146.83 36.04 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -138.72 157.93 45.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.436 1.095 . . . . 0.0 108.662 153.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -125.59 144.16 50.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.644 1.578 . . . . 0.0 109.025 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.248 1.024 0 C-N-CA 125.143 1.377 . . . . 0.0 112.591 166.063 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 34.75 72.62 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.142 2.577 . . . . 0.0 114.61 157.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.77 128.55 9.51 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . 0.319 2.7 p 46.55 -161.92 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.827 2.451 . . . . 0.0 113.059 -174.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -118.89 -73.58 0.64 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.878 0.871 . . . . 0.0 109.826 -171.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.1 t -135.11 133.68 20.99 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 119.736 1.153 . . . . 0.0 108.059 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.59 122.09 4.39 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.177 2.585 . . . . 0.0 111.606 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 163.29 27.54 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.235 1.014 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.26 80.84 1.83 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.665 0.745 . . . . 0.0 110.68 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 m -56.15 -10.79 0.92 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.861 2.065 . . . . 0.0 112.346 168.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -111.0 5.84 20.57 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.631 -1.293 . . . . 0.0 113.825 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.31 118.49 4.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.505 0.593 . . . . 0.0 109.807 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -140.98 165.32 27.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.789 1.636 . . . . 0.0 109.957 166.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.555 ' CE2' ' HB2' ' A' ' 91' ' ' LEU . 12.4 m-30 -108.58 155.26 20.86 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 165.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.04 174.68 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 128.406 2.682 . . . . 0.0 107.997 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 48.64 44.8 21.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.397 1.079 . . . . 0.0 110.18 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.76 61.35 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 t -64.38 166.01 8.86 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.925 1.345 . . . . 0.0 109.424 168.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.81 4.63 6.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.209 1.404 . . . . 0.0 111.381 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -126.15 -0.92 7.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.437 2.295 . . . . 0.0 116.908 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.91 166.74 0.53 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.81 2.844 . . . . 0.0 109.125 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 tt -123.65 140.44 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.95 157.33 21.1 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.76 154.53 44.1 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.473 1.509 . . . . 0.0 108.076 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -139.42 141.01 37.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -158.18 -174.35 4.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.504 0.722 . . . . 0.0 110.311 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 m -97.73 107.14 38.16 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.013 1.725 . . . . 0.0 107.141 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -58.79 128.81 29.44 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 121.233 1.476 . . . . 0.0 109.013 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.9 mt -95.35 98.26 10.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 126.694 1.997 . . . . 0.0 105.845 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -75.04 28.58 0.09 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.519 0.728 . . . . 0.0 111.787 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -66.69 131.19 45.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -76.59 52.55 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.113 -0.992 . . . . 0.0 111.213 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.47 -14.43 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.093 1.357 . . . . 0.0 111.0 -164.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.05 141.89 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.44 -65.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.42 -168.08 31.74 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -124.05 138.69 54.41 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.65 118.9 29.21 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.459 HG13 HG22 ' A' ' 77' ' ' VAL . 3.8 mp -93.51 149.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -145.13 102.88 3.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.75 127.76 39.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -123.69 164.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.01 110.66 21.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 48.39 -165.73 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 128.11 2.564 . . . . 0.0 113.596 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.21 7.33 0.07 OUTLIER Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.789 -1.562 . . . . 0.0 114.44 161.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -79.98 -12.19 59.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 121.734 2.767 . . . . 0.0 110.037 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.91 -11.37 6.11 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.863 1.697 . . . . 0.0 113.206 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mt -45.06 105.82 0.49 Allowed Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 128.26 2.624 . . . . 0.0 110.969 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.67 128.38 11.71 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.123 2.549 . . . . 0.0 110.188 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mm -84.89 -62.36 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.95 155.37 34.11 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 107.676 -164.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.13 151.65 40.93 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 174.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.69 158.37 15.3 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.046 0.841 . . . . 0.0 110.792 -156.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.87 154.21 49.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.693 1.197 . . . . 0.0 108.272 -167.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.16 -177.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.5 -57.44 5.8 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -163.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t 157.53 -43.36 0.0 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 128.073 2.549 . . . . 0.0 111.936 -163.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -129.47 37.16 4.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.093 1.315 . . . . 0.0 110.377 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.4 134.77 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.11 -5.71 13.03 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.274 1.416 . . . . 0.0 113.57 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -142.18 130.79 22.63 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.475 1.91 . . . . 0.0 107.336 174.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.22 166.61 24.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -151.74 147.03 26.2 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.664 -1.272 . . . . 0.0 109.328 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.84 158.28 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.754 1.621 . . . . 0.0 108.641 -166.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.09 178.01 7.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.529 1.132 . . . . 0.0 108.889 -174.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 23.65 77.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 165.01 25.92 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 161.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -143.65 135.88 13.27 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.629 1.172 . . . . 0.0 107.975 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 161.67 42.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.191 1.927 . . . . 0.0 111.914 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.27 -14.63 63.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.657 1.599 . . . . 0.0 113.338 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.81 152.01 13.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 118.779 1.289 . . . . 0.0 108.234 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.49 127.73 32.76 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.309 1.844 . . . . 0.0 108.012 174.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -116.47 120.29 38.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.89 102.51 13.17 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 168.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 mt -94.48 89.65 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.2 p -94.58 150.31 20.37 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.707 -0.621 . . . . 0.0 110.293 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 39' ' ' ILE . 40.0 t -147.12 123.69 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -172.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.3 mt -118.61 139.65 45.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.5 m -106.06 115.97 31.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.114 1.766 . . . . 0.0 107.532 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.38 137.57 51.91 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.452 1.501 . . . . 0.0 109.779 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.06 -176.66 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.524 1.929 . . . . 0.0 109.154 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -35.2 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.154 1.382 . . . . 0.0 111.793 161.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.98 29.74 35.82 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.728 167.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.08 158.06 30.4 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 119.155 1.478 . . . . 0.0 111.113 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.8 151.43 51.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.674 1.99 . . . . 0.0 105.736 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.08 -171.04 3.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 144.71 88.99 Favored Pre-proline 0 C--O 1.242 0.676 0 O-C-N 120.877 -1.139 . . . . 0.0 108.631 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -63.7 136.6 54.56 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 107.979 -1.585 . . . . 0.0 107.979 171.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.96 96.59 6.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.8 m -114.2 143.54 44.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.555 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 95.0 mt -134.17 111.29 10.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 t -84.52 155.26 22.22 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -163.29 131.9 3.88 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 108.973 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -95.99 78.74 3.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.07 0.948 . . . . 0.0 110.578 169.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.256 1.398 0 C-N-CA 123.807 0.843 . . . . 0.0 110.236 167.067 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mtt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.05 -17.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.648 2.379 . . . . 0.0 113.28 170.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.97 -152.71 24.71 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -160.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.2 p 60.18 47.02 9.78 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.666 1.986 . . . . 0.0 113.724 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.43 -79.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.591 1.156 . . . . 0.0 109.389 170.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.24 133.51 71.67 Favored Pre-proline 0 N--CA 1.448 -0.571 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -173.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.28 116.72 4.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 N-CA-C 105.986 -2.352 . . . . 0.0 105.986 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -73.67 177.5 5.38 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.109 0.964 . . . . 0.0 111.64 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.504 HD13 ' CG ' ' A' ' 26' ' ' TRP . 92.3 mt -69.39 76.92 0.39 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.851 0.834 . . . . 0.0 108.929 161.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m -60.48 -27.88 67.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.202 1.001 . . . . 0.0 109.043 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . . . -83.89 3.89 31.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.53 1.532 . . . . 0.0 114.338 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.34 117.76 7.1 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.124 -0.985 . . . . 0.0 110.409 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -153.02 165.66 34.87 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 168.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 7.5 m-30 -97.54 160.28 14.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.41 172.63 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.278 1.831 . . . . 0.0 106.555 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.71 44.87 19.85 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.246 1.018 . . . . 0.0 110.707 164.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -80.1 52.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.319 1.848 . . . . 0.0 109.695 -169.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 20' ' ' SER . 10.9 t -80.75 174.68 11.37 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.625 1.57 . . . . 0.0 109.684 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -80.33 -1.35 40.7 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.322 -0.861 . . . . 0.0 112.325 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.423 ' H ' HG23 ' A' ' 18' ' ' THR . 58.3 p -125.29 0.92 7.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 126.435 1.894 . . . . 0.0 115.839 -167.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.25 173.28 2.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.564 2.345 . . . . 0.0 106.591 160.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tt -121.98 143.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 160.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.07 163.24 18.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.52 157.68 42.0 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.224 1.41 . . . . 0.0 108.852 170.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -138.43 147.91 43.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 163.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.504 ' CG ' HD13 ' A' ' 9' ' ' LEU . 23.7 p90 -153.58 -179.73 8.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 163.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -94.19 106.95 25.56 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.55 138.96 73.37 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.923 1.749 . . . . 0.0 110.059 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 132.23 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.347 1.859 . . . . 0.0 106.537 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.95 18.67 21.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -64.44 158.28 24.26 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -165.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -82.65 43.77 0.85 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.791 -1.193 . . . . 0.0 111.656 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -171.05 -21.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.544 -0.723 . . . . 0.0 112.786 -174.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.29 121.23 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.914 0.886 . . . . 0.0 109.213 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.413 ' HB ' HD12 ' A' ' 80' ' ' LEU . 3.4 mt -83.71 -46.41 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.08 -153.61 23.62 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.38 -1.39 . . . . 0.0 114.259 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.445 ' CD2' HG23 ' A' ' 79' ' ' THR . 1.8 m-85 -138.27 145.81 41.74 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.52 118.73 27.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.77 1.628 . . . . 0.0 107.658 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.535 HG12 HG22 ' A' ' 77' ' ' VAL . 71.8 mt -114.01 115.25 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -168.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.3 m -126.72 103.78 7.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -87.72 138.45 19.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.98 174.052 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.37 163.23 38.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.5 118.64 22.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' H ' ' HA ' ' A' ' 73' ' ' TYR . . . 60.01 13.63 3.84 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.121 2.569 . . . . 0.0 115.33 165.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.76 17.54 60.61 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.057 -1.027 . . . . 0.0 111.875 -166.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -76.34 -6.34 51.13 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.762 1.781 . . . . 0.0 111.405 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.13 -37.98 3.52 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.634 2.064 . . . . 0.0 110.753 -174.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.1 mt -45.2 101.67 0.27 Allowed Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 128.6 2.76 . . . . 0.0 110.145 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.4 152.54 34.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.483 2.122 . . . . 0.0 110.02 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.9 mp -106.49 -92.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 161.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.05 170.55 16.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.981 1.264 . . . . 0.0 110.289 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.98 124.1 48.54 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.613 1.965 . . . . 0.0 107.062 173.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 159.3 15.79 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.068 2.547 . . . . 0.0 109.294 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.22 153.73 46.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 162.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -171.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.086 1.312 . . . . 0.0 111.098 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 p 168.2 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.614 1.965 . . . . 0.0 110.932 -162.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -124.66 20.23 8.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.513 1.525 . . . . 0.0 110.405 -171.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.82 124.34 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.11 3.28 51.53 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.531 1.539 . . . . 0.0 112.809 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -163.28 127.79 2.95 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 110.981 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -139.1 162.54 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.254 1.388 . . . . 0.0 109.133 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -138.19 148.26 44.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.736 1.214 . . . . 0.0 108.121 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.17 143.82 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 107.862 -174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 66' ' ' GLY . 1.9 m -141.79 -175.45 4.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -169.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.549 ' H ' HG22 ' A' ' 65' ' ' THR . . . 61.45 25.96 65.76 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 124.166 0.889 . . . . 0.0 111.855 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -79.51 165.87 22.55 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 170.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -130.19 133.02 24.46 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 165.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -79.19 169.57 18.85 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.233 2.622 . . . . 0.0 110.374 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.83 -4.17 49.57 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.769 -1.017 . . . . 0.0 114.209 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 mm -126.34 165.07 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.469 1.635 . . . . 0.0 107.412 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -86.44 149.42 25.0 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.068 -1.02 . . . . 0.0 109.274 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.419 ' HA ' ' H ' ' A' ' 44' ' ' ALA . 3.9 m-85 -138.26 130.65 29.01 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.885 0.874 . . . . 0.0 109.363 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.14 108.34 19.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 165.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.472 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.9 mp -98.5 94.67 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.5 p -95.91 153.26 17.85 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 110.672 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 39' ' ' ILE . 39.7 t -142.09 98.05 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -172.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -92.14 129.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.445 HG23 ' CD2' ' A' ' 37' ' ' TYR . 92.2 m -106.43 125.08 50.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.194 1.397 . . . . 0.0 107.754 -174.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.413 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -123.56 148.77 46.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 111.448 -170.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.5 -176.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.051 2.14 . . . . 0.0 107.49 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.41 ' H ' HG23 ' A' ' 33' ' ' THR . 7.5 t30 -34.46 108.42 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 111.1 165.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.78 43.13 1.62 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.681 2.086 . . . . 0.0 112.923 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.39 158.99 30.09 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -167.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -146.47 161.9 39.44 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.87 1.668 . . . . 0.0 108.452 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.5 m -89.0 -169.94 2.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.158 0.583 . . . . 0.0 109.683 172.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.39 152.46 94.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.49 103.66 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.475 2.116 . . . . 0.0 108.574 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 p -87.03 139.55 30.46 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -145.16 172.78 12.62 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -147.2 134.3 20.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 156.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -79.64 104.02 9.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.551 1.94 . . . . 0.0 107.043 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -107.58 108.84 20.3 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.052 -1.655 . . . . 0.0 112.84 171.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 148.4 31.16 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 157.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 C--O 1.243 0.731 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.527 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -151.79 173.02 15.26 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.35 1.86 . . . . 0.0 108.367 174.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.59 134.78 2.66 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 118.475 0.58 . . . . 0.0 111.787 173.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 p 57.6 9.85 0.9 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.833 2.453 . . . . 0.0 116.158 165.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -61.41 -79.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.198 1.399 . . . . 0.0 112.813 -148.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.8 t -77.42 134.22 66.67 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.17 132.83 30.96 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.829 2.353 . . . . 0.0 112.199 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.05 156.73 17.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.651 1.98 . . . . 0.0 109.554 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.492 HD13 ' CG ' ' A' ' 26' ' ' TRP . 85.3 mt -73.39 87.45 1.54 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.161 0.984 . . . . 0.0 109.95 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 m -66.55 -10.04 41.1 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.393 0.677 . . . . 0.0 112.252 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.46 0.11 55.13 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.411 -1.43 . . . . 0.0 112.487 171.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.31 106.65 0.21 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.981 1.264 . . . . 0.0 111.475 -172.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -140.54 138.48 34.55 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.775 1.23 . . . . 0.0 109.644 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.58 156.47 16.71 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.49 167.6 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.182 1.793 . . . . 0.0 109.05 169.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 50.52 61.03 3.43 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 108.673 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.0 mm -81.02 64.23 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.385 1.874 . . . . 0.0 107.833 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.3 t -95.08 171.84 8.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.242 1.02 . . . . 0.0 111.561 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.57 -4.33 36.33 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.832 1.253 . . . . 0.0 112.351 -165.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.9 p -124.99 -14.53 6.61 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.947 1.299 . . . . 0.0 114.052 -171.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.535 ' HA ' HD23 ' A' ' 67' ' ' LEU . 2.5 p -174.46 148.43 1.21 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.859 1.264 . . . . 0.0 111.517 -166.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.25 132.17 70.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.78 156.39 25.5 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.42 128.24 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.023 1.329 . . . . 0.0 109.071 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -98.51 151.21 20.86 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CG ' HD13 ' A' ' 9' ' ' LEU . 44.1 p90 -151.32 174.99 12.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 150.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -87.9 141.87 31.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 171.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.14 123.41 5.61 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 N-CA-C 105.877 -2.393 . . . . 0.0 105.877 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.16 -19.55 56.69 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 50.39 31.21 5.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.602 2.361 . . . . 0.0 111.681 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -69.49 5.6 1.32 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.47 2.308 . . . . 0.0 113.842 -158.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 64.73 -63.67 0.17 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 112.753 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.325 3.05 . . . . 0.0 113.214 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -53.62 151.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.871 1.269 . . . . 0.0 110.85 167.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.53 -57.17 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.01 -156.2 15.98 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -127.77 144.86 51.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.81 124.03 51.26 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 175.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.606 HG13 HG13 ' A' ' 77' ' ' VAL . 3.0 mp -93.75 156.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 168.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -145.14 142.94 30.07 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.84 138.04 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.98 163.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.22 114.12 21.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 166.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.68 138.51 47.22 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.37 -45.96 1.18 Allowed Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 124.194 0.902 . . . . 0.0 111.499 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -110.65 -26.53 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.907 -0.761 . . . . 0.0 109.651 168.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.57 13.54 81.85 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 120.946 -1.096 . . . . 0.0 111.296 -170.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 mt -41.84 105.55 0.4 Allowed Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 128.157 2.583 . . . . 0.0 108.587 165.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.68 127.24 3.65 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.073 2.515 . . . . 0.0 109.355 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.57 -70.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.89 164.59 31.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.856 0.753 . . . . 0.0 110.251 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.22 126.39 55.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 167.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -104.44 162.81 12.92 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.862 1.665 . . . . 0.0 107.897 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.09 161.33 27.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.748 0.819 . . . . 0.0 109.568 174.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.72 -176.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.34 -71.41 0.23 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.6 t 155.04 -21.94 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 131.657 3.983 . . . . 0.0 109.841 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.9 p -135.03 20.15 3.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.358 1.435 . . . . 0.0 112.641 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.69 128.91 36.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 169.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.89 2.72 11.83 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.273 2.368 . . . . 0.0 112.651 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -138.84 127.68 23.6 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.264 -1.139 . . . . 0.0 109.222 166.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -142.06 164.34 30.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.885 1.674 . . . . 0.0 109.417 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.2 m -133.77 135.82 44.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.54 1.536 . . . . 0.0 107.547 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.88 155.62 4.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 164.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -137.31 170.05 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.075 0.95 . . . . 0.0 109.59 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.07 51.21 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.588 -0.695 . . . . 0.0 111.89 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 21' ' ' SER . 4.1 mm? -61.52 158.02 15.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 128.68 2.792 . . . . 0.0 106.782 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 80.84 39.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.036 1.734 . . . . 0.0 109.344 -170.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.56 124.67 11.4 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.947 1.765 . . . . 0.0 108.682 -169.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.47 -26.5 4.61 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 124.436 1.017 . . . . 0.0 113.488 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.21 166.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.827 1.651 . . . . 0.0 107.219 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.16 126.03 41.1 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.065 1.746 . . . . 0.0 107.244 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.4 126.8 54.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.633 0.773 . . . . 0.0 109.262 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.07 103.36 15.3 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 173.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.33 101.07 11.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.1 p -88.8 143.33 26.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.374 1.083 . . . . 0.0 109.678 173.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.606 HG13 HG13 ' A' ' 39' ' ' ILE . 39.2 t -139.09 119.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 -177.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 mt -124.69 141.18 45.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -98.59 136.42 38.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.77 132.96 55.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.362 1.065 . . . . 0.0 108.51 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 pt -130.09 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.155 1.782 . . . . 0.0 109.675 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -34.11 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.37 2.268 . . . . 0.0 110.021 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.85 53.7 0.05 OUTLIER Glycine 0 CA--C 1.526 0.772 0 C-N-CA 128.284 2.849 . . . . 0.0 113.604 -172.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.87 160.88 34.44 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 118.065 0.932 . . . . 0.0 111.459 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -139.2 146.11 40.12 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 126.326 1.85 . . . . 0.0 108.414 -168.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -84.51 -174.49 5.3 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.409 0.683 . . . . 0.0 110.472 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.65 134.58 93.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 166.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.83 132.57 32.98 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -118.69 111.15 18.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -124.7 152.16 44.07 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 92' ' ' THR . 1.4 tt -132.97 153.61 51.28 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 152.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.511 ' H ' HD23 ' A' ' 91' ' ' LEU . 4.3 t -112.8 135.1 53.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.53 114.5 12.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -85.78 111.85 20.54 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.251 1.148 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.9 mtp . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 154.72 154.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 131.578 3.951 . . . . 0.0 106.203 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.74 151.1 15.23 Favored Glycine 0 C--O 1.235 0.181 0 CA-C-N 119.426 1.012 . . . . 0.0 111.906 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 m -62.45 153.89 30.1 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.149 0.979 . . . . 0.0 109.426 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -85.23 -59.28 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.996 0.518 . . . . 0.0 111.729 -160.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -134.72 138.9 30.88 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 171.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 125.61 12.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.466 2.111 . . . . 0.0 109.056 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.96 166.38 23.15 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 163.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.566 HD13 ' CG ' ' A' ' 26' ' ' TRP . 48.7 mt -66.57 88.68 0.14 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -66.86 -13.65 61.86 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.154 0.982 . . . . 0.0 109.19 171.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.14 4.49 50.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.07 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.94 121.08 11.5 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.073 -1.017 . . . . 0.0 110.027 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -146.83 165.57 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.218 1.007 . . . . 0.0 110.543 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 24' ' ' LEU . 75.0 m-85 -119.64 150.44 40.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.91 0.884 . . . . 0.0 108.895 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.94 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.961 2.104 . . . . 0.0 107.712 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 55.5 45.23 25.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.821 0.848 . . . . 0.0 110.182 161.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.29 56.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.791 2.036 . . . . 0.0 107.035 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.28 166.64 19.71 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -75.11 7.03 3.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.2 p -125.32 -10.13 6.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 115.18 -167.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.88 166.31 0.9 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 127.324 2.25 . . . . 0.0 109.162 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.89 128.41 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.23 150.28 23.6 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 1.1 mt -128.2 141.73 51.38 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.415 1.486 . . . . 0.0 107.994 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -124.88 142.23 51.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.566 ' CG ' HD13 ' A' ' 9' ' ' LEU . 44.2 p90 -156.78 -173.07 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 164.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -108.74 105.46 57.04 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.927 1.291 . . . . 0.0 108.719 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.43 124.67 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.957 2.438 . . . . 0.0 112.076 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.55 103.55 15.16 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.237 1.015 . . . . 0.0 108.797 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -80.61 49.12 1.13 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.564 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 m -61.93 -64.46 0.93 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.985 -166.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 p 156.69 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.828 2.451 . . . . 0.0 112.305 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.85 -4.38 1.77 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.655 1.982 . . . . 0.0 110.157 -163.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -43.19 134.88 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.184 -1.572 . . . . 0.0 109.724 146.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.56 -43.36 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 124.748 1.219 . . . . 0.0 110.26 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.89 -158.24 31.1 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -129.67 125.09 35.22 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 133.22 35.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 174.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.477 HG13 HG13 ' A' ' 77' ' ' VAL . 2.7 mp -110.3 149.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.8 m -140.82 158.83 43.39 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.425 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -138.54 125.59 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 103.908 -2.626 . . . . 0.0 103.908 178.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.31 162.81 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.601 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.68 108.02 19.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.96 -30.34 58.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.222 0.609 . . . . 0.0 112.012 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.9 -18.32 59.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.604 -1.109 . . . . 0.0 115.607 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -148.0 5.77 0.77 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.643 1.721 . . . . 0.0 112.651 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.86 -5.83 5.72 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.76 -1.212 . . . . 0.0 113.34 -173.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.1 mt -45.56 105.54 0.47 Allowed Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 128.742 2.817 . . . . 0.0 110.15 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.56 132.42 12.17 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.507 2.138 . . . . 0.0 110.324 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -83.75 -67.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -160.0 175.27 13.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.045 0.938 . . . . 0.0 109.567 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -122.02 123.41 41.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.436 1.494 . . . . 0.0 107.921 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -105.93 165.81 10.94 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.004 1.722 . . . . 0.0 109.968 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.48 163.17 28.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.202 1.001 . . . . 0.0 108.634 169.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 -176.63 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.67 -64.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -164.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 m 153.55 -13.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.735 4.014 . . . . 0.0 111.344 -169.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -135.97 13.49 3.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.985 0.811 . . . . 0.0 112.535 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.41 138.98 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.54 5.5 5.21 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.075 1.798 . . . . 0.0 112.93 173.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -146.04 124.81 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -145.95 162.93 36.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.656 1.583 . . . . 0.0 108.231 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -144.83 131.96 20.48 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.258 -0.901 . . . . 0.0 108.983 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.94 149.18 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 -170.67 2.13 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.902 1.681 . . . . 0.0 107.004 170.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.5 14.56 75.84 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 120.12 1.327 . . . . 0.0 112.758 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.99 153.74 38.39 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.741 0.816 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -122.16 115.77 30.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.938 1.695 . . . . 0.0 106.834 163.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.54 144.73 85.79 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.292 1.995 . . . . 0.0 110.833 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.0 -10.49 58.55 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.469 1.509 . . . . 0.0 113.729 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.87 151.02 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 119.706 1.753 . . . . 0.0 107.041 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -80.61 120.06 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.465 1.506 . . . . 0.0 108.488 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.45 120.29 37.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.158 1.383 . . . . 0.0 108.387 -168.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.78 90.66 7.37 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.034 1.734 . . . . 0.0 107.375 174.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 41' ' ' VAL . 1.8 mp -84.01 109.52 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -114.43 122.04 45.4 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.133 1.773 . . . . 0.0 111.341 -167.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 39' ' ' ILE . 59.7 t -134.19 132.32 55.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -164.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 tt -143.41 152.79 16.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.419 1.087 . . . . 0.0 111.216 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.3 m -105.29 134.04 49.07 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 106.894 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.78 134.06 55.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.637 1.575 . . . . 0.0 109.034 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -129.67 175.69 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.91 1.284 . . . . 0.0 107.585 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -46.33 110.02 0.24 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.522 0.601 . . . . 0.0 110.106 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.05 42.69 1.21 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 126.516 2.008 . . . . 0.0 113.392 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.72 144.62 12.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -133.45 118.53 18.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -161.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.22 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.92 133.44 41.31 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.896 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.66 109.76 1.72 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.038 2.492 . . . . 0.0 106.524 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -107.28 102.66 11.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.0 m -94.16 158.75 15.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 tt -132.22 101.92 5.57 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 153.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -84.92 119.19 25.08 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -136.72 153.15 50.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.419 1.487 . . . . 0.0 108.74 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.28 157.92 27.65 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 157.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.25 1.092 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.717 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.58 134.77 33.96 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.724 1.616 . . . . 0.0 109.803 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -112.64 160.96 17.36 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.031 2.132 . . . . 0.0 108.577 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.548 HD13 ' CG ' ' A' ' 26' ' ' TRP . 72.7 mt -70.05 87.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.133 0.973 . . . . 0.0 108.686 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.54 -3.9 30.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.468 1.107 . . . . 0.0 111.249 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.57 6.79 15.91 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.62 1.968 . . . . 0.0 112.937 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -52.23 110.99 0.55 Allowed 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.243 1.417 . . . . 0.0 109.172 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.9 m -155.15 165.14 37.61 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.984 0.914 . . . . 0.0 111.964 170.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 12.1 m-30 -110.95 149.97 29.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.198 1.399 . . . . 0.0 109.626 -162.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.93 175.76 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 128.248 2.619 . . . . 0.0 108.207 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 t70 46.1 52.91 9.78 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.827 2.051 . . . . 0.0 110.618 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.2 52.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 127.361 2.265 . . . . 0.0 108.468 -166.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 20' ' ' SER . 14.6 t -77.31 175.2 9.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 110.125 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.61 -5.53 53.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.316 1.046 . . . . 0.0 111.455 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.45 ' H ' HG23 ' A' ' 18' ' ' THR . 58.6 p -122.72 -8.33 8.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.63 1.972 . . . . 0.0 114.732 -162.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -175.11 175.01 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.04 2.536 . . . . 0.0 108.014 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.9 123.13 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 134.94 11.88 Favored Glycine 0 N--CA 1.467 0.75 0 O-C-N 120.415 -1.428 . . . . 0.0 110.043 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.81 155.43 20.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.845 1.322 . . . . 0.0 108.248 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.01 145.27 50.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 162.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.548 ' CG ' HD13 ' A' ' 9' ' ' LEU . 17.0 p90 -157.79 173.64 16.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.526 1.131 . . . . 0.0 109.472 166.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.0 m -90.99 142.6 27.56 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.642 1.11 . . . . 0.0 108.561 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -81.45 125.26 5.0 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.004 1.037 . . . . 0.0 111.997 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.22 88.65 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.209 1.804 . . . . 0.0 110.431 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -79.73 40.49 0.45 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.755 -0.591 . . . . 0.0 111.077 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -35.03 -64.26 0.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.1 p 159.31 -22.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 128.745 2.818 . . . . 0.0 112.761 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 34' ' ' ILE . 0.8 OUTLIER -165.06 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.592 -1.317 . . . . 0.0 111.273 -153.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.401 ' H ' ' H ' ' A' ' 33' ' ' THR . 5.1 tt -43.27 144.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 109.479 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.467 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.2 mp -83.88 -49.47 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.38 -158.2 28.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.51 140.38 52.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 166.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.8 112.46 20.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.56 144.34 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.6 m -131.51 152.59 50.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 145.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 123.8 0.84 . . . . 0.0 111.674 165.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.44 164.47 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.57 99.84 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.425 0 C-N-CA 124.43 1.092 . . . . 0.0 109.475 -177.19 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 118.78 -0.629 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.77 165.24 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.96 2.44 . . . . 0.0 109.718 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -122.81 -82.79 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -148.44 163.55 36.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.579 1.081 . . . . 0.0 109.774 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.77 123.82 48.1 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 164.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -106.61 156.62 18.4 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.13 1.772 . . . . 0.0 108.126 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.445 ' CZ ' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -126.86 153.73 45.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.817 0.847 . . . . 0.0 109.212 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.32 -176.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.81 -61.5 1.76 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.618 -157.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p 154.19 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 131.14 3.776 . . . . 0.0 109.902 -172.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -123.62 7.55 8.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.904 2.082 . . . . 0.0 111.926 -163.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -74.48 139.31 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 109.638 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.59 -5.65 18.33 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 123.996 0.807 . . . . 0.0 114.638 158.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -139.68 121.12 15.06 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.848 -1.383 . . . . 0.0 110.108 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -134.15 167.41 20.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.5 m -142.24 118.54 10.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.626 -1.296 . . . . 0.0 108.256 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -84.48 143.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 -171.83 2.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.15 69.29 Favored Glycine 0 CA--C 1.522 0.476 0 O-C-N 120.772 -1.205 . . . . 0.0 112.166 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.67 165.34 18.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.809 0.804 . . . . 0.0 110.589 165.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -134.3 135.09 23.38 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 126.731 2.012 . . . . 0.0 107.879 159.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.84 165.44 25.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.376 2.05 . . . . 0.0 112.451 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.22 -28.6 8.58 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 126.906 2.193 . . . . 0.0 111.746 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.2 mm -115.67 165.19 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -96.09 143.0 27.61 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -123.74 128.05 49.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.36 95.2 9.92 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -84.95 104.5 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m -88.09 147.87 24.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.26 1.024 . . . . 0.0 110.313 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.9 t -145.46 77.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.33 133.92 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.6 m -94.47 136.96 34.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.467 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -133.48 113.53 12.59 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.609 1.164 . . . . 0.0 107.95 -178.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -109.3 -175.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.117 1.767 . . . . 0.0 108.696 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -34.58 104.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.092 1.357 . . . . 0.0 110.848 163.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.69 29.25 5.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.61 1.576 . . . . 0.0 115.005 170.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.37 144.48 9.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.342 1.571 . . . . 0.0 110.925 -173.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -110.78 142.12 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.763 2.025 . . . . 0.0 106.534 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.79 174.41 10.46 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.84 0.746 . . . . 0.0 109.362 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.59 135.86 92.82 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.2 128.98 22.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 N-CA-C 107.805 -1.652 . . . . 0.0 107.805 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 m -122.6 99.4 6.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.9 m -94.23 163.41 13.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 5.4 mt -132.87 136.16 46.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 164.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 m -84.74 127.87 34.32 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.641 1.976 . . . . 0.0 106.23 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -154.86 147.4 24.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.766 1.166 . . . . 0.0 109.301 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.62 168.01 11.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.293 1.044 . . . . 0.0 110.638 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.251 1.133 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.903 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.99 143.93 20.94 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.174 2.582 . . . . 0.0 111.705 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 174.68 7.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.432 1.893 . . . . 0.0 111.795 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.46 HD13 ' CG ' ' A' ' 26' ' ' TRP . 61.6 mt -77.64 85.39 3.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 166.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m -56.28 -35.29 67.31 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.582 -0.698 . . . . 0.0 110.201 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -74.21 5.99 3.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.484 2.314 . . . . 0.0 113.006 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.07 110.71 0.87 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.178 0.991 . . . . 0.0 111.075 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -125.89 164.45 20.74 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.86 0.864 . . . . 0.0 110.28 162.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 10.5 m-85 -90.73 166.16 13.28 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 155.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 177.21 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 127.287 2.235 . . . . 0.0 105.48 168.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.25 56.98 5.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.172 1.389 . . . . 0.0 110.355 161.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mm -78.77 59.82 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -69.07 173.63 5.33 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.408 -1.432 . . . . 0.0 109.945 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -98.88 22.11 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.649 1.179 . . . . 0.0 111.675 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -121.47 -13.73 8.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.263 1.425 . . . . 0.0 114.491 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p 170.48 171.96 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.032 2.133 . . . . 0.0 107.928 -154.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -137.44 147.63 26.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 166.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.53 163.74 23.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.12 159.25 36.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.399 1.48 . . . . 0.0 108.515 168.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -143.66 136.04 26.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.46 ' CG ' HD13 ' A' ' 9' ' ' LEU . 9.8 p90 -154.66 -177.5 6.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.267 1.027 . . . . 0.0 109.667 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -107.11 106.13 57.48 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.41 130.99 28.36 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.0 1.8 . . . . 0.0 110.029 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 31' ' ' SER . 2.2 mt -94.18 89.26 5.91 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.845 2.458 . . . . 0.0 105.018 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.55 50.38 0.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' LEU . 4.2 m -81.85 124.16 29.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.082 1.753 . . . . 0.0 109.847 168.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -63.39 38.52 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 130.159 3.384 . . . . 0.0 114.786 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -169.27 -12.42 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.823 2.049 . . . . 0.0 110.371 -171.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.62 161.06 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.091 1.356 . . . . 0.0 108.809 162.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.91 -59.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.71 -164.73 33.39 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' HD11 ' A' ' 9' ' ' LEU . 5.1 m-85 -131.21 145.39 51.91 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.83 130.16 56.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.924 1.69 . . . . 0.0 106.975 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.63 133.15 61.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.7 m -128.67 138.56 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.82 123.23 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.487 1.515 . . . . 0.0 108.335 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.19 163.44 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 124.025 0.828 . . . . 0.0 109.304 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 106.24 17.52 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.313 0 C-N-CA 125.499 1.52 . . . . 0.0 109.089 -175.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.57 126.85 13.93 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 122.175 1.917 . . . . 0.0 107.494 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 mm -84.06 -82.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -148.21 175.68 10.86 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.023 -1.048 . . . . 0.0 109.763 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.11 159.83 31.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -148.96 164.86 33.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.622 1.969 . . . . 0.0 107.465 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 153.82 43.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.341 0.656 . . . . 0.0 109.602 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -177.38 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.916 0.78 . . . . 0.0 110.752 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.0 -60.45 2.29 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p 153.64 -41.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 1 C-N-CA 132.504 4.322 . . . . 0.0 107.878 -171.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.6 p -102.48 -1.13 31.2 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.965 1.706 . . . . 0.0 112.902 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.36 129.81 36.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.759 1.223 . . . . 0.0 108.24 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.78 -5.92 21.66 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 125.268 1.413 . . . . 0.0 113.315 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -140.25 116.15 10.33 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.301 1.44 . . . . 0.0 108.321 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.4 136.59 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.3 m -112.19 124.79 53.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.13 165.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.98 1.712 . . . . 0.0 107.629 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.15 -174.29 3.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.45 36.46 30.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.089 0.859 . . . . 0.0 112.536 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.03 162.84 13.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.934 1.293 . . . . 0.0 110.449 171.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.93 135.19 10.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.95 2.5 . . . . 0.0 104.916 162.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.91 170.29 18.3 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.754 2.303 . . . . 0.0 113.099 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.49 -4.83 70.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.772 0.701 . . . . 0.0 113.848 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.9 mm -129.44 147.79 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.944 1.698 . . . . 0.0 106.885 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -84.01 142.85 30.18 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.78 113.69 11.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.301 1.84 . . . . 0.0 106.432 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.21 103.17 13.19 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.921 1.688 . . . . 0.0 107.086 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.449 HG23 HG13 ' A' ' 41' ' ' VAL . 1.5 mp -92.23 107.7 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 80.7 p -92.78 143.56 26.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.289 1.036 . . . . 0.0 110.957 172.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.46 119.19 16.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mt -117.83 129.67 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.0 m -89.77 132.43 35.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.72 126.74 48.14 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.19 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.69 108.72 0.07 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.476 1.91 . . . . 0.0 110.339 169.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.75 26.13 1.05 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.741 1.638 . . . . 0.0 115.543 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.03 159.44 28.04 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.69 1.745 . . . . 0.0 111.688 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.61 141.6 49.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.137 1.775 . . . . 0.0 108.645 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -85.32 -172.62 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.741 0.816 . . . . 0.0 110.252 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.91 136.03 93.23 Favored Pre-proline 0 C--O 1.24 0.578 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.427 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.2 87.45 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.031 3.154 . . . . 0.0 108.482 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.2 m -84.72 92.13 8.12 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -164.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 1.4 m -94.56 150.4 20.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 69.8 mt -134.88 144.47 47.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 160.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.23 129.2 49.59 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -153.57 130.41 10.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 107.573 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.07 137.5 38.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.593 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.38 141.69 39.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.683 1.588 . . . . 0.0 109.429 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.08 161.53 15.81 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.127 2.171 . . . . 0.0 110.404 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 37' ' ' TYR . 67.3 mt -66.93 83.89 0.11 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.132 0.973 . . . . 0.0 109.375 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 m -71.91 1.0 7.82 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.884 1.674 . . . . 0.0 111.175 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -111.74 4.34 18.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.317 2.647 . . . . 0.0 111.693 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.67 114.81 4.21 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.563 1.945 . . . . 0.0 110.195 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -151.11 164.84 35.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.617 0.767 . . . . 0.0 111.19 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 10.3 m-30 -97.29 160.12 14.52 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.511 -0.743 . . . . 0.0 109.212 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.4 170.6 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.841 1.656 . . . . 0.0 107.526 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.7 47.83 17.69 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.836 1.654 . . . . 0.0 109.706 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -80.45 63.01 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -72.18 165.05 25.17 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -74.51 -3.05 28.53 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.331 -0.856 . . . . 0.0 111.212 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -105.51 -16.17 14.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.05 153.18 0.22 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 127.212 2.205 . . . . 0.0 107.924 -169.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.7 138.39 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.79 156.6 23.14 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 171.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.1 mp -122.59 154.52 37.84 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -137.8 139.93 40.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.418 ' CG ' HD13 ' A' ' 9' ' ' LEU . 36.4 p90 -152.95 175.0 13.42 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.073 0.949 . . . . 0.0 108.555 167.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -92.36 107.49 24.0 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.019 1.327 . . . . 0.0 108.094 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.3 134.68 49.87 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.991 -1.196 . . . . 0.0 108.991 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -88.88 -30.04 19.18 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.425 -1.274 . . . . 0.0 112.867 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 p30 42.43 37.69 1.02 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.607 1.192 . . . . 0.0 112.298 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -62.43 170.24 2.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 0.0 110.139 -167.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 p -67.66 -2.2 6.47 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.08 -4.16 0.06 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.401 -1.437 . . . . 0.0 112.925 -164.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.77 145.22 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 163.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.61 -65.94 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 160.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.61 -154.15 12.37 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -163.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.527 ' CD2' HD11 ' A' ' 9' ' ' LEU . 3.4 m-85 -136.24 144.01 44.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -118.9 123.13 43.9 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.421 HG13 HG13 ' A' ' 77' ' ' VAL . 3.0 mp -103.83 146.87 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 m -145.77 112.45 5.94 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.338 1.455 . . . . 0.0 108.699 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.14 131.69 43.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.718 0.807 . . . . 0.0 110.703 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.2 164.23 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.75 114.21 20.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 125.285 1.434 . . . . 0.0 113.315 -177.413 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 mt . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.28 124.02 8.14 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.932 2.421 . . . . 0.0 110.111 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.29 -59.63 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.9 169.22 18.45 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.193 0.906 . . . . 0.0 110.787 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -106.83 157.0 18.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.411 1.484 . . . . 0.0 108.4 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -152.42 166.06 33.12 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.314 1.446 . . . . 0.0 107.828 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.76 161.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.854 1.262 . . . . 0.0 109.979 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.91 -176.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.768 1.627 . . . . 0.0 107.744 172.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -83.69 -61.96 1.7 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.971 -162.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.6 t 155.23 -43.07 0.01 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 130.534 3.534 . . . . 0.0 107.868 -166.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -97.86 -5.73 33.99 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.242 1.417 . . . . 0.0 113.816 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.89 126.05 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.33 -5.58 37.08 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 127.591 2.519 . . . . 0.0 111.637 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -137.76 114.22 10.31 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.296 -1.708 . . . . 0.0 110.573 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.438 ' CD2' HD13 ' A' ' 24' ' ' LEU . 7.4 t80 -139.21 159.24 42.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.315 1.846 . . . . 0.0 107.719 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -147.08 151.21 36.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.04 145.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -168.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.36 -176.4 3.5 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.8 68.75 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 113.565 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.02 144.67 56.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -123.45 98.11 41.45 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.37 166.07 29.57 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.188 1.925 . . . . 0.0 112.609 -159.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.21 -4.67 80.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.001 1.286 . . . . 0.0 113.436 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.44 152.21 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -79.0 111.58 15.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.35 124.44 52.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.14 1.376 . . . . 0.0 109.389 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.33 126.58 33.33 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 169.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 3.0 mp -110.52 96.43 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.76 133.1 34.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.617 1.567 . . . . 0.0 108.617 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 39' ' ' ILE . 21.5 t -141.9 130.5 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -134.85 147.75 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 37' ' ' TYR . 21.7 m -94.24 137.69 33.12 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.73 128.43 55.27 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.379 . . . . 0.0 107.541 -175.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 pt -134.23 177.27 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.966 0.906 . . . . 0.0 108.588 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.69 110.43 0.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.821 0.848 . . . . 0.0 111.264 169.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.74 21.72 7.53 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.488 1.994 . . . . 0.0 114.708 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 157.33 29.75 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 119.583 1.691 . . . . 0.0 110.992 -161.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.041 0.937 . . . . 0.0 109.9 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 m -84.3 -172.6 4.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.03 0.919 . . . . 0.0 111.015 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.63 96.24 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.19 130.49 16.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.268 1.979 . . . . 0.0 108.783 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.2 m -103.61 107.92 18.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 165.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.9 m -111.93 84.69 2.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 mt -77.64 153.04 33.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.77 139.76 50.26 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -147.88 130.42 15.85 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.939 0.896 . . . . 0.0 109.725 157.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.49 122.47 21.34 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 154.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.017 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.7 t . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.0 133.46 8.97 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.608 2.872 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.46 174.89 6.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.75 1.22 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.5 mt -67.9 75.85 0.21 Allowed 'General case' 0 C--N 1.34 0.152 0 C-N-CA 125.988 1.715 . . . . 0.0 109.523 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.8 m -54.13 -27.24 32.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.748 1.619 . . . . 0.0 110.465 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.51 -0.29 49.63 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 114.759 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.0 115.51 2.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.317 1.047 . . . . 0.0 110.904 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.4 165.19 28.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.338 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -117.57 154.06 32.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 108.341 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.78 171.19 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.061 1.744 . . . . 0.0 107.782 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 51.11 52.15 15.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.24 1.816 . . . . 0.0 110.767 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -78.83 55.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.923 2.489 . . . . 0.0 108.591 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -69.12 167.31 16.35 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.449 -1.407 . . . . 0.0 111.451 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -74.61 6.04 4.23 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.427 1.491 . . . . 0.0 111.846 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -125.7 -12.7 6.57 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 p -174.89 159.73 2.76 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.702 1.201 . . . . 0.0 109.42 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 tt -118.21 141.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.16 153.97 21.66 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.72 151.36 39.64 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 126.309 1.844 . . . . 0.0 107.81 169.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -142.32 138.18 31.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -154.13 -170.87 3.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.547 0.689 . . . . 0.0 109.308 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -106.05 105.53 53.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.773 1.229 . . . . 0.0 107.795 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -66.05 133.96 35.19 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.077 1.851 . . . . 0.0 110.841 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mp -94.93 104.58 16.47 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 125.893 1.677 . . . . 0.0 109.833 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.33 41.44 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.015 1.326 . . . . 0.0 110.532 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.6 m -65.3 155.29 35.69 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 160.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -77.5 -50.25 13.03 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.581 0.705 . . . . 0.0 110.791 166.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.39 -24.5 57.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.091 1.357 . . . . 0.0 113.272 -161.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.31 136.51 6.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 126.573 1.949 . . . . 0.0 108.247 171.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.35 -64.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.18 -161.88 26.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.47 146.42 50.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 127.35 46.13 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.07 145.62 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.8 m -134.89 121.35 20.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.537 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.4 125.9 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.64 164.31 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 129.92 38.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.457 0 O-C-N 121.725 -0.61 . . . . 0.0 110.134 166.912 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 mt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.93 156.4 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.51 1.473 . . . . 0.0 109.308 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 mm -93.64 -80.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 166.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -156.39 175.8 13.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.464 1.506 . . . . 0.0 109.659 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -126.72 161.96 26.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.207 1.003 . . . . 0.0 109.587 168.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.81 167.11 28.47 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.674 1.59 . . . . 0.0 110.458 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.44 160.16 32.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.743 1.217 . . . . 0.0 109.056 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -177.77 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.65 -61.5 1.82 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -157.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.0 p 166.29 -29.42 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 130.546 3.538 . . . . 0.0 111.42 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -136.26 28.37 3.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.408 0.623 . . . . 0.0 111.298 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -73.36 136.51 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.19 -5.15 17.54 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 124.221 0.915 . . . . 0.0 113.822 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -145.5 128.17 16.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 106.612 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -139.56 159.83 41.26 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.968 -1.082 . . . . 0.0 108.892 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.0 m -131.92 136.68 47.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.634 1.174 . . . . 0.0 108.645 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.13 131.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 126.404 1.882 . . . . 0.0 106.201 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -99.95 -167.76 1.5 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 165.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.7 32.2 61.79 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 121.013 -1.055 . . . . 0.0 110.95 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.25 157.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 107.968 166.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -144.7 119.93 5.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.11 175.54 6.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -167.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.53 61.44 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.154 -0.803 . . . . 0.0 114.217 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mm -118.01 149.95 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.1 141.02 34.71 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.67 120.74 31.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.756 2.022 . . . . 0.0 108.209 -166.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.59 106.17 15.95 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.537 HG23 HG13 ' A' ' 41' ' ' VAL . 1.8 mp -93.48 108.21 20.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -93.58 139.28 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 109.178 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.39 109.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -106.64 134.17 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 m -94.66 134.56 37.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.17 129.1 51.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 107.73 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 pt -116.63 179.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -39.64 112.75 0.28 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 118.36 -0.829 . . . . 0.0 109.577 169.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.79 60.7 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 C-N-CA 127.054 2.264 . . . . 0.0 113.381 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -166.91 144.97 9.47 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -122.99 140.58 52.88 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.107 1.363 . . . . 0.0 108.018 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -84.82 -170.5 3.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.707 0.765 . . . . 0.0 110.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.83 134.73 96.13 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 160.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.77 107.56 2.47 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.33 2.686 . . . . 0.0 110.566 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 106.62 16.33 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -175.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.5 m -115.29 132.88 56.47 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 mt -124.83 107.44 10.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.06 144.6 33.03 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.702 1.601 . . . . 0.0 108.955 174.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -165.63 160.63 17.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.971 0.909 . . . . 0.0 110.738 163.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -93.19 112.37 24.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.255 1.344 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -169.816 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.74 121.1 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.52 2.147 . . . . 0.0 109.677 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.41 171.05 15.23 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.615 0.766 . . . . 0.0 109.908 163.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.0 mt -76.35 86.13 3.12 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -60.61 -20.31 60.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.117 0.567 . . . . 0.0 111.762 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.85 1.85 57.07 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.896 1.226 . . . . 0.0 112.255 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -54.29 116.23 2.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.225 1.41 . . . . 0.0 110.547 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -142.98 159.24 42.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.639 1.576 . . . . 0.0 109.648 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 9.6 m-30 -106.84 155.17 20.02 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.74 173.21 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 129.13 2.972 . . . . 0.0 108.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.9 58.87 3.4 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.434 1.094 . . . . 0.0 111.689 171.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 mm -76.1 48.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 108.269 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -69.76 166.99 18.1 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.745 -1.222 . . . . 0.0 108.898 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.95 -4.76 37.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.353 -1.467 . . . . 0.0 112.211 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 p -119.56 -10.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.233 1.813 . . . . 0.0 114.79 -168.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.81 168.36 2.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.618 1.167 . . . . 0.0 109.916 -167.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.1 tt -135.98 135.05 50.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.6 162.58 26.78 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.7 mp -135.2 148.54 49.69 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.922 1.289 . . . . 0.0 108.42 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.36 145.55 51.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 164.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -153.97 179.94 8.44 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -100.42 141.87 23.54 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -75.95 123.92 7.67 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.525 1.483 . . . . 0.0 109.06 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.06 -41.09 26.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.091 0.957 . . . . 0.0 112.697 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 37.86 48.61 1.03 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.282 1.833 . . . . 0.0 113.175 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 m -54.26 -62.84 1.4 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.501 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 p -178.45 -104.45 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.39 1.076 . . . . 0.0 108.824 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.1 -4.4 44.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.936 2.095 . . . . 0.0 110.268 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.21 128.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 126.797 2.039 . . . . 0.0 112.857 173.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.49 -61.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.7 -160.89 25.53 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.142 -1.027 . . . . 0.0 112.277 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -130.39 139.68 50.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 114.52 20.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.552 HG13 HG13 ' A' ' 77' ' ' VAL . 3.3 mp -92.69 144.62 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.2 m -138.39 127.85 24.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.3 144.87 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 118.731 0.696 . . . . 0.0 110.081 163.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.51 164.79 30.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 167.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.06 125.1 28.85 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.144 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -89.87 157.51 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.869 2.38 . . . . 0.0 110.757 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mm -133.43 65.76 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.432 1.9 p90 54.59 175.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.909 1.284 . . . . 0.0 114.318 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.14 125.32 36.83 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -105.45 163.63 12.49 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.83 162.41 31.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.015 1.326 . . . . 0.0 107.984 175.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.38 -177.35 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 171.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.42 -66.07 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.297 0.639 . . . . 0.0 110.876 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 157.22 -41.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 128.452 2.701 . . . . 0.0 108.534 -157.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -121.35 15.71 11.33 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.449 -1.407 . . . . 0.0 110.024 -164.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -74.85 141.26 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.746 0.818 . . . . 0.0 110.325 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.48 0.49 14.1 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.431 1.491 . . . . 0.0 114.473 160.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -145.55 128.38 16.34 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.654 1.227 . . . . 0.0 110.077 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.442 ' CD2' HD13 ' A' ' 24' ' ' LEU . 13.7 t80 -149.59 169.06 21.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.654 1.182 . . . . 0.0 109.802 -176.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -151.49 140.35 20.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.616 1.567 . . . . 0.0 109.842 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.58 152.62 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 125.941 1.696 . . . . 0.0 108.147 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 66' ' ' GLY . 22.1 m -134.45 -170.1 2.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.922 1.689 . . . . 0.0 106.627 172.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.67 ' H ' HG22 ' A' ' 65' ' ' THR . . . 67.64 25.75 73.89 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.045 -1.034 . . . . 0.0 111.911 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.75 164.73 21.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.24 1.816 . . . . 0.0 108.744 164.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.03 104.61 10.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.624 2.37 . . . . 0.0 107.523 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.17 140.2 44.28 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.427 2.085 . . . . 0.0 112.41 -163.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.27 -8.26 55.16 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 126.51 2.005 . . . . 0.0 112.711 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.8 158.52 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 162.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -98.74 129.31 45.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.35 1.86 . . . . 0.0 106.901 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -120.24 133.85 55.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.162 0.985 . . . . 0.0 108.745 -170.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.29 116.45 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 160.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.82 104.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -92.81 145.02 24.71 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.338 1.455 . . . . 0.0 111.177 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.552 HG13 HG13 ' A' ' 39' ' ' ILE . 23.2 t -145.18 97.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.2 mt -100.74 129.76 51.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.4 m -92.99 125.98 37.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.44 123.35 39.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.667 1.587 . . . . 0.0 108.478 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.85 -164.85 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.159 1.383 . . . . 0.0 109.463 -170.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -39.56 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.551 0.74 . . . . 0.0 111.964 157.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.1 31.35 4.36 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.437 1.97 . . . . 0.0 114.306 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.66 144.59 11.83 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 119.162 1.481 . . . . 0.0 110.144 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.14 142.49 39.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.338 1.455 . . . . 0.0 108.447 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.18 -176.96 6.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.62 151.33 92.31 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.77 103.96 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.615 2.21 . . . . 0.0 108.471 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.5 m -84.06 97.92 9.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 171.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -122.87 126.31 47.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 4.8 mt -119.36 143.28 47.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 m -100.82 110.33 22.4 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -108.35 123.45 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.207 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -75.51 134.12 40.86 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 149.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.345 1.458 . . . . 0.0 107.424 -178.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.24 128.51 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.498 2.132 . . . . 0.0 111.591 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -104.77 178.09 4.66 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 127.776 2.431 . . . . 0.0 110.356 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.452 HD13 ' CG ' ' A' ' 26' ' ' TRP . 96.3 mt -80.04 83.32 5.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.326 1.05 . . . . 0.0 110.232 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -65.03 -21.35 66.82 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.76 1.624 . . . . 0.0 113.561 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -97.85 8.38 44.81 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.06 1.744 . . . . 0.0 111.633 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.22 102.25 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 109.299 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -135.74 132.01 36.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.53 1.132 . . . . 0.0 109.194 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.81 157.14 35.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.09 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.422 1.089 . . . . 0.0 108.672 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 49.92 44.58 25.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.921 1.688 . . . . 0.0 109.689 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.74 65.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 129.493 3.117 . . . . 0.0 106.762 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -57.96 166.99 1.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.494 1.517 . . . . 0.0 109.717 162.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.85 3.39 8.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.391 1.476 . . . . 0.0 112.517 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 p -117.51 -13.66 10.31 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -172.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.14 161.96 0.78 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.547 1.539 . . . . 0.0 110.088 -162.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 tt -130.22 125.85 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.81 159.2 34.27 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -136.71 138.96 41.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 126.698 1.999 . . . . 0.0 107.422 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.3 mtp-105 -112.12 157.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 160.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.452 ' CG ' HD13 ' A' ' 9' ' ' LEU . 41.2 p90 -162.02 -173.75 3.81 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.982 2.513 . . . . 0.0 106.98 160.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.78 142.15 24.19 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 120.682 1.583 . . . . 0.0 107.885 171.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -75.13 124.41 8.52 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.673 1.582 . . . . 0.0 108.631 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.68 83.18 6.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -75.76 43.55 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.629 0.649 . . . . 0.0 111.344 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.4 p -47.86 -60.73 2.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.404 1.082 . . . . 0.0 113.393 -165.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 p 165.99 -61.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.109 0.964 . . . . 0.0 110.141 -152.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.48 -3.46 0.72 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.541 1.936 . . . . 0.0 109.52 -156.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.12 121.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.86 1.664 . . . . 0.0 110.71 164.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 -56.22 5.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.32 -160.55 21.1 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.88 151.31 49.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 164.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 114.85 20.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.905 1.682 . . . . 0.0 107.501 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.49 142.57 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -145.4 113.18 6.38 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.43 130.57 56.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.175 1.39 . . . . 0.0 109.982 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 164.01 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.28 109.17 20.27 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 126.428 1.891 . . . . 0.0 111.425 -170.186 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.2 mt . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 119.438 -0.315 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.65 156.3 35.72 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.077 2.518 . . . . 0.0 108.927 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.52 -61.86 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 166.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 53' ' ' ASP . 78.1 t80 -160.49 158.67 29.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.447 0.699 . . . . 0.0 109.681 -163.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.61 141.75 30.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.419 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 1.7 p30 -143.84 166.59 24.49 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.85 1.26 . . . . 0.0 110.652 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.53 154.65 47.59 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.417 -1.72 . . . . 0.0 106.868 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -176.91 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.451 1.101 . . . . 0.0 108.286 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.51 -63.11 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -165.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p 152.42 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.684 4.393 . . . . 0.0 107.736 -173.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.1 p -88.57 1.41 55.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.672 1.189 . . . . 0.0 112.625 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.12 134.56 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 125.366 1.466 . . . . 0.0 108.026 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.91 1.6 9.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 0.0 112.963 162.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -143.19 125.82 15.91 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.183 1.393 . . . . 0.0 107.782 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.49 165.1 28.42 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.5 m -141.72 125.8 17.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.99 152.96 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.862 1.665 . . . . 0.0 107.263 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -157.92 0.75 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 173.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.51 38.39 90.97 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 120.214 1.37 . . . . 0.0 112.353 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.21 154.92 30.3 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.18 1.792 . . . . 0.0 107.482 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.87 107.08 4.59 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 125.629 1.572 . . . . 0.0 107.285 -173.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.58 176.18 9.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.651 2.9 . . . . 0.0 113.454 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.53 4.38 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 124.705 1.145 . . . . 0.0 112.099 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.85 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -74.51 136.11 42.2 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.245 1.818 . . . . 0.0 108.894 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -122.39 141.58 51.43 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.86 111.05 22.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.42 101.49 12.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.1 m -94.91 144.53 25.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 110.504 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.9 t -139.55 98.3 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.29 139.83 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.8 m -105.37 133.83 49.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.51 127.73 41.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 pt -134.7 -167.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 110.319 -172.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -34.72 110.92 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.813 2.045 . . . . 0.0 110.531 166.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 27.26 51.8 0.08 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 127.547 2.498 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 160.59 31.06 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.22 1.01 . . . . 0.0 111.25 -163.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -144.88 145.19 31.48 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 127.057 2.143 . . . . 0.0 105.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.86 -176.21 4.37 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.06 147.21 80.9 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.95 99.09 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.308 2.005 . . . . 0.0 108.082 171.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -83.78 119.26 24.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -131.68 137.79 48.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.92 136.2 55.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 93' ' ' GLN . 2.8 m -135.66 179.33 6.4 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.587 ' H ' HG22 ' A' ' 92' ' ' THR . 0.6 OUTLIER 76.68 144.43 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.669 2.388 . . . . 0.0 107.591 -168.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -63.1 -84.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 108.832 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 C--O 1.242 0.673 0 C-N-CA 128.526 2.73 . . . . 0.0 112.573 -160.6 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.24 0.602 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.76 109.31 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.362 2.708 . . . . 0.0 109.533 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 87' ' ' ALA . 6.5 mm100 -61.84 157.62 17.8 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.246 1.818 . . . . 0.0 107.912 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.3 76.65 0.54 Allowed 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 m -57.86 -30.54 65.89 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.655 -0.653 . . . . 0.0 110.637 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.96 -0.44 31.03 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.156 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.465 HD11 ' CE1' ' A' ' 14' ' ' PHE . 2.8 tm? -53.85 125.67 19.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.993 0.917 . . . . 0.0 109.778 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -148.03 149.53 32.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.494 1.118 . . . . 0.0 109.802 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CE1' HD11 ' A' ' 12' ' ' LEU . 16.1 m-30 -112.78 145.53 40.41 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.848 1.204 . . . . 0.0 107.876 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.71 170.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 125.877 1.671 . . . . 0.0 108.305 -170.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 53.06 44.64 30.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.852 1.661 . . . . 0.0 109.569 171.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.83 64.79 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.779 2.432 . . . . 0.0 107.731 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -77.02 164.54 25.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.897 0.879 . . . . 0.0 109.406 168.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.48 7.44 3.63 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.633 -1.292 . . . . 0.0 112.342 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -123.91 -13.82 7.28 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.033 -1.042 . . . . 0.0 113.74 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -175.33 160.59 2.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.829 2.452 . . . . 0.0 108.096 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.25 133.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.63 152.71 20.67 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mp -129.25 155.17 46.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.91 1.284 . . . . 0.0 109.286 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -139.69 151.72 46.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.477 1.111 . . . . 0.0 108.194 169.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -159.06 -165.41 1.6 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.059 1.344 . . . . 0.0 107.928 165.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -112.75 106.89 55.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.07 1.748 . . . . 0.0 107.491 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.14 124.31 10.39 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.518 2.145 . . . . 0.0 111.856 -174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mt -95.96 100.99 12.61 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.048 1.739 . . . . 0.0 107.481 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -80.47 40.98 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.22 0.608 . . . . 0.0 110.384 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -59.24 -35.53 73.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.009 -1.472 . . . . 0.0 114.704 -159.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 p 154.34 -98.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 128.901 2.881 . . . . 0.0 108.791 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.68 -4.02 47.03 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.058 2.543 . . . . 0.0 108.975 -172.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.49 125.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 128.043 2.537 . . . . 0.0 110.171 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.02 -57.98 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -168.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.93 -158.29 23.19 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.472 ' CD2' HG23 ' A' ' 79' ' ' THR . 0.9 OUTLIER -130.59 137.02 49.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 171.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.19 110.87 23.04 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 107.554 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.422 HG13 HG22 ' A' ' 77' ' ' VAL . 3.3 mp -86.75 153.86 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m -144.29 147.88 34.09 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.65 2.38 . . . . 0.0 105.775 173.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -133.53 130.27 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 123.581 0.752 . . . . 0.0 109.975 170.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.75 164.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.006 171.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.36 111.5 20.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.386 0 C-N-CA 125.298 1.439 . . . . 0.0 108.738 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mt . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 118.316 -0.849 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.73 137.65 30.34 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.54 1.493 . . . . 0.0 110.201 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -89.13 -73.52 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.3 175.42 13.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.661 0.743 . . . . 0.0 110.196 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.63 156.9 47.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 165.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -155.67 166.06 34.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.968 1.307 . . . . 0.0 107.505 -167.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.44 175.15 5.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.642 0.734 . . . . 0.0 109.932 -173.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.75 -177.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 156.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.25 -67.56 0.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.743 1.617 . . . . 0.0 112.941 -166.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.4 p 154.71 -20.41 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.568 3.147 . . . . 0.0 114.137 -165.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.3 p -142.34 26.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.449 1.477 . . . . 0.0 112.137 168.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.54 133.35 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.53 -3.27 27.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.779 1.657 . . . . 0.0 113.593 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.78 123.15 8.4 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.632 1.573 . . . . 0.0 107.248 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.84 164.62 27.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.489 1.116 . . . . 0.0 108.351 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -141.89 134.97 29.01 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.58 152.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.114 1.766 . . . . 0.0 107.059 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.43 171.43 11.56 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.33 24.71 33.15 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.516 1.055 . . . . 0.0 112.031 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.72 156.03 19.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.502 1.521 . . . . 0.0 108.547 163.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.15 134.55 16.79 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.611 1.964 . . . . 0.0 107.506 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.72 161.35 27.62 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.764 1.643 . . . . 0.0 114.33 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.09 64.49 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.271 1.415 . . . . 0.0 113.519 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.52 145.45 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.973 1.309 . . . . 0.0 108.201 -170.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -81.47 129.42 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.318 1.847 . . . . 0.0 106.031 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -117.34 128.18 54.79 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.26 88.44 7.49 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 2.7 mp -84.43 116.9 28.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.41 139.91 49.6 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.467 1.907 . . . . 0.0 107.916 -165.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.422 HG22 HG13 ' A' ' 39' ' ' ILE . 26.0 t -145.6 111.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -170.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.8 mt -105.43 144.71 14.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.472 HG23 ' CD2' ' A' ' 37' ' ' TYR . 7.4 m -105.14 142.79 34.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 166.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.65 118.4 19.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.175 1.79 . . . . 0.0 107.851 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 pt -117.17 -168.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.546 0.739 . . . . 0.0 110.184 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -48.98 105.35 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.531 165.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.53 35.25 15.59 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 124.653 1.121 . . . . 0.0 113.48 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.67 144.92 10.41 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -167.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.93 144.94 48.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 m -84.14 -165.36 1.13 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -101.47 163.0 18.73 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.077 -1.639 . . . . 0.0 108.627 168.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 73.6 Cg_endo -70.75 108.79 2.34 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.835 1.69 . . . . 0.0 109.435 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.49 86.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.5 m -94.56 146.28 24.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 121.2 23.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 140.51 29.65 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -154.03 161.94 41.57 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.555 0.742 . . . . 0.0 109.219 161.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -97.66 173.12 7.29 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.462 1.105 . . . . 0.0 109.587 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 C--O 1.256 1.404 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 159.509 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.6 t . . . . . 0 C--O 1.239 0.549 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.01 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.669 2.246 . . . . 0.0 109.62 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -83.14 178.5 8.08 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.615 HD22 ' CD1' ' A' ' 26' ' ' TRP . 88.4 mt -77.72 91.56 4.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 161.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.7 p -61.09 -57.47 12.4 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.149 1.379 . . . . 0.0 108.687 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.9 18.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.045 2.538 . . . . 0.0 113.064 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.56 121.41 8.35 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.736 1.215 . . . . 0.0 108.994 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -154.49 164.89 37.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.056 1.742 . . . . 0.0 109.667 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CZ ' HD21 ' A' ' 24' ' ' LEU . 45.6 m-85 -122.86 152.23 40.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.74 168.85 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.824 1.65 . . . . 0.0 108.501 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 46.72 63.49 1.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.938 2.095 . . . . 0.0 109.494 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.88 65.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -81.23 171.97 14.21 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.896 1.278 . . . . 0.0 109.762 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.09 -0.73 20.06 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p -125.47 -6.01 7.04 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.38 170.85 2.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.631 1.972 . . . . 0.0 108.711 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -132.8 131.78 59.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 162.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.15 149.85 28.3 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 3.1 mt -123.33 151.3 42.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 106.362 172.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -136.18 145.03 45.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.615 ' CD1' HD22 ' A' ' 9' ' ' LEU . 9.0 p90 -156.91 -173.98 4.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.759 1.224 . . . . 0.0 108.9 168.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 m -109.09 106.19 58.39 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.7 123.6 9.94 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 121.543 1.495 . . . . 0.0 110.481 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.14 94.72 3.54 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.554 2.342 . . . . 0.0 105.186 166.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -77.66 38.87 0.26 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.991 0.916 . . . . 0.0 109.225 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.2 m -74.34 -2.82 26.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -159.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p 70.53 -57.91 0.57 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.156 2.582 . . . . 0.0 113.629 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.39 -28.99 69.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 111.525 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -50.91 134.59 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.395 1.878 . . . . 0.0 109.825 170.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.434 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.0 mp -84.4 -65.05 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.82 -160.11 19.63 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -127.89 133.22 49.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.63 127.6 54.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 107.271 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 77' ' ' VAL . 3.1 mp -101.75 152.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 m -138.26 153.69 49.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.267 2.227 . . . . 0.0 106.417 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.36 126.82 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 125.378 1.471 . . . . 0.0 107.55 171.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.18 164.65 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.93 101.94 13.75 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 126.605 1.962 . . . . 0.0 112.389 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.6 mt . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.29 168.2 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.224 1.949 . . . . 0.0 109.015 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.2 mm -111.0 -73.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.502 -2.406 . . . . 0.0 104.502 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -160.14 175.52 12.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.711 1.605 . . . . 0.0 107.916 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.0 159.37 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -152.61 166.03 33.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.053 0.941 . . . . 0.0 110.437 -166.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.15 160.02 33.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.879 0.872 . . . . 0.0 110.302 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.89 -178.32 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 161.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -68.57 -71.3 0.22 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.929 0.871 . . . . 0.0 112.01 -156.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 p 177.07 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.917 3.287 . . . . 0.0 111.183 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -127.32 16.11 7.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.13 130.21 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.03 -6.13 32.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.226 0.917 . . . . 0.0 114.557 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -143.44 125.62 15.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.723 1.209 . . . . 0.0 108.957 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -139.45 160.6 39.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.235 1.414 . . . . 0.0 109.285 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.2 m -134.1 121.46 21.52 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.49 -1.381 . . . . 0.0 107.698 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.3 155.24 3.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 -168.62 1.92 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.866 1.267 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.37 9.96 84.44 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.798 -1.189 . . . . 0.0 113.327 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.5 157.6 30.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.73 133.24 9.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.3 -177.61 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.004 2.469 . . . . 0.0 112.762 -172.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.81 56.82 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.804 2.145 . . . . 0.0 112.199 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mm -131.5 152.14 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 126.416 1.886 . . . . 0.0 107.111 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -94.71 109.84 21.75 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -94.71 124.17 38.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.7 91.66 8.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.51 101.7 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.49 141.93 30.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.652 1.181 . . . . 0.0 109.609 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.456 HG22 HG13 ' A' ' 39' ' ' ILE . 42.8 t -140.79 116.19 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.594 HG23 ' HA ' ' A' ' 88' ' ' PRO 0.347 0.0 OUTLIER -121.75 145.92 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.467 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.9 m -106.04 128.05 53.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.791 2.036 . . . . 0.0 108.179 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.434 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -126.2 123.71 38.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 0.0 108.925 -173.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 3.6 pt -116.61 -173.93 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.065 1.346 . . . . 0.0 109.653 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -34.74 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.394 1.878 . . . . 0.0 111.105 166.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.07 61.5 0.06 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.713 2.102 . . . . 0.0 111.707 -171.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.45 144.79 10.76 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -126.38 124.22 39.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.617 1.567 . . . . 0.0 107.108 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 169.94 13.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.97 134.86 95.91 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.259 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.594 ' HA ' HG23 ' A' ' 78' ' ' ILE . 59.2 Cg_endo -63.1 136.2 55.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.535 2.157 . . . . 0.0 109.247 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.2 m -131.5 97.99 4.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.3 m -106.09 146.87 29.62 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.65 1.18 . . . . 0.0 107.916 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 104.79 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -75.01 115.55 14.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -109.03 137.5 46.84 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.396 1.478 . . . . 0.0 113.491 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.22 163.18 15.11 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.229 . . . . 0.0 111.379 173.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.25 1.12 0 C-N-CA 129.176 2.991 . . . . 0.0 106.231 161.365 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.65 136.44 33.3 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.156 1.904 . . . . 0.0 110.116 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -95.48 168.21 10.84 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.206 0.602 . . . . 0.0 110.186 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.89 80.22 2.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 m -66.3 -20.98 66.25 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.855 0.462 . . . . 0.0 110.239 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.15 7.31 22.25 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.56 -1.337 . . . . 0.0 113.061 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.46 120.73 12.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 110.438 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -136.55 164.98 26.92 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.817 1.247 . . . . 0.0 111.186 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -109.11 151.99 25.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 168.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.0 168.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.73 1.612 . . . . 0.0 107.393 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 42.07 61.54 1.92 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.425 1.89 . . . . 0.0 110.904 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.74 57.15 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.148 1.779 . . . . 0.0 108.441 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -84.83 170.87 12.74 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.891 1.276 . . . . 0.0 110.682 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.19 2.31 9.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.635 1.574 . . . . 0.0 112.079 -174.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 p -125.53 -16.04 5.93 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.831 1.652 . . . . 0.0 114.786 -163.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -178.17 153.69 0.8 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.449 1.9 . . . . 0.0 108.096 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tt -108.55 132.3 56.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.55 158.35 28.53 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 171.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.505 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.8 mp -132.75 152.1 51.84 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 126.129 1.772 . . . . 0.0 108.41 174.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -138.52 143.91 39.72 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.37 -173.85 4.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.592 0.757 . . . . 0.0 109.185 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -108.81 106.67 59.18 Favored Pre-proline 0 C--N 1.334 -0.107 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.55 131.42 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.493 1.462 . . . . 0.0 109.773 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.55 107.35 14.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -72.78 42.93 0.11 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 m -79.03 6.56 9.1 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.397 3.079 . . . . 0.0 114.766 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.6 p 61.31 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 128.057 2.543 . . . . 0.0 114.607 163.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -7.27 17.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.195 1.798 . . . . 0.0 112.448 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 tt -44.26 146.64 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 121.034 -1.041 . . . . 0.0 110.015 159.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 80' ' ' LEU . 3.3 mt -84.51 -61.95 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 171.03 -156.96 27.52 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -170.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.8 143.72 50.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 135.83 53.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.745 2.018 . . . . 0.0 106.248 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.69 125.74 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.1 m -119.25 126.01 50.48 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.31 123.65 61.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.98 163.42 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.335 1.454 . . . . 0.0 108.266 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.56 110.96 16.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 127.764 2.426 . . . . 0.0 112.725 174.43 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt . . . . . 0 N--CA 1.448 -0.575 0 CA-C-O 117.906 -1.045 . . . . 0.0 108.913 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.04 167.18 25.55 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.36 2.04 . . . . 0.0 110.673 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.25 -76.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.81 175.48 13.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 175.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.97 154.25 51.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.006 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.6 166.46 30.22 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.48 1.512 . . . . 0.0 109.265 -163.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HZ ' HD11 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -125.67 171.62 10.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.363 1.065 . . . . 0.0 110.378 177.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.27 -176.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.011 163.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -64.1 -68.93 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.297 1.839 . . . . 0.0 112.362 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.464 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 88.3 p 165.14 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.972 3.309 . . . . 0.0 111.227 -175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . 0.264 97.4 p -131.52 23.94 4.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.534 0.607 . . . . 0.0 111.979 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -73.46 131.55 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.35 -0.13 35.1 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.929 1.252 . . . . 0.0 113.303 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -150.68 114.75 5.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.505 ' CD2' HD13 ' A' ' 24' ' ' LEU . 3.8 t80 -140.85 158.97 43.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -173.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -141.51 132.22 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.66 148.29 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 126.364 1.866 . . . . 0.0 106.778 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.67 -173.76 2.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.525 1.53 . . . . 0.0 108.295 -174.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.06 16.79 80.41 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 120.662 -1.274 . . . . 0.0 113.557 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 151.7 45.42 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.16 100.26 7.13 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.5 162.9 40.11 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.395 3.397 . . . . 0.0 113.769 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.57 5.85 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.727 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.59 138.39 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 159.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 39.4 t0 -83.0 158.74 22.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.578 0.751 . . . . 0.0 110.463 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -135.44 123.01 22.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.346 1.458 . . . . 0.0 108.648 -167.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.86 109.3 22.03 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.86 90.91 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.3 p -84.83 104.4 14.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.871 0.868 . . . . 0.0 111.071 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.82 119.42 45.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -116.74 139.56 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.958 1.303 . . . . 0.0 108.264 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.2 m -105.55 134.17 49.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.461 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -129.7 115.43 17.32 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.3 pt -104.29 -164.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 125.362 1.465 . . . . 0.0 108.316 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -34.66 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.07 0.948 . . . . 0.0 111.056 167.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.25 60.65 0.05 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 128.933 3.158 . . . . 0.0 113.261 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.25 166.15 38.89 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.78 146.94 51.52 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.875 1.27 . . . . 0.0 108.253 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 m -84.04 -172.24 4.05 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.139 0.971 . . . . 0.0 110.032 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.69 135.77 71.26 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 162.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.27 155.34 67.86 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.758 2.306 . . . . 0.0 110.892 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -127.3 98.18 5.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 166.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.5 m -94.15 109.01 20.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.8 mt -88.76 155.12 19.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 157.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.5 m -127.74 147.94 50.41 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -155.78 124.52 6.01 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.19 0.905 . . . . 0.0 110.648 -173.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -67.45 -27.08 66.74 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -169.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.25 1.13 0 C-N-CA 128.771 2.828 . . . . 0.0 114.813 166.738 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -69.05 133.48 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.99 1.793 . . . . 0.0 109.74 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.1 166.86 11.05 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.677 1.591 . . . . 0.0 108.952 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.444 HD22 ' CD1' ' A' ' 26' ' ' TRP . 80.0 mt -70.39 88.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.896 0.855 . . . . 0.0 109.201 176.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m -73.4 -11.52 60.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.812 0.845 . . . . 0.0 112.006 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.39 14.28 30.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.644 1.111 . . . . 0.0 112.082 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.99 109.14 0.59 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.18 -0.95 . . . . 0.0 110.893 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 m -136.57 146.19 45.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.176 1.79 . . . . 0.0 110.128 -170.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 14.2 m-30 -111.3 144.68 40.1 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 177.99 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 128.691 2.796 . . . . 0.0 108.06 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.14 51.14 13.45 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.143 1.777 . . . . 0.0 109.408 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.7 mt -84.01 65.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -87.63 162.54 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.652 1.181 . . . . 0.0 109.056 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.68 -2.38 22.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.218 1.407 . . . . 0.0 111.311 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -107.22 -15.73 14.58 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.383 1.873 . . . . 0.0 114.079 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p 176.25 154.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.053 1.741 . . . . 0.0 109.911 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 128.96 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.58 133.39 11.61 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -174.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.8 mp -110.03 143.05 40.61 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -124.65 146.48 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.444 ' CD1' HD22 ' A' ' 9' ' ' LEU . 42.0 p90 -149.97 -171.43 3.9 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 165.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -103.31 107.26 55.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -57.08 139.5 90.13 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.49 1.46 . . . . 0.0 110.749 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -88.88 108.97 19.83 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.969 1.708 . . . . 0.0 108.852 164.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.66 28.33 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.321 1.448 . . . . 0.0 112.063 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.0 m -79.38 150.49 31.36 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.494 -1.379 . . . . 0.0 110.455 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 p -83.0 -34.71 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.516 0.598 . . . . 0.0 111.409 167.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.13 -12.0 59.89 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.458 1.103 . . . . 0.0 112.207 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.7 152.25 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 161.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.406 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.6 mp -90.62 -67.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 160.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.86 -160.93 22.39 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -130.47 142.15 50.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 118.14 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 mp -93.2 143.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.7 m -141.26 133.56 28.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.56 138.07 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 125.128 1.371 . . . . 0.0 111.899 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.41 164.7 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.68 117.65 20.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 127.357 2.263 . . . . 0.0 113.084 173.23 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.44 159.82 25.75 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.647 2.898 . . . . 0.0 110.239 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.04 -69.4 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.69 164.29 23.95 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.943 1.297 . . . . 0.0 109.511 -172.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.23 144.85 40.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.94 1.696 . . . . 0.0 110.34 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -134.76 164.62 27.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.854 1.662 . . . . 0.0 108.026 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.62 152.46 51.25 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.807 0.843 . . . . 0.0 109.842 177.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.22 -177.71 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.86 -0.525 . . . . 0.0 109.81 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -80.49 -54.86 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.234 0.54 . . . . 0.0 112.169 -150.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p 153.93 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 130.865 3.666 . . . . 0.0 109.916 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.8 p -123.64 10.31 9.04 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.752 1.621 . . . . 0.0 111.22 -164.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.93 137.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.05 1.0 9.84 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.378 1.466 . . . . 0.0 112.714 166.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.94 123.83 12.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.819 1.248 . . . . 0.0 110.008 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.453 ' CD2' HD13 ' A' ' 24' ' ' LEU . 7.4 t80 -140.14 151.28 45.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.401 1.88 . . . . 0.0 107.542 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.6 m -130.95 126.64 36.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.796 1.18 . . . . 0.0 109.244 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.48 153.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.89 177.11 8.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 166.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.09 7.01 88.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.706 1.146 . . . . 0.0 112.86 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 159.75 19.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 164.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -137.04 127.54 16.07 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.65 171.58 14.09 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.27 1.314 . . . . 0.0 110.575 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.11 -12.23 40.69 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.147 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.52 162.1 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -92.26 125.84 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -107.25 142.44 37.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.8 1.182 . . . . 0.0 108.886 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.37 110.87 23.38 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 168.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.89 103.1 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.3 p -92.86 145.91 24.03 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.959 -1.088 . . . . 0.0 109.774 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 t -146.35 72.08 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-O 122.501 1.143 . . . . 0.0 108.96 -168.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mt -84.8 134.65 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.7 m -89.52 142.45 27.66 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -128.88 138.01 51.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.883 1.273 . . . . 0.0 109.114 177.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 pt -133.87 -169.06 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.049 1.339 . . . . 0.0 109.068 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -34.06 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.089 1.756 . . . . 0.0 110.84 162.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 36.74 42.95 0.75 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.985 2.707 . . . . 0.0 114.603 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.46 166.04 38.19 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 120.402 2.101 . . . . 0.0 113.839 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.76 156.03 31.36 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.499 1.919 . . . . 0.0 107.057 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 m -84.1 -170.2 2.97 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 155.53 87.55 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.712 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.74 105.53 1.97 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.903 3.069 . . . . 0.0 110.434 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 m -89.84 74.71 7.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 171.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.3 m -94.58 115.33 27.45 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 10.9 mt -95.64 145.02 25.58 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 m -104.87 135.43 46.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -155.18 169.0 25.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 166.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -95.38 137.54 34.3 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.25 1.1 0 O-C-N 125.383 1.677 . . . . 0.0 110.551 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 136.55 42.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.448 2.098 . . . . 0.0 110.723 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -75.69 163.18 27.57 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.583 165.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.11 80.3 0.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.44 1.096 . . . . 0.0 109.105 163.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 m -58.15 -27.78 64.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.68 0.792 . . . . 0.0 110.859 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 5.18 49.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.761 0.825 . . . . 0.0 111.918 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.7 129.3 22.55 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.315 1.046 . . . . 0.0 109.653 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 p -149.58 164.21 35.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.482 1.113 . . . . 0.0 110.39 165.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -116.65 146.43 42.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 172.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.52 164.21 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.915 1.286 . . . . 0.0 109.261 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 45.71 59.63 3.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.268 1.827 . . . . 0.0 109.949 -173.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.15 66.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 128.667 2.787 . . . . 0.0 105.804 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 t -94.64 165.35 12.55 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.686 1.594 . . . . 0.0 109.679 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.6 5.29 4.96 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.279 -1.513 . . . . 0.0 113.375 -168.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.1 p -126.5 -12.74 6.11 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -174.0 152.33 1.9 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.949 1.3 . . . . 0.0 108.949 -167.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.49 122.07 61.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.14 151.82 23.97 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.74 153.4 42.47 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.438 1.495 . . . . 0.0 109.71 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -140.05 145.04 37.21 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.66 1.584 . . . . 0.0 106.733 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -160.25 168.71 24.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 164.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.0 m -90.05 140.71 27.54 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 116.883 -1.927 . . . . 0.0 106.888 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.36 141.6 4.93 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.125 1.216 . . . . 0.0 109.023 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mp -83.51 -35.26 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.961 -170.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 49.84 34.86 8.26 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.301 2.24 . . . . 0.0 111.776 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 p -50.34 -46.97 56.03 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.302 1.041 . . . . 0.0 112.824 -162.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 p 153.91 -86.32 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 131.371 3.868 . . . . 0.0 104.973 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -5.43 58.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.51 1.124 . . . . 0.0 111.045 -170.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -34.86 129.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.937 1.295 . . . . 0.0 111.162 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.21 -49.47 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 174.21 -164.86 36.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -127.02 150.88 49.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 162.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.85 122.96 42.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.433 HG13 HG22 ' A' ' 77' ' ' VAL . 2.7 mp -104.67 144.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.8 m -145.45 111.26 5.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 143.09 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.829 0.823 . . . . 0.0 110.773 160.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.17 164.33 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 166.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.38 126.89 31.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 163.129 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.9 mt . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 117.301 -1.333 . . . . 0.0 107.901 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 137.81 28.65 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.304 2.003 . . . . 0.0 110.0 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.0 93.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.323 1.0 OUTLIER 54.45 176.95 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.323 2.249 . . . . 0.0 113.28 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.07 159.32 42.47 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.725 -1.235 . . . . 0.0 110.205 165.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -149.33 165.93 30.52 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.252 1.821 . . . . 0.0 111.221 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.07 165.52 18.7 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.629 1.571 . . . . 0.0 109.482 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -178.11 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.168 0.987 . . . . 0.0 109.119 164.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.25 -50.74 8.64 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.028 -1.045 . . . . 0.0 112.528 -157.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.408 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 32.3 p 157.18 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 1 C-N-CA 132.217 4.207 . . . . 0.0 112.141 174.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -124.9 10.4 8.26 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.9 t -73.61 132.44 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.59 6.37 18.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.075 1.322 . . . . 0.0 112.312 170.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -150.08 120.4 7.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.79 -1.418 . . . . 0.0 107.38 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -143.99 166.27 25.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -132.37 129.0 38.81 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.038 0.935 . . . . 0.0 108.763 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -95.78 154.88 3.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.04 178.45 6.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.388 1.475 . . . . 0.0 107.142 169.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 5.0 73.88 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 119.036 0.834 . . . . 0.0 112.956 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.72 158.8 26.55 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.626 0.727 . . . . 0.0 109.555 167.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.19 103.78 5.61 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.0 169.64 14.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.091 2.527 . . . . 0.0 111.032 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.22 -18.75 50.86 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.595 -0.691 . . . . 0.0 112.176 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mm -124.56 153.38 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.669 1.988 . . . . 0.0 108.155 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -86.25 145.84 26.78 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.658 1.583 . . . . 0.0 108.365 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.56 134.85 51.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.257 1.023 . . . . 0.0 111.87 -175.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.28 104.18 14.1 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.506 1.923 . . . . 0.0 107.098 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -90.52 105.66 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -101.5 136.29 41.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 118.412 0.551 . . . . 0.0 111.873 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 39' ' ' ILE . 38.8 t -135.36 108.42 9.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.07 137.42 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -98.78 129.97 45.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.39 112.43 18.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pt -104.45 -164.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -48.62 111.13 0.42 Allowed 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.531 -0.731 . . . . 0.0 110.61 161.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.49 24.76 59.83 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.068 -0.851 . . . . 0.0 114.802 156.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.33 156.39 21.04 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -132.78 153.22 51.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 108.531 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.58 178.41 7.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.78 154.23 94.41 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 121.496 -0.753 . . . . 0.0 110.197 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.87 110.53 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.964 3.109 . . . . 0.0 110.839 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.8 m -85.44 97.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 169.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 m -96.5 153.42 17.85 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.55 135.19 44.19 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 159.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.67 143.29 38.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.37 2.268 . . . . 0.0 108.537 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -164.69 148.61 9.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.559 1.527 . . . . 0.0 110.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -110.94 143.53 41.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.84 1.256 . . . . 0.0 109.626 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.257 1.456 0 C-N-CA 127.572 2.349 . . . . 0.0 111.635 -171.71 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.31 105.61 1.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.316 2.01 . . . . 0.0 109.209 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.29 169.98 1.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 114.248 165.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.462 HD13 ' CG ' ' A' ' 26' ' ' TRP . 95.0 mt -67.24 71.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.449 2.3 . . . . 0.0 110.088 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m -50.68 -27.01 6.16 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 111.846 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -87.37 4.59 42.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.772 1.169 . . . . 0.0 112.566 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -55.17 118.42 4.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 109.276 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.0 m -153.33 134.1 13.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.454 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -91.39 146.25 23.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.45 174.23 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 128.845 2.858 . . . . 0.0 109.24 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.374 2.6 p30 43.07 45.62 4.64 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.113 1.765 . . . . 0.0 112.3 -178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.44 62.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 128.117 2.567 . . . . 0.0 107.473 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 20' ' ' SER . 7.7 t -73.78 174.55 8.28 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.781 1.232 . . . . 0.0 108.972 168.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.73 -4.7 39.06 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.187 -0.946 . . . . 0.0 111.674 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.471 ' H ' HG23 ' A' ' 18' ' ' THR . 53.7 p -125.58 -9.2 6.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 -158.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 p -176.81 171.91 2.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.188 2.595 . . . . 0.0 108.134 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.65 147.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 142.75 15.64 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 171.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mp -108.82 144.14 37.07 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 124.529 1.132 . . . . 0.0 108.119 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -118.21 150.38 39.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.462 ' CG ' HD13 ' A' ' 9' ' ' LEU . 47.7 p90 -151.87 -166.12 2.41 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 161.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.92 143.19 39.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.53 129.32 19.83 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.055 1.17 . . . . 0.0 109.39 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.64 96.98 9.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -74.52 45.87 0.25 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.38 0.672 . . . . 0.0 109.327 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.8 m -69.48 2.46 3.08 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.079 -1.638 . . . . 0.0 112.269 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 p 48.13 25.66 0.87 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.787 2.835 . . . . 0.0 114.859 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -165.27 -16.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.881 1.272 . . . . 0.0 111.044 -171.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 9.4 tt -39.01 140.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 110.141 156.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.401 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.2 mp -84.79 -63.39 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 165.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.33 -156.9 13.75 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -168.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -135.7 147.42 48.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 133.97 55.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.0 mp -108.81 143.0 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -133.87 128.13 33.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 161.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.651 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.27 137.52 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.173 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.36 164.69 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.14 1.376 . . . . 0.0 109.429 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.07 125.94 30.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 C-N-CA 123.591 0.756 . . . . 0.0 110.312 173.441 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.6 mt . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.94 147.16 43.22 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.83 2.354 . . . . 0.0 110.945 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.0 mm -84.85 -74.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.01 175.64 7.46 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.683 1.993 . . . . 0.0 108.66 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.84 156.83 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.727 1.211 . . . . 0.0 110.255 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -148.2 166.43 27.93 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.737 1.215 . . . . 0.0 110.503 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.77 155.72 49.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.673 1.989 . . . . 0.0 109.935 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.75 -177.21 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.883 1.273 . . . . 0.0 109.864 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.66 -57.71 3.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.527 0.731 . . . . 0.0 112.087 -160.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p 154.7 -29.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 131.089 3.756 . . . . 0.0 111.42 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -123.26 -0.66 8.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.256 1.023 . . . . 0.0 109.506 -167.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.1 t -74.43 124.75 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.0 1.11 33.55 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.46 1.1 . . . . 0.0 112.901 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -142.18 114.21 8.14 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.456 1.102 . . . . 0.0 108.259 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -145.98 137.82 25.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -113.42 146.99 38.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.947 1.299 . . . . 0.0 108.836 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.51 148.54 24.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 125.631 1.572 . . . . 0.0 107.181 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.88 -168.78 1.87 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.28 4.34 90.23 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.692 -1.255 . . . . 0.0 113.973 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 149.56 49.65 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.933 1.293 . . . . 0.0 109.965 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -146.9 93.81 4.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.454 1.902 . . . . 0.0 108.643 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.62 167.59 23.81 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.997 3.131 . . . . 0.0 114.982 -152.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.85 -15.85 61.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.128 1.347 . . . . 0.0 112.735 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.15 151.52 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 167.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -89.48 134.41 34.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.309 1.444 . . . . 0.0 108.039 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -118.51 117.33 28.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -167.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.42 113.63 21.32 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 170.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.651 HG23 HG13 ' A' ' 41' ' ' VAL . 1.9 mp -102.66 105.1 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -91.03 138.24 31.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.097 0.559 . . . . 0.0 109.508 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -134.52 129.54 52.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -131.8 131.42 62.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 m -83.09 144.23 30.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.401 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -125.68 129.88 50.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 15.6 pt -116.1 175.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -35.37 105.0 0.03 OUTLIER 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.023 1.729 . . . . 0.0 110.119 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.1 26.37 0.87 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.812 1.672 . . . . 0.0 114.823 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.42 144.71 15.93 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.55 1.675 . . . . 0.0 109.663 -160.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.01 117.64 22.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.2 1.0 . . . . 0.0 108.499 -162.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.11 -179.0 6.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 148.8 86.06 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.7 137.7 70.23 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 162.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -129.13 95.99 4.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 168.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.7 m -94.84 149.21 21.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.32 135.0 45.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 166.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t -120.91 140.79 51.33 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -165.24 139.89 5.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -96.81 165.06 12.29 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 161.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.246 0.87 0 C-N-CA 126.865 2.066 . . . . 0.0 111.315 169.748 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.37 117.21 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.746 2.297 . . . . 0.0 109.511 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.27 169.46 11.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.524 HD13 ' CG ' ' A' ' 26' ' ' TRP . 55.2 mt -78.51 86.73 4.51 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.5 m -76.04 -29.37 58.04 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.53 1.132 . . . . 0.0 111.35 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.61 4.77 20.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.823 1.249 . . . . 0.0 112.611 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.57 129.78 37.56 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.8 1.64 . . . . 0.0 109.853 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.3 m -150.72 165.23 34.1 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -99.72 155.83 17.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 108.724 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.12 167.96 9.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.689 1.996 . . . . 0.0 106.983 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.83 56.21 2.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 128.278 2.631 . . . . 0.0 110.232 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -78.25 65.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.197 2.199 . . . . 0.0 106.232 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -88.18 168.16 12.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.465 1.106 . . . . 0.0 111.3 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.37 12.79 0.69 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.171 2.188 . . . . 0.0 112.465 -174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.4 p -125.68 -15.9 5.89 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p -178.53 147.14 0.39 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -161.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -115.45 140.33 37.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.74 162.29 18.59 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mp -139.15 153.39 47.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.586 1.554 . . . . 0.0 108.988 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -134.71 155.32 50.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.524 ' CG ' HD13 ' A' ' 9' ' ' LEU . 42.5 p90 -165.35 -170.83 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.415 1.486 . . . . 0.0 108.858 166.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -105.42 106.44 56.06 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.726 1.21 . . . . 0.0 108.521 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -62.24 124.87 15.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.373 2.049 . . . . 0.0 110.632 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.1 mt -93.52 96.67 10.03 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 128.643 2.777 . . . . 0.0 108.042 175.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -74.67 34.12 0.1 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.446 1.098 . . . . 0.0 111.931 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 29' ' ' LEU . 30.4 m -56.2 119.63 6.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.821 2.448 . . . . 0.0 109.216 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 p -67.63 41.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.734 2.414 . . . . 0.0 113.443 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -167.18 -19.7 0.02 OUTLIER 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.741 1.616 . . . . 0.0 111.904 -167.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -55.15 144.44 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.23 -52.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 166.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.66 -152.73 14.56 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.04 136.14 45.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.03 125.82 44.61 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.81 155.05 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 m -142.69 153.52 43.46 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.899 1.68 . . . . 0.0 107.169 167.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.28 135.28 61.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 125.819 1.647 . . . . 0.0 108.999 167.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.55 164.08 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.43 110.24 20.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 128.625 2.77 . . . . 0.0 115.686 176.698 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.26 171.44 18.03 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.358 2.039 . . . . 0.0 109.633 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.72 -95.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 162.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -146.96 166.02 28.04 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.475 0.71 . . . . 0.0 110.371 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -134.23 103.89 5.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.553 1.541 . . . . 0.0 106.988 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.51 159.11 16.19 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HZ ' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -105.75 176.02 5.3 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.527 1.131 . . . . 0.0 108.039 176.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -175.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 161.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -79.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.468 1.907 . . . . 0.0 112.041 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p 172.2 -18.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 1 C-N-CA 132.651 4.38 . . . . 0.0 110.883 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -134.27 27.15 3.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.4 t -73.99 138.62 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.92 -1.95 19.02 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.977 0.798 . . . . 0.0 112.265 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.58 114.33 5.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -138.04 141.36 40.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 m -127.21 152.06 47.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.9 0.88 . . . . 0.0 109.358 -171.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.53 156.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.505 1.922 . . . . 0.0 106.944 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -130.67 -163.14 1.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.163 1.785 . . . . 0.0 106.374 174.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.51 7.9 69.97 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 120.093 -1.629 . . . . 0.0 114.105 166.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.4 149.67 31.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.186 1.394 . . . . 0.0 108.226 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -126.19 102.07 27.76 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 107.893 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 157.84 57.82 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.622 2.215 . . . . 0.0 112.383 -165.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.55 -30.06 11.19 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.681 1.134 . . . . 0.0 110.543 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.79 158.82 3.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -100.96 145.19 28.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.022 1.329 . . . . 0.0 108.347 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -131.26 134.8 46.77 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.32 116.35 22.96 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 121.22 51.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 p -116.18 142.67 46.52 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.822 0.849 . . . . 0.0 110.687 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.92 128.77 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.09 153.4 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.43 1.014 . . . . 0.0 111.894 175.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -105.84 122.89 47.03 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 126.467 1.907 . . . . 0.0 107.739 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.408 HD11 ' HZ ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -114.68 132.91 56.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.7 pt -126.3 178.13 4.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.476 1.111 . . . . 0.0 108.837 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -34.53 103.53 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.281 1.832 . . . . 0.0 110.823 163.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.51 11.47 2.67 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.868 2.175 . . . . 0.0 115.055 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.36 145.85 17.89 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.203 1.501 . . . . 0.0 110.153 -156.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -126.85 155.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.316 1.447 . . . . 0.0 109.494 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -107.54 -166.86 1.19 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.85 2.06 . . . . 0.0 108.604 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.62 134.6 39.57 Favored Pre-proline 0 C--O 1.239 0.543 0 O-C-N 121.016 -1.052 . . . . 0.0 108.678 163.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 127.72 19.5 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.93 2.42 . . . . 0.0 107.214 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.2 m -86.41 103.7 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.2 m -101.4 121.53 42.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.95 150.43 44.78 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.1 m -132.62 136.9 46.81 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -161.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -157.33 142.63 17.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -159.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.08 159.64 15.21 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.867 -0.52 . . . . 0.0 109.878 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.767 1.627 . . . . 0.0 110.063 -170.245 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.7 t . . . . . 0 C--O 1.239 0.52 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.36 143.49 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.04 1.826 . . . . 0.0 109.442 174.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -102.59 169.29 8.74 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 166.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -74.5 80.34 1.94 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 m -61.37 -25.75 67.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.798 0.839 . . . . 0.0 110.544 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.0 -2.47 34.1 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.662 1.585 . . . . 0.0 113.696 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.37 115.14 3.04 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.773 1.229 . . . . 0.0 110.55 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p -134.54 160.97 36.4 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.864 1.266 . . . . 0.0 110.345 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 8.7 m-30 -105.28 143.78 32.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.04 164.96 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.881 1.672 . . . . 0.0 108.348 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 t0 51.7 45.06 28.74 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.96 1.304 . . . . 0.0 110.554 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mt -75.91 63.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 128.811 2.845 . . . . 0.0 106.94 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 20' ' ' SER . 14.5 t -87.45 173.77 8.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 111.137 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.36 0.43 16.86 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.637 1.975 . . . . 0.0 112.861 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.479 ' H ' HG23 ' A' ' 18' ' ' THR . 55.7 p -113.39 -15.7 12.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -176.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p 176.29 161.7 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.674 1.99 . . . . 0.0 107.536 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.15 127.67 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.85 157.39 29.66 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.633 -1.292 . . . . 0.0 110.143 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.79 150.33 52.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.774 -1.427 . . . . 0.0 108.483 172.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -137.29 133.85 35.46 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -157.54 173.38 16.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.6 m -86.58 106.3 10.09 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.726 1.211 . . . . 0.0 110.093 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.62 124.26 13.4 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.345 1.363 . . . . 0.0 109.29 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.15 101.44 13.0 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -79.34 49.95 1.04 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.536 0.734 . . . . 0.0 109.097 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -61.91 -55.55 28.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.582 1.553 . . . . 0.0 110.164 -168.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p 154.72 -88.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 130.389 3.476 . . . . 0.0 108.891 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.08 -3.64 52.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.978 2.511 . . . . 0.0 110.026 -170.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -35.98 133.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.039 1.336 . . . . 0.0 111.255 166.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -84.32 -48.24 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 164.87 -158.29 31.03 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -132.15 145.2 51.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -119.89 113.1 20.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.43 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.9 m -145.08 117.58 8.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.425 1.89 . . . . 0.0 107.382 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.09 131.44 40.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.289 0.636 . . . . 0.0 111.064 162.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.48 164.52 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 161.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.56 110.9 11.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.348 0 C-N-CA 124.371 1.068 . . . . 0.0 113.652 -171.422 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.9 mt . . . . . 0 CA--C 1.546 0.792 0 CA-C-O 119.02 -0.515 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.68 131.04 12.06 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.725 2.283 . . . . 0.0 109.008 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.5 mm -84.64 -73.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -157.51 170.46 22.38 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.848 0.859 . . . . 0.0 109.925 173.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.3 150.59 39.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 163.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -152.71 165.91 33.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.48 1.112 . . . . 0.0 108.565 -166.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.12 168.15 15.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.377 0.671 . . . . 0.0 110.53 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.01 -177.01 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.12 . . . . 0.0 108.66 167.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -71.02 -66.42 0.61 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.756 -0.59 . . . . 0.0 111.219 -167.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.445 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 9.5 p 163.78 -23.02 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 130.787 3.635 . . . . 0.0 112.016 -176.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.9 p -132.9 22.93 4.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.988 0.813 . . . . 0.0 112.764 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.54 131.93 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.95 3.26 19.3 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.388 2.423 . . . . 0.0 113.357 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -153.93 119.64 5.26 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.654 1.582 . . . . 0.0 108.225 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -134.94 164.37 27.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.326 1.45 . . . . 0.0 108.081 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.5 m -131.96 147.98 52.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.88 145.04 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' GLY . 0.9 OUTLIER -115.85 -170.76 1.85 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 171.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' H ' HG22 ' A' ' 65' ' ' THR . . . 78.25 17.97 77.11 Favored Glycine 0 CA--C 1.522 0.473 0 O-C-N 120.873 -1.142 . . . . 0.0 111.666 176.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 157.44 20.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.617 1.208 . . . . 0.0 108.691 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 136.41 15.98 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.96 156.12 60.33 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.906 1.737 . . . . 0.0 110.964 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.53 -27.58 8.33 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.527 1.061 . . . . 0.0 113.109 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.17 156.14 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 126.038 1.735 . . . . 0.0 107.818 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.97 135.33 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 107.445 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.26 127.17 51.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.4 106.74 16.23 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.427 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.3 mp -98.94 103.12 14.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 174.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 142.16 27.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.939 2.096 . . . . 0.0 108.315 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -146.7 92.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mm -84.34 138.86 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.739 1.216 . . . . 0.0 108.274 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 100.0 m -105.81 131.71 52.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.0 113.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . 0.3 2.6 pt -109.37 -164.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.672 1.189 . . . . 0.0 109.991 -166.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -50.83 108.78 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.315 -1.491 . . . . 0.0 110.52 160.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.18 50.46 2.2 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.583 2.04 . . . . 0.0 113.097 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 144.17 7.58 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -120.26 153.45 36.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 107.931 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -84.42 -165.85 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.579 0.704 . . . . 0.0 112.31 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.64 144.67 73.83 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 151.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.43 137.28 50.29 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.774 1.649 . . . . 0.0 108.879 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.6 m -105.21 104.86 14.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -124.26 137.17 54.54 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.1 126.38 39.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -93.52 145.43 24.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -154.73 138.85 16.49 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -94.97 136.02 35.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.738 1.215 . . . . 0.0 108.279 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.257 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -175.129 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.957 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.05 129.92 27.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.261 1.974 . . . . 0.0 110.558 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.22 178.42 4.78 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.139 1.376 . . . . 0.0 110.881 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.472 HD13 ' CG ' ' A' ' 26' ' ' TRP . 63.1 mt -71.76 86.85 0.95 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -58.57 -20.12 43.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.272 1.429 . . . . 0.0 111.217 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -93.46 6.27 48.74 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.708 1.603 . . . . 0.0 113.585 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.99 106.81 0.54 Allowed 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.723 -1.236 . . . . 0.0 109.905 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -143.36 163.91 31.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.547 1.139 . . . . 0.0 110.046 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 13.4 m-30 -109.02 159.7 16.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.08 168.17 7.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.616 1.966 . . . . 0.0 107.068 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 42.34 59.81 2.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 126.201 1.801 . . . . 0.0 109.653 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mm -79.89 60.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -73.63 175.54 7.03 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.595 1.958 . . . . 0.0 109.966 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -4.97 53.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.997 1.319 . . . . 0.0 112.636 172.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 p -110.78 -12.42 14.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.561 1.544 . . . . 0.0 114.459 -166.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 p 173.84 171.13 0.19 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.034 1.734 . . . . 0.0 108.233 -163.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.79 150.12 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 161.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.26 159.3 14.65 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 171.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.01 146.31 49.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 125.508 1.523 . . . . 0.0 108.184 176.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -124.25 156.83 36.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 158.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.472 ' CG ' HD13 ' A' ' 9' ' ' LEU . 32.6 p90 -161.38 -173.87 4.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.086 1.755 . . . . 0.0 106.973 163.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -104.04 107.55 57.36 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -59.37 124.07 14.74 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.715 1.61 . . . . 0.0 109.125 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.2 mt -93.4 -19.23 21.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.641 0.776 . . . . 0.0 112.878 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 43.45 29.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.193 2.597 . . . . 0.0 113.577 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 m -87.83 104.95 17.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -167.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -41.88 -1.85 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 131.518 3.927 . . . . 0.0 119.509 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.52 -14.45 8.22 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 130.167 3.387 . . . . 0.0 112.137 -171.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 12.6 tt -60.43 161.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.105 2.162 . . . . 0.0 111.061 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -98.77 -47.99 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 166.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.94 40.99 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.442 ' CD1' HD11 ' A' ' 9' ' ' LEU . 11.3 m-85 -126.91 107.24 9.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 171.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.5 121.95 28.93 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.64 147.4 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -145.49 99.51 3.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.814 1.245 . . . . 0.0 107.672 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.56 134.16 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 120.665 -1.272 . . . . 0.0 109.064 163.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.25 165.13 24.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 136.42 42.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.539 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.925 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -60.97 160.87 24.07 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.716 1.61 . . . . 0.0 111.196 162.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.79 -86.95 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 121.367 1.894 . . . . 0.0 110.555 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.54 146.67 40.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.457 1.503 . . . . 0.0 107.439 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -147.51 162.55 38.84 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.852 1.261 . . . . 0.0 109.437 -168.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.34 153.36 43.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.359 1.463 . . . . 0.0 108.219 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.63 -176.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 108.866 165.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.15 -58.45 5.98 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -161.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 p 153.83 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 130.789 3.636 . . . . 0.0 110.747 -167.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -105.47 3.41 29.49 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 113.233 -166.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.9 150.67 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.98 -2.83 6.49 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 127.016 2.246 . . . . 0.0 113.201 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -160.73 128.7 4.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.727 -1.455 . . . . 0.0 107.883 -171.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -150.08 167.03 27.98 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.961 0.8 . . . . 0.0 109.049 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.4 m -132.9 136.66 46.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.413 1.485 . . . . 0.0 109.999 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.29 165.2 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.93 1.692 . . . . 0.0 107.469 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' GLY . 2.9 m -143.53 -170.69 3.35 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.359 -1.463 . . . . 0.0 107.06 164.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.506 ' H ' HG22 ' A' ' 65' ' ' THR . . . 72.09 15.51 76.55 Favored Glycine 0 N--CA 1.463 0.471 0 C-N-CA 124.713 1.149 . . . . 0.0 112.642 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.64 158.97 35.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.344 1.058 . . . . 0.0 108.826 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.51 107.25 23.57 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 170.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.9 168.05 19.8 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.065 2.51 . . . . 0.0 110.756 -173.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.4 -31.18 4.57 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.505 1.05 . . . . 0.0 110.692 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.07 155.24 3.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -101.28 142.7 32.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.103 1.761 . . . . 0.0 108.242 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -134.59 120.48 19.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.043 1.337 . . . . 0.0 109.913 -162.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.15 95.75 9.24 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.406 HD13 ' CE2' ' A' ' 14' ' ' PHE . 2.4 mp -84.58 105.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p -88.56 147.5 24.57 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 167.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.85 112.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 mt -112.32 129.31 68.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -82.59 134.86 35.18 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 113.71 18.79 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 18.3 pt -107.58 -167.83 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.961 1.704 . . . . 0.0 110.029 -173.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -44.1 110.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.317 0.508 . . . . 0.0 109.902 167.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.6 63.44 0.06 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.563 2.506 . . . . 0.0 114.121 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.71 158.32 19.17 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.36 150.18 45.03 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.74 -178.28 6.82 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.726 0.774 . . . . 0.0 109.992 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 149.01 98.52 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.184 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.31 102.5 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.325 2.017 . . . . 0.0 108.186 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 m -91.86 93.55 8.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 m -113.2 149.52 33.59 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -146.67 68.52 1.17 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.667 0.746 . . . . 0.0 110.131 -171.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.4 t -72.28 133.23 44.91 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -157.88 141.7 15.7 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.051 2.141 . . . . 0.0 108.753 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -91.11 157.9 16.96 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.76 0.824 . . . . 0.0 110.682 -175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.25 1.125 0 CA-C-O 115.51 -2.186 . . . . 0.0 108.225 178.779 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.34 120.48 5.31 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.584 2.189 . . . . 0.0 110.769 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -80.89 169.89 16.97 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.298 1.039 . . . . 0.0 110.634 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.401 HD13 ' CG ' ' A' ' 26' ' ' TRP . 81.5 mt -70.13 79.65 0.51 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.2 m -65.79 -14.14 60.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.752 2.021 . . . . 0.0 111.627 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -113.38 24.16 12.51 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.32 1.448 . . . . 0.0 111.458 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.55 127.03 29.25 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.435 0.694 . . . . 0.0 110.847 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.15 165.13 31.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.005 0.922 . . . . 0.0 111.309 172.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 9.9 m-85 -112.06 154.81 24.83 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.838 1.255 . . . . 0.0 108.348 169.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.0 174.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.961 2.104 . . . . 0.0 106.624 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 56.34 47.13 19.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 0.0 108.791 161.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 mt -79.92 66.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.203 2.201 . . . . 0.0 106.937 -174.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -66.73 176.96 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.974 1.31 . . . . 0.0 109.447 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.02 -3.98 32.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.05 0.94 . . . . 0.0 113.369 162.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -125.44 -15.25 6.2 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 -162.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.18 168.02 4.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 108.525 -170.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 tt -134.56 124.09 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.132 -0.98 . . . . 0.0 108.445 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.46 161.3 46.51 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.526 HD13 ' CD2' ' A' ' 62' ' ' TYR . 3.0 mp -133.44 161.0 35.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.936 1.294 . . . . 0.0 108.856 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -138.61 147.82 43.39 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 160.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.401 ' CG ' HD13 ' A' ' 9' ' ' LEU . 12.1 p90 -157.09 172.45 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 158.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 m -79.13 107.09 5.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 124.452 1.101 . . . . 0.0 109.266 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -60.66 133.88 50.98 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.544 1.23 . . . . 0.0 109.033 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.98 133.55 38.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.744 2.018 . . . . 0.0 107.367 166.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -121.31 36.77 4.51 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 m -79.62 101.69 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.437 2.295 . . . . 0.0 108.298 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -59.16 84.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.778 1.631 . . . . 0.0 113.146 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 165.8 -25.38 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 131.438 3.895 . . . . 0.0 109.415 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.24 160.32 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.135 1.774 . . . . 0.0 109.908 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.68 -47.19 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.33 -155.35 24.17 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.293 0.497 . . . . 0.0 111.983 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -137.08 129.63 30.09 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 116.78 33.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.548 HG13 HG22 ' A' ' 77' ' ' VAL . 1.5 mp -89.23 150.56 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 123.427 1.584 . . . . 0.0 107.554 171.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 m -146.21 148.41 32.48 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 171.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.8 133.81 48.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.47 164.65 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 107.618 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.27 119.82 23.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 130.15 3.38 . . . . 0.0 118.826 160.892 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.75 147.63 17.32 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.912 3.075 . . . . 0.0 109.7 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -101.92 -76.4 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.23 171.68 18.14 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 120.849 1.658 . . . . 0.0 110.808 176.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.25 152.97 33.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.878 1.271 . . . . 0.0 109.39 171.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -145.84 165.7 28.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.26 160.61 39.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -177.4 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -59.82 -68.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.09 1.356 . . . . 0.0 110.561 -165.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t 178.81 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 129.206 3.003 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.8 p -136.33 48.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.37 124.78 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.457 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.19 -1.12 44.64 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.366 1.46 . . . . 0.0 114.213 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -158.94 132.94 7.63 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 127.108 2.163 . . . . 0.0 106.929 169.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CD2' HD13 ' A' ' 24' ' ' LEU . 14.0 t80 -135.51 164.6 27.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -142.65 145.79 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -110.88 144.63 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 66' ' ' GLY . 2.6 m -128.29 -178.19 4.45 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 65' ' ' THR . . . 73.91 13.07 81.02 Favored Glycine 0 N--CA 1.463 0.439 0 C-N-CA 123.979 0.799 . . . . 0.0 113.35 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -69.99 165.58 21.48 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.125 0.97 . . . . 0.0 108.847 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.96 105.56 13.87 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.953 1.701 . . . . 0.0 108.56 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.93 152.94 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.007 2.471 . . . . 0.0 110.192 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 -43.89 1.32 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 125.991 1.758 . . . . 0.0 109.188 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -84.09 165.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 122.747 1.261 . . . . 0.0 108.804 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -101.34 138.14 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 128.407 2.683 . . . . 0.0 106.57 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -133.96 142.43 47.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.05 0.841 . . . . 0.0 110.681 -158.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.31 89.74 3.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.277 1.431 . . . . 0.0 109.988 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 5.1 mp -83.99 111.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -170.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -111.36 125.79 54.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.211 1.804 . . . . 0.0 108.718 -164.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 39' ' ' ILE . 22.0 t -134.41 103.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 mt -84.55 144.38 9.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -105.58 131.16 53.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.7 150.22 51.99 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.338 1.426 . . . . 0.0 109.19 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.0 pt -135.72 -179.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.85 1.26 . . . . 0.0 108.954 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -35.2 116.78 0.37 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.61 1.564 . . . . 0.0 110.301 168.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 47.03 2.19 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 124.786 1.304 . . . . 0.0 112.186 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.11 155.45 26.59 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.247 1.023 . . . . 0.0 111.226 -165.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -151.49 127.96 10.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -178.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.82 141.79 84.99 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.374 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.2 100.36 0.87 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.857 2.372 . . . . 0.0 108.568 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 m -83.59 125.89 32.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.7 m -125.32 155.35 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 mt -140.29 141.6 35.76 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.9 m -77.57 146.83 36.04 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -138.72 157.93 45.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.436 1.095 . . . . 0.0 108.662 153.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -125.59 144.16 50.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.644 1.578 . . . . 0.0 109.025 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.248 1.024 0 C-N-CA 125.143 1.377 . . . . 0.0 112.591 166.063 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.59 122.09 4.39 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.177 2.585 . . . . 0.0 111.606 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 163.29 27.54 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.235 1.014 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.26 80.84 1.83 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.665 0.745 . . . . 0.0 110.68 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 m -56.15 -10.79 0.92 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.861 2.065 . . . . 0.0 112.346 168.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -111.0 5.84 20.57 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.631 -1.293 . . . . 0.0 113.825 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.31 118.49 4.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.505 0.593 . . . . 0.0 109.807 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -140.98 165.32 27.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.789 1.636 . . . . 0.0 109.957 166.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.555 ' CE2' ' HB2' ' A' ' 91' ' ' LEU . 12.4 m-30 -108.58 155.26 20.86 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 165.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.04 174.68 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 128.406 2.682 . . . . 0.0 107.997 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 48.64 44.8 21.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.397 1.079 . . . . 0.0 110.18 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.76 61.35 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 t -64.38 166.01 8.86 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.925 1.345 . . . . 0.0 109.424 168.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.81 4.63 6.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.209 1.404 . . . . 0.0 111.381 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -126.15 -0.92 7.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.437 2.295 . . . . 0.0 116.908 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.91 166.74 0.53 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.81 2.844 . . . . 0.0 109.125 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 tt -123.65 140.44 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.95 157.33 21.1 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.76 154.53 44.1 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.473 1.509 . . . . 0.0 108.076 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -139.42 141.01 37.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -158.18 -174.35 4.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.504 0.722 . . . . 0.0 110.311 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 m -97.73 107.14 38.16 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.013 1.725 . . . . 0.0 107.141 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -58.79 128.81 29.44 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 121.233 1.476 . . . . 0.0 109.013 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.9 mt -95.35 98.26 10.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 126.694 1.997 . . . . 0.0 105.845 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -75.04 28.58 0.09 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.519 0.728 . . . . 0.0 111.787 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -66.69 131.19 45.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -76.59 52.55 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.113 -0.992 . . . . 0.0 111.213 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.47 -14.43 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.093 1.357 . . . . 0.0 111.0 -164.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.05 141.89 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.44 -65.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.42 -168.08 31.74 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -124.05 138.69 54.41 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.65 118.9 29.21 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.459 HG13 HG22 ' A' ' 77' ' ' VAL . 3.8 mp -93.51 149.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -145.13 102.88 3.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.75 127.76 39.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -123.69 164.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.01 110.66 21.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.387 0 C-N-CA 128.11 2.564 . . . . 0.0 113.596 -178.632 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.67 128.38 11.71 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.123 2.549 . . . . 0.0 110.188 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mm -84.89 -62.36 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.95 155.37 34.11 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 107.676 -164.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.13 151.65 40.93 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 174.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.69 158.37 15.3 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.046 0.841 . . . . 0.0 110.792 -156.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.87 154.21 49.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.693 1.197 . . . . 0.0 108.272 -167.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.16 -177.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.5 -57.44 5.8 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -163.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t 157.53 -43.36 0.0 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 128.073 2.549 . . . . 0.0 111.936 -163.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -129.47 37.16 4.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.093 1.315 . . . . 0.0 110.377 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.4 134.77 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.11 -5.71 13.03 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.274 1.416 . . . . 0.0 113.57 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -142.18 130.79 22.63 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.475 1.91 . . . . 0.0 107.336 174.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.22 166.61 24.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -151.74 147.03 26.2 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.664 -1.272 . . . . 0.0 109.328 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.84 158.28 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.754 1.621 . . . . 0.0 108.641 -166.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.09 178.01 7.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.529 1.132 . . . . 0.0 108.889 -174.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 23.65 77.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 165.01 25.92 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 161.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -143.65 135.88 13.27 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.629 1.172 . . . . 0.0 107.975 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 161.67 42.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.191 1.927 . . . . 0.0 111.914 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.27 -14.63 63.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.657 1.599 . . . . 0.0 113.338 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.81 152.01 13.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 118.779 1.289 . . . . 0.0 108.234 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.49 127.73 32.76 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.309 1.844 . . . . 0.0 108.012 174.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -116.47 120.29 38.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.89 102.51 13.17 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 168.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 mt -94.48 89.65 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.2 p -94.58 150.31 20.37 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.707 -0.621 . . . . 0.0 110.293 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 39' ' ' ILE . 40.0 t -147.12 123.69 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -172.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.3 mt -118.61 139.65 45.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.5 m -106.06 115.97 31.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.114 1.766 . . . . 0.0 107.532 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.38 137.57 51.91 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.452 1.501 . . . . 0.0 109.779 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.06 -176.66 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.524 1.929 . . . . 0.0 109.154 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -35.2 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.154 1.382 . . . . 0.0 111.793 161.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.98 29.74 35.82 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.728 167.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.08 158.06 30.4 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 119.155 1.478 . . . . 0.0 111.113 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.8 151.43 51.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.674 1.99 . . . . 0.0 105.736 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.08 -171.04 3.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 144.71 88.99 Favored Pre-proline 0 C--O 1.242 0.676 0 O-C-N 120.877 -1.139 . . . . 0.0 108.631 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -63.7 136.6 54.56 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 107.979 -1.585 . . . . 0.0 107.979 171.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.96 96.59 6.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.8 m -114.2 143.54 44.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.555 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 95.0 mt -134.17 111.29 10.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 t -84.52 155.26 22.22 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -163.29 131.9 3.88 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 108.973 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -95.99 78.74 3.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.07 0.948 . . . . 0.0 110.578 169.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.256 1.398 0 C-N-CA 123.807 0.843 . . . . 0.0 110.236 167.067 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.28 116.72 4.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 N-CA-C 105.986 -2.352 . . . . 0.0 105.986 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -73.67 177.5 5.38 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.109 0.964 . . . . 0.0 111.64 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.504 HD13 ' CG ' ' A' ' 26' ' ' TRP . 92.3 mt -69.39 76.92 0.39 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.851 0.834 . . . . 0.0 108.929 161.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m -60.48 -27.88 67.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.202 1.001 . . . . 0.0 109.043 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . . . -83.89 3.89 31.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.53 1.532 . . . . 0.0 114.338 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.34 117.76 7.1 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.124 -0.985 . . . . 0.0 110.409 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -153.02 165.66 34.87 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 168.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 7.5 m-30 -97.54 160.28 14.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.41 172.63 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.278 1.831 . . . . 0.0 106.555 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.71 44.87 19.85 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.246 1.018 . . . . 0.0 110.707 164.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -80.1 52.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.319 1.848 . . . . 0.0 109.695 -169.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 20' ' ' SER . 10.9 t -80.75 174.68 11.37 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.625 1.57 . . . . 0.0 109.684 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -80.33 -1.35 40.7 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.322 -0.861 . . . . 0.0 112.325 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.423 ' H ' HG23 ' A' ' 18' ' ' THR . 58.3 p -125.29 0.92 7.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 126.435 1.894 . . . . 0.0 115.839 -167.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.25 173.28 2.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.564 2.345 . . . . 0.0 106.591 160.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tt -121.98 143.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 160.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.07 163.24 18.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.52 157.68 42.0 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.224 1.41 . . . . 0.0 108.852 170.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -138.43 147.91 43.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 163.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.504 ' CG ' HD13 ' A' ' 9' ' ' LEU . 23.7 p90 -153.58 -179.73 8.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 163.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -94.19 106.95 25.56 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.55 138.96 73.37 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.923 1.749 . . . . 0.0 110.059 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 132.23 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.347 1.859 . . . . 0.0 106.537 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.95 18.67 21.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -64.44 158.28 24.26 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -165.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -82.65 43.77 0.85 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.791 -1.193 . . . . 0.0 111.656 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -171.05 -21.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.544 -0.723 . . . . 0.0 112.786 -174.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.29 121.23 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.914 0.886 . . . . 0.0 109.213 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.413 ' HB ' HD12 ' A' ' 80' ' ' LEU . 3.4 mt -83.71 -46.41 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.08 -153.61 23.62 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.38 -1.39 . . . . 0.0 114.259 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.445 ' CD2' HG23 ' A' ' 79' ' ' THR . 1.8 m-85 -138.27 145.81 41.74 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.52 118.73 27.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.77 1.628 . . . . 0.0 107.658 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.535 HG12 HG22 ' A' ' 77' ' ' VAL . 71.8 mt -114.01 115.25 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -168.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.3 m -126.72 103.78 7.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -87.72 138.45 19.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.98 174.052 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.37 163.23 38.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.5 118.64 22.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.419 ' H ' ' HA ' ' A' ' 73' ' ' TYR . . . . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 128.121 2.569 . . . . 0.0 115.33 165.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.1 mt . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 118.387 -0.815 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.4 152.54 34.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.483 2.122 . . . . 0.0 110.02 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.9 mp -106.49 -92.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 161.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.05 170.55 16.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.981 1.264 . . . . 0.0 110.289 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.98 124.1 48.54 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.613 1.965 . . . . 0.0 107.062 173.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 159.3 15.79 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.068 2.547 . . . . 0.0 109.294 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.22 153.73 46.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 162.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -171.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.086 1.312 . . . . 0.0 111.098 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 p 168.2 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.614 1.965 . . . . 0.0 110.932 -162.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -124.66 20.23 8.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.513 1.525 . . . . 0.0 110.405 -171.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.82 124.34 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.11 3.28 51.53 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.531 1.539 . . . . 0.0 112.809 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -163.28 127.79 2.95 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 110.981 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -139.1 162.54 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.254 1.388 . . . . 0.0 109.133 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -138.19 148.26 44.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.736 1.214 . . . . 0.0 108.121 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.17 143.82 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 107.862 -174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 66' ' ' GLY . 1.9 m -141.79 -175.45 4.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -169.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.549 ' H ' HG22 ' A' ' 65' ' ' THR . . . 61.45 25.96 65.76 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 124.166 0.889 . . . . 0.0 111.855 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -79.51 165.87 22.55 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 170.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -130.19 133.02 24.46 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 165.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -79.19 169.57 18.85 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.233 2.622 . . . . 0.0 110.374 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.83 -4.17 49.57 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.769 -1.017 . . . . 0.0 114.209 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 mm -126.34 165.07 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.469 1.635 . . . . 0.0 107.412 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -86.44 149.42 25.0 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.068 -1.02 . . . . 0.0 109.274 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.419 ' HA ' ' H ' ' A' ' 44' ' ' ALA . 3.9 m-85 -138.26 130.65 29.01 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.885 0.874 . . . . 0.0 109.363 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.14 108.34 19.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 165.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.472 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.9 mp -98.5 94.67 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.5 p -95.91 153.26 17.85 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 110.672 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 39' ' ' ILE . 39.7 t -142.09 98.05 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -172.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -92.14 129.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.445 HG23 ' CD2' ' A' ' 37' ' ' TYR . 92.2 m -106.43 125.08 50.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.194 1.397 . . . . 0.0 107.754 -174.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.413 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -123.56 148.77 46.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 111.448 -170.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.5 -176.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.051 2.14 . . . . 0.0 107.49 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.41 ' H ' HG23 ' A' ' 33' ' ' THR . 7.5 t30 -34.46 108.42 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 111.1 165.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.78 43.13 1.62 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.681 2.086 . . . . 0.0 112.923 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.39 158.99 30.09 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -167.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -146.47 161.9 39.44 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.87 1.668 . . . . 0.0 108.452 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.5 m -89.0 -169.94 2.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.158 0.583 . . . . 0.0 109.683 172.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.39 152.46 94.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.49 103.66 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.475 2.116 . . . . 0.0 108.574 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 p -87.03 139.55 30.46 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -145.16 172.78 12.62 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -147.2 134.3 20.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 156.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -79.64 104.02 9.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.551 1.94 . . . . 0.0 107.043 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.58 108.84 20.3 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.052 -1.655 . . . . 0.0 112.84 171.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 148.4 31.16 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 157.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 C--O 1.243 0.731 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.527 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.17 132.83 30.96 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.829 2.353 . . . . 0.0 112.199 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.05 156.73 17.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.651 1.98 . . . . 0.0 109.554 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.492 HD13 ' CG ' ' A' ' 26' ' ' TRP . 85.3 mt -73.39 87.45 1.54 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.161 0.984 . . . . 0.0 109.95 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 m -66.55 -10.04 41.1 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.393 0.677 . . . . 0.0 112.252 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.46 0.11 55.13 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.411 -1.43 . . . . 0.0 112.487 171.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.31 106.65 0.21 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.981 1.264 . . . . 0.0 111.475 -172.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -140.54 138.48 34.55 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.775 1.23 . . . . 0.0 109.644 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.58 156.47 16.71 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.49 167.6 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.182 1.793 . . . . 0.0 109.05 169.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 50.52 61.03 3.43 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 108.673 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.0 mm -81.02 64.23 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.385 1.874 . . . . 0.0 107.833 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.3 t -95.08 171.84 8.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.242 1.02 . . . . 0.0 111.561 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.57 -4.33 36.33 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.832 1.253 . . . . 0.0 112.351 -165.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.9 p -124.99 -14.53 6.61 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.947 1.299 . . . . 0.0 114.052 -171.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.535 ' HA ' HD23 ' A' ' 67' ' ' LEU . 2.5 p -174.46 148.43 1.21 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.859 1.264 . . . . 0.0 111.517 -166.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.25 132.17 70.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.78 156.39 25.5 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.42 128.24 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.023 1.329 . . . . 0.0 109.071 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -98.51 151.21 20.86 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CG ' HD13 ' A' ' 9' ' ' LEU . 44.1 p90 -151.32 174.99 12.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 150.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -87.9 141.87 31.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 171.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.14 123.41 5.61 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 N-CA-C 105.877 -2.393 . . . . 0.0 105.877 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.16 -19.55 56.69 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 50.39 31.21 5.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.602 2.361 . . . . 0.0 111.681 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -69.49 5.6 1.32 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.47 2.308 . . . . 0.0 113.842 -158.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 64.73 -63.67 0.17 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 112.753 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.325 3.05 . . . . 0.0 113.214 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -53.62 151.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.871 1.269 . . . . 0.0 110.85 167.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.53 -57.17 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.01 -156.2 15.98 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -127.77 144.86 51.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.81 124.03 51.26 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 175.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.606 HG13 HG13 ' A' ' 77' ' ' VAL . 3.0 mp -93.75 156.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 168.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -145.14 142.94 30.07 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.84 138.04 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.98 163.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.22 114.12 21.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 166.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.762 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 mt . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 117.6 -1.19 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.68 127.24 3.65 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.073 2.515 . . . . 0.0 109.355 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.57 -70.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.89 164.59 31.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.856 0.753 . . . . 0.0 110.251 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.22 126.39 55.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 167.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -104.44 162.81 12.92 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.862 1.665 . . . . 0.0 107.897 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.09 161.33 27.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.748 0.819 . . . . 0.0 109.568 174.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.72 -176.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.34 -71.41 0.23 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.6 t 155.04 -21.94 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 131.657 3.983 . . . . 0.0 109.841 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.9 p -135.03 20.15 3.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.358 1.435 . . . . 0.0 112.641 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.69 128.91 36.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 169.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.89 2.72 11.83 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.273 2.368 . . . . 0.0 112.651 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -138.84 127.68 23.6 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.264 -1.139 . . . . 0.0 109.222 166.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -142.06 164.34 30.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.885 1.674 . . . . 0.0 109.417 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.2 m -133.77 135.82 44.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.54 1.536 . . . . 0.0 107.547 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.88 155.62 4.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 164.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -137.31 170.05 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.075 0.95 . . . . 0.0 109.59 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.07 51.21 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.588 -0.695 . . . . 0.0 111.89 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 21' ' ' SER . 4.1 mm? -61.52 158.02 15.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 128.68 2.792 . . . . 0.0 106.782 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 80.84 39.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.036 1.734 . . . . 0.0 109.344 -170.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.56 124.67 11.4 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.947 1.765 . . . . 0.0 108.682 -169.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.47 -26.5 4.61 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 124.436 1.017 . . . . 0.0 113.488 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.21 166.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.827 1.651 . . . . 0.0 107.219 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.16 126.03 41.1 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.065 1.746 . . . . 0.0 107.244 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.4 126.8 54.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.633 0.773 . . . . 0.0 109.262 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.07 103.36 15.3 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 173.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.33 101.07 11.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.1 p -88.8 143.33 26.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.374 1.083 . . . . 0.0 109.678 173.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.606 HG13 HG13 ' A' ' 39' ' ' ILE . 39.2 t -139.09 119.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 -177.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 mt -124.69 141.18 45.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -98.59 136.42 38.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.77 132.96 55.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.362 1.065 . . . . 0.0 108.51 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 pt -130.09 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.155 1.782 . . . . 0.0 109.675 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -34.11 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.37 2.268 . . . . 0.0 110.021 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.85 53.7 0.05 OUTLIER Glycine 0 CA--C 1.526 0.772 0 C-N-CA 128.284 2.849 . . . . 0.0 113.604 -172.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.87 160.88 34.44 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 118.065 0.932 . . . . 0.0 111.459 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -139.2 146.11 40.12 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 126.326 1.85 . . . . 0.0 108.414 -168.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -84.51 -174.49 5.3 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.409 0.683 . . . . 0.0 110.472 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.65 134.58 93.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 166.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.83 132.57 32.98 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -118.69 111.15 18.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -124.7 152.16 44.07 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 92' ' ' THR . 1.4 tt -132.97 153.61 51.28 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 152.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.511 ' H ' HD23 ' A' ' 91' ' ' LEU . 4.3 t -112.8 135.1 53.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.53 114.5 12.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -85.78 111.85 20.54 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.251 1.148 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 C--O 1.238 0.466 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 125.61 12.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.466 2.111 . . . . 0.0 109.056 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.96 166.38 23.15 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 163.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.566 HD13 ' CG ' ' A' ' 26' ' ' TRP . 48.7 mt -66.57 88.68 0.14 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -66.86 -13.65 61.86 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.154 0.982 . . . . 0.0 109.19 171.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.14 4.49 50.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.07 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.94 121.08 11.5 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.073 -1.017 . . . . 0.0 110.027 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -146.83 165.57 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.218 1.007 . . . . 0.0 110.543 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 24' ' ' LEU . 75.0 m-85 -119.64 150.44 40.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.91 0.884 . . . . 0.0 108.895 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.94 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.961 2.104 . . . . 0.0 107.712 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 55.5 45.23 25.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.821 0.848 . . . . 0.0 110.182 161.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.29 56.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.791 2.036 . . . . 0.0 107.035 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.28 166.64 19.71 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -75.11 7.03 3.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.2 p -125.32 -10.13 6.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 115.18 -167.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.88 166.31 0.9 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 127.324 2.25 . . . . 0.0 109.162 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.89 128.41 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.23 150.28 23.6 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 1.1 mt -128.2 141.73 51.38 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.415 1.486 . . . . 0.0 107.994 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -124.88 142.23 51.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.566 ' CG ' HD13 ' A' ' 9' ' ' LEU . 44.2 p90 -156.78 -173.07 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 164.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -108.74 105.46 57.04 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.927 1.291 . . . . 0.0 108.719 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.43 124.67 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.957 2.438 . . . . 0.0 112.076 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.55 103.55 15.16 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.237 1.015 . . . . 0.0 108.797 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -80.61 49.12 1.13 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.564 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 m -61.93 -64.46 0.93 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.985 -166.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 p 156.69 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.828 2.451 . . . . 0.0 112.305 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.85 -4.38 1.77 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.655 1.982 . . . . 0.0 110.157 -163.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -43.19 134.88 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.184 -1.572 . . . . 0.0 109.724 146.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.56 -43.36 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 124.748 1.219 . . . . 0.0 110.26 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.89 -158.24 31.1 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -129.67 125.09 35.22 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 133.22 35.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 174.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.477 HG13 HG13 ' A' ' 77' ' ' VAL . 2.7 mp -110.3 149.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.8 m -140.82 158.83 43.39 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.425 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -138.54 125.59 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 103.908 -2.626 . . . . 0.0 103.908 178.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.31 162.81 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.601 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.68 108.02 19.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 123.222 0.609 . . . . 0.0 112.012 -175.542 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.1 mt . . . . . 0 CA--C 1.539 0.528 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.56 132.42 12.17 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.507 2.138 . . . . 0.0 110.324 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -83.75 -67.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -160.0 175.27 13.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.045 0.938 . . . . 0.0 109.567 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -122.02 123.41 41.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.436 1.494 . . . . 0.0 107.921 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -105.93 165.81 10.94 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.004 1.722 . . . . 0.0 109.968 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.48 163.17 28.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.202 1.001 . . . . 0.0 108.634 169.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 -176.63 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.67 -64.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -164.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 m 153.55 -13.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.735 4.014 . . . . 0.0 111.344 -169.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -135.97 13.49 3.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.985 0.811 . . . . 0.0 112.535 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.41 138.98 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.54 5.5 5.21 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.075 1.798 . . . . 0.0 112.93 173.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -146.04 124.81 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -145.95 162.93 36.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.656 1.583 . . . . 0.0 108.231 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -144.83 131.96 20.48 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.258 -0.901 . . . . 0.0 108.983 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.94 149.18 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 -170.67 2.13 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.902 1.681 . . . . 0.0 107.004 170.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.5 14.56 75.84 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 120.12 1.327 . . . . 0.0 112.758 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.99 153.74 38.39 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.741 0.816 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -122.16 115.77 30.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.938 1.695 . . . . 0.0 106.834 163.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.54 144.73 85.79 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.292 1.995 . . . . 0.0 110.833 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.0 -10.49 58.55 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.469 1.509 . . . . 0.0 113.729 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.87 151.02 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 119.706 1.753 . . . . 0.0 107.041 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -80.61 120.06 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.465 1.506 . . . . 0.0 108.488 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.45 120.29 37.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.158 1.383 . . . . 0.0 108.387 -168.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.78 90.66 7.37 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.034 1.734 . . . . 0.0 107.375 174.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 41' ' ' VAL . 1.8 mp -84.01 109.52 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -114.43 122.04 45.4 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.133 1.773 . . . . 0.0 111.341 -167.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 39' ' ' ILE . 59.7 t -134.19 132.32 55.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -164.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 tt -143.41 152.79 16.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.419 1.087 . . . . 0.0 111.216 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.3 m -105.29 134.04 49.07 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 106.894 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.78 134.06 55.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.637 1.575 . . . . 0.0 109.034 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -129.67 175.69 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.91 1.284 . . . . 0.0 107.585 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -46.33 110.02 0.24 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.522 0.601 . . . . 0.0 110.106 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.05 42.69 1.21 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 126.516 2.008 . . . . 0.0 113.392 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.72 144.62 12.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -133.45 118.53 18.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -161.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.22 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.92 133.44 41.31 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.896 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.66 109.76 1.72 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.038 2.492 . . . . 0.0 106.524 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -107.28 102.66 11.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.0 m -94.16 158.75 15.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 tt -132.22 101.92 5.57 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 153.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -84.92 119.19 25.08 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -136.72 153.15 50.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.419 1.487 . . . . 0.0 108.74 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.28 157.92 27.65 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 157.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.25 1.092 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.717 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -133.67 112.77 11.69 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 121.365 1.893 . . . . 0.0 108.363 170.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 51.92 -110.18 1.05 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 -168.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.5 p -134.4 162.88 30.99 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.968 1.707 . . . . 0.0 107.12 161.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -135.16 -77.75 0.44 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.554 1.07 . . . . 0.0 108.432 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.8 t -70.48 133.89 86.86 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.58 134.77 33.96 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.724 1.616 . . . . 0.0 109.803 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -112.64 160.96 17.36 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.031 2.132 . . . . 0.0 108.577 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.548 HD13 ' CG ' ' A' ' 26' ' ' TRP . 72.7 mt -70.05 87.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.133 0.973 . . . . 0.0 108.686 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.54 -3.9 30.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.468 1.107 . . . . 0.0 111.249 -172.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.57 6.79 15.91 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.62 1.968 . . . . 0.0 112.937 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -52.23 110.99 0.55 Allowed 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.243 1.417 . . . . 0.0 109.172 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.9 m -155.15 165.14 37.61 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.984 0.914 . . . . 0.0 111.964 170.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 12.1 m-30 -110.95 149.97 29.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.198 1.399 . . . . 0.0 109.626 -162.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.93 175.76 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 128.248 2.619 . . . . 0.0 108.207 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 t70 46.1 52.91 9.78 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.827 2.051 . . . . 0.0 110.618 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.2 52.38 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 127.361 2.265 . . . . 0.0 108.468 -166.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 20' ' ' SER . 14.6 t -77.31 175.2 9.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.042 1.337 . . . . 0.0 110.125 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.61 -5.53 53.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.316 1.046 . . . . 0.0 111.455 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.45 ' H ' HG23 ' A' ' 18' ' ' THR . 58.6 p -122.72 -8.33 8.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.63 1.972 . . . . 0.0 114.732 -162.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 p -175.11 175.01 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.04 2.536 . . . . 0.0 108.014 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.9 123.13 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 134.94 11.88 Favored Glycine 0 N--CA 1.467 0.75 0 O-C-N 120.415 -1.428 . . . . 0.0 110.043 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.81 155.43 20.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.845 1.322 . . . . 0.0 108.248 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.01 145.27 50.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 162.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.548 ' CG ' HD13 ' A' ' 9' ' ' LEU . 17.0 p90 -157.79 173.64 16.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.526 1.131 . . . . 0.0 109.472 166.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.0 m -90.99 142.6 27.56 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.642 1.11 . . . . 0.0 108.561 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -81.45 125.26 5.0 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-N 120.004 1.037 . . . . 0.0 111.997 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.7 mt -96.22 88.65 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.209 1.804 . . . . 0.0 110.431 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -79.73 40.49 0.45 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.755 -0.591 . . . . 0.0 111.077 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -35.03 -64.26 0.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.1 p 159.31 -22.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 128.745 2.818 . . . . 0.0 112.761 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 34' ' ' ILE . 0.8 OUTLIER -165.06 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.592 -1.317 . . . . 0.0 111.273 -153.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.401 ' H ' ' H ' ' A' ' 33' ' ' THR . 5.1 tt -43.27 144.04 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.584 1.554 . . . . 0.0 109.479 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.467 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.2 mp -83.88 -49.47 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.38 -158.2 28.38 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.51 140.38 52.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 166.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.8 112.46 20.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.56 144.34 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.6 m -131.51 152.59 50.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.19 145.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 123.8 0.84 . . . . 0.0 111.674 165.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.44 164.47 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.57 99.84 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.4 121.58 11.21 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.43 1.092 . . . . 0.0 109.475 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.37 -33.18 2.61 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -168.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -138.81 175.96 9.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.022 1.329 . . . . 0.0 108.31 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.04 9.06 78.59 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-O 117.935 -1.48 . . . . 0.0 113.142 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.3 mt -45.69 105.53 0.47 Allowed Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 119.191 1.496 . . . . 0.0 110.257 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.77 165.24 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.96 2.44 . . . . 0.0 109.718 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -122.81 -82.79 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -148.44 163.55 36.81 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.579 1.081 . . . . 0.0 109.774 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.77 123.82 48.1 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 164.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -106.61 156.62 18.4 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.13 1.772 . . . . 0.0 108.126 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.445 ' CZ ' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -126.86 153.73 45.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.817 0.847 . . . . 0.0 109.212 -178.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.32 -176.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.81 -61.5 1.76 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.618 -157.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.4 p 154.19 -22.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 131.14 3.776 . . . . 0.0 109.902 -172.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -123.62 7.55 8.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.904 2.082 . . . . 0.0 111.926 -163.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -74.48 139.31 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.505 1.122 . . . . 0.0 109.638 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.59 -5.65 18.33 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 123.996 0.807 . . . . 0.0 114.638 158.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -139.68 121.12 15.06 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.848 -1.383 . . . . 0.0 110.108 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -134.15 167.41 20.71 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.5 m -142.24 118.54 10.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.626 -1.296 . . . . 0.0 108.256 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -84.48 143.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 -171.83 2.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.15 69.29 Favored Glycine 0 CA--C 1.522 0.476 0 O-C-N 120.772 -1.205 . . . . 0.0 112.166 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.67 165.34 18.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.809 0.804 . . . . 0.0 110.589 165.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -134.3 135.09 23.38 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 126.731 2.012 . . . . 0.0 107.879 159.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.84 165.44 25.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.376 2.05 . . . . 0.0 112.451 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.22 -28.6 8.58 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 126.906 2.193 . . . . 0.0 111.746 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.2 mm -115.67 165.19 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -96.09 143.0 27.61 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -123.74 128.05 49.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.36 95.2 9.92 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -84.95 104.5 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m -88.09 147.87 24.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.26 1.024 . . . . 0.0 110.313 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.9 t -145.46 77.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.33 133.92 28.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.6 m -94.47 136.96 34.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.467 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -133.48 113.53 12.59 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.609 1.164 . . . . 0.0 107.95 -178.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -109.3 -175.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.117 1.767 . . . . 0.0 108.696 -173.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -34.58 104.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.092 1.357 . . . . 0.0 110.848 163.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.69 29.25 5.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.61 1.576 . . . . 0.0 115.005 170.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.37 144.48 9.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.342 1.571 . . . . 0.0 110.925 -173.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -110.78 142.12 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.763 2.025 . . . . 0.0 106.534 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.79 174.41 10.46 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.84 0.746 . . . . 0.0 109.362 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.59 135.86 92.82 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.2 128.98 22.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 N-CA-C 107.805 -1.652 . . . . 0.0 107.805 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.4 m -122.6 99.4 6.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.9 m -94.23 163.41 13.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 5.4 mt -132.87 136.16 46.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 164.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 m -84.74 127.87 34.32 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.641 1.976 . . . . 0.0 106.23 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -154.86 147.4 24.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.766 1.166 . . . . 0.0 109.301 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.62 168.01 11.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.293 1.044 . . . . 0.0 110.638 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.251 1.133 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 177.903 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptt? . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -144.19 162.71 35.64 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 120.868 1.667 . . . . 0.0 110.858 -169.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.87 141.44 47.51 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.1 68.98 0.55 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.373 1.869 . . . . 0.0 110.76 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.35 -60.04 2.78 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.068 1.347 . . . . 0.0 110.326 -170.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -139.72 134.09 15.92 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 164.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.99 143.93 20.94 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.174 2.582 . . . . 0.0 111.705 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -94.29 174.68 7.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.432 1.893 . . . . 0.0 111.795 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.46 HD13 ' CG ' ' A' ' 26' ' ' TRP . 61.6 mt -77.64 85.39 3.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 166.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m -56.28 -35.29 67.31 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.582 -0.698 . . . . 0.0 110.201 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -74.21 5.99 3.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.484 2.314 . . . . 0.0 113.006 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.07 110.71 0.87 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.178 0.991 . . . . 0.0 111.075 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -125.89 164.45 20.74 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.86 0.864 . . . . 0.0 110.28 162.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 10.5 m-85 -90.73 166.16 13.28 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 155.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.61 177.21 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 127.287 2.235 . . . . 0.0 105.48 168.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 56.25 56.98 5.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.172 1.389 . . . . 0.0 110.355 161.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.8 mm -78.77 59.82 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -69.07 173.63 5.33 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.408 -1.432 . . . . 0.0 109.945 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -98.88 22.11 10.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.649 1.179 . . . . 0.0 111.675 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -121.47 -13.73 8.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.263 1.425 . . . . 0.0 114.491 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p 170.48 171.96 0.06 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.032 2.133 . . . . 0.0 107.928 -154.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 tt -137.44 147.63 26.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 166.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.53 163.74 23.98 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.12 159.25 36.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.399 1.48 . . . . 0.0 108.515 168.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -143.66 136.04 26.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.46 ' CG ' HD13 ' A' ' 9' ' ' LEU . 9.8 p90 -154.66 -177.5 6.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.267 1.027 . . . . 0.0 109.667 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -107.11 106.13 57.48 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.41 130.99 28.36 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.0 1.8 . . . . 0.0 110.029 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 31' ' ' SER . 2.2 mt -94.18 89.26 5.91 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.845 2.458 . . . . 0.0 105.018 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.55 50.38 0.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' LEU . 4.2 m -81.85 124.16 29.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.082 1.753 . . . . 0.0 109.847 168.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -63.39 38.52 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 130.159 3.384 . . . . 0.0 114.786 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -169.27 -12.42 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.823 2.049 . . . . 0.0 110.371 -171.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.62 161.06 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.091 1.356 . . . . 0.0 108.809 162.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mt -109.91 -59.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 168.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.71 -164.73 33.39 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' CD1' HD11 ' A' ' 9' ' ' LEU . 5.1 m-85 -131.21 145.39 51.91 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.83 130.16 56.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.924 1.69 . . . . 0.0 106.975 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.63 133.15 61.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.7 m -128.67 138.56 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.82 123.23 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.487 1.515 . . . . 0.0 108.335 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.19 163.44 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 124.025 0.828 . . . . 0.0 109.304 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 106.24 17.52 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.09 99.29 0.35 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.499 1.52 . . . . 0.0 109.089 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.06 -18.82 2.91 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.075 -1.403 . . . . 0.0 113.305 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -131.88 -5.42 3.57 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.876 1.338 . . . . 0.0 111.159 168.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.25 -1.24 43.12 Favored Glycine 0 C--N 1.34 0.803 0 O-C-N 121.192 -0.943 . . . . 0.0 113.346 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mt -43.09 106.13 0.46 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 128.261 2.624 . . . . 0.0 109.998 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.57 126.85 13.93 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 122.175 1.917 . . . . 0.0 107.494 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 mm -84.06 -82.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -148.21 175.68 10.86 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.023 -1.048 . . . . 0.0 109.763 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.11 159.83 31.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 166.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -148.96 164.86 33.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.622 1.969 . . . . 0.0 107.465 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.98 153.82 43.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.341 0.656 . . . . 0.0 109.602 -173.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.16 -177.38 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.916 0.78 . . . . 0.0 110.752 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.0 -60.45 2.29 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p 153.64 -41.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 1 C-N-CA 132.504 4.322 . . . . 0.0 107.878 -171.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.6 p -102.48 -1.13 31.2 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.965 1.706 . . . . 0.0 112.902 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.36 129.81 36.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 124.759 1.223 . . . . 0.0 108.24 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.78 -5.92 21.66 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 125.268 1.413 . . . . 0.0 113.315 172.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -140.25 116.15 10.33 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.301 1.44 . . . . 0.0 108.321 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.4 136.59 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.3 m -112.19 124.79 53.2 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.13 165.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.98 1.712 . . . . 0.0 107.629 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.15 -174.29 3.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.45 36.46 30.18 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.089 0.859 . . . . 0.0 112.536 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.03 162.84 13.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.934 1.293 . . . . 0.0 110.449 171.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.93 135.19 10.81 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.95 2.5 . . . . 0.0 104.916 162.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.91 170.29 18.3 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.754 2.303 . . . . 0.0 113.099 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.49 -4.83 70.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.772 0.701 . . . . 0.0 113.848 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.9 mm -129.44 147.79 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.944 1.698 . . . . 0.0 106.885 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -84.01 142.85 30.18 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.78 113.69 11.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.301 1.84 . . . . 0.0 106.432 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.21 103.17 13.19 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.921 1.688 . . . . 0.0 107.086 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.449 HG23 HG13 ' A' ' 41' ' ' VAL . 1.5 mp -92.23 107.7 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 80.7 p -92.78 143.56 26.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 124.289 1.036 . . . . 0.0 110.957 172.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -138.46 119.19 16.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mt -117.83 129.67 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.0 m -89.77 132.43 35.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.72 126.74 48.14 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.19 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.69 108.72 0.07 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.476 1.91 . . . . 0.0 110.339 169.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.75 26.13 1.05 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.741 1.638 . . . . 0.0 115.543 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.03 159.44 28.04 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.69 1.745 . . . . 0.0 111.688 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.61 141.6 49.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.137 1.775 . . . . 0.0 108.645 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -85.32 -172.62 4.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.741 0.816 . . . . 0.0 110.252 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.91 136.03 93.23 Favored Pre-proline 0 C--O 1.24 0.578 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.427 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.2 87.45 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.031 3.154 . . . . 0.0 108.482 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.2 m -84.72 92.13 8.12 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -164.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 76' ' ' SER . 1.4 m -94.56 150.4 20.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 69.8 mt -134.88 144.47 47.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 160.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.23 129.2 49.59 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -170.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -153.57 130.41 10.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 107.573 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -77.07 137.5 38.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 163.593 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -68.16 22.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 117.109 2.263 . . . . 0.0 117.109 -164.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 67.88 61.72 4.75 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -170.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -171.26 75.05 0.06 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -171.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' H ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -135.78 -106.06 0.21 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.441 177.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.429 ' H ' ' HB3' ' A' ' 5' ' ' GLU . 90.1 t -92.19 133.87 29.43 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.38 141.69 39.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.683 1.588 . . . . 0.0 109.429 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.08 161.53 15.81 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 127.127 2.171 . . . . 0.0 110.404 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 37' ' ' TYR . 67.3 mt -66.93 83.89 0.11 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.132 0.973 . . . . 0.0 109.375 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 m -71.91 1.0 7.82 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.884 1.674 . . . . 0.0 111.175 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -111.74 4.34 18.41 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.317 2.647 . . . . 0.0 111.693 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.67 114.81 4.21 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.563 1.945 . . . . 0.0 110.195 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -151.11 164.84 35.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.617 0.767 . . . . 0.0 111.19 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 10.3 m-30 -97.29 160.12 14.52 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.511 -0.743 . . . . 0.0 109.212 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.4 170.6 4.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.841 1.656 . . . . 0.0 107.526 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.7 47.83 17.69 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.836 1.654 . . . . 0.0 109.706 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -80.45 63.01 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -72.18 165.05 25.17 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 161.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -74.51 -3.05 28.53 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.331 -0.856 . . . . 0.0 111.212 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.2 p -105.51 -16.17 14.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.05 153.18 0.22 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 127.212 2.205 . . . . 0.0 107.924 -169.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.7 138.39 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.79 156.6 23.14 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 171.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.1 mp -122.59 154.52 37.84 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -137.8 139.93 40.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.418 ' CG ' HD13 ' A' ' 9' ' ' LEU . 36.4 p90 -152.95 175.0 13.42 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.073 0.949 . . . . 0.0 108.555 167.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -92.36 107.49 24.0 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.019 1.327 . . . . 0.0 108.094 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -62.3 134.68 49.87 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.991 -1.196 . . . . 0.0 108.991 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -88.88 -30.04 19.18 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.425 -1.274 . . . . 0.0 112.867 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 p30 42.43 37.69 1.02 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.607 1.192 . . . . 0.0 112.298 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -62.43 170.24 2.5 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 0.0 110.139 -167.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 p -67.66 -2.2 6.47 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.08 -4.16 0.06 Allowed 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.401 -1.437 . . . . 0.0 112.925 -164.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.77 145.22 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 163.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.61 -65.94 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 160.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.61 -154.15 12.37 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -163.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.527 ' CD2' HD11 ' A' ' 9' ' ' LEU . 3.4 m-85 -136.24 144.01 44.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -118.9 123.13 43.9 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.421 HG13 HG13 ' A' ' 77' ' ' VAL . 3.0 mp -103.83 146.87 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 m -145.77 112.45 5.94 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.338 1.455 . . . . 0.0 108.699 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.14 131.69 43.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.718 0.807 . . . . 0.0 110.703 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.2 164.23 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.75 114.21 20.94 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.75 -6.04 3.29 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.285 1.434 . . . . 0.0 113.315 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.43 -17.08 47.31 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.583 -1.121 . . . . 0.0 114.726 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -150.83 17.04 0.78 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.691 1.745 . . . . 0.0 111.742 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.62 1.52 8.71 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.836 -1.165 . . . . 0.0 114.407 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.7 mt -45.55 106.24 0.53 Allowed Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 127.778 2.431 . . . . 0.0 109.743 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.28 124.02 8.14 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.932 2.421 . . . . 0.0 110.111 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.29 -59.63 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.9 169.22 18.45 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.193 0.906 . . . . 0.0 110.787 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -106.83 157.0 18.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.411 1.484 . . . . 0.0 108.4 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -152.42 166.06 33.12 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.314 1.446 . . . . 0.0 107.828 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.76 161.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.854 1.262 . . . . 0.0 109.979 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.91 -176.39 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 125.768 1.627 . . . . 0.0 107.744 172.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -83.69 -61.96 1.7 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.971 -162.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.6 t 155.23 -43.07 0.01 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 130.534 3.534 . . . . 0.0 107.868 -166.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -97.86 -5.73 33.99 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.242 1.417 . . . . 0.0 113.816 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.89 126.05 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.33 -5.58 37.08 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 127.591 2.519 . . . . 0.0 111.637 163.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -137.76 114.22 10.31 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.296 -1.708 . . . . 0.0 110.573 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.438 ' CD2' HD13 ' A' ' 24' ' ' LEU . 7.4 t80 -139.21 159.24 42.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.315 1.846 . . . . 0.0 107.719 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 m -147.08 151.21 36.5 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.04 145.78 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -168.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.36 -176.4 3.5 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.8 68.75 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 120.526 -1.359 . . . . 0.0 113.565 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.02 144.67 56.91 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -123.45 98.11 41.45 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.37 166.07 29.57 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.188 1.925 . . . . 0.0 112.609 -159.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.21 -4.67 80.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 125.001 1.286 . . . . 0.0 113.436 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.44 152.21 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -79.0 111.58 15.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.35 124.44 52.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.14 1.376 . . . . 0.0 109.389 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.33 126.58 33.33 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 169.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 3.0 mp -110.52 96.43 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.76 133.1 34.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.617 1.567 . . . . 0.0 108.617 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.421 HG13 HG13 ' A' ' 39' ' ' ILE . 21.5 t -141.9 130.5 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -134.85 147.75 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 37' ' ' TYR . 21.7 m -94.24 137.69 33.12 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.73 128.43 55.27 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.379 . . . . 0.0 107.541 -175.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 pt -134.23 177.27 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.966 0.906 . . . . 0.0 108.588 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.69 110.43 0.13 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.821 0.848 . . . . 0.0 111.264 169.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.74 21.72 7.53 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.488 1.994 . . . . 0.0 114.708 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 157.33 29.75 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 119.583 1.691 . . . . 0.0 110.992 -161.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.041 0.937 . . . . 0.0 109.9 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 m -84.3 -172.6 4.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.03 0.919 . . . . 0.0 111.015 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.63 96.24 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.19 130.49 16.5 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.268 1.979 . . . . 0.0 108.783 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.2 m -103.61 107.92 18.98 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 165.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.9 m -111.93 84.69 2.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 mt -77.64 153.04 33.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.77 139.76 50.26 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -147.88 130.42 15.85 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.939 0.896 . . . . 0.0 109.725 157.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -72.49 122.47 21.34 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 154.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.017 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 163.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -164.4 -28.64 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.018 -1.051 . . . . 0.0 110.754 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.71 -124.62 1.11 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 174.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -78.18 -165.24 0.64 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.37 1.068 . . . . 0.0 109.516 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -99.14 -80.27 0.47 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.019 163.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.7 t -119.18 132.93 23.77 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 168.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.0 133.46 8.97 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.608 2.872 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.46 174.89 6.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.75 1.22 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.5 mt -67.9 75.85 0.21 Allowed 'General case' 0 C--N 1.34 0.152 0 C-N-CA 125.988 1.715 . . . . 0.0 109.523 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.8 m -54.13 -27.24 32.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.748 1.619 . . . . 0.0 110.465 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -83.51 -0.29 49.63 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 114.759 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.0 115.51 2.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.317 1.047 . . . . 0.0 110.904 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.4 165.19 28.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.69 1.596 . . . . 0.0 110.338 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -117.57 154.06 32.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.413 1.485 . . . . 0.0 108.341 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.78 171.19 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.061 1.744 . . . . 0.0 107.782 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 51.11 52.15 15.53 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 126.24 1.816 . . . . 0.0 110.767 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -78.83 55.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.923 2.489 . . . . 0.0 108.591 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -69.12 167.31 16.35 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.449 -1.407 . . . . 0.0 111.451 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -74.61 6.04 4.23 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.427 1.491 . . . . 0.0 111.846 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -125.7 -12.7 6.57 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 p -174.89 159.73 2.76 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.702 1.201 . . . . 0.0 109.42 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 tt -118.21 141.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.16 153.97 21.66 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.72 151.36 39.64 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 126.309 1.844 . . . . 0.0 107.81 169.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -142.32 138.18 31.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -154.13 -170.87 3.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.547 0.689 . . . . 0.0 109.308 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.8 m -106.05 105.53 53.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.773 1.229 . . . . 0.0 107.795 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -66.05 133.96 35.19 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.077 1.851 . . . . 0.0 110.841 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mp -94.93 104.58 16.47 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 125.893 1.677 . . . . 0.0 109.833 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.33 41.44 0.18 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.015 1.326 . . . . 0.0 110.532 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.6 m -65.3 155.29 35.69 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 160.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -77.5 -50.25 13.03 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.581 0.705 . . . . 0.0 110.791 166.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.39 -24.5 57.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.091 1.357 . . . . 0.0 113.272 -161.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.31 136.51 6.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 126.573 1.949 . . . . 0.0 108.247 171.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.35 -64.87 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.18 -161.88 26.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -171.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.47 146.42 50.81 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 171.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.67 127.35 46.13 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.07 145.62 13.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.8 m -134.89 121.35 20.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.537 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.4 125.9 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.64 164.31 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.82 129.92 38.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 172.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.79 -23.26 62.35 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.725 -0.61 . . . . 0.0 110.134 166.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.89 -45.24 96.59 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 123.444 0.545 . . . . 0.0 112.246 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -155.3 141.65 18.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.53 19.12 0.4 Allowed Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.732 2.11 . . . . 0.0 115.343 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.5 mt -46.13 106.68 0.59 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.484 1.914 . . . . 0.0 109.569 151.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.93 156.4 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.51 1.473 . . . . 0.0 109.308 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 mm -93.64 -80.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 166.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -156.39 175.8 13.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.464 1.506 . . . . 0.0 109.659 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -126.72 161.96 26.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.207 1.003 . . . . 0.0 109.587 168.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -150.81 167.11 28.47 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.674 1.59 . . . . 0.0 110.458 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.44 160.16 32.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.743 1.217 . . . . 0.0 109.056 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -177.77 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.65 -61.5 1.82 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -157.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.0 p 166.29 -29.42 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 130.546 3.538 . . . . 0.0 111.42 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -136.26 28.37 3.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.408 0.623 . . . . 0.0 111.298 -177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -73.36 136.51 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.19 -5.15 17.54 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 124.221 0.915 . . . . 0.0 113.822 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -145.5 128.17 16.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.133 1.773 . . . . 0.0 106.612 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -139.56 159.83 41.26 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.968 -1.082 . . . . 0.0 108.892 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.0 m -131.92 136.68 47.56 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.634 1.174 . . . . 0.0 108.645 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 t -115.13 131.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 126.404 1.882 . . . . 0.0 106.201 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -99.95 -167.76 1.5 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 165.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.7 32.2 61.79 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 121.013 -1.055 . . . . 0.0 110.95 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.25 157.72 15.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 107.968 166.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -144.7 119.93 5.93 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.11 175.54 6.5 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.233 2.622 . . . . 0.0 113.176 -167.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.53 61.44 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.154 -0.803 . . . . 0.0 114.217 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mm -118.01 149.95 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.1 141.02 34.71 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.67 120.74 31.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.756 2.022 . . . . 0.0 108.209 -166.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.59 106.17 15.95 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.537 HG23 HG13 ' A' ' 41' ' ' VAL . 1.8 mp -93.48 108.21 20.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -93.58 139.28 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.813 1.245 . . . . 0.0 109.178 172.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.39 109.22 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -106.64 134.17 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 m -94.66 134.56 37.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.17 129.1 51.98 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 107.73 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 pt -116.63 179.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -39.64 112.75 0.28 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 118.36 -0.829 . . . . 0.0 109.577 169.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.79 60.7 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 C-N-CA 127.054 2.264 . . . . 0.0 113.381 -176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -166.91 144.97 9.47 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -122.99 140.58 52.88 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.107 1.363 . . . . 0.0 108.018 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -84.82 -170.5 3.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.707 0.765 . . . . 0.0 110.716 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.83 134.73 96.13 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 160.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.77 107.56 2.47 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.33 2.686 . . . . 0.0 110.566 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.64 106.62 16.33 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -175.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.5 m -115.29 132.88 56.47 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 mt -124.83 107.44 10.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.06 144.6 33.03 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.702 1.601 . . . . 0.0 108.955 174.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -165.63 160.63 17.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.971 0.909 . . . . 0.0 110.738 163.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -93.19 112.37 24.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.255 1.344 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -169.816 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.5 mtt . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.59 145.16 40.24 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 120.296 1.407 . . . . 0.0 110.008 169.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.26 77.47 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.5 p -137.26 141.65 41.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.363 0.582 . . . . 0.0 110.483 165.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -77.18 -100.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.2 t -133.21 135.02 24.83 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 127.431 2.293 . . . . 0.0 104.838 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.74 121.1 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.52 2.147 . . . . 0.0 109.677 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.41 171.05 15.23 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.615 0.766 . . . . 0.0 109.908 163.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.0 mt -76.35 86.13 3.12 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -60.61 -20.31 60.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.117 0.567 . . . . 0.0 111.762 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.85 1.85 57.07 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.896 1.226 . . . . 0.0 112.255 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -54.29 116.23 2.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.225 1.41 . . . . 0.0 110.547 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 m -142.98 159.24 42.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.639 1.576 . . . . 0.0 109.648 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 9.6 m-30 -106.84 155.17 20.02 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.74 173.21 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 129.13 2.972 . . . . 0.0 108.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.9 t0 43.9 58.87 3.4 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.434 1.094 . . . . 0.0 111.689 171.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 mm -76.1 48.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 108.269 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -69.76 166.99 18.1 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.745 -1.222 . . . . 0.0 108.898 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.95 -4.76 37.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.353 -1.467 . . . . 0.0 112.211 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 p -119.56 -10.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.233 1.813 . . . . 0.0 114.79 -168.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.81 168.36 2.1 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.618 1.167 . . . . 0.0 109.916 -167.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.1 tt -135.98 135.05 50.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.6 162.58 26.78 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.7 mp -135.2 148.54 49.69 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.922 1.289 . . . . 0.0 108.42 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.36 145.55 51.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 164.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -153.97 179.94 8.44 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -100.42 141.87 23.54 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -75.95 123.92 7.67 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.525 1.483 . . . . 0.0 109.06 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.06 -41.09 26.34 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.091 0.957 . . . . 0.0 112.697 -177.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 p30 37.86 48.61 1.03 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 126.282 1.833 . . . . 0.0 113.175 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 m -54.26 -62.84 1.4 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.501 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 p -178.45 -104.45 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.39 1.076 . . . . 0.0 108.824 -168.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.1 -4.4 44.22 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.936 2.095 . . . . 0.0 110.268 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.21 128.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 126.797 2.039 . . . . 0.0 112.857 173.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.49 -61.7 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.7 -160.89 25.53 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.142 -1.027 . . . . 0.0 112.277 -170.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -130.39 139.68 50.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.67 114.52 20.69 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.552 HG13 HG13 ' A' ' 77' ' ' VAL . 3.3 mp -92.69 144.62 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.2 m -138.39 127.85 24.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.3 144.87 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 118.731 0.696 . . . . 0.0 110.081 163.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.51 164.79 30.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 167.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.06 125.1 28.85 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.31 95.37 0.43 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 163.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.46 -17.48 3.31 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.1 -0.833 . . . . 0.0 114.562 172.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -145.34 154.54 42.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.544 1.672 . . . . 0.0 108.436 162.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.54 12.49 1.92 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.218 0.913 . . . . 0.0 113.837 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.9 mt -45.53 105.13 0.44 Allowed Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 129.333 3.053 . . . . 0.0 109.176 166.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -89.87 157.51 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.869 2.38 . . . . 0.0 110.757 171.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mm -133.43 65.76 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.432 1.9 p90 54.59 175.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.909 1.284 . . . . 0.0 114.318 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -129.14 125.32 36.83 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -105.45 163.63 12.49 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.83 162.41 31.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.015 1.326 . . . . 0.0 107.984 175.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.38 -177.35 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 171.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -61.42 -66.07 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.297 0.639 . . . . 0.0 110.876 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 157.22 -41.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 128.452 2.701 . . . . 0.0 108.534 -157.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.8 p -121.35 15.71 11.33 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.449 -1.407 . . . . 0.0 110.024 -164.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.9 t -74.85 141.26 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.746 0.818 . . . . 0.0 110.325 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.48 0.49 14.1 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.431 1.491 . . . . 0.0 114.473 160.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -145.55 128.38 16.34 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.654 1.227 . . . . 0.0 110.077 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.442 ' CD2' HD13 ' A' ' 24' ' ' LEU . 13.7 t80 -149.59 169.06 21.82 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.654 1.182 . . . . 0.0 109.802 -176.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -151.49 140.35 20.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.616 1.567 . . . . 0.0 109.842 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.58 152.62 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 125.941 1.696 . . . . 0.0 108.147 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 66' ' ' GLY . 22.1 m -134.45 -170.1 2.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.922 1.689 . . . . 0.0 106.627 172.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.67 ' H ' HG22 ' A' ' 65' ' ' THR . . . 67.64 25.75 73.89 Favored Glycine 0 CA--C 1.527 0.788 0 O-C-N 121.045 -1.034 . . . . 0.0 111.911 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.75 164.73 21.52 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.24 1.816 . . . . 0.0 108.744 164.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.03 104.61 10.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 127.624 2.37 . . . . 0.0 107.523 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.17 140.2 44.28 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.427 2.085 . . . . 0.0 112.41 -163.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.27 -8.26 55.16 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 126.51 2.005 . . . . 0.0 112.711 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.1 mp -88.8 158.52 2.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 162.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -98.74 129.31 45.18 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.35 1.86 . . . . 0.0 106.901 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -120.24 133.85 55.39 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.162 0.985 . . . . 0.0 108.745 -170.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.29 116.45 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 160.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.82 104.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -92.81 145.02 24.71 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.338 1.455 . . . . 0.0 111.177 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.552 HG13 HG13 ' A' ' 39' ' ' ILE . 23.2 t -145.18 97.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.2 mt -100.74 129.76 51.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.4 m -92.99 125.98 37.84 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.44 123.35 39.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.667 1.587 . . . . 0.0 108.478 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.85 -164.85 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.159 1.383 . . . . 0.0 109.463 -170.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -39.56 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.551 0.74 . . . . 0.0 111.964 157.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.1 31.35 4.36 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.437 1.97 . . . . 0.0 114.306 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.66 144.59 11.83 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 119.162 1.481 . . . . 0.0 110.144 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.14 142.49 39.83 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.338 1.455 . . . . 0.0 108.447 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.18 -176.96 6.39 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 169.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.62 151.33 92.31 Favored Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.77 103.96 0.92 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.615 2.21 . . . . 0.0 108.471 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.5 m -84.06 97.92 9.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 171.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -122.87 126.31 47.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 4.8 mt -119.36 143.28 47.5 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 m -100.82 110.33 22.4 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -108.35 123.45 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.207 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -75.51 134.12 40.86 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 149.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.248 0.994 0 C-N-CA 125.345 1.458 . . . . 0.0 107.424 -178.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.05 178.22 9.67 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 165.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 114.85 -149.44 18.85 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.0 p -69.16 93.66 0.62 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.32 -64.93 0.77 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.043 1.337 . . . . 0.0 109.642 -169.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.2 133.96 20.6 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.24 128.51 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.498 2.132 . . . . 0.0 111.591 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -104.77 178.09 4.66 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 127.776 2.431 . . . . 0.0 110.356 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.452 HD13 ' CG ' ' A' ' 26' ' ' TRP . 96.3 mt -80.04 83.32 5.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.326 1.05 . . . . 0.0 110.232 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -65.03 -21.35 66.82 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.76 1.624 . . . . 0.0 113.561 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -97.85 8.38 44.81 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.06 1.744 . . . . 0.0 111.633 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.22 102.25 0.21 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 109.299 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -135.74 132.01 36.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.53 1.132 . . . . 0.0 109.194 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.81 157.14 35.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.94 165.09 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 124.422 1.089 . . . . 0.0 108.672 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 49.92 44.58 25.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.921 1.688 . . . . 0.0 109.689 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.74 65.87 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 129.493 3.117 . . . . 0.0 106.762 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -57.96 166.99 1.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.494 1.517 . . . . 0.0 109.717 162.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.85 3.39 8.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.391 1.476 . . . . 0.0 112.517 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.0 p -117.51 -13.66 10.31 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -172.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.14 161.96 0.78 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.547 1.539 . . . . 0.0 110.088 -162.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.6 tt -130.22 125.85 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.81 159.2 34.27 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mp -136.71 138.96 41.57 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 126.698 1.999 . . . . 0.0 107.422 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.3 mtp-105 -112.12 157.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 160.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.452 ' CG ' HD13 ' A' ' 9' ' ' LEU . 41.2 p90 -162.02 -173.75 3.81 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.982 2.513 . . . . 0.0 106.98 160.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.78 142.15 24.19 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 120.682 1.583 . . . . 0.0 107.885 171.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -75.13 124.41 8.52 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.673 1.582 . . . . 0.0 108.631 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.68 83.18 6.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -75.76 43.55 0.26 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.629 0.649 . . . . 0.0 111.344 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.4 p -47.86 -60.73 2.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.404 1.082 . . . . 0.0 113.393 -165.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 p 165.99 -61.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.109 0.964 . . . . 0.0 110.141 -152.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.48 -3.46 0.72 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.541 1.936 . . . . 0.0 109.52 -156.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -34.12 121.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.86 1.664 . . . . 0.0 110.71 164.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.28 -56.22 5.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.32 -160.55 21.1 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -127.88 151.31 49.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 164.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 114.85 20.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.905 1.682 . . . . 0.0 107.501 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.49 142.57 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -145.4 113.18 6.38 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.43 130.57 56.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.175 1.39 . . . . 0.0 109.982 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 164.01 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.28 109.17 20.27 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 41.71 -151.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.428 1.891 . . . . 0.0 111.425 -170.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.26 8.88 15.29 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.654 1.121 . . . . 0.0 113.914 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.14 173.49 9.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.388 1.594 . . . . 0.0 109.503 -166.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.35 -34.77 75.91 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.771 169.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.2 mt -45.0 101.21 0.25 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 127.815 2.446 . . . . 0.0 111.383 -172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.65 156.3 35.72 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.077 2.518 . . . . 0.0 108.927 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.52 -61.86 2.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 166.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 53' ' ' ASP . 78.1 t80 -160.49 158.67 29.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.447 0.699 . . . . 0.0 109.681 -163.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.61 141.75 30.76 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.419 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 1.7 p30 -143.84 166.59 24.49 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.85 1.26 . . . . 0.0 110.652 178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.53 154.65 47.59 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.417 -1.72 . . . . 0.0 106.868 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -176.91 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.451 1.101 . . . . 0.0 108.286 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.51 -63.11 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -165.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p 152.42 -39.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 1 C-N-CA 132.684 4.393 . . . . 0.0 107.736 -173.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.1 p -88.57 1.41 55.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.672 1.189 . . . . 0.0 112.625 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.12 134.56 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 125.366 1.466 . . . . 0.0 108.026 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.91 1.6 9.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 0.0 112.963 162.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -143.19 125.82 15.91 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.183 1.393 . . . . 0.0 107.782 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -141.49 165.1 28.42 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 170.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.5 m -141.72 125.8 17.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -93.99 152.96 3.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.862 1.665 . . . . 0.0 107.263 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -157.92 0.75 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 173.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.51 38.39 90.97 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 120.214 1.37 . . . . 0.0 112.353 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.21 154.92 30.3 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.18 1.792 . . . . 0.0 107.482 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.87 107.08 4.59 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 125.629 1.572 . . . . 0.0 107.285 -173.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.58 176.18 9.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.651 2.9 . . . . 0.0 113.454 -163.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.53 4.38 Favored Glycine 0 C--N 1.34 0.77 0 C-N-CA 124.705 1.145 . . . . 0.0 112.099 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.85 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 170.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -74.51 136.11 42.2 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.245 1.818 . . . . 0.0 108.894 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -122.39 141.58 51.43 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.86 111.05 22.53 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.42 101.49 12.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.1 m -94.91 144.53 25.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.566 1.146 . . . . 0.0 110.504 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.9 t -139.55 98.3 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm -89.29 139.83 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.8 m -105.37 133.83 49.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.51 127.73 41.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 pt -134.7 -167.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 110.319 -172.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -34.72 110.92 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.813 2.045 . . . . 0.0 110.531 166.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 27.26 51.8 0.08 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 127.547 2.498 . . . . 0.0 113.854 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 160.59 31.06 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.22 1.01 . . . . 0.0 111.25 -163.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -144.88 145.19 31.48 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 127.057 2.143 . . . . 0.0 105.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.86 -176.21 4.37 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.06 147.21 80.9 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.781 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.95 99.09 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.308 2.005 . . . . 0.0 108.082 171.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -83.78 119.26 24.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -131.68 137.79 48.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.92 136.2 55.01 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 93' ' ' GLN . 2.8 m -135.66 179.33 6.4 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.587 ' H ' HG22 ' A' ' 92' ' ' THR . 0.6 OUTLIER 76.68 144.43 0.08 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.669 2.388 . . . . 0.0 107.591 -168.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -63.1 -84.43 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 108.832 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 C--O 1.242 0.673 0 C-N-CA 128.526 2.73 . . . . 0.0 112.573 -160.6 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.95 34.98 1.01 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.795 1.638 . . . . 0.0 111.607 -172.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.31 -162.17 19.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 125.832 1.682 . . . . 0.0 109.712 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.2 p -147.8 69.5 1.13 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.266 2.226 . . . . 0.0 105.485 -169.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.09 -35.01 74.26 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.314 0.645 . . . . 0.0 112.175 -157.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.0 t -116.78 134.37 22.95 Favored Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -65.76 109.31 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.362 2.708 . . . . 0.0 109.533 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 87' ' ' ALA . 6.5 mm100 -61.84 157.62 17.8 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.246 1.818 . . . . 0.0 107.912 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.3 76.65 0.54 Allowed 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 m -57.86 -30.54 65.89 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.655 -0.653 . . . . 0.0 110.637 173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.96 -0.44 31.03 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.78 1.232 . . . . 0.0 113.156 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.465 HD11 ' CE1' ' A' ' 14' ' ' PHE . 2.8 tm? -53.85 125.67 19.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.993 0.917 . . . . 0.0 109.778 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.9 m -148.03 149.53 32.29 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.494 1.118 . . . . 0.0 109.802 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CE1' HD11 ' A' ' 12' ' ' LEU . 16.1 m-30 -112.78 145.53 40.41 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.848 1.204 . . . . 0.0 107.876 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.71 170.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 125.877 1.671 . . . . 0.0 108.305 -170.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 53.06 44.64 30.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.852 1.661 . . . . 0.0 109.569 171.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.83 64.79 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 127.779 2.432 . . . . 0.0 107.731 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -77.02 164.54 25.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.897 0.879 . . . . 0.0 109.406 168.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.48 7.44 3.63 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.633 -1.292 . . . . 0.0 112.342 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -123.91 -13.82 7.28 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.033 -1.042 . . . . 0.0 113.74 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -175.33 160.59 2.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.829 2.452 . . . . 0.0 108.096 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.25 133.24 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.63 152.71 20.67 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mp -129.25 155.17 46.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.91 1.284 . . . . 0.0 109.286 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -139.69 151.72 46.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.477 1.111 . . . . 0.0 108.194 169.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -159.06 -165.41 1.6 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.059 1.344 . . . . 0.0 107.928 165.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -112.75 106.89 55.17 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.07 1.748 . . . . 0.0 107.491 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.14 124.31 10.39 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.518 2.145 . . . . 0.0 111.856 -174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mt -95.96 100.99 12.61 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.048 1.739 . . . . 0.0 107.481 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -80.47 40.98 0.52 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.22 0.608 . . . . 0.0 110.384 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -59.24 -35.53 73.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.009 -1.472 . . . . 0.0 114.704 -159.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 p 154.34 -98.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 128.901 2.881 . . . . 0.0 108.791 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.68 -4.02 47.03 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.058 2.543 . . . . 0.0 108.975 -172.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.49 125.69 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 128.043 2.537 . . . . 0.0 110.171 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.02 -57.98 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -168.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.93 -158.29 23.19 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.472 ' CD2' HG23 ' A' ' 79' ' ' THR . 0.9 OUTLIER -130.59 137.02 49.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 171.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -107.19 110.87 23.04 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 107.554 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.422 HG13 HG22 ' A' ' 77' ' ' VAL . 3.3 mp -86.75 153.86 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m -144.29 147.88 34.09 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.65 2.38 . . . . 0.0 105.775 173.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -133.53 130.27 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 123.581 0.752 . . . . 0.0 109.975 170.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.75 164.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.006 171.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.36 111.5 20.55 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.75 105.56 1.6 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.298 1.439 . . . . 0.0 108.738 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.07 -26.34 1.43 Allowed Glycine 0 CA--C 1.519 0.339 0 O-C-N 121.223 -0.923 . . . . 0.0 111.002 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.9 -4.03 2.49 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.57 0.685 . . . . 0.0 110.575 161.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.97 13.85 35.7 Favored Glycine 0 CA--C 1.527 0.795 0 O-C-N 120.392 -1.442 . . . . 0.0 111.996 -171.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mt -46.48 106.21 0.55 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 127.584 2.353 . . . . 0.0 108.883 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.73 137.65 30.34 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.54 1.493 . . . . 0.0 110.201 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -89.13 -73.52 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.3 175.42 13.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.661 0.743 . . . . 0.0 110.196 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.63 156.9 47.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 165.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -155.67 166.06 34.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.968 1.307 . . . . 0.0 107.505 -167.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.44 175.15 5.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.642 0.734 . . . . 0.0 109.932 -173.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.75 -177.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 156.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -63.25 -67.56 0.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.743 1.617 . . . . 0.0 112.941 -166.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.4 p 154.71 -20.41 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.568 3.147 . . . . 0.0 114.137 -165.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.3 p -142.34 26.2 1.82 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.449 1.477 . . . . 0.0 112.137 168.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.54 133.35 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.53 -3.27 27.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.779 1.657 . . . . 0.0 113.593 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -150.78 123.15 8.4 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.632 1.573 . . . . 0.0 107.248 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -135.84 164.62 27.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.489 1.116 . . . . 0.0 108.351 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -141.89 134.97 29.01 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.58 152.51 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.114 1.766 . . . . 0.0 107.059 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.43 171.43 11.56 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.33 24.71 33.15 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.516 1.055 . . . . 0.0 112.031 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.72 156.03 19.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.502 1.521 . . . . 0.0 108.547 163.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.15 134.55 16.79 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.611 1.964 . . . . 0.0 107.506 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.72 161.35 27.62 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.764 1.643 . . . . 0.0 114.33 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.09 64.49 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.271 1.415 . . . . 0.0 113.519 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -116.52 145.45 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 124.973 1.309 . . . . 0.0 108.201 -170.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -81.47 129.42 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.318 1.847 . . . . 0.0 106.031 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -117.34 128.18 54.79 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.26 88.44 7.49 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.459 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 2.7 mp -84.43 116.9 28.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.41 139.91 49.6 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 126.467 1.907 . . . . 0.0 107.916 -165.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.422 HG22 HG13 ' A' ' 39' ' ' ILE . 26.0 t -145.6 111.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -170.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.8 mt -105.43 144.71 14.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.472 HG23 ' CD2' ' A' ' 37' ' ' TYR . 7.4 m -105.14 142.79 34.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 166.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.65 118.4 19.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.175 1.79 . . . . 0.0 107.851 -173.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 pt -117.17 -168.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.546 0.739 . . . . 0.0 110.184 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -48.98 105.35 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.531 165.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 48.53 35.25 15.59 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 124.653 1.121 . . . . 0.0 113.48 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.67 144.92 10.41 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -167.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -122.93 144.94 48.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 m -84.14 -165.36 1.13 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -101.47 163.0 18.73 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.077 -1.639 . . . . 0.0 108.627 168.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 73.6 Cg_endo -70.75 108.79 2.34 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.835 1.69 . . . . 0.0 109.435 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.49 86.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.5 m -94.56 146.28 24.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.75 121.2 23.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 165.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 140.51 29.65 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -154.03 161.94 41.57 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.555 0.742 . . . . 0.0 109.219 161.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -97.66 173.12 7.29 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.462 1.105 . . . . 0.0 109.587 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 C--O 1.256 1.404 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 159.509 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 117.922 -1.037 . . . . 0.0 108.878 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -133.58 174.9 9.93 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.207 1.403 . . . . 0.0 108.576 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.02 151.94 0.91 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.184 0.897 . . . . 0.0 111.394 -175.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p 95.79 148.0 0.02 OUTLIER 'General case' 0 C--O 1.238 0.46 1 C-N-CA 132.619 4.368 . . . . 0.0 108.78 -168.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -130.41 -63.83 0.87 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.08 0.952 . . . . 0.0 110.199 -171.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.6 t -126.79 134.06 25.68 Favored Pre-proline 0 C--O 1.239 0.549 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.01 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.669 2.246 . . . . 0.0 109.62 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -83.14 178.5 8.08 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.615 HD22 ' CD1' ' A' ' 26' ' ' TRP . 88.4 mt -77.72 91.56 4.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 161.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.7 p -61.09 -57.47 12.4 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.149 1.379 . . . . 0.0 108.687 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -72.9 18.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.045 2.538 . . . . 0.0 113.064 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.56 121.41 8.35 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.736 1.215 . . . . 0.0 108.994 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.8 m -154.49 164.89 37.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.056 1.742 . . . . 0.0 109.667 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CZ ' HD21 ' A' ' 24' ' ' LEU . 45.6 m-85 -122.86 152.23 40.94 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.74 168.85 7.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.824 1.65 . . . . 0.0 108.501 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 46.72 63.49 1.89 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.938 2.095 . . . . 0.0 109.494 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.88 65.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -81.23 171.97 14.21 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.896 1.278 . . . . 0.0 109.762 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.09 -0.73 20.06 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.5 p -125.47 -6.01 7.04 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -175.38 170.85 2.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.631 1.972 . . . . 0.0 108.711 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -132.8 131.78 59.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 162.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.15 149.85 28.3 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 3.1 mt -123.33 151.3 42.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 106.362 172.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -136.18 145.03 45.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.615 ' CD1' HD22 ' A' ' 9' ' ' LEU . 9.0 p90 -156.91 -173.98 4.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.759 1.224 . . . . 0.0 108.9 168.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.4 m -109.09 106.19 58.39 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.7 123.6 9.94 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 121.543 1.495 . . . . 0.0 110.481 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.14 94.72 3.54 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.554 2.342 . . . . 0.0 105.186 166.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -77.66 38.87 0.26 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.991 0.916 . . . . 0.0 109.225 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.2 m -74.34 -2.82 26.89 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -159.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p 70.53 -57.91 0.57 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.156 2.582 . . . . 0.0 113.629 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.39 -28.99 69.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 111.525 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -50.91 134.59 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 126.395 1.878 . . . . 0.0 109.825 170.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.0 mp -84.4 -65.05 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.82 -160.11 19.63 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -127.89 133.22 49.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.63 127.6 54.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.232 1.413 . . . . 0.0 107.271 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 77' ' ' VAL . 3.1 mp -101.75 152.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 m -138.26 153.69 49.07 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 127.267 2.227 . . . . 0.0 106.417 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.36 126.82 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 125.378 1.471 . . . . 0.0 107.55 171.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.18 164.65 27.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.93 101.94 13.75 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 47.65 -150.99 0.11 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.605 1.962 . . . . 0.0 112.389 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.37 8.62 31.99 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 120.44 -1.412 . . . . 0.0 113.036 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -80.32 -6.23 57.63 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.885 2.342 . . . . 0.0 112.155 -167.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.93 -20.88 6.08 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 126.585 2.04 . . . . 0.0 113.007 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.6 mt -44.04 105.19 0.42 Allowed Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 129.354 3.062 . . . . 0.0 108.486 163.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.29 168.2 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.224 1.949 . . . . 0.0 109.015 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.2 mm -111.0 -73.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.502 -2.406 . . . . 0.0 104.502 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -160.14 175.52 12.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.711 1.605 . . . . 0.0 107.916 173.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.0 159.37 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -152.61 166.03 33.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.053 0.941 . . . . 0.0 110.437 -166.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.15 160.02 33.35 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.879 0.872 . . . . 0.0 110.302 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.89 -178.32 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 161.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -68.57 -71.3 0.22 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.929 0.871 . . . . 0.0 112.01 -156.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 p 177.07 -25.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.917 3.287 . . . . 0.0 111.183 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.4 p -127.32 16.11 7.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.13 130.21 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.03 -6.13 32.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.226 0.917 . . . . 0.0 114.557 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -143.44 125.62 15.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.723 1.209 . . . . 0.0 108.957 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -139.45 160.6 39.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.235 1.414 . . . . 0.0 109.285 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.2 m -134.1 121.46 21.52 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.49 -1.381 . . . . 0.0 107.698 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 t -87.3 155.24 3.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 -168.62 1.92 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.866 1.267 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.37 9.96 84.44 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 120.798 -1.189 . . . . 0.0 113.327 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.5 157.6 30.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 170.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -146.73 133.24 9.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.3 -177.61 2.8 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.004 2.469 . . . . 0.0 112.762 -172.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.51 -18.81 56.82 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.804 2.145 . . . . 0.0 112.199 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mm -131.5 152.14 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 126.416 1.886 . . . . 0.0 107.111 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -94.71 109.84 21.75 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -94.71 124.17 38.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.7 91.66 8.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.51 101.7 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.49 141.93 30.42 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.652 1.181 . . . . 0.0 109.609 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.456 HG22 HG13 ' A' ' 39' ' ' ILE . 42.8 t -140.79 116.19 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.594 HG23 ' HA ' ' A' ' 88' ' ' PRO 0.347 0.0 OUTLIER -121.75 145.92 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 175.467 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.9 m -106.04 128.05 53.59 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.791 2.036 . . . . 0.0 108.179 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.434 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -126.2 123.71 38.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.138 1.375 . . . . 0.0 108.925 -173.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 3.6 pt -116.61 -173.93 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 125.065 1.346 . . . . 0.0 109.653 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -34.74 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.394 1.878 . . . . 0.0 111.105 166.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.07 61.5 0.06 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 126.713 2.102 . . . . 0.0 111.707 -171.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.45 144.79 10.76 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -126.38 124.22 39.71 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.617 1.567 . . . . 0.0 107.108 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 169.94 13.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.97 134.86 95.91 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.259 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.594 ' HA ' HG23 ' A' ' 78' ' ' ILE . 59.2 Cg_endo -63.1 136.2 55.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.535 2.157 . . . . 0.0 109.247 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.2 m -131.5 97.99 4.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -174.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.3 m -106.09 146.87 29.62 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.65 1.18 . . . . 0.0 107.916 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 104.79 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -75.01 115.55 14.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -109.03 137.5 46.84 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.396 1.478 . . . . 0.0 113.491 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.22 163.18 15.11 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.771 1.229 . . . . 0.0 111.379 173.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.25 1.12 0 C-N-CA 129.176 2.991 . . . . 0.0 106.231 161.365 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ttt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -160.92 134.38 6.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.09 143.34 0.97 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.693 1.616 . . . . 0.0 111.028 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.34 129.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.989 1.716 . . . . 0.0 107.686 -153.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -109.0 -68.83 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.7 t -133.05 136.57 27.78 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.65 136.44 33.3 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.156 1.904 . . . . 0.0 110.116 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -95.48 168.21 10.84 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.206 0.602 . . . . 0.0 110.186 171.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.89 80.22 2.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 m -66.3 -20.98 66.25 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.855 0.462 . . . . 0.0 110.239 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.15 7.31 22.25 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.56 -1.337 . . . . 0.0 113.061 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.46 120.73 12.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 110.438 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 p -136.55 164.98 26.92 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.817 1.247 . . . . 0.0 111.186 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -109.11 151.99 25.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 168.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.0 168.61 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.73 1.612 . . . . 0.0 107.393 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 42.07 61.54 1.92 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.425 1.89 . . . . 0.0 110.904 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.74 57.15 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.148 1.779 . . . . 0.0 108.441 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -84.83 170.87 12.74 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.891 1.276 . . . . 0.0 110.682 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.19 2.31 9.36 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.635 1.574 . . . . 0.0 112.079 -174.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 p -125.53 -16.04 5.93 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.831 1.652 . . . . 0.0 114.786 -163.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -178.17 153.69 0.8 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.449 1.9 . . . . 0.0 108.096 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.0 tt -108.55 132.3 56.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.55 158.35 28.53 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 171.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.505 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.8 mp -132.75 152.1 51.84 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 126.129 1.772 . . . . 0.0 108.41 174.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -138.52 143.91 39.72 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.37 -173.85 4.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.592 0.757 . . . . 0.0 109.185 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -108.81 106.67 59.18 Favored Pre-proline 0 C--N 1.334 -0.107 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.55 131.42 29.61 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.493 1.462 . . . . 0.0 109.773 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.55 107.35 14.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -72.78 42.93 0.11 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 m -79.03 6.56 9.1 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.397 3.079 . . . . 0.0 114.766 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.6 p 61.31 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 128.057 2.543 . . . . 0.0 114.607 163.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.3 -7.27 17.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.195 1.798 . . . . 0.0 112.448 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.6 tt -44.26 146.64 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 121.034 -1.041 . . . . 0.0 110.015 159.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.461 ' HB ' HD12 ' A' ' 80' ' ' LEU . 3.3 mt -84.51 -61.95 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 170.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 171.03 -156.96 27.52 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -170.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.8 143.72 50.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 135.83 53.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.745 2.018 . . . . 0.0 106.248 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.69 125.74 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.1 m -119.25 126.01 50.48 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.31 123.65 61.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 175.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.98 163.42 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.335 1.454 . . . . 0.0 108.266 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.56 110.96 16.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 45.87 -155.39 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.764 2.426 . . . . 0.0 112.725 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.48 18.9 6.35 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 118.838 -0.979 . . . . 0.0 112.761 168.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -86.08 -6.47 59.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.123 1.461 . . . . 0.0 110.303 -175.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.41 -16.01 3.21 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 127.283 2.373 . . . . 0.0 113.98 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt -45.66 106.14 0.53 Allowed Pre-proline 0 N--CA 1.448 -0.575 0 C-N-CA 129.816 3.246 . . . . 0.0 108.913 168.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.04 167.18 25.55 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.36 2.04 . . . . 0.0 110.673 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.25 -76.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -159.81 175.48 13.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.308 -0.87 . . . . 0.0 109.303 175.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.97 154.25 51.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.006 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -150.6 166.46 30.22 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.48 1.512 . . . . 0.0 109.265 -163.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HZ ' HD11 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -125.67 171.62 10.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.363 1.065 . . . . 0.0 110.378 177.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.27 -176.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.011 163.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -64.1 -68.93 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.297 1.839 . . . . 0.0 112.362 -170.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.464 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 88.3 p 165.14 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.972 3.309 . . . . 0.0 111.227 -175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . 0.264 97.4 p -131.52 23.94 4.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.534 0.607 . . . . 0.0 111.979 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -73.46 131.55 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.35 -0.13 35.1 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.929 1.252 . . . . 0.0 113.303 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -150.68 114.75 5.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.505 ' CD2' HD13 ' A' ' 24' ' ' LEU . 3.8 t80 -140.85 158.97 43.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -173.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -141.51 132.22 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.66 148.29 13.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 126.364 1.866 . . . . 0.0 106.778 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.67 -173.76 2.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.525 1.53 . . . . 0.0 108.295 -174.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.06 16.79 80.41 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 120.662 -1.274 . . . . 0.0 113.557 169.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 151.7 45.42 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.603 0.716 . . . . 0.0 110.701 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.16 100.26 7.13 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 -169.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.5 162.9 40.11 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.395 3.397 . . . . 0.0 113.769 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.57 5.85 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.727 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.59 138.39 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 159.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' GLN . 39.4 t0 -83.0 158.74 22.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.578 0.751 . . . . 0.0 110.463 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -135.44 123.01 22.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.346 1.458 . . . . 0.0 108.648 -167.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.86 109.3 22.03 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.86 90.91 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.3 p -84.83 104.4 14.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.871 0.868 . . . . 0.0 111.071 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.82 119.42 45.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -116.74 139.56 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.958 1.303 . . . . 0.0 108.264 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 53.2 m -105.55 134.17 49.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.461 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -129.7 115.43 17.32 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.3 pt -104.29 -164.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 125.362 1.465 . . . . 0.0 108.316 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -34.66 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.07 0.948 . . . . 0.0 111.056 167.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.25 60.65 0.05 OUTLIER Glycine 0 C--N 1.335 0.516 0 C-N-CA 128.933 3.158 . . . . 0.0 113.261 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.25 166.15 38.89 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.78 146.94 51.52 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.875 1.27 . . . . 0.0 108.253 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 m -84.04 -172.24 4.05 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.139 0.971 . . . . 0.0 110.032 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.69 135.77 71.26 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 162.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.27 155.34 67.86 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.758 2.306 . . . . 0.0 110.892 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -127.3 98.18 5.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 166.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.5 m -94.15 109.01 20.82 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.8 mt -88.76 155.12 19.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 157.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.5 m -127.74 147.94 50.41 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -155.78 124.52 6.01 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.19 0.905 . . . . 0.0 110.648 -173.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -67.45 -27.08 66.74 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -169.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.25 1.13 0 C-N-CA 128.771 2.828 . . . . 0.0 114.813 166.738 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtp . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.8 ptt85 -56.6 167.55 0.71 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.342 0.657 . . . . 0.0 111.876 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 148.81 6.62 0.22 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.539 1.066 . . . . 0.0 114.42 171.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 p -76.71 71.09 3.27 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.623 1.569 . . . . 0.0 110.468 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -66.75 0.55 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.763 0.825 . . . . 0.0 109.515 173.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t -72.0 133.96 83.59 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -69.05 133.48 26.97 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.99 1.793 . . . . 0.0 109.74 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.1 166.86 11.05 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.677 1.591 . . . . 0.0 108.952 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.444 HD22 ' CD1' ' A' ' 26' ' ' TRP . 80.0 mt -70.39 88.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.896 0.855 . . . . 0.0 109.201 176.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 m -73.4 -11.52 60.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.812 0.845 . . . . 0.0 112.006 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -104.39 14.28 30.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.644 1.111 . . . . 0.0 112.082 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.99 109.14 0.59 Allowed 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.18 -0.95 . . . . 0.0 110.893 -178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 m -136.57 146.19 45.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.176 1.79 . . . . 0.0 110.128 -170.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 91' ' ' LEU . 14.2 m-30 -111.3 144.68 40.1 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 177.99 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 128.691 2.796 . . . . 0.0 108.06 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.14 51.14 13.45 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.143 1.777 . . . . 0.0 109.408 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.7 mt -84.01 65.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -87.63 162.54 17.08 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.652 1.181 . . . . 0.0 109.056 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.68 -2.38 22.96 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.218 1.407 . . . . 0.0 111.311 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 p -107.22 -15.73 14.58 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 126.383 1.873 . . . . 0.0 114.079 -174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p 176.25 154.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.053 1.741 . . . . 0.0 109.911 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 128.96 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.58 133.39 11.61 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -174.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 62' ' ' TYR . 2.8 mp -110.03 143.05 40.61 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -124.65 146.48 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 167.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.444 ' CD1' HD22 ' A' ' 9' ' ' LEU . 42.0 p90 -149.97 -171.43 3.9 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 165.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -103.31 107.26 55.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -57.08 139.5 90.13 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.49 1.46 . . . . 0.0 110.749 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -88.88 108.97 19.83 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 125.969 1.708 . . . . 0.0 108.852 164.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.66 28.33 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.321 1.448 . . . . 0.0 112.063 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.0 m -79.38 150.49 31.36 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.494 -1.379 . . . . 0.0 110.455 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 p -83.0 -34.71 26.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.516 0.598 . . . . 0.0 111.409 167.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.13 -12.0 59.89 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.458 1.103 . . . . 0.0 112.207 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.7 152.25 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 161.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.406 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.6 mp -90.62 -67.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 160.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.86 -160.93 22.39 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -130.47 142.15 50.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 118.14 31.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 mp -93.2 143.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.7 m -141.26 133.56 28.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.56 138.07 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 125.128 1.371 . . . . 0.0 111.899 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.41 164.7 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.68 117.65 20.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 37.55 -138.79 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.357 2.263 . . . . 0.0 113.084 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.91 4.29 86.06 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 117.707 -1.607 . . . . 0.0 112.539 170.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.2 -0.2 53.86 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 121.085 2.442 . . . . 0.0 110.738 -166.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.98 -15.21 5.34 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.179 1.371 . . . . 0.0 114.324 168.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.3 mt -45.9 105.37 0.46 Allowed Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 127.33 2.252 . . . . 0.0 110.33 161.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.44 159.82 25.75 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.647 2.898 . . . . 0.0 110.239 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mp -120.04 -69.4 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.69 164.29 23.95 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.943 1.297 . . . . 0.0 109.511 -172.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.23 144.85 40.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.94 1.696 . . . . 0.0 110.34 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -134.76 164.62 27.14 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.854 1.662 . . . . 0.0 108.026 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.62 152.46 51.25 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.807 0.843 . . . . 0.0 109.842 177.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.22 -177.71 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 121.86 -0.525 . . . . 0.0 109.81 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -80.49 -54.86 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.234 0.54 . . . . 0.0 112.169 -150.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p 153.93 -31.62 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 130.865 3.666 . . . . 0.0 109.916 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.8 p -123.64 10.31 9.04 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.752 1.621 . . . . 0.0 111.22 -164.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.93 137.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.05 1.0 9.84 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.378 1.466 . . . . 0.0 112.714 166.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -145.94 123.83 12.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.819 1.248 . . . . 0.0 110.008 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.453 ' CD2' HD13 ' A' ' 24' ' ' LEU . 7.4 t80 -140.14 151.28 45.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.401 1.88 . . . . 0.0 107.542 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.6 m -130.95 126.64 36.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.796 1.18 . . . . 0.0 109.244 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.48 153.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.89 177.11 8.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 166.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.09 7.01 88.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.706 1.146 . . . . 0.0 112.86 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.87 159.75 19.01 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 164.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -137.04 127.54 16.07 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.65 171.58 14.09 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.27 1.314 . . . . 0.0 110.575 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.11 -12.23 40.69 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.147 171.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.52 162.1 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -92.26 125.84 37.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -107.25 142.44 37.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.8 1.182 . . . . 0.0 108.886 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.37 110.87 23.38 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 168.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.89 103.1 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.3 p -92.86 145.91 24.03 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.959 -1.088 . . . . 0.0 109.774 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 t -146.35 72.08 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-O 122.501 1.143 . . . . 0.0 108.96 -168.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mt -84.8 134.65 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -169.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.7 m -89.52 142.45 27.66 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -128.88 138.01 51.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.883 1.273 . . . . 0.0 109.114 177.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 pt -133.87 -169.06 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.049 1.339 . . . . 0.0 109.068 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -34.06 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.089 1.756 . . . . 0.0 110.84 162.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 36.74 42.95 0.75 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 127.985 2.707 . . . . 0.0 114.603 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.46 166.04 38.19 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 120.402 2.101 . . . . 0.0 113.839 -172.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.76 156.03 31.36 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.499 1.919 . . . . 0.0 107.057 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 m -84.1 -170.2 2.97 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 162.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 155.53 87.55 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.712 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.74 105.53 1.97 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.903 3.069 . . . . 0.0 110.434 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 m -89.84 74.71 7.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 171.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.3 m -94.58 115.33 27.45 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 10.9 mt -95.64 145.02 25.58 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 m -104.87 135.43 46.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -155.18 169.0 25.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 166.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -95.38 137.54 34.3 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.25 1.1 0 O-C-N 125.383 1.677 . . . . 0.0 110.551 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 117.133 -1.413 . . . . 0.0 108.195 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 163.39 -39.93 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.741 2.416 . . . . 0.0 112.301 175.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.28 106.42 3.12 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 -173.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.7 p 45.6 -147.0 0.13 Allowed 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.992 1.717 . . . . 0.0 111.201 -167.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -132.94 -56.89 0.93 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.158 1.783 . . . . 0.0 110.185 170.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.4 t -147.29 139.57 14.11 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 172.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 136.55 42.24 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.448 2.098 . . . . 0.0 110.723 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -75.69 163.18 27.57 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.583 165.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.11 80.3 0.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.44 1.096 . . . . 0.0 109.105 163.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 m -58.15 -27.78 64.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.68 0.792 . . . . 0.0 110.859 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -90.94 5.18 49.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.761 0.825 . . . . 0.0 111.918 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.7 129.3 22.55 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.315 1.046 . . . . 0.0 109.653 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 p -149.58 164.21 35.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.482 1.113 . . . . 0.0 110.39 165.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -116.65 146.43 42.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 172.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.52 164.21 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.915 1.286 . . . . 0.0 109.261 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 45.71 59.63 3.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.268 1.827 . . . . 0.0 109.949 -173.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.15 66.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 128.667 2.787 . . . . 0.0 105.804 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 t -94.64 165.35 12.55 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.686 1.594 . . . . 0.0 109.679 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.6 5.29 4.96 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.279 -1.513 . . . . 0.0 113.375 -168.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.1 p -126.5 -12.74 6.11 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -174.0 152.33 1.9 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.949 1.3 . . . . 0.0 108.949 -167.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.49 122.07 61.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.14 151.82 23.97 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.74 153.4 42.47 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.438 1.495 . . . . 0.0 109.71 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -140.05 145.04 37.21 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.66 1.584 . . . . 0.0 106.733 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -160.25 168.71 24.75 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 164.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 34.0 m -90.05 140.71 27.54 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 116.883 -1.927 . . . . 0.0 106.888 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.36 141.6 4.93 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.125 1.216 . . . . 0.0 109.023 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mp -83.51 -35.26 24.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.961 -170.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 49.84 34.86 8.26 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.301 2.24 . . . . 0.0 111.776 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 p -50.34 -46.97 56.03 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.302 1.041 . . . . 0.0 112.824 -162.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 p 153.91 -86.32 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 131.371 3.868 . . . . 0.0 104.973 -174.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -5.43 58.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.51 1.124 . . . . 0.0 111.045 -170.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -34.86 129.53 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.937 1.295 . . . . 0.0 111.162 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.21 -49.47 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 174.21 -164.86 36.2 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -127.02 150.88 49.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 162.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.85 122.96 42.48 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.433 HG13 HG22 ' A' ' 77' ' ' VAL . 2.7 mp -104.67 144.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.8 m -145.45 111.26 5.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 143.09 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.829 0.823 . . . . 0.0 110.773 160.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.17 164.33 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 166.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.38 126.89 31.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.67 84.2 0.29 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 163.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.34 -45.08 0.06 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.897 1.236 . . . . 0.0 110.659 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -141.16 -2.92 1.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.515 0.726 . . . . 0.0 111.432 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.39 12.71 61.56 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 120.25 -1.531 . . . . 0.0 112.395 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.9 mt -46.17 106.61 0.58 Allowed Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 127.293 2.237 . . . . 0.0 107.901 162.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.47 137.81 28.65 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.304 2.003 . . . . 0.0 110.0 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.0 93.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . 0.323 1.0 OUTLIER 54.45 176.95 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.323 2.249 . . . . 0.0 113.28 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.07 159.32 42.47 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.725 -1.235 . . . . 0.0 110.205 165.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -149.33 165.93 30.52 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.252 1.821 . . . . 0.0 111.221 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.07 165.52 18.7 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.629 1.571 . . . . 0.0 109.482 -174.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -178.11 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.168 0.987 . . . . 0.0 109.119 164.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.25 -50.74 8.64 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.028 -1.045 . . . . 0.0 112.528 -157.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.408 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 32.3 p 157.18 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 1 C-N-CA 132.217 4.207 . . . . 0.0 112.141 174.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -124.9 10.4 8.26 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.9 t -73.61 132.44 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.59 6.37 18.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.075 1.322 . . . . 0.0 112.312 170.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -150.08 120.4 7.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.79 -1.418 . . . . 0.0 107.38 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -143.99 166.27 25.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -132.37 129.0 38.81 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.038 0.935 . . . . 0.0 108.763 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 t -95.78 154.88 3.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.04 178.45 6.68 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.388 1.475 . . . . 0.0 107.142 169.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 5.0 73.88 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 119.036 0.834 . . . . 0.0 112.956 174.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.72 158.8 26.55 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.626 0.727 . . . . 0.0 109.555 167.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.19 103.78 5.61 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.0 169.64 14.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.091 2.527 . . . . 0.0 111.032 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.22 -18.75 50.86 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.595 -0.691 . . . . 0.0 112.176 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mm -124.56 153.38 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.669 1.988 . . . . 0.0 108.155 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -86.25 145.84 26.78 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.658 1.583 . . . . 0.0 108.365 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.56 134.85 51.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.257 1.023 . . . . 0.0 111.87 -175.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -84.28 104.18 14.1 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.506 1.923 . . . . 0.0 107.098 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -90.52 105.66 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -101.5 136.29 41.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 118.412 0.551 . . . . 0.0 111.873 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 39' ' ' ILE . 38.8 t -135.36 108.42 9.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.07 137.42 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -98.78 129.97 45.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.39 112.43 18.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 pt -104.45 -164.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -48.62 111.13 0.42 Allowed 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.531 -0.731 . . . . 0.0 110.61 161.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.49 24.76 59.83 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.068 -0.851 . . . . 0.0 114.802 156.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.33 156.39 21.04 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -132.78 153.22 51.44 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.883 1.673 . . . . 0.0 108.531 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.58 178.41 7.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.78 154.23 94.41 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 121.496 -0.753 . . . . 0.0 110.197 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.87 110.53 2.6 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.964 3.109 . . . . 0.0 110.839 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.8 m -85.44 97.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 169.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 m -96.5 153.42 17.85 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 165.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.55 135.19 44.19 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 159.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.67 143.29 38.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.37 2.268 . . . . 0.0 108.537 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -164.69 148.61 9.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 120.559 1.527 . . . . 0.0 110.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -110.94 143.53 41.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.84 1.256 . . . . 0.0 109.626 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.257 1.456 0 C-N-CA 127.572 2.349 . . . . 0.0 111.635 -171.71 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.7 mtt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.84 152.79 51.98 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.267 1.394 . . . . 0.0 108.334 161.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.77 -165.4 17.48 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -164.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.01 165.47 13.28 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -64.67 -48.9 73.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.392 0.277 . . . . 0.0 111.12 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.2 t -143.05 141.43 19.55 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.31 105.61 1.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.316 2.01 . . . . 0.0 109.209 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.29 169.98 1.46 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 114.248 165.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.462 HD13 ' CG ' ' A' ' 26' ' ' TRP . 95.0 mt -67.24 71.14 0.1 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.449 2.3 . . . . 0.0 110.088 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m -50.68 -27.01 6.16 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 111.846 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -87.37 4.59 42.42 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.772 1.169 . . . . 0.0 112.566 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -55.17 118.42 4.34 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.69 1.196 . . . . 0.0 109.276 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.0 m -153.33 134.1 13.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.454 175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -91.39 146.25 23.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.45 174.23 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 128.845 2.858 . . . . 0.0 109.24 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.374 2.6 p30 43.07 45.62 4.64 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.113 1.765 . . . . 0.0 112.3 -178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.44 62.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 128.117 2.567 . . . . 0.0 107.473 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 20' ' ' SER . 7.7 t -73.78 174.55 8.28 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.781 1.232 . . . . 0.0 108.972 168.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.73 -4.7 39.06 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.187 -0.946 . . . . 0.0 111.674 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.471 ' H ' HG23 ' A' ' 18' ' ' THR . 53.7 p -125.58 -9.2 6.82 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 -158.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 p -176.81 171.91 2.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.188 2.595 . . . . 0.0 108.134 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.65 147.86 28.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 142.75 15.64 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 171.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mp -108.82 144.14 37.07 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 124.529 1.132 . . . . 0.0 108.119 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -118.21 150.38 39.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.462 ' CG ' HD13 ' A' ' 9' ' ' LEU . 47.7 p90 -151.87 -166.12 2.41 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 161.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.92 143.19 39.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.53 129.32 19.83 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.055 1.17 . . . . 0.0 109.39 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.64 96.98 9.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -74.52 45.87 0.25 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.38 0.672 . . . . 0.0 109.327 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.8 m -69.48 2.46 3.08 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.079 -1.638 . . . . 0.0 112.269 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.4 p 48.13 25.66 0.87 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.787 2.835 . . . . 0.0 114.859 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -165.27 -16.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.881 1.272 . . . . 0.0 111.044 -171.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 9.4 tt -39.01 140.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 110.141 156.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.401 ' HB ' HD12 ' A' ' 80' ' ' LEU . 4.2 mp -84.79 -63.39 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 165.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.33 -156.9 13.75 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -168.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -135.7 147.42 48.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 133.97 55.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.0 mp -108.81 143.0 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -133.87 128.13 33.99 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 161.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.651 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.27 137.52 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.173 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.36 164.69 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.14 1.376 . . . . 0.0 109.429 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.07 125.94 30.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.71 77.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.591 0.756 . . . . 0.0 110.312 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.35 -18.11 71.11 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 117.353 -1.804 . . . . 0.0 116.341 -165.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -142.66 2.73 1.42 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.583 2.191 . . . . 0.0 112.369 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.38 -13.58 15.55 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.617 -1.302 . . . . 0.0 114.144 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.6 mt -45.48 106.25 0.53 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 128.324 2.649 . . . . 0.0 110.72 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.94 147.16 43.22 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.83 2.354 . . . . 0.0 110.945 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.0 mm -84.85 -74.07 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.01 175.64 7.46 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.683 1.993 . . . . 0.0 108.66 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.84 156.83 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.727 1.211 . . . . 0.0 110.255 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -148.2 166.43 27.93 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.737 1.215 . . . . 0.0 110.503 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.77 155.72 49.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.673 1.989 . . . . 0.0 109.935 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.75 -177.21 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.883 1.273 . . . . 0.0 109.864 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.66 -57.71 3.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.527 0.731 . . . . 0.0 112.087 -160.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p 154.7 -29.26 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 131.089 3.756 . . . . 0.0 111.42 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -123.26 -0.66 8.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.256 1.023 . . . . 0.0 109.506 -167.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 65.1 t -74.43 124.75 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.0 1.11 33.55 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.46 1.1 . . . . 0.0 112.901 171.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -142.18 114.21 8.14 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.456 1.102 . . . . 0.0 108.259 -175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -145.98 137.82 25.09 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -113.42 146.99 38.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.947 1.299 . . . . 0.0 108.836 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.51 148.54 24.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 125.631 1.572 . . . . 0.0 107.181 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.88 -168.78 1.87 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.28 4.34 90.23 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 120.692 -1.255 . . . . 0.0 113.973 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 149.56 49.65 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.933 1.293 . . . . 0.0 109.965 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -146.9 93.81 4.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.454 1.902 . . . . 0.0 108.643 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.62 167.59 23.81 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.997 3.131 . . . . 0.0 114.982 -152.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.85 -15.85 61.73 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.128 1.347 . . . . 0.0 112.735 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.15 151.52 3.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 167.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -89.48 134.41 34.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.309 1.444 . . . . 0.0 108.039 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -118.51 117.33 28.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -167.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.42 113.63 21.32 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 170.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.651 HG23 HG13 ' A' ' 41' ' ' VAL . 1.9 mp -102.66 105.1 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -91.03 138.24 31.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.097 0.559 . . . . 0.0 109.508 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.1 t -134.52 129.54 52.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -131.8 131.42 62.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 m -83.09 144.23 30.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 171.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.401 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -125.68 129.88 50.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 173.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 15.6 pt -116.1 175.21 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -35.37 105.0 0.03 OUTLIER 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.023 1.729 . . . . 0.0 110.119 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.1 26.37 0.87 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.812 1.672 . . . . 0.0 114.823 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.42 144.71 15.93 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.55 1.675 . . . . 0.0 109.663 -160.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.01 117.64 22.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.2 1.0 . . . . 0.0 108.499 -162.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.11 -179.0 6.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.46 148.8 86.06 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.7 137.7 70.23 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 162.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -129.13 95.99 4.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 168.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.7 m -94.84 149.21 21.49 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.32 135.0 45.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 166.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 t -120.91 140.79 51.33 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -165.24 139.89 5.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -96.81 165.06 12.29 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 161.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.246 0.87 0 C-N-CA 126.865 2.066 . . . . 0.0 111.315 169.748 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 154.52 158.55 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 130.406 3.482 . . . . 0.0 111.378 168.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.02 165.42 30.25 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 158.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.02 177.76 4.77 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 109.538 164.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.52 -72.54 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.685 1.594 . . . . 0.0 110.675 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.3 t -143.97 146.98 36.32 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.233 1.813 . . . . 0.0 106.197 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.37 117.21 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.746 2.297 . . . . 0.0 109.511 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.27 169.46 11.42 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.524 HD13 ' CG ' ' A' ' 26' ' ' TRP . 55.2 mt -78.51 86.73 4.51 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.5 m -76.04 -29.37 58.04 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.53 1.132 . . . . 0.0 111.35 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.61 4.77 20.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.823 1.249 . . . . 0.0 112.611 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.57 129.78 37.56 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.8 1.64 . . . . 0.0 109.853 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.3 m -150.72 165.23 34.1 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.465 -0.772 . . . . 0.0 110.533 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -99.72 155.83 17.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 108.724 170.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.12 167.96 9.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.689 1.996 . . . . 0.0 106.983 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 40.83 56.21 2.92 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 128.278 2.631 . . . . 0.0 110.232 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -78.25 65.22 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.197 2.199 . . . . 0.0 106.232 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -88.18 168.16 12.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.465 1.106 . . . . 0.0 111.3 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.37 12.79 0.69 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.171 2.188 . . . . 0.0 112.465 -174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.4 p -125.68 -15.9 5.89 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 p -178.53 147.14 0.39 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -161.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -115.45 140.33 37.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.74 162.29 18.59 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 171.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mp -139.15 153.39 47.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.586 1.554 . . . . 0.0 108.988 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -134.71 155.32 50.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.524 ' CG ' HD13 ' A' ' 9' ' ' LEU . 42.5 p90 -165.35 -170.83 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.415 1.486 . . . . 0.0 108.858 166.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -105.42 106.44 56.06 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.726 1.21 . . . . 0.0 108.521 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -62.24 124.87 15.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.373 2.049 . . . . 0.0 110.632 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.1 mt -93.52 96.67 10.03 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 128.643 2.777 . . . . 0.0 108.042 175.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -74.67 34.12 0.1 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.446 1.098 . . . . 0.0 111.931 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 29' ' ' LEU . 30.4 m -56.2 119.63 6.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.821 2.448 . . . . 0.0 109.216 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 p -67.63 41.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.734 2.414 . . . . 0.0 113.443 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -167.18 -19.7 0.02 OUTLIER 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.741 1.616 . . . . 0.0 111.904 -167.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -55.15 144.44 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.23 -52.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 166.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.66 -152.73 14.56 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.04 136.14 45.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.03 125.82 44.61 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.81 155.05 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 m -142.69 153.52 43.46 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.899 1.68 . . . . 0.0 107.169 167.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.28 135.28 61.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 125.819 1.647 . . . . 0.0 108.999 167.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.55 164.08 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.43 110.24 20.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.7 9.43 0.08 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.625 2.77 . . . . 0.0 115.686 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.11 12.06 68.05 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.96 -1.087 . . . . 0.0 112.732 -166.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -78.72 42.27 0.44 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.341 1.856 . . . . 0.0 110.076 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.57 -55.49 3.34 Favored Glycine 0 CA--C 1.524 0.653 0 O-C-N 120.522 -1.361 . . . . 0.0 112.933 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.7 mt -45.74 105.19 0.44 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 129.548 3.139 . . . . 0.0 110.272 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.26 171.44 18.03 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.358 2.039 . . . . 0.0 109.633 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.72 -95.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 162.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -146.96 166.02 28.04 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.475 0.71 . . . . 0.0 110.371 -170.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -134.23 103.89 5.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.553 1.541 . . . . 0.0 106.988 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.51 159.11 16.19 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HZ ' HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -105.75 176.02 5.3 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.527 1.131 . . . . 0.0 108.039 176.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -175.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 161.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -79.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.468 1.907 . . . . 0.0 112.041 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p 172.2 -18.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.452 1 C-N-CA 132.651 4.38 . . . . 0.0 110.883 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.4 p -134.27 27.15 3.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.4 t -73.99 138.62 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.92 -1.95 19.02 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.977 0.798 . . . . 0.0 112.265 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.58 114.33 5.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -138.04 141.36 40.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -170.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 m -127.21 152.06 47.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.9 0.88 . . . . 0.0 109.358 -171.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.53 156.58 39.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.505 1.922 . . . . 0.0 106.944 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -130.67 -163.14 1.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.163 1.785 . . . . 0.0 106.374 174.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.51 7.9 69.97 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 120.093 -1.629 . . . . 0.0 114.105 166.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.4 149.67 31.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.186 1.394 . . . . 0.0 108.226 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -126.19 102.07 27.76 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 107.893 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.47 157.84 57.82 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.622 2.215 . . . . 0.0 112.383 -165.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.55 -30.06 11.19 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.681 1.134 . . . . 0.0 110.543 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.79 158.82 3.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -100.96 145.19 28.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.022 1.329 . . . . 0.0 108.347 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -131.26 134.8 46.77 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.32 116.35 22.96 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.07 121.22 51.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 p -116.18 142.67 46.52 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.822 0.849 . . . . 0.0 110.687 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.92 128.77 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.09 153.4 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.43 1.014 . . . . 0.0 111.894 175.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 m -105.84 122.89 47.03 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 126.467 1.907 . . . . 0.0 107.739 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.408 HD11 ' HZ ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -114.68 132.91 56.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.7 pt -126.3 178.13 4.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.476 1.111 . . . . 0.0 108.837 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -34.53 103.53 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.281 1.832 . . . . 0.0 110.823 163.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.51 11.47 2.67 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.868 2.175 . . . . 0.0 115.055 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.36 145.85 17.89 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.203 1.501 . . . . 0.0 110.153 -156.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -126.85 155.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.316 1.447 . . . . 0.0 109.494 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -107.54 -166.86 1.19 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.85 2.06 . . . . 0.0 108.604 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.62 134.6 39.57 Favored Pre-proline 0 C--O 1.239 0.543 0 O-C-N 121.016 -1.052 . . . . 0.0 108.678 163.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 127.72 19.5 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.93 2.42 . . . . 0.0 107.214 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.2 m -86.41 103.7 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 165.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.2 m -101.4 121.53 42.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 171.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.95 150.43 44.78 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.1 m -132.62 136.9 46.81 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -161.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -157.33 142.63 17.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -159.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.08 159.64 15.21 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.867 -0.52 . . . . 0.0 109.878 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p . . . . . 0 C--O 1.247 0.963 0 C-N-CA 125.767 1.627 . . . . 0.0 110.063 -170.245 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptm . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? 153.79 147.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.003 2.921 . . . . 0.0 109.131 163.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 109.97 51.36 0.64 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 123.559 0.599 . . . . 0.0 111.778 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.41 40.84 1.9 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 160.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -112.37 -67.17 1.02 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.378 0.671 . . . . 0.0 109.978 -155.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.24 135.75 31.0 Favored Pre-proline 0 C--O 1.239 0.52 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.36 143.49 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.04 1.826 . . . . 0.0 109.442 174.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -102.59 169.29 8.74 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 166.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 77.5 mt -74.5 80.34 1.94 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 m -61.37 -25.75 67.37 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.798 0.839 . . . . 0.0 110.544 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.0 -2.47 34.1 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.662 1.585 . . . . 0.0 113.696 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.37 115.14 3.04 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.773 1.229 . . . . 0.0 110.55 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 p -134.54 160.97 36.4 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.864 1.266 . . . . 0.0 110.345 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 8.7 m-30 -105.28 143.78 32.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.04 164.96 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 125.881 1.672 . . . . 0.0 108.348 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.4 t0 51.7 45.06 28.74 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.96 1.304 . . . . 0.0 110.554 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mt -75.91 63.75 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 128.811 2.845 . . . . 0.0 106.94 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 20' ' ' SER . 14.5 t -87.45 173.77 8.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 111.137 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.36 0.43 16.86 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.637 1.975 . . . . 0.0 112.861 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.479 ' H ' HG23 ' A' ' 18' ' ' THR . 55.7 p -113.39 -15.7 12.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -176.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p 176.29 161.7 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.674 1.99 . . . . 0.0 107.536 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.15 127.67 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.85 157.39 29.66 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.633 -1.292 . . . . 0.0 110.143 173.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.79 150.33 52.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 120.774 -1.427 . . . . 0.0 108.483 172.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -137.29 133.85 35.46 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -157.54 173.38 16.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.6 m -86.58 106.3 10.09 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.726 1.211 . . . . 0.0 110.093 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.62 124.26 13.4 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.345 1.363 . . . . 0.0 109.29 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.15 101.44 13.0 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -79.34 49.95 1.04 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.536 0.734 . . . . 0.0 109.097 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -61.91 -55.55 28.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.582 1.553 . . . . 0.0 110.164 -168.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p 154.72 -88.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 130.389 3.476 . . . . 0.0 108.891 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.08 -3.64 52.59 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 127.978 2.511 . . . . 0.0 110.026 -170.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -35.98 133.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.039 1.336 . . . . 0.0 111.255 166.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -84.32 -48.24 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . 164.87 -158.29 31.03 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -170.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -132.15 145.2 51.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 169.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -119.89 113.1 20.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.43 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.9 m -145.08 117.58 8.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.425 1.89 . . . . 0.0 107.382 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.09 131.44 40.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.289 0.636 . . . . 0.0 111.064 162.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.48 164.52 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 161.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.56 110.9 11.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.09 -17.36 64.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.371 1.068 . . . . 0.0 113.652 -171.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.53 -25.72 56.03 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 119.728 1.149 . . . . 0.0 112.663 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -136.65 -13.54 1.71 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.378 1.089 . . . . 0.0 113.549 -171.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.71 6.72 88.84 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.758 1.647 . . . . 0.0 114.306 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.9 mt -45.67 105.93 0.51 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.985 1.714 . . . . 0.0 111.091 167.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.68 131.04 12.06 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.725 2.283 . . . . 0.0 109.008 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.5 mm -84.64 -73.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -157.51 170.46 22.38 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.848 0.859 . . . . 0.0 109.925 173.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.3 150.59 39.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 163.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -152.71 165.91 33.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.48 1.112 . . . . 0.0 108.565 -166.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.12 168.15 15.03 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.377 0.671 . . . . 0.0 110.53 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.01 -177.01 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.12 . . . . 0.0 108.66 167.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -71.02 -66.42 0.61 Allowed 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.756 -0.59 . . . . 0.0 111.219 -167.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.445 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 9.5 p 163.78 -23.02 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 130.787 3.635 . . . . 0.0 112.016 -176.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.9 p -132.9 22.93 4.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.988 0.813 . . . . 0.0 112.764 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.54 131.93 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.95 3.26 19.3 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.388 2.423 . . . . 0.0 113.357 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -153.93 119.64 5.26 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.654 1.582 . . . . 0.0 108.225 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -134.94 164.37 27.75 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.326 1.45 . . . . 0.0 108.081 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.5 m -131.96 147.98 52.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.88 145.04 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 172.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 66' ' ' GLY . 0.9 OUTLIER -115.85 -170.76 1.85 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 171.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' H ' HG22 ' A' ' 65' ' ' THR . . . 78.25 17.97 77.11 Favored Glycine 0 CA--C 1.522 0.473 0 O-C-N 120.873 -1.142 . . . . 0.0 111.666 176.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 157.44 20.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.617 1.208 . . . . 0.0 108.691 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.09 136.41 15.98 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.96 156.12 60.33 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.906 1.737 . . . . 0.0 110.964 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.53 -27.58 8.33 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.527 1.061 . . . . 0.0 113.109 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.17 156.14 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 126.038 1.735 . . . . 0.0 107.818 -173.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.97 135.33 33.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 107.445 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -121.26 127.17 51.12 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.4 106.74 16.23 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.427 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.3 mp -98.94 103.12 14.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 174.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 142.16 27.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.939 2.096 . . . . 0.0 108.315 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -146.7 92.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mm -84.34 138.86 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.739 1.216 . . . . 0.0 108.274 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 100.0 m -105.81 131.71 52.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.0 113.25 13.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . 0.3 2.6 pt -109.37 -164.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.672 1.189 . . . . 0.0 109.991 -166.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -50.83 108.78 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.315 -1.491 . . . . 0.0 110.52 160.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.18 50.46 2.2 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.583 2.04 . . . . 0.0 113.097 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -173.43 144.17 7.58 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -120.26 153.45 36.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 107.931 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -84.42 -165.85 1.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.579 0.704 . . . . 0.0 112.31 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.64 144.67 73.83 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 151.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.43 137.28 50.29 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.774 1.649 . . . . 0.0 108.879 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.6 m -105.21 104.86 14.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -124.26 137.17 54.54 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.1 126.38 39.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -93.52 145.43 24.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -154.73 138.85 16.49 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -94.97 136.02 35.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.738 1.215 . . . . 0.0 108.279 169.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.257 1.453 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -175.129 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.25 62.83 1.63 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.67 171.03 13.54 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -149.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.28 150.6 12.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.483 1.513 . . . . 0.0 107.839 171.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.08 -63.74 1.05 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.002 0.921 . . . . 0.0 110.905 -174.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.6 t -43.01 134.6 3.01 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 127.739 2.415 . . . . 0.0 111.957 -152.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.05 129.92 27.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.261 1.974 . . . . 0.0 110.558 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.22 178.42 4.78 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.139 1.376 . . . . 0.0 110.881 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.472 HD13 ' CG ' ' A' ' 26' ' ' TRP . 63.1 mt -71.76 86.85 0.95 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 163.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -58.57 -20.12 43.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.272 1.429 . . . . 0.0 111.217 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -93.46 6.27 48.74 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.708 1.603 . . . . 0.0 113.585 174.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.99 106.81 0.54 Allowed 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.723 -1.236 . . . . 0.0 109.905 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -143.36 163.91 31.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.547 1.139 . . . . 0.0 110.046 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 13.4 m-30 -109.02 159.7 16.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.08 168.17 7.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.616 1.966 . . . . 0.0 107.068 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 42.34 59.81 2.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 126.201 1.801 . . . . 0.0 109.653 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mm -79.89 60.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -73.63 175.54 7.03 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.595 1.958 . . . . 0.0 109.966 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.24 -4.97 53.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.997 1.319 . . . . 0.0 112.636 172.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 p -110.78 -12.42 14.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.561 1.544 . . . . 0.0 114.459 -166.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 p 173.84 171.13 0.19 Allowed 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 126.034 1.734 . . . . 0.0 108.233 -163.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 tt -129.79 150.12 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 161.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.26 159.3 14.65 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 171.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.01 146.31 49.48 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 125.508 1.523 . . . . 0.0 108.184 176.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -124.25 156.83 36.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 158.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.472 ' CG ' HD13 ' A' ' 9' ' ' LEU . 32.6 p90 -161.38 -173.87 4.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.086 1.755 . . . . 0.0 106.973 163.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -104.04 107.55 57.36 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -59.37 124.07 14.74 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.715 1.61 . . . . 0.0 109.125 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.2 mt -93.4 -19.23 21.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.641 0.776 . . . . 0.0 112.878 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 43.45 29.85 0.28 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.193 2.597 . . . . 0.0 113.577 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 m -87.83 104.95 17.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -167.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.3 p -41.88 -1.85 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 131.518 3.927 . . . . 0.0 119.509 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.52 -14.45 8.22 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 130.167 3.387 . . . . 0.0 112.137 -171.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 12.6 tt -60.43 161.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.105 2.162 . . . . 0.0 111.061 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mt -98.77 -47.99 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 166.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.94 40.99 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.442 ' CD1' HD11 ' A' ' 9' ' ' LEU . 11.3 m-85 -126.91 107.24 9.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 171.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.5 121.95 28.93 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.64 147.4 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -145.49 99.51 3.3 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.814 1.245 . . . . 0.0 107.672 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.56 134.16 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 120.665 -1.272 . . . . 0.0 109.064 163.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.25 165.13 24.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.61 136.42 42.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.5 162.26 10.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 165.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.63 -11.48 7.1 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 117.933 -1.481 . . . . 0.0 115.431 164.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -146.46 165.12 30.34 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 121.891 2.845 . . . . 0.0 107.988 162.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.8 -0.3 18.22 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.036 -1.424 . . . . 0.0 115.298 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.6 mt -46.05 105.98 0.52 Allowed Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 128.3 2.64 . . . . 0.0 111.399 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -60.97 160.87 24.07 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.716 1.61 . . . . 0.0 111.196 162.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mm -114.79 -86.95 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.16 168.45 20.34 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 121.367 1.894 . . . . 0.0 110.555 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -114.54 146.67 40.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.457 1.503 . . . . 0.0 107.439 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -147.51 162.55 38.84 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.852 1.261 . . . . 0.0 109.437 -168.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.34 153.36 43.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.359 1.463 . . . . 0.0 108.219 -176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.63 -176.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.193 0.906 . . . . 0.0 108.866 165.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.15 -58.45 5.98 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -161.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 p 153.83 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 130.789 3.636 . . . . 0.0 110.747 -167.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p -105.47 3.41 29.49 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.793 1.237 . . . . 0.0 113.233 -166.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.9 150.67 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.98 -2.83 6.49 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 127.016 2.246 . . . . 0.0 113.201 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -160.73 128.7 4.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.727 -1.455 . . . . 0.0 107.883 -171.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -150.08 167.03 27.98 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.961 0.8 . . . . 0.0 109.049 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.4 m -132.9 136.66 46.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.413 1.485 . . . . 0.0 109.999 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.29 165.2 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.93 1.692 . . . . 0.0 107.469 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' GLY . 2.9 m -143.53 -170.69 3.35 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.359 -1.463 . . . . 0.0 107.06 164.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.506 ' H ' HG22 ' A' ' 65' ' ' THR . . . 72.09 15.51 76.55 Favored Glycine 0 N--CA 1.463 0.471 0 C-N-CA 124.713 1.149 . . . . 0.0 112.642 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.64 158.97 35.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.344 1.058 . . . . 0.0 108.826 175.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -126.51 107.25 23.57 Favored Pre-proline 0 N--CA 1.445 -0.702 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 170.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.9 168.05 19.8 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.065 2.51 . . . . 0.0 110.756 -173.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.4 -31.18 4.57 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.505 1.05 . . . . 0.0 110.692 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.07 155.24 3.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -101.28 142.7 32.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.103 1.761 . . . . 0.0 108.242 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -134.59 120.48 19.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.043 1.337 . . . . 0.0 109.913 -162.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.15 95.75 9.24 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.406 HD13 ' CE2' ' A' ' 14' ' ' PHE . 2.4 mp -84.58 105.42 13.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p -88.56 147.5 24.57 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 167.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.85 112.25 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 mt -112.32 129.31 68.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 37.2 m -82.59 134.86 35.18 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 113.71 18.79 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 18.3 pt -107.58 -167.83 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.961 1.704 . . . . 0.0 110.029 -173.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -44.1 110.01 0.19 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.317 0.508 . . . . 0.0 109.902 167.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 25.6 63.44 0.06 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 127.563 2.506 . . . . 0.0 114.121 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.71 158.32 19.17 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.36 150.18 45.03 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.74 -178.28 6.82 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.726 0.774 . . . . 0.0 109.992 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 149.01 98.52 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.184 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.31 102.5 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.325 2.017 . . . . 0.0 108.186 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.9 m -91.86 93.55 8.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 m -113.2 149.52 33.59 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -146.67 68.52 1.17 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.667 0.746 . . . . 0.0 110.131 -171.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.4 t -72.28 133.23 44.91 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -157.88 141.7 15.7 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.051 2.141 . . . . 0.0 108.753 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -91.11 157.9 16.96 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.76 0.824 . . . . 0.0 110.682 -175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.25 1.125 0 CA-C-O 115.51 -2.186 . . . . 0.0 108.225 178.779 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.27 -169.28 2.82 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.566 1.146 . . . . 0.0 108.332 168.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.85 35.04 23.0 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-O 119.214 -0.77 . . . . 0.0 111.92 167.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.5 m -151.15 144.72 24.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.447 1.499 . . . . 0.0 107.2 167.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -97.89 -106.01 0.19 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 158.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t -97.7 144.72 28.48 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.875 1.27 . . . . 0.0 108.457 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.34 120.48 5.31 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.584 2.189 . . . . 0.0 110.769 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -80.89 169.89 16.97 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.298 1.039 . . . . 0.0 110.634 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.401 HD13 ' CG ' ' A' ' 26' ' ' TRP . 81.5 mt -70.13 79.65 0.51 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 166.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.2 m -65.79 -14.14 60.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.752 2.021 . . . . 0.0 111.627 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -113.38 24.16 12.51 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.32 1.448 . . . . 0.0 111.458 176.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.55 127.03 29.25 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.435 0.694 . . . . 0.0 110.847 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.15 165.13 31.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.005 0.922 . . . . 0.0 111.309 172.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 9.9 m-85 -112.06 154.81 24.83 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.838 1.255 . . . . 0.0 108.348 169.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.0 174.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.961 2.104 . . . . 0.0 106.624 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 56.34 47.13 19.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 0.0 108.791 161.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 mt -79.92 66.48 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.203 2.201 . . . . 0.0 106.937 -174.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -66.73 176.96 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.974 1.31 . . . . 0.0 109.447 177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.02 -3.98 32.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.05 0.94 . . . . 0.0 113.369 162.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.8 p -125.44 -15.25 6.2 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 -162.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.18 168.02 4.08 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 108.525 -170.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 tt -134.56 124.09 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.132 -0.98 . . . . 0.0 108.445 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.46 161.3 46.51 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.526 HD13 ' CD2' ' A' ' 62' ' ' TYR . 3.0 mp -133.44 161.0 35.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.936 1.294 . . . . 0.0 108.856 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 ptt-85 -138.61 147.82 43.39 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 160.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.401 ' CG ' HD13 ' A' ' 9' ' ' LEU . 12.1 p90 -157.09 172.45 18.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 158.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 m -79.13 107.09 5.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 124.452 1.101 . . . . 0.0 109.266 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -60.66 133.88 50.98 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.544 1.23 . . . . 0.0 109.033 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.98 133.55 38.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.744 2.018 . . . . 0.0 107.367 166.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -121.31 36.77 4.51 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 m -79.62 101.69 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.437 2.295 . . . . 0.0 108.298 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -59.16 84.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.778 1.631 . . . . 0.0 113.146 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 165.8 -25.38 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 131.438 3.895 . . . . 0.0 109.415 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.24 160.32 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.135 1.774 . . . . 0.0 109.908 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.68 -47.19 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.33 -155.35 24.17 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 118.293 0.497 . . . . 0.0 111.983 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -137.08 129.63 30.09 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 116.78 33.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.548 HG13 HG22 ' A' ' 77' ' ' VAL . 1.5 mp -89.23 150.56 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 123.427 1.584 . . . . 0.0 107.554 171.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 m -146.21 148.41 32.48 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 171.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.8 133.81 48.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.319 -2.475 . . . . 0.0 104.319 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.47 164.65 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 126.613 1.965 . . . . 0.0 107.618 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.27 119.82 23.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 167.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 44.9 15.5 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 130.15 3.38 . . . . 0.0 118.826 160.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.9 23.43 65.65 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 120.447 -1.408 . . . . 0.0 111.745 -164.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -70.73 4.54 2.43 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.833 2.853 . . . . 0.0 111.838 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.55 -53.88 3.79 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 126.67 2.081 . . . . 0.0 108.686 -167.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt -44.56 104.94 0.41 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 128.937 2.895 . . . . 0.0 111.042 -177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.75 147.63 17.32 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.912 3.075 . . . . 0.0 109.7 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.275 1.1 mp -101.92 -76.4 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.23 171.68 18.14 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 120.849 1.658 . . . . 0.0 110.808 176.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.25 152.97 33.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.878 1.271 . . . . 0.0 109.39 171.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -145.84 165.7 28.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.26 160.61 39.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 -177.4 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -59.82 -68.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.09 1.356 . . . . 0.0 110.561 -165.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t 178.81 -42.01 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 129.206 3.003 . . . . 0.0 109.661 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.8 p -136.33 48.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.37 124.78 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.457 173.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.19 -1.12 44.64 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.366 1.46 . . . . 0.0 114.213 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -158.94 132.94 7.63 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 127.108 2.163 . . . . 0.0 106.929 169.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CD2' HD13 ' A' ' 24' ' ' LEU . 14.0 t80 -135.51 164.6 27.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -142.65 145.79 33.81 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -110.88 144.63 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 66' ' ' GLY . 2.6 m -128.29 -178.19 4.45 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 65' ' ' THR . . . 73.91 13.07 81.02 Favored Glycine 0 N--CA 1.463 0.439 0 C-N-CA 123.979 0.799 . . . . 0.0 113.35 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -69.99 165.58 21.48 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.125 0.97 . . . . 0.0 108.847 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.96 105.56 13.87 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.953 1.701 . . . . 0.0 108.56 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.93 152.94 63.7 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.007 2.471 . . . . 0.0 110.192 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 -43.89 1.32 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 125.991 1.758 . . . . 0.0 109.188 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.5 mp -84.09 165.32 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 122.747 1.261 . . . . 0.0 108.804 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -101.34 138.14 38.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 128.407 2.683 . . . . 0.0 106.57 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -133.96 142.43 47.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.05 0.841 . . . . 0.0 110.681 -158.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.31 89.74 3.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.277 1.431 . . . . 0.0 109.988 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 5.1 mp -83.99 111.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -170.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -111.36 125.79 54.23 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.211 1.804 . . . . 0.0 108.718 -164.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.548 HG22 HG13 ' A' ' 39' ' ' ILE . 22.0 t -134.41 103.75 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -173.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.4 mt -84.55 144.38 9.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.8 m -105.58 131.16 53.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.7 150.22 51.99 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.338 1.426 . . . . 0.0 109.19 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.0 pt -135.72 -179.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.85 1.26 . . . . 0.0 108.954 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -35.2 116.78 0.37 Allowed 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 125.61 1.564 . . . . 0.0 110.301 168.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.56 47.03 2.19 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 124.786 1.304 . . . . 0.0 112.186 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.11 155.45 26.59 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.247 1.023 . . . . 0.0 111.226 -165.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -151.49 127.96 10.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.33 -178.35 6.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.82 141.79 84.99 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.374 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.2 100.36 0.87 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.857 2.372 . . . . 0.0 108.568 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 m -83.59 125.89 32.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.7 m -125.32 155.35 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 mt -140.29 141.6 35.76 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.9 m -77.57 146.83 36.04 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 172.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -138.72 157.93 45.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.436 1.095 . . . . 0.0 108.662 153.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -125.59 144.16 50.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.644 1.578 . . . . 0.0 109.025 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.248 1.024 0 C-N-CA 125.143 1.377 . . . . 0.0 112.591 166.063 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 34.75 72.62 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.142 2.577 . . . . 0.0 114.61 157.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.77 128.55 9.51 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . 0.319 2.7 p 46.55 -161.92 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.827 2.451 . . . . 0.0 113.059 -174.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -118.89 -73.58 0.64 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.878 0.871 . . . . 0.0 109.826 -171.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.1 t -135.11 133.68 20.99 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 119.736 1.153 . . . . 0.0 108.059 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.59 122.09 4.39 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.177 2.585 . . . . 0.0 111.606 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 163.29 27.54 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.235 1.014 . . . . 0.0 111.133 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.26 80.84 1.83 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.665 0.745 . . . . 0.0 110.68 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.8 m -56.15 -10.79 0.92 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.861 2.065 . . . . 0.0 112.346 168.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -111.0 5.84 20.57 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.631 -1.293 . . . . 0.0 113.825 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.31 118.49 4.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.505 0.593 . . . . 0.0 109.807 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -140.98 165.32 27.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.789 1.636 . . . . 0.0 109.957 166.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.555 ' CE2' ' HB2' ' A' ' 91' ' ' LEU . 12.4 m-30 -108.58 155.26 20.86 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 165.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.04 174.68 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 C-N-CA 128.406 2.682 . . . . 0.0 107.997 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 48.64 44.8 21.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.397 1.079 . . . . 0.0 110.18 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.76 61.35 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 t -64.38 166.01 8.86 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.925 1.345 . . . . 0.0 109.424 168.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.81 4.63 6.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.209 1.404 . . . . 0.0 111.381 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -126.15 -0.92 7.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.437 2.295 . . . . 0.0 116.908 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.91 166.74 0.53 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.81 2.844 . . . . 0.0 109.125 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 tt -123.65 140.44 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.95 157.33 21.1 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.76 154.53 44.1 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.473 1.509 . . . . 0.0 108.076 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -139.42 141.01 37.51 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -158.18 -174.35 4.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.504 0.722 . . . . 0.0 110.311 166.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 m -97.73 107.14 38.16 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 126.013 1.725 . . . . 0.0 107.141 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -58.79 128.81 29.44 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 CA-C-N 121.233 1.476 . . . . 0.0 109.013 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.9 mt -95.35 98.26 10.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 126.694 1.997 . . . . 0.0 105.845 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -75.04 28.58 0.09 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.519 0.728 . . . . 0.0 111.787 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -66.69 131.19 45.45 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -76.59 52.55 0.81 Allowed 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.113 -0.992 . . . . 0.0 111.213 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 179.47 -14.43 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.093 1.357 . . . . 0.0 111.0 -164.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.05 141.89 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.44 -65.73 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.42 -168.08 31.74 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -168.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -124.05 138.69 54.41 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.767 -2.309 . . . . 0.0 104.767 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.65 118.9 29.21 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.459 HG13 HG22 ' A' ' 77' ' ' VAL . 3.8 mp -93.51 149.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -145.13 102.88 3.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.75 127.76 39.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -123.69 164.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -91.01 110.66 21.93 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 48.39 -165.73 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 128.11 2.564 . . . . 0.0 113.596 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.21 7.33 0.07 OUTLIER Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.789 -1.562 . . . . 0.0 114.44 161.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -79.98 -12.19 59.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 121.734 2.767 . . . . 0.0 110.037 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.91 -11.37 6.11 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.863 1.697 . . . . 0.0 113.206 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mt -45.06 105.82 0.49 Allowed Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 128.26 2.624 . . . . 0.0 110.969 169.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.67 128.38 11.71 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.123 2.549 . . . . 0.0 110.188 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mm -84.89 -62.36 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.95 155.37 34.11 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 107.676 -164.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.13 151.65 40.93 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 174.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.69 158.37 15.3 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 124.046 0.841 . . . . 0.0 110.792 -156.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.87 154.21 49.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.693 1.197 . . . . 0.0 108.272 -167.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.16 -177.25 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.5 -57.44 5.8 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -163.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 t 157.53 -43.36 0.0 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 128.073 2.549 . . . . 0.0 111.936 -163.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.9 p -129.47 37.16 4.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.093 1.315 . . . . 0.0 110.377 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.4 134.77 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 168.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.11 -5.71 13.03 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.274 1.416 . . . . 0.0 113.57 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -142.18 130.79 22.63 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.475 1.91 . . . . 0.0 107.336 174.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.22 166.61 24.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.7 m -151.74 147.03 26.2 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.664 -1.272 . . . . 0.0 109.328 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.84 158.28 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.754 1.621 . . . . 0.0 108.641 -166.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.09 178.01 7.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.529 1.132 . . . . 0.0 108.889 -174.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.29 23.65 77.62 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.5 165.01 25.92 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 161.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -143.65 135.88 13.27 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.629 1.172 . . . . 0.0 107.975 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.38 161.67 42.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.191 1.927 . . . . 0.0 111.914 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.27 -14.63 63.37 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.657 1.599 . . . . 0.0 113.338 169.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.81 152.01 13.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 118.779 1.289 . . . . 0.0 108.234 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.49 127.73 32.76 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.309 1.844 . . . . 0.0 108.012 174.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -116.47 120.29 38.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.89 102.51 13.17 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 168.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 mt -94.48 89.65 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.2 p -94.58 150.31 20.37 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.707 -0.621 . . . . 0.0 110.293 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 39' ' ' ILE . 40.0 t -147.12 123.69 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -172.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.3 mt -118.61 139.65 45.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.5 m -106.06 115.97 31.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.114 1.766 . . . . 0.0 107.532 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.38 137.57 51.91 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.452 1.501 . . . . 0.0 109.779 -170.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.06 -176.66 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.524 1.929 . . . . 0.0 109.154 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -35.2 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.154 1.382 . . . . 0.0 111.793 161.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.98 29.74 35.82 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.728 167.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.08 158.06 30.4 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 119.155 1.478 . . . . 0.0 111.113 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.8 151.43 51.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.674 1.99 . . . . 0.0 105.736 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.08 -171.04 3.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.67 144.71 88.99 Favored Pre-proline 0 C--O 1.242 0.676 0 O-C-N 120.877 -1.139 . . . . 0.0 108.631 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -63.7 136.6 54.56 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 107.979 -1.585 . . . . 0.0 107.979 171.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.96 96.59 6.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 172.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.8 m -114.2 143.54 44.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.555 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 95.0 mt -134.17 111.29 10.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 t -84.52 155.26 22.22 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -163.29 131.9 3.88 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 108.973 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -95.99 78.74 3.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.07 0.948 . . . . 0.0 110.578 169.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.256 1.398 0 C-N-CA 123.807 0.843 . . . . 0.0 110.236 167.067 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mtt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.05 -17.27 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.648 2.379 . . . . 0.0 113.28 170.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.97 -152.71 24.71 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -160.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.2 p 60.18 47.02 9.78 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.666 1.986 . . . . 0.0 113.724 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.43 -79.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.591 1.156 . . . . 0.0 109.389 170.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.24 133.51 71.67 Favored Pre-proline 0 N--CA 1.448 -0.571 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -173.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.28 116.72 4.61 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 N-CA-C 105.986 -2.352 . . . . 0.0 105.986 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -73.67 177.5 5.38 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.109 0.964 . . . . 0.0 111.64 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.504 HD13 ' CG ' ' A' ' 26' ' ' TRP . 92.3 mt -69.39 76.92 0.39 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.851 0.834 . . . . 0.0 108.929 161.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m -60.48 -27.88 67.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.202 1.001 . . . . 0.0 109.043 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . . . -83.89 3.89 31.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.53 1.532 . . . . 0.0 114.338 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.34 117.76 7.1 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.124 -0.985 . . . . 0.0 110.409 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -153.02 165.66 34.87 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 168.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CZ ' ' HB ' ' A' ' 75' ' ' ILE . 7.5 m-30 -97.54 160.28 14.41 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.41 172.63 4.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.278 1.831 . . . . 0.0 106.555 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.71 44.87 19.85 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.246 1.018 . . . . 0.0 110.707 164.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mm -80.1 52.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 126.319 1.848 . . . . 0.0 109.695 -169.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 20' ' ' SER . 10.9 t -80.75 174.68 11.37 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.625 1.57 . . . . 0.0 109.684 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -80.33 -1.35 40.7 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.322 -0.861 . . . . 0.0 112.325 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.423 ' H ' HG23 ' A' ' 18' ' ' THR . 58.3 p -125.29 0.92 7.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 126.435 1.894 . . . . 0.0 115.839 -167.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.25 173.28 2.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.564 2.345 . . . . 0.0 106.591 160.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 tt -121.98 143.97 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 160.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.07 163.24 18.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.52 157.68 42.0 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.224 1.41 . . . . 0.0 108.852 170.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -138.43 147.91 43.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 163.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.504 ' CG ' HD13 ' A' ' 9' ' ' LEU . 23.7 p90 -153.58 -179.73 8.05 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 163.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -94.19 106.95 25.56 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.55 138.96 73.37 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.923 1.749 . . . . 0.0 110.059 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 132.23 41.24 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.347 1.859 . . . . 0.0 106.537 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -105.95 18.67 21.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -64.44 158.28 24.26 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -165.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.3 p -82.65 43.77 0.85 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.791 -1.193 . . . . 0.0 111.656 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 82' ' ' ASN . 0.3 OUTLIER -171.05 -21.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.544 -0.723 . . . . 0.0 112.786 -174.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.29 121.23 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.914 0.886 . . . . 0.0 109.213 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.413 ' HB ' HD12 ' A' ' 80' ' ' LEU . 3.4 mt -83.71 -46.41 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.08 -153.61 23.62 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.38 -1.39 . . . . 0.0 114.259 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.445 ' CD2' HG23 ' A' ' 79' ' ' THR . 1.8 m-85 -138.27 145.81 41.74 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.52 118.73 27.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.77 1.628 . . . . 0.0 107.658 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.535 HG12 HG22 ' A' ' 77' ' ' VAL . 71.8 mt -114.01 115.25 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -168.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.3 m -126.72 103.78 7.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -167.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -87.72 138.45 19.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.98 174.052 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.37 163.23 38.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.5 118.64 22.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' H ' ' HA ' ' A' ' 73' ' ' TYR . . . 60.01 13.63 3.84 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.121 2.569 . . . . 0.0 115.33 165.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.76 17.54 60.61 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.057 -1.027 . . . . 0.0 111.875 -166.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -76.34 -6.34 51.13 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.762 1.781 . . . . 0.0 111.405 -172.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.13 -37.98 3.52 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.634 2.064 . . . . 0.0 110.753 -174.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.1 mt -45.2 101.67 0.27 Allowed Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 128.6 2.76 . . . . 0.0 110.145 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.4 152.54 34.49 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.483 2.122 . . . . 0.0 110.02 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.9 mp -106.49 -92.22 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 161.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -146.05 170.55 16.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.981 1.264 . . . . 0.0 110.289 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.98 124.1 48.54 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.613 1.965 . . . . 0.0 107.062 173.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 159.3 15.79 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 128.068 2.547 . . . . 0.0 109.294 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.22 153.73 46.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 162.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -171.98 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.086 1.312 . . . . 0.0 111.098 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 p 168.2 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.614 1.965 . . . . 0.0 110.932 -162.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -124.66 20.23 8.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.513 1.525 . . . . 0.0 110.405 -171.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.82 124.34 30.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.11 3.28 51.53 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.531 1.539 . . . . 0.0 112.809 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -163.28 127.79 2.95 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 110.981 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -139.1 162.54 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.254 1.388 . . . . 0.0 109.133 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -138.19 148.26 44.66 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.736 1.214 . . . . 0.0 108.121 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.17 143.82 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 107.862 -174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 66' ' ' GLY . 1.9 m -141.79 -175.45 4.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -169.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.549 ' H ' HG22 ' A' ' 65' ' ' THR . . . 61.45 25.96 65.76 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 124.166 0.889 . . . . 0.0 111.855 -173.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -79.51 165.87 22.55 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 170.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -130.19 133.02 24.46 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 165.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -79.19 169.57 18.85 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.233 2.622 . . . . 0.0 110.374 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.83 -4.17 49.57 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.769 -1.017 . . . . 0.0 114.209 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 mm -126.34 165.07 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 119.469 1.635 . . . . 0.0 107.412 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -86.44 149.42 25.0 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.068 -1.02 . . . . 0.0 109.274 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.419 ' HA ' ' H ' ' A' ' 44' ' ' ALA . 3.9 m-85 -138.26 130.65 29.01 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.885 0.874 . . . . 0.0 109.363 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.14 108.34 19.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 165.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.472 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 2.9 mp -98.5 94.67 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.5 p -95.91 153.26 17.85 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.38 -0.825 . . . . 0.0 110.672 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 39' ' ' ILE . 39.7 t -142.09 98.05 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 -172.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -92.14 129.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.445 HG23 ' CD2' ' A' ' 37' ' ' TYR . 92.2 m -106.43 125.08 50.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.194 1.397 . . . . 0.0 107.754 -174.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.413 HD12 ' HB ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -123.56 148.77 46.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 111.448 -170.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.5 -176.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 127.051 2.14 . . . . 0.0 107.49 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.41 ' H ' HG23 ' A' ' 33' ' ' THR . 7.5 t30 -34.46 108.42 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 111.1 165.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.78 43.13 1.62 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.681 2.086 . . . . 0.0 112.923 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.39 158.99 30.09 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -167.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -146.47 161.9 39.44 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.87 1.668 . . . . 0.0 108.452 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.5 m -89.0 -169.94 2.71 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.158 0.583 . . . . 0.0 109.683 172.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.39 152.46 94.51 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.49 103.66 1.46 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.475 2.116 . . . . 0.0 108.574 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 p -87.03 139.55 30.46 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 m -145.16 172.78 12.62 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -147.2 134.3 20.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 156.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -79.64 104.02 9.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.551 1.94 . . . . 0.0 107.043 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.58 108.84 20.3 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.052 -1.655 . . . . 0.0 112.84 171.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 148.4 31.16 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 157.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 C--O 1.243 0.731 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -178.527 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -151.79 173.02 15.26 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.35 1.86 . . . . 0.0 108.367 174.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.59 134.78 2.66 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 118.475 0.58 . . . . 0.0 111.787 173.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 p 57.6 9.85 0.9 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.833 2.453 . . . . 0.0 116.158 165.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -61.41 -79.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.198 1.399 . . . . 0.0 112.813 -148.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.8 t -77.42 134.22 66.67 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.17 132.83 30.96 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.829 2.353 . . . . 0.0 112.199 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.05 156.73 17.48 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.651 1.98 . . . . 0.0 109.554 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.492 HD13 ' CG ' ' A' ' 26' ' ' TRP . 85.3 mt -73.39 87.45 1.54 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.161 0.984 . . . . 0.0 109.95 -173.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.9 m -66.55 -10.04 41.1 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.393 0.677 . . . . 0.0 112.252 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.46 0.11 55.13 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.411 -1.43 . . . . 0.0 112.487 171.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.31 106.65 0.21 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.981 1.264 . . . . 0.0 111.475 -172.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -140.54 138.48 34.55 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.775 1.23 . . . . 0.0 109.644 -173.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.58 156.47 16.71 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.49 167.6 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.182 1.793 . . . . 0.0 109.05 169.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 50.52 61.03 3.43 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 108.673 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.0 mm -81.02 64.23 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.385 1.874 . . . . 0.0 107.833 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.3 t -95.08 171.84 8.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.242 1.02 . . . . 0.0 111.561 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.57 -4.33 36.33 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.832 1.253 . . . . 0.0 112.351 -165.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.9 p -124.99 -14.53 6.61 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.947 1.299 . . . . 0.0 114.052 -171.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.535 ' HA ' HD23 ' A' ' 67' ' ' LEU . 2.5 p -174.46 148.43 1.21 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.859 1.264 . . . . 0.0 111.517 -166.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.25 132.17 70.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.78 156.39 25.5 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.42 128.24 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.023 1.329 . . . . 0.0 109.071 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -98.51 151.21 20.86 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CG ' HD13 ' A' ' 9' ' ' LEU . 44.1 p90 -151.32 174.99 12.66 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 150.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -87.9 141.87 31.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 171.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.14 123.41 5.61 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 N-CA-C 105.877 -2.393 . . . . 0.0 105.877 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.16 -19.55 56.69 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 50.39 31.21 5.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.602 2.361 . . . . 0.0 111.681 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -69.49 5.6 1.32 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.47 2.308 . . . . 0.0 113.842 -158.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 64.73 -63.67 0.17 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 129.139 2.976 . . . . 0.0 112.753 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -21.18 66.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.325 3.05 . . . . 0.0 113.214 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -53.62 151.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.871 1.269 . . . . 0.0 110.85 167.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.53 -57.17 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.01 -156.2 15.98 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -127.77 144.86 51.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.81 124.03 51.26 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 175.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.606 HG13 HG13 ' A' ' 77' ' ' VAL . 3.0 mp -93.75 156.26 3.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 168.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.5 m -145.14 142.94 30.07 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.84 138.04 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.98 163.56 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.22 114.12 21.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 166.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.68 138.51 47.22 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.37 -45.96 1.18 Allowed Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 124.194 0.902 . . . . 0.0 111.499 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -110.65 -26.53 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.907 -0.761 . . . . 0.0 109.651 168.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.57 13.54 81.85 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 120.946 -1.096 . . . . 0.0 111.296 -170.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.8 mt -41.84 105.55 0.4 Allowed Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 128.157 2.583 . . . . 0.0 108.587 165.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.68 127.24 3.65 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.073 2.515 . . . . 0.0 109.355 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.57 -70.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.89 164.59 31.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.856 0.753 . . . . 0.0 110.251 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.22 126.39 55.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 167.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -104.44 162.81 12.92 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.862 1.665 . . . . 0.0 107.897 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.09 161.33 27.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.748 0.819 . . . . 0.0 109.568 174.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.72 -176.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.34 -71.41 0.23 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -166.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.6 t 155.04 -21.94 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 131.657 3.983 . . . . 0.0 109.841 -168.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.9 p -135.03 20.15 3.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.358 1.435 . . . . 0.0 112.641 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.69 128.91 36.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 169.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.89 2.72 11.83 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.273 2.368 . . . . 0.0 112.651 171.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -138.84 127.68 23.6 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.264 -1.139 . . . . 0.0 109.222 166.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -142.06 164.34 30.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.885 1.674 . . . . 0.0 109.417 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.2 m -133.77 135.82 44.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.54 1.536 . . . . 0.0 107.547 174.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.88 155.62 4.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 164.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -137.31 170.05 16.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.075 0.95 . . . . 0.0 109.59 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.98 28.07 51.21 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.588 -0.695 . . . . 0.0 111.89 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 21' ' ' SER . 4.1 mm? -61.52 158.02 15.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 128.68 2.792 . . . . 0.0 106.782 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.53 80.84 39.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.036 1.734 . . . . 0.0 109.344 -170.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.56 124.67 11.4 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.947 1.765 . . . . 0.0 108.682 -169.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.47 -26.5 4.61 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 124.436 1.017 . . . . 0.0 113.488 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.21 166.71 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.827 1.651 . . . . 0.0 107.219 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.16 126.03 41.1 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.065 1.746 . . . . 0.0 107.244 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -115.4 126.8 54.83 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.633 0.773 . . . . 0.0 109.262 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.07 103.36 15.3 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 173.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -89.33 101.07 11.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.1 p -88.8 143.33 26.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.374 1.083 . . . . 0.0 109.678 173.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.606 HG13 HG13 ' A' ' 39' ' ' ILE . 39.2 t -139.09 119.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 -177.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 mt -124.69 141.18 45.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -98.59 136.42 38.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.77 132.96 55.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.362 1.065 . . . . 0.0 108.51 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 pt -130.09 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.155 1.782 . . . . 0.0 109.675 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -34.11 99.12 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.37 2.268 . . . . 0.0 110.021 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 24.85 53.7 0.05 OUTLIER Glycine 0 CA--C 1.526 0.772 0 C-N-CA 128.284 2.849 . . . . 0.0 113.604 -172.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.87 160.88 34.44 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 118.065 0.932 . . . . 0.0 111.459 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -139.2 146.11 40.12 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 126.326 1.85 . . . . 0.0 108.414 -168.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -84.51 -174.49 5.3 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.409 0.683 . . . . 0.0 110.472 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.65 134.58 93.86 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 166.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.83 132.57 32.98 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -118.69 111.15 18.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.6 m -124.7 152.16 44.07 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 92' ' ' THR . 1.4 tt -132.97 153.61 51.28 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 152.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.511 ' H ' HD23 ' A' ' 91' ' ' LEU . 4.3 t -112.8 135.1 53.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.53 114.5 12.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -85.78 111.85 20.54 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m . . . . . 0 C--O 1.251 1.148 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.9 mtp . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 154.72 154.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 131.578 3.951 . . . . 0.0 106.203 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.74 151.1 15.23 Favored Glycine 0 C--O 1.235 0.181 0 CA-C-N 119.426 1.012 . . . . 0.0 111.906 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 m -62.45 153.89 30.1 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.149 0.979 . . . . 0.0 109.426 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -85.23 -59.28 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.996 0.518 . . . . 0.0 111.729 -160.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -134.72 138.9 30.88 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 171.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.9 125.61 12.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.466 2.111 . . . . 0.0 109.056 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.96 166.38 23.15 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 163.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.566 HD13 ' CG ' ' A' ' 26' ' ' TRP . 48.7 mt -66.57 88.68 0.14 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 m -66.86 -13.65 61.86 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.154 0.982 . . . . 0.0 109.19 171.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.14 4.49 50.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.973 1.709 . . . . 0.0 114.07 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.94 121.08 11.5 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.073 -1.017 . . . . 0.0 110.027 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -146.83 165.57 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.218 1.007 . . . . 0.0 110.543 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 24' ' ' LEU . 75.0 m-85 -119.64 150.44 40.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.91 0.884 . . . . 0.0 108.895 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.57 174.94 2.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.961 2.104 . . . . 0.0 107.712 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 55.5 45.23 25.48 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.821 0.848 . . . . 0.0 110.182 161.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.29 56.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.791 2.036 . . . . 0.0 107.035 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.28 166.64 19.71 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -75.11 7.03 3.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.2 p -125.32 -10.13 6.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 115.18 -167.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.88 166.31 0.9 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 127.324 2.25 . . . . 0.0 109.162 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.89 128.41 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.23 150.28 23.6 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 14' ' ' PHE . 1.1 mt -128.2 141.73 51.38 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.415 1.486 . . . . 0.0 107.994 172.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -124.88 142.23 51.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.566 ' CG ' HD13 ' A' ' 9' ' ' LEU . 44.2 p90 -156.78 -173.07 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 164.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -108.74 105.46 57.04 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.927 1.291 . . . . 0.0 108.719 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.43 124.67 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.957 2.438 . . . . 0.0 112.076 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.55 103.55 15.16 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.237 1.015 . . . . 0.0 108.797 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -80.61 49.12 1.13 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.564 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 m -61.93 -64.46 0.93 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.985 -166.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 p 156.69 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.828 2.451 . . . . 0.0 112.305 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.85 -4.38 1.77 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.655 1.982 . . . . 0.0 110.157 -163.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -43.19 134.88 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.184 -1.572 . . . . 0.0 109.724 146.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.56 -43.36 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 124.748 1.219 . . . . 0.0 110.26 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.89 -158.24 31.1 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.504 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -129.67 125.09 35.22 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.62 133.22 35.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 174.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.477 HG13 HG13 ' A' ' 77' ' ' VAL . 2.7 mp -110.3 149.62 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 65.8 m -140.82 158.83 43.39 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 169.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.425 HG13 HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -138.54 125.59 26.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 103.908 -2.626 . . . . 0.0 103.908 178.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.31 162.81 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.601 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.68 108.02 19.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.96 -30.34 58.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.222 0.609 . . . . 0.0 112.012 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.9 -18.32 59.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.604 -1.109 . . . . 0.0 115.607 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -148.0 5.77 0.77 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.643 1.721 . . . . 0.0 112.651 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.86 -5.83 5.72 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.76 -1.212 . . . . 0.0 113.34 -173.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.1 mt -45.56 105.54 0.47 Allowed Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 128.742 2.817 . . . . 0.0 110.15 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.56 132.42 12.17 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.507 2.138 . . . . 0.0 110.324 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -83.75 -67.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -160.0 175.27 13.2 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.045 0.938 . . . . 0.0 109.567 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -122.02 123.41 41.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.436 1.494 . . . . 0.0 107.921 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -105.93 165.81 10.94 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.004 1.722 . . . . 0.0 109.968 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.48 163.17 28.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.202 1.001 . . . . 0.0 108.634 169.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 -176.63 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -67.67 -64.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -164.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 m 153.55 -13.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.735 4.014 . . . . 0.0 111.344 -169.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.1 p -135.97 13.49 3.36 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.985 0.811 . . . . 0.0 112.535 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.41 138.98 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.54 5.5 5.21 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.075 1.798 . . . . 0.0 112.93 173.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -146.04 124.81 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -145.95 162.93 36.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.656 1.583 . . . . 0.0 108.231 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -144.83 131.96 20.48 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.258 -0.901 . . . . 0.0 108.983 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.94 149.18 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.68 -170.67 2.13 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.902 1.681 . . . . 0.0 107.004 170.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.5 14.56 75.84 Favored Glycine 0 N--CA 1.47 0.938 0 CA-C-N 120.12 1.327 . . . . 0.0 112.758 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.99 153.74 38.39 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.741 0.816 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -122.16 115.77 30.12 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.938 1.695 . . . . 0.0 106.834 163.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.54 144.73 85.79 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.292 1.995 . . . . 0.0 110.833 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.0 -10.49 58.55 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.469 1.509 . . . . 0.0 113.729 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.87 151.02 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 119.706 1.753 . . . . 0.0 107.041 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -80.61 120.06 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.465 1.506 . . . . 0.0 108.488 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.45 120.29 37.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.158 1.383 . . . . 0.0 108.387 -168.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.78 90.66 7.37 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.034 1.734 . . . . 0.0 107.375 174.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 41' ' ' VAL . 1.8 mp -84.01 109.52 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 m -114.43 122.04 45.4 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 126.133 1.773 . . . . 0.0 111.341 -167.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 39' ' ' ILE . 59.7 t -134.19 132.32 55.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -164.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 tt -143.41 152.79 16.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.419 1.087 . . . . 0.0 111.216 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.3 m -105.29 134.04 49.07 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 106.894 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.78 134.06 55.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.637 1.575 . . . . 0.0 109.034 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 pt -129.67 175.69 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.91 1.284 . . . . 0.0 107.585 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -46.33 110.02 0.24 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.522 0.601 . . . . 0.0 110.106 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 38.05 42.69 1.21 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 126.516 2.008 . . . . 0.0 113.392 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.72 144.62 12.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -133.45 118.53 18.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -161.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.22 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.92 133.44 41.31 Favored Pre-proline 0 C--O 1.237 0.403 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.896 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.66 109.76 1.72 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.038 2.492 . . . . 0.0 106.524 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -107.28 102.66 11.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.0 m -94.16 158.75 15.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 tt -132.22 101.92 5.57 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 153.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.6 m -84.92 119.19 25.08 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -136.72 153.15 50.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.419 1.487 . . . . 0.0 108.74 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.28 157.92 27.65 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 157.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.25 1.092 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.717 . . . . . . . . 0 0 . 1 stop_ save_